[{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/CODE_OF_CONDUCT.html","id":"our-pledge","dir":"","previous_headings":"","what":"Our Pledge","title":"Contributor Covenant Code of Conduct","text":"members, contributors, leaders pledge make participation community harassment-free experience everyone, regardless age, body size, visible invisible disability, ethnicity, sex characteristics, gender identity expression, level experience, education, socio-economic status, nationality, personal appearance, race, caste, color, religion, sexual identity orientation. pledge act interact ways contribute open, welcoming, diverse, inclusive, healthy community.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/CODE_OF_CONDUCT.html","id":"our-standards","dir":"","previous_headings":"","what":"Our Standards","title":"Contributor Covenant Code of Conduct","text":"Examples behavior contributes positive environment community include: Demonstrating empathy kindness toward people respectful differing opinions, viewpoints, experiences Giving gracefully accepting constructive feedback Accepting responsibility apologizing affected mistakes, learning experience Focusing best just us individuals, overall community Examples unacceptable behavior include: use sexualized language imagery, sexual attention advances kind Trolling, insulting derogatory comments, personal political attacks Public private harassment Publishing others‚Äô private information, physical email address, without explicit permission conduct reasonably considered inappropriate professional setting","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/CODE_OF_CONDUCT.html","id":"enforcement-responsibilities","dir":"","previous_headings":"","what":"Enforcement Responsibilities","title":"Contributor Covenant Code of Conduct","text":"Community leaders responsible clarifying enforcing standards acceptable behavior take appropriate fair corrective action response behavior deem inappropriate, threatening, offensive, harmful. Community leaders right responsibility remove, edit, reject comments, commits, code, wiki edits, issues, contributions aligned Code Conduct, communicate reasons moderation decisions appropriate.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/CODE_OF_CONDUCT.html","id":"scope","dir":"","previous_headings":"","what":"Scope","title":"Contributor Covenant Code of Conduct","text":"Code Conduct applies within community spaces, also applies individual officially representing community public spaces. Examples representing community include using official e-mail address, posting via official social media account, acting appointed representative online offline event.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/CODE_OF_CONDUCT.html","id":"enforcement","dir":"","previous_headings":"","what":"Enforcement","title":"Contributor Covenant Code of Conduct","text":"Instances abusive, harassing, otherwise unacceptable behavior may reported community leaders responsible enforcement [INSERT CONTACT METHOD]. complaints reviewed investigated promptly fairly. community leaders obligated respect privacy security reporter incident.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/CODE_OF_CONDUCT.html","id":"enforcement-guidelines","dir":"","previous_headings":"","what":"Enforcement Guidelines","title":"Contributor Covenant Code of Conduct","text":"Community leaders follow Community Impact Guidelines determining consequences action deem violation Code Conduct:","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/CODE_OF_CONDUCT.html","id":"id_1-correction","dir":"","previous_headings":"Enforcement Guidelines","what":"1. Correction","title":"Contributor Covenant Code of Conduct","text":"Community Impact: Use inappropriate language behavior deemed unprofessional unwelcome community. Consequence: private, written warning community leaders, providing clarity around nature violation explanation behavior inappropriate. public apology may requested.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/CODE_OF_CONDUCT.html","id":"id_2-warning","dir":"","previous_headings":"Enforcement Guidelines","what":"2. Warning","title":"Contributor Covenant Code of Conduct","text":"Community Impact: violation single incident series actions. Consequence: warning consequences continued behavior. interaction people involved, including unsolicited interaction enforcing Code Conduct, specified period time. includes avoiding interactions community spaces well external channels like social media. Violating terms may lead temporary permanent ban.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/CODE_OF_CONDUCT.html","id":"id_3-temporary-ban","dir":"","previous_headings":"Enforcement Guidelines","what":"3. Temporary Ban","title":"Contributor Covenant Code of Conduct","text":"Community Impact: serious violation community standards, including sustained inappropriate behavior. Consequence: temporary ban sort interaction public communication community specified period time. public private interaction people involved, including unsolicited interaction enforcing Code Conduct, allowed period. Violating terms may lead permanent ban.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/CODE_OF_CONDUCT.html","id":"id_4-permanent-ban","dir":"","previous_headings":"Enforcement Guidelines","what":"4. Permanent Ban","title":"Contributor Covenant Code of Conduct","text":"Community Impact: Demonstrating pattern violation community standards, including sustained inappropriate behavior, harassment individual, aggression toward disparagement classes individuals. Consequence: permanent ban sort public interaction within community.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/CODE_OF_CONDUCT.html","id":"attribution","dir":"","previous_headings":"","what":"Attribution","title":"Contributor Covenant Code of Conduct","text":"Code Conduct adapted Contributor Covenant, version 2.1, available https://www.contributor-covenant.org/version/2/1/code_of_conduct.html. Community Impact Guidelines inspired Mozilla‚Äôs code conduct enforcement ladder. answers common questions code conduct, see FAQ https://www.contributor-covenant.org/faq. Translations available https://www.contributor-covenant.org/translations.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/CONTRIBUTING.html","id":null,"dir":"","previous_headings":"","what":"Contribution Guidelines","title":"Contribution Guidelines","text":"üôè Thank taking time contribute! input deeply valued, whether issue, pull request, even feedback, regardless size, content scope.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/CONTRIBUTING.html","id":"table-of-contents","dir":"","previous_headings":"","what":"Table of contents","title":"Contribution Guidelines","text":"üë∂ Getting started üìî Code Conduct üóÉ License üìú Issues üö© Pull requests üíª Coding guidelines üèÜ Recognition model ‚ùì Questions","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/CONTRIBUTING.html","id":"getting-started","dir":"","previous_headings":"","what":"Getting started","title":"Contribution Guidelines","text":"Please refer project documentation brief introduction. Please also see articles within project documentation additional information.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/CONTRIBUTING.html","id":"code-of-conduct","dir":"","previous_headings":"","what":"Code of Conduct","title":"Contribution Guidelines","text":"Code Conduct governs project. Participants contributors expected follow rules outlined therein.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/CONTRIBUTING.html","id":"license","dir":"","previous_headings":"","what":"License","title":"Contribution Guidelines","text":"contributions covered project‚Äôs license.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/CONTRIBUTING.html","id":"issues","dir":"","previous_headings":"","what":"Issues","title":"Contribution Guidelines","text":"use GitHub track issues, feature requests, bugs. submitting new issue, please check issue already reported. issue already exists, please upvote existing issue üëç. new feature requests, please elaborate context benefit feature users, developers, relevant personas.","code":""},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/CONTRIBUTING.html","id":"github-flow","dir":"","previous_headings":"Pull requests","what":"GitHub Flow","title":"Contribution Guidelines","text":"repository uses GitHub Flow model collaboration. submit pull request: Create branch Please see branch naming convention . don‚Äôt write access repository, please fork . Make changes Make sure code passes checks imposed GitHub Actions well documented well tested unit tests sufficiently covering changes introduced Create pull request (PR) pull request description, please link relevant issue (), provide detailed description change, include assumptions. Address review comments, Post approval Merge PR write access. Otherwise, reviewer merge PR behalf. Pat back Congratulations! üéâ now official contributor project! grateful contribution.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/CONTRIBUTING.html","id":"branch-naming-convention","dir":"","previous_headings":"Pull requests","what":"Branch naming convention","title":"Contribution Guidelines","text":"Suppose changes related current issue current project; please name branch follows: <issue_id>_<short_description>. Please use underscore (_) delimiter word separation. example, 420_fix_ui_bug suitable branch name change resolving UI-related bug reported issue number 420 current project. change affects multiple repositories, please name branches follows: <issue_id>_<issue_repo>_<short description>. example, 69_awesomeproject_fix_spelling_error reference issue 69 reported project awesomeproject aims resolve one spelling errors multiple (likely related) repositories.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/CONTRIBUTING.html","id":"monorepo-and-stageddependencies","dir":"","previous_headings":"Pull requests","what":"monorepo and staged.dependencies","title":"Contribution Guidelines","text":"Sometimes might need change upstream dependent package(s) able submit meaningful change. using staged.dependencies functionality simulate monorepo behavior. dependency configuration already specified project‚Äôs staged_dependencies.yaml file. need name feature branches appropriately. exception branch naming convention described . Please refer staged.dependencies package documentation details.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/CONTRIBUTING.html","id":"coding-guidelines","dir":"","previous_headings":"","what":"Coding guidelines","title":"Contribution Guidelines","text":"repository follows unified processes standards adopted maintainers ensure software development carried consistently within teams cohesively across repositories.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/CONTRIBUTING.html","id":"style-guide","dir":"","previous_headings":"Coding guidelines","what":"Style guide","title":"Contribution Guidelines","text":"repository follows standard tidyverse style guide uses lintr lint checks. Customized lint configurations available repository‚Äôs .lintr file.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/CONTRIBUTING.html","id":"dependency-management","dir":"","previous_headings":"Coding guidelines","what":"Dependency management","title":"Contribution Guidelines","text":"Lightweight right weight. repository follows tinyverse recommedations limiting dependencies minimum.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/CONTRIBUTING.html","id":"dependency-version-management","dir":"","previous_headings":"Coding guidelines","what":"Dependency version management","title":"Contribution Guidelines","text":"code compatible (!) historical versions given dependenct package, required specify minimal version DESCRIPTION file. particular: development version requires (imports) development version another package - required put abc (>= 1.2.3.9000).","code":""},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/CONTRIBUTING.html","id":"r--package-versions","dir":"","previous_headings":"Coding guidelines > Recommended development environment & tools","what":"R & package versions","title":"Contribution Guidelines","text":"continuously test packages newest R version along recent dependencies CRAN BioConductor. recommend working environment also set way. can find details R version packages used R CMD check GitHub Action execution log - step prints R sessionInfo(). discover bugs older R versions older set dependencies, please create relevant bug reports.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/CONTRIBUTING.html","id":"pre-commit","dir":"","previous_headings":"Coding guidelines > Recommended development environment & tools","what":"pre-commit","title":"Contribution Guidelines","text":"highly recommend use pre-commit tool combined R hooks pre-commit execute checks committing pushing changes. Pre-commit hooks already available repository‚Äôs .pre-commit-config.yaml file.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/CONTRIBUTING.html","id":"recognition-model","dir":"","previous_headings":"","what":"Recognition model","title":"Contribution Guidelines","text":"mentioned previously, contributions deeply valued appreciated. contribution data available part repository insights, recognize significant contribution hence add contributor package authors list, following rules enforced: Minimum 5% lines code authored* (determined git blame query) top 5 contributors terms number commits lines added lines removed* *Excluding auto-generated code, including limited roxygen comments renv.lock files. package maintainer also reserves right adjust criteria recognize contributions.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/CONTRIBUTING.html","id":"questions","dir":"","previous_headings":"","what":"Questions","title":"Contribution Guidelines","text":"questions regarding contribution guidelines, please contact package/repository maintainer.","code":""},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/SECURITY.html","id":"reporting-security-issues","dir":"","previous_headings":"","what":"Reporting Security Issues","title":"Security Policy","text":"believe found security vulnerability repositories organization, please report us coordinated disclosure. Please report security vulnerabilities public GitHub issues, discussions, pull requests. Instead, please send email vulnerability.management[@]roche.com. Please include much information listed can help us better understand resolve issue: type issue (e.g., buffer overflow, SQL injection, cross-site scripting) Full paths source file(s) related manifestation issue location affected source code (tag/branch/commit direct URL) special configuration required reproduce issue Step--step instructions reproduce issue Proof--concept exploit code (possible) Impact issue, including attacker might exploit issue information help us triage report quickly.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/SECURITY.html","id":"data-security-standards-dss","dir":"","previous_headings":"","what":"Data Security Standards (DSS)","title":"Security Policy","text":"Please make sure reporting issues form bug, feature, pull request, sensitive information PII, PHI, PCI completely removed text attachments, including pictures videos.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron.html","id":"introduction","dir":"Articles","previous_headings":"","what":"Introduction","title":"Introduction to Chevron","text":"chevron R package provides functions produce standard tables, listings graphs (TLGs) used analyze report clinical trials data. ensemble function used produce particular output stored S4 object virtual class chevron_tlg. type output associated specific class: chevron_t tables, chevron_l listings chevron_g graphs. standard output associated one chevron_tlg object. contain following objects separate slots: main function also refereed TLG-function. preprocess function. postprocess function","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron.html","id":"tlg-functions","dir":"Articles","previous_headings":"Introduction","what":"TLG-functions","title":"Introduction to Chevron","text":"TLG-functions chevron use packages produce final outputs, example rtables tern used create tables, ggplot2, lattice, grid used create graphs, rlistings create listings. TLG-functions chevron dmt01_main, aet02_main, aet02_main following properties: produce narrow defined output (currently standards Roche GDS). Note, naming convention <gds template id>_main indicates Roche GDS defined standard may different implementations. , alternatively, GDS template id can regarded guideline function name chevron standard. , possible, arguments modify standard. Generally, arguments may change structure table (arm variable, variables summarized) also parameterize cell content (.e.¬†alpha-level p-value). always first argument adam_db collection ADaM datasets (ADSL, ADAE, ADRS, etc.). Please read adam_db Argument vignette package details.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron.html","id":"preprocessing","dir":"Articles","previous_headings":"Introduction","what":"preprocessing","title":"Introduction to Chevron","text":"preprocess functions chevron use base, dplyr dunlin packages process input data object turn suitable input TLG-functions. preprocess chevron dmt01_pre, aet02_pre, aet02_pre following properties: return list data.frame object amenable processing TLG-functions. message. arguments modify standard. always first argument adam_db collection ADaM datasets (ADSL, ADAE, ADRS, etc.). Please read adam_db Argument vignette package details. Please note ultimate responsible person preprocessing functions end user. provided preprocessing function template users modify depending need/data. preprocessing function printed allow modification script generated citril.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron.html","id":"postprocessing","dir":"Articles","previous_headings":"Introduction","what":"postprocessing","title":"Introduction to Chevron","text":"default, Postprocessing function returns input null report input rows. postprocessing function chevron_tlg object must least tlg formal arguments.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron.html","id":"example-aet02","dir":"Articles","previous_headings":"","what":"Example AET02","title":"Introduction to Chevron","text":"example, GDS template aet02 implemented chevron chevropn_tlg objects name aet02. first load data list data.frame, table represents domain. aet02 output created follows: function associated particular slot can retrieved corresponding method: main, lyt, preprocess postprocess datasets. standard functions can used .","code":"library(chevron) #> Registered S3 method overwritten by 'tern': #>   method   from  #>   tidy.glm broom data(syn_data, package = \"chevron\") run(aet02, syn_data) #>   MedDRA System Organ Class                                    A: Drug X    B: Placebo   C: Combination #>     MedDRA Preferred Term                                        (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Total number of patients with at least one adverse event     13 (86.7%)   14 (93.3%)     15 (100%)    #>   Overall total number of events                                   58           59             99       #>   cl B.2                                                                                                #>     Total number of patients with at least one adverse event   11 (73.3%)   8 (53.3%)      10 (66.7%)   #>     Total number of events                                         18           15             20       #>     dcd B.2.2.3.1                                              8 (53.3%)    6 (40.0%)      7 (46.7%)    #>     dcd B.2.1.2.1                                              5 (33.3%)    6 (40.0%)      5 (33.3%)    #>   cl D.1                                                                                                #>     Total number of patients with at least one adverse event   9 (60.0%)    5 (33.3%)      11 (73.3%)   #>     Total number of events                                         13           9              19       #>     dcd D.1.1.1.1                                              4 (26.7%)    4 (26.7%)      7 (46.7%)    #>     dcd D.1.1.4.2                                              6 (40.0%)    2 (13.3%)      7 (46.7%)    #>   cl A.1                                                                                                #>     Total number of patients with at least one adverse event   7 (46.7%)    6 (40.0%)      10 (66.7%)   #>     Total number of events                                         8            11             16       #>     dcd A.1.1.1.2                                              5 (33.3%)    6 (40.0%)      6 (40.0%)    #>     dcd A.1.1.1.1                                              3 (20.0%)     1 (6.7%)      6 (40.0%)    #>   cl B.1                                                                                                #>     Total number of patients with at least one adverse event   5 (33.3%)    6 (40.0%)      8 (53.3%)    #>     Total number of events                                         6            6              12       #>     dcd B.1.1.1.1                                              5 (33.3%)    6 (40.0%)      8 (53.3%)    #>   cl C.2                                                                                                #>     Total number of patients with at least one adverse event   6 (40.0%)    4 (26.7%)      8 (53.3%)    #>     Total number of events                                         6            4              12       #>     dcd C.2.1.2.1                                              6 (40.0%)    4 (26.7%)      8 (53.3%)    #>   cl D.2                                                                                                #>     Total number of patients with at least one adverse event   2 (13.3%)    5 (33.3%)      7 (46.7%)    #>     Total number of events                                         3            5              10       #>     dcd D.2.1.5.3                                              2 (13.3%)    5 (33.3%)      7 (46.7%)    #>   cl C.1                                                                                                #>     Total number of patients with at least one adverse event   4 (26.7%)    4 (26.7%)      5 (33.3%)    #>     Total number of events                                         4            9              10       #>     dcd C.1.1.1.3                                              4 (26.7%)    4 (26.7%)      5 (33.3%) main(aet02) #> function (adam_db, arm_var = \"ACTARM\", row_split_var = \"AEBODSYS\",  #>     lbl_overall = NULL, summary_labels = list(all = aet02_label,  #>         TOTAL = c(nonunique = \"Overall total number of events\")),  #>     ...)  #> { #>     assert_all_tablenames(adam_db, \"adsl\", \"adae\") #>     assert_string(arm_var) #>     assert_character(row_split_var, null.ok = TRUE) #>     assert_string(lbl_overall, null.ok = TRUE) #>     assert_valid_variable(adam_db$adsl, c(\"USUBJID\", arm_var),  #>         types = list(c(\"character\", \"factor\"))) #>     assert_valid_variable(adam_db$adae, c(arm_var, row_split_var,  #>         \"AEDECOD\"), types = list(c(\"character\", \"factor\"))) #>     assert_valid_variable(adam_db$adae, \"USUBJID\", empty_ok = TRUE,  #>         types = list(c(\"character\", \"factor\"))) #>     assert_valid_var_pair(adam_db$adsl, adam_db$adae, arm_var) #>     assert_list(summary_labels, null.ok = TRUE) #>     assert_subset(names(summary_labels), c(\"all\", \"TOTAL\", row_split_var)) #>     assert_subset(unique(unlist(lapply(summary_labels, names))),  #>         c(\"unique\", \"nonunique\", \"unique_count\")) #>     summary_labels <- expand_list(summary_labels, c(\"TOTAL\",  #>         row_split_var)) #>     lbl_overall <- render_safe(lbl_overall) #>     lbl_row_split <- var_labels_for(adam_db$adae, row_split_var) #>     lbl_aedecod <- var_labels_for(adam_db$adae, \"AEDECOD\") #>     lyt <- occurrence_lyt(arm_var = arm_var, lbl_overall = lbl_overall,  #>         row_split_var = row_split_var, lbl_row_split = lbl_row_split,  #>         medname_var = \"AEDECOD\", lbl_medname_var = lbl_aedecod,  #>         summary_labels = summary_labels, count_by = NULL) #>     tbl <- build_table(lyt, adam_db$adae, alt_counts_df = adam_db$adsl) #>     tbl #> } #> <bytecode: 0x557118440740> #> <environment: namespace:chevron> res <- preprocess(aet02)(syn_data)  # or foo <- aet02@preprocess res <- foo(syn_data)  str(res, max.level = 0) #> List of 13"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron.html","id":"chevron_tlg-object-customization","dir":"Articles","previous_headings":"","what":"chevron_tlg object customization","title":"Introduction to Chevron","text":"instances useful customize chevron_tlg object, example changing pre processing functions script generated. Please modify code directly inside pre_fun, make sure function returns named list data frames. Please careful argument names. default argument pre functions override argument spec.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron.html","id":"custom-chevron_tlg-object-creation","dir":"Articles","previous_headings":"","what":"Custom chevron_tlg object creation","title":"Introduction to Chevron","text":"cases, may want create new chevron_tlg template. create chevron_tlg object scratch, use provided constructors corresponding desired output: chevron_t() tables. chevron_l() listings. chevron_g() graphs. Note ensure correct execution run function, name first argument main function must adam_db; input list data.frame object pre-process. name first argument preprocess function must adam_db; input list object create TLG output finally, name first argument postprocess function must tlg, input TableTree object post-process. Validation criteria enforce rules upon creation chevron_tlg object.","code":"library(rtables) library(tern) my_template <- chevron_t(   main = \"<your main function to build the table>\",   preprocess = \"<your pre function to process the data>\",   postprocess = \"<your post function to add custom sorting>\" )  run(my_template, syn_data)"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"general-concepts","dir":"Articles","previous_headings":"GENERAL","what":"General Concepts","title":"Chevron Catalog","text":"chevron collection functions creates tables, listings, graphs following Roche standards clinical trials reporting. loading R packages trial data, output created main function run(...) . Two arguments object= adam_db= always expected function. object= specifies Roche Standard Template ID use. adam_db= specifies input dataset. mandatory optional arguments within run function vary depending template ID called. access arguments required functions used template, simply try ?template (e.g.¬†?aet01) see detailed descriptions instructions.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"input-dataset-and-dataset-names","dir":"Articles","previous_headings":"GENERAL > General Concepts","what":"1. Input dataset and dataset names","title":"Chevron Catalog","text":"input dataset expected argument adam_db= run(...) function collection ADaM datasets list object. ADaM dataset expected object data frame. ADaM datasets read individually, user need combine list object provide name list adam_db=. Also, element list expected corresponding ADaM dataset names. Conventional ADaM dataset names, including adsl,adex, adae, adlb,advs,adeg,adcm,admh,adrs, adtte, can picked chevron one exception.","code":"std_data <- list(adsl = adsl, adae = adae) run(object = aet01_nollt, adam_db = std_data)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"expected-variables-in-input-analysis-dataset","dir":"Articles","previous_headings":"GENERAL > General Concepts","what":"2. Expected variables in input analysis dataset","title":"Chevron Catalog","text":"default, chevron pull subject-level information either adsl adsub merge analysis dataset underlying preprocessing steps. analysis dataset fed adam_db= expected variables required analysis available.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"character-vs-factor","dir":"Articles","previous_headings":"GENERAL > General Concepts","what":"3. Character vs Factor","title":"Chevron Catalog","text":"output generation, often need specify particular sorting order variable time display. chevron, character variable needs factorized pre-specified levels display order. encountering cases, instance, \"ARM \" Asian group \"ARM B\" Asian White groups, able produce outputs like demographic table unless \"RACE\" factorized provide access level attribute variable \"RACE\" arm split. noted feature comes rtables instead chevron. \"RACE\" character variable rather factor leads error message showing ‚ÄúError: Error applying analysis function (var - RACE): Number rows generated analysis function match across columns,‚Äù recommended convert analysis variable \"RACE\" factor. resolve issue, simply try factorizing variable \"RACE\":","code":"proc_data <- syn_data proc_data$adsl <- proc_data$adsl %>%   mutate(RACE = case_when(     ARMCD == \"ARM A\" ~ \"ASIAN\",     ARMCD == \"ARM B\" & !.data$RACE %in% c(\"WHITE\", \"ASIAN\") ~ \"ASIAN\",     TRUE ~ RACE   )) run(dmt01, proc_data) proc_data$adsl$RACE <- as.factor(proc_data$adsl$RACE) run(dmt01, proc_data) #>                                        A: Drug X    B: Placebo   C: Combination   All Patients #>                                          (N=15)       (N=15)         (N=15)          (N=45)    #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Age (yr)                                                                                     #>     n                                      15           15             15              45      #>     Mean (SD)                          31.3 (5.3)   35.1 (9.0)     36.6 (6.4)      34.3 (7.3)  #>     Median                                31.0         35.0           35.0            34.0     #>     Min - Max                           24 - 40      24 - 57        24 - 49         24 - 57    #>   Age Group                                                                                    #>     n                                      15           15             15              45      #>     <65                                15 (100%)    15 (100%)      15 (100%)       45 (100%)   #>   Sex                                                                                          #>     n                                      15           15             15              45      #>     Male                               3 (20.0%)    7 (46.7%)      5 (33.3%)       15 (33.3%)  #>     Female                             12 (80.0%)   8 (53.3%)      10 (66.7%)      30 (66.7%)  #>   Ethnicity                                                                                    #>     n                                      15           15             15              45      #>     HISPANIC OR LATINO                 2 (13.3%)        0              0            2 (4.4%)   #>     NOT HISPANIC OR LATINO             13 (86.7%)   15 (100%)      13 (86.7%)      41 (91.1%)  #>     NOT REPORTED                           0            0          2 (13.3%)        2 (4.4%)   #>   RACE                                                                                         #>     n                                      15           15             15              45      #>     AMERICAN INDIAN OR ALASKA NATIVE       0            0           1 (6.7%)        1 (2.2%)   #>     ASIAN                              15 (100%)    13 (86.7%)     8 (53.3%)       36 (80.0%)  #>     BLACK OR AFRICAN AMERICAN              0            0          4 (26.7%)        4 (8.9%)   #>     WHITE                                  0        2 (13.3%)      2 (13.3%)        4 (8.9%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"testing-the-codes-for-plot-generation","dir":"Articles","previous_headings":"GENERAL > General Concepts","what":"4. Testing the codes for plot generation","title":"Chevron Catalog","text":"run function calling Graphics Template ID returns gTree object used downstream workflow output generation. two alternative approaches rendering plot: (1) draw = TRUE run function enable generated plot automatically created viewed via Plots tab, (2) calling function grid.draw package grid can utilized render plot viewing testing purpose. See example :","code":"proc_data <- log_filter(syn_data, PARAMCD == \"OS\", \"adtte\")  # method 1 run(kmg01, proc_data, dataset = \"adtte\", draw = TRUE)  # method 2 res <- run(kmg01, proc_data, dataset = \"adtte\") grid::grid.newpage() grid::grid.draw(res)"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"lbl_overall-column-of-total","dir":"Articles","previous_headings":"GENERAL > General Control Arguments","what":"1. lbl_overall: Column of Total","title":"Chevron Catalog","text":"generic argument lbl_overall controls whether column total produced . lbl_overall = NULL suppresses total, lbl_overall = \"Patients\" produces total.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"column-counts-nxxx","dir":"Articles","previous_headings":"GENERAL > General Control Arguments","what":"2. Column counts: N=xxx","title":"Chevron Catalog","text":"Column counts displayed default. generic argument controlling whether count unique number subjects (N=xxx) displayed column header . Users allowed customize display N=xxx forcing display_columncounts = FALSE wipe column counts away postprocessing (precautions recommended).","code":"tbl <- run(dmt01, syn_data) # table with column counts tbl@col_info@display_columncounts <- FALSE tbl # no column counts now #>                                        A: Drug X    B: Placebo   C: Combination   All Patients #>                                          (N=15)       (N=15)         (N=15)          (N=45)    #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Age (yr)                                                                                     #>     n                                      15           15             15              45      #>     Mean (SD)                          31.3 (5.3)   35.1 (9.0)     36.6 (6.4)      34.3 (7.3)  #>     Median                                31.0         35.0           35.0            34.0     #>     Min - Max                           24 - 40      24 - 57        24 - 49         24 - 57    #>   Age Group                                                                                    #>     n                                      15           15             15              45      #>     <65                                15 (100%)    15 (100%)      15 (100%)       45 (100%)   #>   Sex                                                                                          #>     n                                      15           15             15              45      #>     Male                               3 (20.0%)    7 (46.7%)      5 (33.3%)       15 (33.3%)  #>     Female                             12 (80.0%)   8 (53.3%)      10 (66.7%)      30 (66.7%)  #>   Ethnicity                                                                                    #>     n                                      15           15             15              45      #>     HISPANIC OR LATINO                 2 (13.3%)        0              0            2 (4.4%)   #>     NOT HISPANIC OR LATINO             13 (86.7%)   15 (100%)      13 (86.7%)      41 (91.1%)  #>     NOT REPORTED                           0            0          2 (13.3%)        2 (4.4%)   #>   RACE                                                                                         #>     n                                      15           15             15              45      #>     AMERICAN INDIAN OR ALASKA NATIVE       0        2 (13.3%)       1 (6.7%)        3 (6.7%)   #>     ASIAN                              8 (53.3%)    10 (66.7%)     8 (53.3%)       26 (57.8%)  #>     BLACK OR AFRICAN AMERICAN          4 (26.7%)     1 (6.7%)      4 (26.7%)       9 (20.0%)   #>     WHITE                              3 (20.0%)    2 (13.3%)      2 (13.3%)       7 (15.6%)"},{"path":[]},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"safety-summary","dir":"Articles","previous_headings":"TABLES > Safety Summary (AET01)","what":"1. Safety Summary","title":"Chevron Catalog","text":"aet01 template produces standard safety summary.","code":"run(aet01, syn_data, arm_var = \"ARM\") #>                                                                A: Drug X    B: Placebo   C: Combination #>                                                                  (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Total number of patients with at least one AE                13 (86.7%)   14 (93.3%)     15 (100%)    #>   Total number of AEs                                              58           59             99       #>   Total number of deaths                                       2 (13.3%)    4 (26.7%)      3 (20.0%)    #>   Total number of patients withdrawn from study due to an AE       0            0           1 (6.7%)    #>   Total number of patients with at least one                                                            #>     AE with fatal outcome                                      8 (53.3%)    8 (53.3%)      10 (66.7%)   #>     Serious AE                                                 12 (80.0%)   12 (80.0%)     11 (73.3%)   #>     Serious AE leading to withdrawal from treatment                0            0          2 (13.3%)    #>     Serious AE leading to dose modification/interruption       4 (26.7%)    3 (20.0%)      4 (26.7%)    #>     Related Serious AE                                         8 (53.3%)    8 (53.3%)      10 (66.7%)   #>     AE leading to withdrawal from treatment                    2 (13.3%)    3 (20.0%)      3 (20.0%)    #>     AE leading to dose modification/interruption               6 (40.0%)    9 (60.0%)      11 (73.3%)   #>     Related AE                                                 11 (73.3%)   10 (66.7%)     13 (86.7%)   #>     Related AE leading to withdrawal from treatment                0        3 (20.0%)          0        #>     Related AE leading to dose modification/interruption        1 (6.7%)    4 (26.7%)      9 (60.0%)    #>     Severe AE (at greatest intensity)                          11 (73.3%)   10 (66.7%)     12 (80.0%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"safety-summary-with-modified-rows","dir":"Articles","previous_headings":"TABLES > Safety Summary (AET01)","what":"2. Safety Summary with Modified Rows","title":"Chevron Catalog","text":"Analyses ‚ÄúTotal number patients least one‚Äù can removed, added, modified editing parameter anl_vars. analysis abbreviated name analysis interest, supported variable ADAE derived condition interest. defined analyses currently include \"FATAL\", \"SER\", \"SERWD\", \"SERDSM\", \"RELSER\", \"WD\", \"DSM\", \"REL\", \"RELWD\", \"RELDSM\", \"SEV\". modification made, analyses must listed argument anl_vars. example shows adding customized analysis \"RELCTC35\".","code":"proc_data <- syn_data proc_data$adae <- proc_data$adae %>%   filter(.data$ANL01FL == \"Y\") %>%   mutate(     FATAL = with_label(.data$AESDTH == \"Y\", \"AE with fatal outcome\"),     SER = with_label(.data$AESER == \"Y\", \"Serious AE\"),     SEV = with_label(.data$ASEV == \"SEVERE\", \"Severe AE (at greatest intensity)\"),     REL = with_label(.data$AREL == \"Y\", \"Related AE\"),     WD = with_label(.data$AEACN == \"DRUG WITHDRAWN\", \"AE leading to withdrawal from treatment\"),     DSM = with_label(       .data$AEACN %in% c(\"DRUG INTERRUPTED\", \"DOSE INCREASED\", \"DOSE REDUCED\"),       \"AE leading to dose modification/interruption\"     ),     SERWD = with_label(.data$SER & .data$WD, \"Serious AE leading to withdrawal from treatment\"),     SERDSM = with_label(.data$SER & .data$DSM, \"Serious AE leading to dose modification/interruption\"),     RELSER = with_label(.data$SER & .data$REL, \"Related Serious AE\"),     RELWD = with_label(.data$REL & .data$WD, \"Related AE leading to withdrawal from treatment\"),     RELDSM = with_label(.data$REL & .data$DSM, \"Related AE leading to dose modification/interruption\"),     CTC35 = with_label(.data$ATOXGR %in% c(\"3\", \"4\", \"5\"), \"Grade 3-5 AE\"),     CTC45 = with_label(.data$ATOXGR %in% c(\"4\", \"5\"), \"Grade 4/5 AE\"),     RELCTC35 = with_label(.data$ATOXGR %in% c(\"3\", \"4\", \"5\") & .data$AEREL == \"Y\", \"Related Grade 3-5\")   )  proc_data$adsl <- proc_data$adsl %>%   mutate(DCSREAS = reformat(.data$DCSREAS, missing_rule))  run(aet01, proc_data, anl_vars = list(safety_var = c(\"FATAL\", \"SER\", \"RELSER\", \"RELCTC35\")), auto_pre = FALSE) #>                                                                A: Drug X    B: Placebo   C: Combination #>                                                                  (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Total number of patients with at least one AE                13 (86.7%)   14 (93.3%)     15 (100%)    #>   Total number of AEs                                              58           59             99       #>   Total number of deaths                                       2 (13.3%)    4 (26.7%)      3 (20.0%)    #>   Total number of patients withdrawn from study due to an AE       0            0           1 (6.7%)    #>   Total number of patients with at least one                                                            #>     AE with fatal outcome                                      8 (53.3%)    8 (53.3%)      10 (66.7%)   #>     Serious AE                                                 12 (80.0%)   12 (80.0%)     11 (73.3%)   #>     Related Serious AE                                         8 (53.3%)    8 (53.3%)      10 (66.7%)   #>     Related Grade 3-5                                          11 (73.3%)   10 (66.7%)     12 (80.0%)"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"safety-summary-adverse-events-of-special-interest","dir":"Articles","previous_headings":"TABLES > Safety Summary (Adverse Events of Special Interest) (AET01_AESI)","what":"1. Safety Summary (Adverse Events of Special Interest)","title":"Chevron Catalog","text":"aet01_aesi template produces standard safety summary adverse events special interest.","code":"run(aet01_aesi, syn_data) #>                                                                                   A: Drug X    B: Placebo   C: Combination #>                                                                                     (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Total number of patients with at least one AE                                   13 (86.7%)   14 (93.3%)     15 (100%)    #>   Total number of AEs                                                                 58           59             99       #>   Total number of patients with at least one AE by worst grade                                                             #>     Grade 1                                                                           0         1 (6.7%)       1 (6.7%)    #>     Grade 2                                                                        1 (6.7%)     1 (6.7%)       1 (6.7%)    #>     Grade 3                                                                        1 (6.7%)    2 (13.3%)       1 (6.7%)    #>     Grade 4                                                                       3 (20.0%)    2 (13.3%)      2 (13.3%)    #>     Grade 5 (fatal outcome)                                                       8 (53.3%)    8 (53.3%)      10 (66.7%)   #>   Total number of patients with study drug withdrawn due to AE                    2 (13.3%)    3 (20.0%)      3 (20.0%)    #>   Total number of patients with dose modified/interrupted due to AE               6 (40.0%)    9 (60.0%)      11 (73.3%)   #>   Total number of patients with treatment received for AE                         10 (66.7%)   10 (66.7%)     14 (93.3%)   #>   Total number of patients with all non-fatal AEs resolved                        9 (60.0%)    10 (66.7%)     12 (80.0%)   #>   Total number of patients with at least one unresolved or ongoing non-fatal AE   10 (66.7%)   9 (60.0%)      14 (93.3%)   #>   Total number of patients with at least one serious AE                           12 (80.0%)   12 (80.0%)     11 (73.3%)   #>   Total number of patients with at least one related AE                           11 (73.3%)   10 (66.7%)     13 (86.7%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"safety-summary-adverse-events-of-special-interest-optional-lines","dir":"Articles","previous_headings":"TABLES > Safety Summary (Adverse Events of Special Interest) (AET01_AESI)","what":"2. Safety Summary (Adverse Events of Special Interest) (optional lines)","title":"Chevron Catalog","text":"Additional analyses can added argument aesi_vars, please type ?aet01_aesi console find list pre-defined optional analyses HELP.","code":"run(aet01_aesi, syn_data, aesi_vars = c(\"RESLWD\", \"RELSER\")) #>                                                                                   A: Drug X    B: Placebo   C: Combination #>                                                                                     (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Total number of patients with at least one AE                                   13 (86.7%)   14 (93.3%)     15 (100%)    #>   Total number of AEs                                                                 58           59             99       #>   Total number of patients with at least one AE by worst grade                                                             #>     Grade 1                                                                           0         1 (6.7%)       1 (6.7%)    #>     Grade 2                                                                        1 (6.7%)     1 (6.7%)       1 (6.7%)    #>     Grade 3                                                                        1 (6.7%)    2 (13.3%)       1 (6.7%)    #>     Grade 4                                                                       3 (20.0%)    2 (13.3%)      2 (13.3%)    #>     Grade 5 (fatal outcome)                                                       8 (53.3%)    8 (53.3%)      10 (66.7%)   #>   Total number of patients with study drug withdrawn due to AE                    2 (13.3%)    3 (20.0%)      3 (20.0%)    #>   Total number of patients with dose modified/interrupted due to AE               6 (40.0%)    9 (60.0%)      11 (73.3%)   #>   Total number of patients with treatment received for AE                         10 (66.7%)   10 (66.7%)     14 (93.3%)   #>   Total number of patients with all non-fatal AEs resolved                        9 (60.0%)    10 (66.7%)     12 (80.0%)   #>   Total number of patients with at least one unresolved or ongoing non-fatal AE   10 (66.7%)   9 (60.0%)      14 (93.3%)   #>   Total number of patients with at least one serious AE                           12 (80.0%)   12 (80.0%)     11 (73.3%)   #>   Total number of patients with at least one related AE                           11 (73.3%)   10 (66.7%)     13 (86.7%)   #>     No. of patients with serious, related AE                                      8 (53.3%)    8 (53.3%)      10 (66.7%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"safety-summary-adverse-events-of-special-interest-for-studies-with-multiple-drugs","dir":"Articles","previous_headings":"TABLES > Safety Summary (Adverse Events of Special Interest) (AET01_AESI)","what":"3. Safety Summary (Adverse Events of Special Interest) (for studies with multiple drugs)","title":"Chevron Catalog","text":"studies one study drug, users need define analyses adae add argument aesi_vars following example . pre-defined analysis available moment.","code":""},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"adverse-events","dir":"Articles","previous_headings":"TABLES > Adverse Events (AET02)","what":"1. Adverse Events","title":"Chevron Catalog","text":"template aet02 produces standard adverse event summary MedDRA system organ class preferred term. template include column total default. ‚ÄòPatients‚Äô column can added argument lbl_overall = \"Patients\". Missing values \"AEBODSYS\", \"AEDECOD\" labeled Coding Available.","code":"run(aet02, syn_data) #>   MedDRA System Organ Class                                    A: Drug X    B: Placebo   C: Combination #>     MedDRA Preferred Term                                        (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Total number of patients with at least one adverse event     13 (86.7%)   14 (93.3%)     15 (100%)    #>   Overall total number of events                                   58           59             99       #>   cl B.2                                                                                                #>     Total number of patients with at least one adverse event   11 (73.3%)   8 (53.3%)      10 (66.7%)   #>     Total number of events                                         18           15             20       #>     dcd B.2.2.3.1                                              8 (53.3%)    6 (40.0%)      7 (46.7%)    #>     dcd B.2.1.2.1                                              5 (33.3%)    6 (40.0%)      5 (33.3%)    #>   cl D.1                                                                                                #>     Total number of patients with at least one adverse event   9 (60.0%)    5 (33.3%)      11 (73.3%)   #>     Total number of events                                         13           9              19       #>     dcd D.1.1.1.1                                              4 (26.7%)    4 (26.7%)      7 (46.7%)    #>     dcd D.1.1.4.2                                              6 (40.0%)    2 (13.3%)      7 (46.7%)    #>   cl A.1                                                                                                #>     Total number of patients with at least one adverse event   7 (46.7%)    6 (40.0%)      10 (66.7%)   #>     Total number of events                                         8            11             16       #>     dcd A.1.1.1.2                                              5 (33.3%)    6 (40.0%)      6 (40.0%)    #>     dcd A.1.1.1.1                                              3 (20.0%)     1 (6.7%)      6 (40.0%)    #>   cl B.1                                                                                                #>     Total number of patients with at least one adverse event   5 (33.3%)    6 (40.0%)      8 (53.3%)    #>     Total number of events                                         6            6              12       #>     dcd B.1.1.1.1                                              5 (33.3%)    6 (40.0%)      8 (53.3%)    #>   cl C.2                                                                                                #>     Total number of patients with at least one adverse event   6 (40.0%)    4 (26.7%)      8 (53.3%)    #>     Total number of events                                         6            4              12       #>     dcd C.2.1.2.1                                              6 (40.0%)    4 (26.7%)      8 (53.3%)    #>   cl D.2                                                                                                #>     Total number of patients with at least one adverse event   2 (13.3%)    5 (33.3%)      7 (46.7%)    #>     Total number of events                                         3            5              10       #>     dcd D.2.1.5.3                                              2 (13.3%)    5 (33.3%)      7 (46.7%)    #>   cl C.1                                                                                                #>     Total number of patients with at least one adverse event   4 (26.7%)    4 (26.7%)      5 (33.3%)    #>     Total number of events                                         4            9              10       #>     dcd C.1.1.1.3                                              4 (26.7%)    4 (26.7%)      5 (33.3%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"adverse-events-with-high-level-term","dir":"Articles","previous_headings":"TABLES > Adverse Events (AET02)","what":"2. Adverse Events (with High-level Term)","title":"Chevron Catalog","text":"syntax displays adverse events MedDRA system organ class, high-level term preferred term.","code":"run(aet02, syn_data, row_split_var = c(\"AEBODSYS\", \"AEHLT\")) #>   MedDRA System Organ Class                                                                               #>     High Level Term                                              A: Drug X    B: Placebo   C: Combination #>       MedDRA Preferred Term                                        (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Total number of patients with at least one adverse event       13 (86.7%)   14 (93.3%)     15 (100%)    #>   Overall total number of events                                     58           59             99       #>   cl B.2                                                                                                  #>     Total number of patients with at least one adverse event     11 (73.3%)   8 (53.3%)      10 (66.7%)   #>     Total number of events                                           18           15             20       #>     hlt B.2.2.3                                                                                           #>       Total number of patients with at least one adverse event   8 (53.3%)    6 (40.0%)      7 (46.7%)    #>       Total number of events                                         9            7              13       #>       dcd B.2.2.3.1                                              8 (53.3%)    6 (40.0%)      7 (46.7%)    #>     hlt B.2.1.2                                                                                           #>       Total number of patients with at least one adverse event   5 (33.3%)    6 (40.0%)      5 (33.3%)    #>       Total number of events                                         9            8              7        #>       dcd B.2.1.2.1                                              5 (33.3%)    6 (40.0%)      5 (33.3%)    #>   cl D.1                                                                                                  #>     Total number of patients with at least one adverse event     9 (60.0%)    5 (33.3%)      11 (73.3%)   #>     Total number of events                                           13           9              19       #>     hlt D.1.1.1                                                                                           #>       Total number of patients with at least one adverse event   4 (26.7%)    4 (26.7%)      7 (46.7%)    #>       Total number of events                                         5            7              11       #>       dcd D.1.1.1.1                                              4 (26.7%)    4 (26.7%)      7 (46.7%)    #>     hlt D.1.1.4                                                                                           #>       Total number of patients with at least one adverse event   6 (40.0%)    2 (13.3%)      7 (46.7%)    #>       Total number of events                                         8            2              8        #>       dcd D.1.1.4.2                                              6 (40.0%)    2 (13.3%)      7 (46.7%)    #>   cl A.1                                                                                                  #>     Total number of patients with at least one adverse event     7 (46.7%)    6 (40.0%)      10 (66.7%)   #>     Total number of events                                           8            11             16       #>     hlt A.1.1.1                                                                                           #>       Total number of patients with at least one adverse event   7 (46.7%)    6 (40.0%)      10 (66.7%)   #>       Total number of events                                         8            11             16       #>       dcd A.1.1.1.2                                              5 (33.3%)    6 (40.0%)      6 (40.0%)    #>       dcd A.1.1.1.1                                              3 (20.0%)     1 (6.7%)      6 (40.0%)    #>   cl B.1                                                                                                  #>     Total number of patients with at least one adverse event     5 (33.3%)    6 (40.0%)      8 (53.3%)    #>     Total number of events                                           6            6              12       #>     hlt B.1.1.1                                                                                           #>       Total number of patients with at least one adverse event   5 (33.3%)    6 (40.0%)      8 (53.3%)    #>       Total number of events                                         6            6              12       #>       dcd B.1.1.1.1                                              5 (33.3%)    6 (40.0%)      8 (53.3%)    #>   cl C.2                                                                                                  #>     Total number of patients with at least one adverse event     6 (40.0%)    4 (26.7%)      8 (53.3%)    #>     Total number of events                                           6            4              12       #>     hlt C.2.1.2                                                                                           #>       Total number of patients with at least one adverse event   6 (40.0%)    4 (26.7%)      8 (53.3%)    #>       Total number of events                                         6            4              12       #>       dcd C.2.1.2.1                                              6 (40.0%)    4 (26.7%)      8 (53.3%)    #>   cl D.2                                                                                                  #>     Total number of patients with at least one adverse event     2 (13.3%)    5 (33.3%)      7 (46.7%)    #>     Total number of events                                           3            5              10       #>     hlt D.2.1.5                                                                                           #>       Total number of patients with at least one adverse event   2 (13.3%)    5 (33.3%)      7 (46.7%)    #>       Total number of events                                         3            5              10       #>       dcd D.2.1.5.3                                              2 (13.3%)    5 (33.3%)      7 (46.7%)    #>   cl C.1                                                                                                  #>     Total number of patients with at least one adverse event     4 (26.7%)    4 (26.7%)      5 (33.3%)    #>     Total number of events                                           4            9              10       #>     hlt C.1.1.1                                                                                           #>       Total number of patients with at least one adverse event   4 (26.7%)    4 (26.7%)      5 (33.3%)    #>       Total number of events                                         4            9              10       #>       dcd C.1.1.1.3                                              4 (26.7%)    4 (26.7%)      5 (33.3%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"adverse-events-preferred-terms-only","dir":"Articles","previous_headings":"TABLES > Adverse Events (AET02)","what":"3. Adverse Events (Preferred Terms only)","title":"Chevron Catalog","text":"syntax displays adverse events preferred term .","code":"run(aet02, syn_data, row_split_var = NULL) #>                                                              A: Drug X    B: Placebo   C: Combination #>   MedDRA Preferred Term                                        (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Total number of patients with at least one adverse event   13 (86.7%)   14 (93.3%)     15 (100%)    #>   Overall total number of events                                 58           59             99       #>   dcd B.2.2.3.1                                              8 (53.3%)    6 (40.0%)      7 (46.7%)    #>   dcd B.1.1.1.1                                              5 (33.3%)    6 (40.0%)      8 (53.3%)    #>   dcd C.2.1.2.1                                              6 (40.0%)    4 (26.7%)      8 (53.3%)    #>   dcd A.1.1.1.2                                              5 (33.3%)    6 (40.0%)      6 (40.0%)    #>   dcd B.2.1.2.1                                              5 (33.3%)    6 (40.0%)      5 (33.3%)    #>   dcd D.1.1.1.1                                              4 (26.7%)    4 (26.7%)      7 (46.7%)    #>   dcd D.1.1.4.2                                              6 (40.0%)    2 (13.3%)      7 (46.7%)    #>   dcd D.2.1.5.3                                              2 (13.3%)    5 (33.3%)      7 (46.7%)    #>   dcd C.1.1.1.3                                              4 (26.7%)    4 (26.7%)      5 (33.3%)    #>   dcd A.1.1.1.1                                              3 (20.0%)     1 (6.7%)      6 (40.0%)"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"adverse-events-by-greatest-intensity","dir":"Articles","previous_headings":"TABLES > Adverse Events by Greatest Intensity(AET03)","what":"1. Adverse Events by Greatest Intensity","title":"Chevron Catalog","text":"aet03 template produces standard adverse event greatest intensity summary","code":"run(aet03, syn_data) #>   MedDRA System Organ Class   A: Drug X    B: Placebo   C: Combination #>     MedDRA Preferred Term       (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   - Any Intensity -           13 (86.7%)   14 (93.3%)     15 (100%)    #>   MILD                            0         1 (6.7%)       1 (6.7%)    #>   MODERATE                    2 (13.3%)    3 (20.0%)      2 (13.3%)    #>   SEVERE                      11 (73.3%)   10 (66.7%)     12 (80.0%)   #>   cl B.2                                                               #>     - Any Intensity -         11 (73.3%)   8 (53.3%)      10 (66.7%)   #>     MILD                      6 (40.0%)    2 (13.3%)      5 (33.3%)    #>     MODERATE                  5 (33.3%)    6 (40.0%)      5 (33.3%)    #>     dcd B.2.2.3.1                                                      #>       - Any Intensity -       8 (53.3%)    6 (40.0%)      7 (46.7%)    #>       MILD                    8 (53.3%)    6 (40.0%)      7 (46.7%)    #>     dcd B.2.1.2.1                                                      #>       - Any Intensity -       5 (33.3%)    6 (40.0%)      5 (33.3%)    #>       MODERATE                5 (33.3%)    6 (40.0%)      5 (33.3%)    #>   cl D.1                                                               #>     - Any Intensity -         9 (60.0%)    5 (33.3%)      11 (73.3%)   #>     MODERATE                  5 (33.3%)     1 (6.7%)      4 (26.7%)    #>     SEVERE                    4 (26.7%)    4 (26.7%)      7 (46.7%)    #>     dcd D.1.1.1.1                                                      #>       - Any Intensity -       4 (26.7%)    4 (26.7%)      7 (46.7%)    #>       SEVERE                  4 (26.7%)    4 (26.7%)      7 (46.7%)    #>     dcd D.1.1.4.2                                                      #>       - Any Intensity -       6 (40.0%)    2 (13.3%)      7 (46.7%)    #>       MODERATE                6 (40.0%)    2 (13.3%)      7 (46.7%)    #>   cl A.1                                                               #>     - Any Intensity -         7 (46.7%)    6 (40.0%)      10 (66.7%)   #>     MILD                      2 (13.3%)        0          4 (26.7%)    #>     MODERATE                  5 (33.3%)    6 (40.0%)      6 (40.0%)    #>     dcd A.1.1.1.2                                                      #>       - Any Intensity -       5 (33.3%)    6 (40.0%)      6 (40.0%)    #>       MODERATE                5 (33.3%)    6 (40.0%)      6 (40.0%)    #>     dcd A.1.1.1.1                                                      #>       - Any Intensity -       3 (20.0%)     1 (6.7%)      6 (40.0%)    #>       MILD                    3 (20.0%)     1 (6.7%)      6 (40.0%)    #>   cl B.1                                                               #>     - Any Intensity -         5 (33.3%)    6 (40.0%)      8 (53.3%)    #>     SEVERE                    5 (33.3%)    6 (40.0%)      8 (53.3%)    #>     dcd B.1.1.1.1                                                      #>       - Any Intensity -       5 (33.3%)    6 (40.0%)      8 (53.3%)    #>       SEVERE                  5 (33.3%)    6 (40.0%)      8 (53.3%)    #>   cl C.2                                                               #>     - Any Intensity -         6 (40.0%)    4 (26.7%)      8 (53.3%)    #>     MODERATE                  6 (40.0%)    4 (26.7%)      8 (53.3%)    #>     dcd C.2.1.2.1                                                      #>       - Any Intensity -       6 (40.0%)    4 (26.7%)      8 (53.3%)    #>       MODERATE                6 (40.0%)    4 (26.7%)      8 (53.3%)    #>   cl D.2                                                               #>     - Any Intensity -         2 (13.3%)    5 (33.3%)      7 (46.7%)    #>     MILD                      2 (13.3%)    5 (33.3%)      7 (46.7%)    #>     dcd D.2.1.5.3                                                      #>       - Any Intensity -       2 (13.3%)    5 (33.3%)      7 (46.7%)    #>       MILD                    2 (13.3%)    5 (33.3%)      7 (46.7%)    #>   cl C.1                                                               #>     - Any Intensity -         4 (26.7%)    4 (26.7%)      5 (33.3%)    #>     SEVERE                    4 (26.7%)    4 (26.7%)      5 (33.3%)    #>     dcd C.1.1.1.3                                                      #>       - Any Intensity -       4 (26.7%)    4 (26.7%)      5 (33.3%)    #>       SEVERE                  4 (26.7%)    4 (26.7%)      5 (33.3%)"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"adverse-events-by-highest-nci-ctcae-grade","dir":"Articles","previous_headings":"TABLES > Adverse Events by Highest NCI CTCAE Grade (AET04)","what":"1. Adverse Events by Highest NCI CTCAE Grade","title":"Chevron Catalog","text":"aet04 template produces standard adverse event highest NCI CTCAE grade summary. default, template includes grouped grades ‚ÄòGrade 1-2‚Äô ‚ÄòGrade 3-4‚Äô. default template removes rows 0 count. treatment group adverse event, treatment group automatically displayed providing defined ADSL.","code":"run(aet04, syn_data) #>   MedDRA System Organ Class                                                            #>     MedDRA Preferred Term                     A: Drug X    B: Placebo   C: Combination #>                               Grade             (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   - Any adverse events -                                                               #>                               - Any Grade -   13 (86.7%)   14 (93.3%)     15 (100%)    #>                               Grade 1-2        1 (6.7%)    2 (13.3%)      2 (13.3%)    #>                               1                   0         1 (6.7%)       1 (6.7%)    #>                               2                1 (6.7%)     1 (6.7%)       1 (6.7%)    #>                               Grade 3-4       4 (26.7%)    4 (26.7%)      3 (20.0%)    #>                               3                1 (6.7%)    2 (13.3%)       1 (6.7%)    #>                               4               3 (20.0%)    2 (13.3%)      2 (13.3%)    #>                               Grade 5         8 (53.3%)    8 (53.3%)      10 (66.7%)   #>   cl B.2                                                                               #>     - Overall -                                                                        #>                               - Any Grade -   11 (73.3%)   8 (53.3%)      10 (66.7%)   #>                               Grade 1-2       6 (40.0%)    2 (13.3%)      5 (33.3%)    #>                               1               6 (40.0%)    2 (13.3%)      5 (33.3%)    #>                               Grade 3-4       5 (33.3%)    6 (40.0%)      5 (33.3%)    #>                               3               5 (33.3%)    6 (40.0%)      5 (33.3%)    #>     dcd B.2.2.3.1                                                                      #>                               - Any Grade -   8 (53.3%)    6 (40.0%)      7 (46.7%)    #>                               Grade 1-2       8 (53.3%)    6 (40.0%)      7 (46.7%)    #>                               1               8 (53.3%)    6 (40.0%)      7 (46.7%)    #>     dcd B.2.1.2.1                                                                      #>                               - Any Grade -   5 (33.3%)    6 (40.0%)      5 (33.3%)    #>                               Grade 3-4       5 (33.3%)    6 (40.0%)      5 (33.3%)    #>                               3               5 (33.3%)    6 (40.0%)      5 (33.3%)    #>   cl D.1                                                                               #>     - Overall -                                                                        #>                               - Any Grade -   9 (60.0%)    5 (33.3%)      11 (73.3%)   #>                               Grade 3-4       5 (33.3%)     1 (6.7%)      4 (26.7%)    #>                               3               5 (33.3%)     1 (6.7%)      4 (26.7%)    #>                               Grade 5         4 (26.7%)    4 (26.7%)      7 (46.7%)    #>     dcd D.1.1.1.1                                                                      #>                               - Any Grade -   4 (26.7%)    4 (26.7%)      7 (46.7%)    #>                               Grade 5         4 (26.7%)    4 (26.7%)      7 (46.7%)    #>     dcd D.1.1.4.2                                                                      #>                               - Any Grade -   6 (40.0%)    2 (13.3%)      7 (46.7%)    #>                               Grade 3-4       6 (40.0%)    2 (13.3%)      7 (46.7%)    #>                               3               6 (40.0%)    2 (13.3%)      7 (46.7%)    #>   cl A.1                                                                               #>     - Overall -                                                                        #>                               - Any Grade -   7 (46.7%)    6 (40.0%)      10 (66.7%)   #>                               Grade 1-2       7 (46.7%)    6 (40.0%)      10 (66.7%)   #>                               1               2 (13.3%)        0          4 (26.7%)    #>                               2               5 (33.3%)    6 (40.0%)      6 (40.0%)    #>     dcd A.1.1.1.2                                                                      #>                               - Any Grade -   5 (33.3%)    6 (40.0%)      6 (40.0%)    #>                               Grade 1-2       5 (33.3%)    6 (40.0%)      6 (40.0%)    #>                               2               5 (33.3%)    6 (40.0%)      6 (40.0%)    #>     dcd A.1.1.1.1                                                                      #>                               - Any Grade -   3 (20.0%)     1 (6.7%)      6 (40.0%)    #>                               Grade 1-2       3 (20.0%)     1 (6.7%)      6 (40.0%)    #>                               1               3 (20.0%)     1 (6.7%)      6 (40.0%)    #>   cl B.1                                                                               #>     - Overall -                                                                        #>                               - Any Grade -   5 (33.3%)    6 (40.0%)      8 (53.3%)    #>                               Grade 5         5 (33.3%)    6 (40.0%)      8 (53.3%)    #>     dcd B.1.1.1.1                                                                      #>                               - Any Grade -   5 (33.3%)    6 (40.0%)      8 (53.3%)    #>                               Grade 5         5 (33.3%)    6 (40.0%)      8 (53.3%)    #>   cl C.2                                                                               #>     - Overall -                                                                        #>                               - Any Grade -   6 (40.0%)    4 (26.7%)      8 (53.3%)    #>                               Grade 1-2       6 (40.0%)    4 (26.7%)      8 (53.3%)    #>                               2               6 (40.0%)    4 (26.7%)      8 (53.3%)    #>     dcd C.2.1.2.1                                                                      #>                               - Any Grade -   6 (40.0%)    4 (26.7%)      8 (53.3%)    #>                               Grade 1-2       6 (40.0%)    4 (26.7%)      8 (53.3%)    #>                               2               6 (40.0%)    4 (26.7%)      8 (53.3%)    #>   cl D.2                                                                               #>     - Overall -                                                                        #>                               - Any Grade -   2 (13.3%)    5 (33.3%)      7 (46.7%)    #>                               Grade 1-2       2 (13.3%)    5 (33.3%)      7 (46.7%)    #>                               1               2 (13.3%)    5 (33.3%)      7 (46.7%)    #>     dcd D.2.1.5.3                                                                      #>                               - Any Grade -   2 (13.3%)    5 (33.3%)      7 (46.7%)    #>                               Grade 1-2       2 (13.3%)    5 (33.3%)      7 (46.7%)    #>                               1               2 (13.3%)    5 (33.3%)      7 (46.7%)    #>   cl C.1                                                                               #>     - Overall -                                                                        #>                               - Any Grade -   4 (26.7%)    4 (26.7%)      5 (33.3%)    #>                               Grade 3-4       4 (26.7%)    4 (26.7%)      5 (33.3%)    #>                               4               4 (26.7%)    4 (26.7%)      5 (33.3%)    #>     dcd C.1.1.1.3                                                                      #>                               - Any Grade -   4 (26.7%)    4 (26.7%)      5 (33.3%)    #>                               Grade 3-4       4 (26.7%)    4 (26.7%)      5 (33.3%)    #>                               4               4 (26.7%)    4 (26.7%)      5 (33.3%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"adverse-events-by-highest-nci-ctcae-grade-fill-in-of-grades","dir":"Articles","previous_headings":"TABLES > Adverse Events by Highest NCI CTCAE Grade (AET04)","what":"2. Adverse Events by Highest NCI CTCAE Grade (Fill in of Grades)","title":"Chevron Catalog","text":", preferred terms, grades occur grades displayed, can achieved specifying argument prune_0 = FALSE.","code":"run(aet04, syn_data, prune_0 = FALSE) #>   MedDRA System Organ Class                                                            #>     MedDRA Preferred Term                     A: Drug X    B: Placebo   C: Combination #>                               Grade             (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   - Any adverse events -                                                               #>                               - Any Grade -   13 (86.7%)   14 (93.3%)     15 (100%)    #>                               Grade 1-2        1 (6.7%)    2 (13.3%)      2 (13.3%)    #>                               1                   0         1 (6.7%)       1 (6.7%)    #>                               2                1 (6.7%)     1 (6.7%)       1 (6.7%)    #>                               Grade 3-4       4 (26.7%)    4 (26.7%)      3 (20.0%)    #>                               3                1 (6.7%)    2 (13.3%)       1 (6.7%)    #>                               4               3 (20.0%)    2 (13.3%)      2 (13.3%)    #>                               Grade 5         8 (53.3%)    8 (53.3%)      10 (66.7%)   #>   cl B.2                                                                               #>     - Overall -                                                                        #>                               - Any Grade -   11 (73.3%)   8 (53.3%)      10 (66.7%)   #>                               Grade 1-2       6 (40.0%)    2 (13.3%)      5 (33.3%)    #>                               1               6 (40.0%)    2 (13.3%)      5 (33.3%)    #>                               2                   0            0              0        #>                               Grade 3-4       5 (33.3%)    6 (40.0%)      5 (33.3%)    #>                               3               5 (33.3%)    6 (40.0%)      5 (33.3%)    #>                               4                   0            0              0        #>                               Grade 5             0            0              0        #>     dcd B.2.2.3.1                                                                      #>                               - Any Grade -   8 (53.3%)    6 (40.0%)      7 (46.7%)    #>                               Grade 1-2       8 (53.3%)    6 (40.0%)      7 (46.7%)    #>                               1               8 (53.3%)    6 (40.0%)      7 (46.7%)    #>                               2                   0            0              0        #>                               Grade 3-4           0            0              0        #>                               3                   0            0              0        #>                               4                   0            0              0        #>                               Grade 5             0            0              0        #>     dcd B.2.1.2.1                                                                      #>                               - Any Grade -   5 (33.3%)    6 (40.0%)      5 (33.3%)    #>                               Grade 1-2           0            0              0        #>                               1                   0            0              0        #>                               2                   0            0              0        #>                               Grade 3-4       5 (33.3%)    6 (40.0%)      5 (33.3%)    #>                               3               5 (33.3%)    6 (40.0%)      5 (33.3%)    #>                               4                   0            0              0        #>                               Grade 5             0            0              0        #>   cl D.1                                                                               #>     - Overall -                                                                        #>                               - Any Grade -   9 (60.0%)    5 (33.3%)      11 (73.3%)   #>                               Grade 1-2           0            0              0        #>                               1                   0            0              0        #>                               2                   0            0              0        #>                               Grade 3-4       5 (33.3%)     1 (6.7%)      4 (26.7%)    #>                               3               5 (33.3%)     1 (6.7%)      4 (26.7%)    #>                               4                   0            0              0        #>                               Grade 5         4 (26.7%)    4 (26.7%)      7 (46.7%)    #>     dcd D.1.1.1.1                                                                      #>                               - Any Grade -   4 (26.7%)    4 (26.7%)      7 (46.7%)    #>                               Grade 1-2           0            0              0        #>                               1                   0            0              0        #>                               2                   0            0              0        #>                               Grade 3-4           0            0              0        #>                               3                   0            0              0        #>                               4                   0            0              0        #>                               Grade 5         4 (26.7%)    4 (26.7%)      7 (46.7%)    #>     dcd D.1.1.4.2                                                                      #>                               - Any Grade -   6 (40.0%)    2 (13.3%)      7 (46.7%)    #>                               Grade 1-2           0            0              0        #>                               1                   0            0              0        #>                               2                   0            0              0        #>                               Grade 3-4       6 (40.0%)    2 (13.3%)      7 (46.7%)    #>                               3               6 (40.0%)    2 (13.3%)      7 (46.7%)    #>                               4                   0            0              0        #>                               Grade 5             0            0              0        #>   cl A.1                                                                               #>     - Overall -                                                                        #>                               - Any Grade -   7 (46.7%)    6 (40.0%)      10 (66.7%)   #>                               Grade 1-2       7 (46.7%)    6 (40.0%)      10 (66.7%)   #>                               1               2 (13.3%)        0          4 (26.7%)    #>                               2               5 (33.3%)    6 (40.0%)      6 (40.0%)    #>                               Grade 3-4           0            0              0        #>                               3                   0            0              0        #>                               4                   0            0              0        #>                               Grade 5             0            0              0        #>     dcd A.1.1.1.2                                                                      #>                               - Any Grade -   5 (33.3%)    6 (40.0%)      6 (40.0%)    #>                               Grade 1-2       5 (33.3%)    6 (40.0%)      6 (40.0%)    #>                               1                   0            0              0        #>                               2               5 (33.3%)    6 (40.0%)      6 (40.0%)    #>                               Grade 3-4           0            0              0        #>                               3                   0            0              0        #>                               4                   0            0              0        #>                               Grade 5             0            0              0        #>     dcd A.1.1.1.1                                                                      #>                               - Any Grade -   3 (20.0%)     1 (6.7%)      6 (40.0%)    #>                               Grade 1-2       3 (20.0%)     1 (6.7%)      6 (40.0%)    #>                               1               3 (20.0%)     1 (6.7%)      6 (40.0%)    #>                               2                   0            0              0        #>                               Grade 3-4           0            0              0        #>                               3                   0            0              0        #>                               4                   0            0              0        #>                               Grade 5             0            0              0        #>   cl B.1                                                                               #>     - Overall -                                                                        #>                               - Any Grade -   5 (33.3%)    6 (40.0%)      8 (53.3%)    #>                               Grade 1-2           0            0              0        #>                               1                   0            0              0        #>                               2                   0            0              0        #>                               Grade 3-4           0            0              0        #>                               3                   0            0              0        #>                               4                   0            0              0        #>                               Grade 5         5 (33.3%)    6 (40.0%)      8 (53.3%)    #>     dcd B.1.1.1.1                                                                      #>                               - Any Grade -   5 (33.3%)    6 (40.0%)      8 (53.3%)    #>                               Grade 1-2           0            0              0        #>                               1                   0            0              0        #>                               2                   0            0              0        #>                               Grade 3-4           0            0              0        #>                               3                   0            0              0        #>                               4                   0            0              0        #>                               Grade 5         5 (33.3%)    6 (40.0%)      8 (53.3%)    #>   cl C.2                                                                               #>     - Overall -                                                                        #>                               - Any Grade -   6 (40.0%)    4 (26.7%)      8 (53.3%)    #>                               Grade 1-2       6 (40.0%)    4 (26.7%)      8 (53.3%)    #>                               1                   0            0              0        #>                               2               6 (40.0%)    4 (26.7%)      8 (53.3%)    #>                               Grade 3-4           0            0              0        #>                               3                   0            0              0        #>                               4                   0            0              0        #>                               Grade 5             0            0              0        #>     dcd C.2.1.2.1                                                                      #>                               - Any Grade -   6 (40.0%)    4 (26.7%)      8 (53.3%)    #>                               Grade 1-2       6 (40.0%)    4 (26.7%)      8 (53.3%)    #>                               1                   0            0              0        #>                               2               6 (40.0%)    4 (26.7%)      8 (53.3%)    #>                               Grade 3-4           0            0              0        #>                               3                   0            0              0        #>                               4                   0            0              0        #>                               Grade 5             0            0              0        #>   cl D.2                                                                               #>     - Overall -                                                                        #>                               - Any Grade -   2 (13.3%)    5 (33.3%)      7 (46.7%)    #>                               Grade 1-2       2 (13.3%)    5 (33.3%)      7 (46.7%)    #>                               1               2 (13.3%)    5 (33.3%)      7 (46.7%)    #>                               2                   0            0              0        #>                               Grade 3-4           0            0              0        #>                               3                   0            0              0        #>                               4                   0            0              0        #>                               Grade 5             0            0              0        #>     dcd D.2.1.5.3                                                                      #>                               - Any Grade -   2 (13.3%)    5 (33.3%)      7 (46.7%)    #>                               Grade 1-2       2 (13.3%)    5 (33.3%)      7 (46.7%)    #>                               1               2 (13.3%)    5 (33.3%)      7 (46.7%)    #>                               2                   0            0              0        #>                               Grade 3-4           0            0              0        #>                               3                   0            0              0        #>                               4                   0            0              0        #>                               Grade 5             0            0              0        #>   cl C.1                                                                               #>     - Overall -                                                                        #>                               - Any Grade -   4 (26.7%)    4 (26.7%)      5 (33.3%)    #>                               Grade 1-2           0            0              0        #>                               1                   0            0              0        #>                               2                   0            0              0        #>                               Grade 3-4       4 (26.7%)    4 (26.7%)      5 (33.3%)    #>                               3                   0            0              0        #>                               4               4 (26.7%)    4 (26.7%)      5 (33.3%)    #>                               Grade 5             0            0              0        #>     dcd C.1.1.1.3                                                                      #>                               - Any Grade -   4 (26.7%)    4 (26.7%)      5 (33.3%)    #>                               Grade 1-2           0            0              0        #>                               1                   0            0              0        #>                               2                   0            0              0        #>                               Grade 3-4       4 (26.7%)    4 (26.7%)      5 (33.3%)    #>                               3                   0            0              0        #>                               4               4 (26.7%)    4 (26.7%)      5 (33.3%)    #>                               Grade 5             0            0              0"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"adverse-events-by-highest-nci-ctcae-grade-with-modified-grouping-of-grade","dir":"Articles","previous_headings":"TABLES > Adverse Events by Highest NCI CTCAE Grade (AET04)","what":"3. Adverse Events by Highest NCI CTCAE Grade with modified grouping of grade","title":"Chevron Catalog","text":"Collapsing grade 3-4 grade 5, can achieved modifying definition grade groups argument grade_groups.","code":"grade_groups <- list(   \"Grade 1-2\" = c(\"1\", \"2\"),   \"Grade 3-5\" = c(\"3\", \"4\", \"5\") )  run(aet04, syn_data, grade_groups = grade_groups, prune_0 = FALSE) #>   MedDRA System Organ Class                                                            #>     MedDRA Preferred Term                     A: Drug X    B: Placebo   C: Combination #>                               Grade             (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   - Any adverse events -                                                               #>                               - Any Grade -   13 (86.7%)   14 (93.3%)     15 (100%)    #>                               Grade 1-2        1 (6.7%)    2 (13.3%)      2 (13.3%)    #>                               1                   0         1 (6.7%)       1 (6.7%)    #>                               2                1 (6.7%)     1 (6.7%)       1 (6.7%)    #>                               Grade 3-5       12 (80.0%)   12 (80.0%)     13 (86.7%)   #>                               3                1 (6.7%)    2 (13.3%)       1 (6.7%)    #>                               4               3 (20.0%)    2 (13.3%)      2 (13.3%)    #>                               5               8 (53.3%)    8 (53.3%)      10 (66.7%)   #>   cl B.2                                                                               #>     - Overall -                                                                        #>                               - Any Grade -   11 (73.3%)   8 (53.3%)      10 (66.7%)   #>                               Grade 1-2       6 (40.0%)    2 (13.3%)      5 (33.3%)    #>                               1               6 (40.0%)    2 (13.3%)      5 (33.3%)    #>                               2                   0            0              0        #>                               Grade 3-5       5 (33.3%)    6 (40.0%)      5 (33.3%)    #>                               3               5 (33.3%)    6 (40.0%)      5 (33.3%)    #>                               4                   0            0              0        #>                               5                   0            0              0        #>     dcd B.2.2.3.1                                                                      #>                               - Any Grade -   8 (53.3%)    6 (40.0%)      7 (46.7%)    #>                               Grade 1-2       8 (53.3%)    6 (40.0%)      7 (46.7%)    #>                               1               8 (53.3%)    6 (40.0%)      7 (46.7%)    #>                               2                   0            0              0        #>                               Grade 3-5           0            0              0        #>                               3                   0            0              0        #>                               4                   0            0              0        #>                               5                   0            0              0        #>     dcd B.2.1.2.1                                                                      #>                               - Any Grade -   5 (33.3%)    6 (40.0%)      5 (33.3%)    #>                               Grade 1-2           0            0              0        #>                               1                   0            0              0        #>                               2                   0            0              0        #>                               Grade 3-5       5 (33.3%)    6 (40.0%)      5 (33.3%)    #>                               3               5 (33.3%)    6 (40.0%)      5 (33.3%)    #>                               4                   0            0              0        #>                               5                   0            0              0        #>   cl D.1                                                                               #>     - Overall -                                                                        #>                               - Any Grade -   9 (60.0%)    5 (33.3%)      11 (73.3%)   #>                               Grade 1-2           0            0              0        #>                               1                   0            0              0        #>                               2                   0            0              0        #>                               Grade 3-5       9 (60.0%)    5 (33.3%)      11 (73.3%)   #>                               3               5 (33.3%)     1 (6.7%)      4 (26.7%)    #>                               4                   0            0              0        #>                               5               4 (26.7%)    4 (26.7%)      7 (46.7%)    #>     dcd D.1.1.1.1                                                                      #>                               - Any Grade -   4 (26.7%)    4 (26.7%)      7 (46.7%)    #>                               Grade 1-2           0            0              0        #>                               1                   0            0              0        #>                               2                   0            0              0        #>                               Grade 3-5       4 (26.7%)    4 (26.7%)      7 (46.7%)    #>                               3                   0            0              0        #>                               4                   0            0              0        #>                               5               4 (26.7%)    4 (26.7%)      7 (46.7%)    #>     dcd D.1.1.4.2                                                                      #>                               - Any Grade -   6 (40.0%)    2 (13.3%)      7 (46.7%)    #>                               Grade 1-2           0            0              0        #>                               1                   0            0              0        #>                               2                   0            0              0        #>                               Grade 3-5       6 (40.0%)    2 (13.3%)      7 (46.7%)    #>                               3               6 (40.0%)    2 (13.3%)      7 (46.7%)    #>                               4                   0            0              0        #>                               5                   0            0              0        #>   cl A.1                                                                               #>     - Overall -                                                                        #>                               - Any Grade -   7 (46.7%)    6 (40.0%)      10 (66.7%)   #>                               Grade 1-2       7 (46.7%)    6 (40.0%)      10 (66.7%)   #>                               1               2 (13.3%)        0          4 (26.7%)    #>                               2               5 (33.3%)    6 (40.0%)      6 (40.0%)    #>                               Grade 3-5           0            0              0        #>                               3                   0            0              0        #>                               4                   0            0              0        #>                               5                   0            0              0        #>     dcd A.1.1.1.2                                                                      #>                               - Any Grade -   5 (33.3%)    6 (40.0%)      6 (40.0%)    #>                               Grade 1-2       5 (33.3%)    6 (40.0%)      6 (40.0%)    #>                               1                   0            0              0        #>                               2               5 (33.3%)    6 (40.0%)      6 (40.0%)    #>                               Grade 3-5           0            0              0        #>                               3                   0            0              0        #>                               4                   0            0              0        #>                               5                   0            0              0        #>     dcd A.1.1.1.1                                                                      #>                               - Any Grade -   3 (20.0%)     1 (6.7%)      6 (40.0%)    #>                               Grade 1-2       3 (20.0%)     1 (6.7%)      6 (40.0%)    #>                               1               3 (20.0%)     1 (6.7%)      6 (40.0%)    #>                               2                   0            0              0        #>                               Grade 3-5           0            0              0        #>                               3                   0            0              0        #>                               4                   0            0              0        #>                               5                   0            0              0        #>   cl B.1                                                                               #>     - Overall -                                                                        #>                               - Any Grade -   5 (33.3%)    6 (40.0%)      8 (53.3%)    #>                               Grade 1-2           0            0              0        #>                               1                   0            0              0        #>                               2                   0            0              0        #>                               Grade 3-5       5 (33.3%)    6 (40.0%)      8 (53.3%)    #>                               3                   0            0              0        #>                               4                   0            0              0        #>                               5               5 (33.3%)    6 (40.0%)      8 (53.3%)    #>     dcd B.1.1.1.1                                                                      #>                               - Any Grade -   5 (33.3%)    6 (40.0%)      8 (53.3%)    #>                               Grade 1-2           0            0              0        #>                               1                   0            0              0        #>                               2                   0            0              0        #>                               Grade 3-5       5 (33.3%)    6 (40.0%)      8 (53.3%)    #>                               3                   0            0              0        #>                               4                   0            0              0        #>                               5               5 (33.3%)    6 (40.0%)      8 (53.3%)    #>   cl C.2                                                                               #>     - Overall -                                                                        #>                               - Any Grade -   6 (40.0%)    4 (26.7%)      8 (53.3%)    #>                               Grade 1-2       6 (40.0%)    4 (26.7%)      8 (53.3%)    #>                               1                   0            0              0        #>                               2               6 (40.0%)    4 (26.7%)      8 (53.3%)    #>                               Grade 3-5           0            0              0        #>                               3                   0            0              0        #>                               4                   0            0              0        #>                               5                   0            0              0        #>     dcd C.2.1.2.1                                                                      #>                               - Any Grade -   6 (40.0%)    4 (26.7%)      8 (53.3%)    #>                               Grade 1-2       6 (40.0%)    4 (26.7%)      8 (53.3%)    #>                               1                   0            0              0        #>                               2               6 (40.0%)    4 (26.7%)      8 (53.3%)    #>                               Grade 3-5           0            0              0        #>                               3                   0            0              0        #>                               4                   0            0              0        #>                               5                   0            0              0        #>   cl D.2                                                                               #>     - Overall -                                                                        #>                               - Any Grade -   2 (13.3%)    5 (33.3%)      7 (46.7%)    #>                               Grade 1-2       2 (13.3%)    5 (33.3%)      7 (46.7%)    #>                               1               2 (13.3%)    5 (33.3%)      7 (46.7%)    #>                               2                   0            0              0        #>                               Grade 3-5           0            0              0        #>                               3                   0            0              0        #>                               4                   0            0              0        #>                               5                   0            0              0        #>     dcd D.2.1.5.3                                                                      #>                               - Any Grade -   2 (13.3%)    5 (33.3%)      7 (46.7%)    #>                               Grade 1-2       2 (13.3%)    5 (33.3%)      7 (46.7%)    #>                               1               2 (13.3%)    5 (33.3%)      7 (46.7%)    #>                               2                   0            0              0        #>                               Grade 3-5           0            0              0        #>                               3                   0            0              0        #>                               4                   0            0              0        #>                               5                   0            0              0        #>   cl C.1                                                                               #>     - Overall -                                                                        #>                               - Any Grade -   4 (26.7%)    4 (26.7%)      5 (33.3%)    #>                               Grade 1-2           0            0              0        #>                               1                   0            0              0        #>                               2                   0            0              0        #>                               Grade 3-5       4 (26.7%)    4 (26.7%)      5 (33.3%)    #>                               3                   0            0              0        #>                               4               4 (26.7%)    4 (26.7%)      5 (33.3%)    #>                               5                   0            0              0        #>     dcd C.1.1.1.3                                                                      #>                               - Any Grade -   4 (26.7%)    4 (26.7%)      5 (33.3%)    #>                               Grade 1-2           0            0              0        #>                               1                   0            0              0        #>                               2                   0            0              0        #>                               Grade 3-5       4 (26.7%)    4 (26.7%)      5 (33.3%)    #>                               3                   0            0              0        #>                               4               4 (26.7%)    4 (26.7%)      5 (33.3%)    #>                               5                   0            0              0"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"adverse-event-rate-adjusted-for-patient-years-at-risk---first-occurrence","dir":"Articles","previous_headings":"TABLES > Adverse Event Rate Adjusted for Patient-Years at Risk - First Occurrence (AET05)","what":"1. Adverse Event Rate Adjusted for Patient-Years at Risk - First Occurrence","title":"Chevron Catalog","text":"aet05 template produces standard adverse event rate adjusted patient-years risk summary considering first occurrence . default, adsaftte parameter codes containing string \"TTE\" included output. Users expected filter parameter(s) interest input safety time--event dataset pre-processing needed. input safety time--event dataset, censoring variable CNSR, 0 indicates occurrence event interest 1 denotes censoring.","code":"proc_data <- log_filter(syn_data, PARAMCD == \"AETTE1\", \"adsaftte\")  run(aet05, proc_data) #>                                                     A: Drug X       B: Placebo      C: Combination #>                                                      (N=15)           (N=15)            (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Time to first occurrence of any adverse event                                                    #>     Total patient-years at risk                       31.0              9.0              22.0      #>     Number of adverse events observed                   5               13                8        #>     AE rate per 100 patient-years                     16.13           143.75            36.30      #>     95% CI                                        (1.99, 30.27)   (65.61, 221.89)   (11.15, 61.45)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"adverse-event-rate-adjusted-for-patient-years-at-risk---first-occurrence-setting-type-of-confidence-interval","dir":"Articles","previous_headings":"TABLES > Adverse Event Rate Adjusted for Patient-Years at Risk - First Occurrence (AET05)","what":"2. Adverse Event Rate Adjusted for Patient-Years at Risk - First Occurrence (setting type of confidence interval)","title":"Chevron Catalog","text":"type confidence interval rate can specified argument conf_type. Options include normal (default), normal_log exact. confidence interval can adjusted argument conf_level.","code":"run(aet05, syn_data, conf_level = 0.90, conf_type = \"exact\") #>                                                              A: Drug X         B: Placebo      C: Combination  #>                                                               (N=15)             (N=15)            (N=15)      #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Time to first occurrence of a grade 3-5 adverse event                                                        #>     Total patient-years at risk                                10.3               6.3                8.3       #>     Number of adverse events observed                           12                 14                13        #>     AE rate per 100 patient-years                             116.36             223.74            156.98      #>     90% CI                                                (67.14, 188.53)   (135.27, 349.78)   (92.86, 249.59) #>   Time to first occurrence of any adverse event                                                                #>     Total patient-years at risk                                31.0               9.0               22.0       #>     Number of adverse events observed                            5                 13                 8        #>     AE rate per 100 patient-years                              16.13             143.75             36.30      #>     90% CI                                                 (6.36, 33.91)    (85.03, 228.55)    (18.06, 65.50)  #>   Time to first occurrence of any serious adverse event                                                        #>     Total patient-years at risk                                32.9               7.6                9.4       #>     Number of adverse events observed                            4                 14                13        #>     AE rate per 100 patient-years                              12.15             183.83            137.79      #>     90% CI                                                 (4.15, 27.80)    (111.14, 287.38)   (81.50, 219.06)"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"adverse-event-rate-adjusted-for-patient-years-at-risk---all-occurrences","dir":"Articles","previous_headings":"TABLES > Adverse Event Rate Adjusted for Patient-Years at Risk - All Occurrences (AET05_ALL)","what":"1. Adverse Event Rate Adjusted for Patient-Years at Risk - All Occurrences","title":"Chevron Catalog","text":"aet05_all template produces standard adverse event rate adjusted patient-years risk summary considering occurrences. default, adsaftte parameter codes containing string \"TOT\" parameter code \"AEREPTTE\" required. \"TOT\" parameters store number occurrences adverse event interests. Parameter code \"AEREPTTE\" stores time end adverse event reporting period years contribute summary ‚Äútotal patient-years risk‚Äù output. Users expected filter parameters interest input analysis dataset pre-processing, needed. input safety time--event dataset, censoring variable CNSR, 0 indicates occurrence event interest 1 denotes censoring.","code":"proc_data <- log_filter(syn_data, PARAMCD == \"AETOT1\" | PARAMCD == \"AEREPTTE\", \"adsaftte\")  run(aet05_all, proc_data) #>                                                  A: Drug X        B: Placebo      C: Combination  #>                                                    (N=15)           (N=15)            (N=15)      #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Number of occurrences of any adverse event                                                      #>     Total patient-years at risk                     44.4             44.2              44.4       #>     Number of adverse events observed                29               49                56        #>     AE rate per 100 patient-years                  65.32            110.76            126.15      #>     95% CI                                     (41.54, 89.09)   (79.75, 141.77)   (93.11, 159.19)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"adverse-event-rate-adjusted-for-patient-years-at-risk---all-occurrences-setting-type-of-confidence-interval","dir":"Articles","previous_headings":"TABLES > Adverse Event Rate Adjusted for Patient-Years at Risk - All Occurrences (AET05_ALL)","what":"2. Adverse Event Rate Adjusted for Patient-Years at Risk - All Occurrences (setting type of confidence interval)","title":"Chevron Catalog","text":"type confidence interval rate can specified argument conf_type. Options include normal (default), normal_log, exact, byar. confidence interval can adjusted argument conf_level.","code":"run(aet05_all, syn_data, conf_level = 0.90, conf_type = \"exact\") #>                                                           A: Drug X         B: Placebo       C: Combination  #>                                                             (N=15)            (N=15)             (N=15)      #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Number of occurrences of a grade 3-5 adverse event                                                         #>     Total patient-years at risk                              44.4              44.2               44.4       #>     Number of adverse events observed                         65                54                 95        #>     AE rate per 100 patient-years                           146.40            122.06             214.00      #>     90% CI                                             (117.86, 179.97)   (96.08, 153.12)   (179.22, 253.80) #>   Number of occurrences of any adverse event                                                                 #>     Total patient-years at risk                              44.4              44.2               44.4       #>     Number of adverse events observed                         29                49                 56        #>     AE rate per 100 patient-years                           65.32             110.76             126.15      #>     90% CI                                              (46.73, 89.06)    (86.08, 140.53)   (99.76, 157.60)  #>   Number of occurrences of any serious adverse event                                                         #>     Total patient-years at risk                              44.4              44.2               44.4       #>     Number of adverse events observed                         9                 36                 60        #>     AE rate per 100 patient-years                           20.27              81.37             135.16      #>     90% CI                                              (10.57, 35.37)    (60.42, 107.46)   (107.80, 167.58)"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"most-common-5-adverse-events","dir":"Articles","previous_headings":"TABLES > Most Common (>=5%) Adverse Events (AET10)","what":"1. Most Common (>=5%) Adverse Events","title":"Chevron Catalog","text":"aet10 template produces standard common adverse events occurring relative frequency >=5% output.","code":"run(aet10, syn_data) #>                           A: Drug X   B: Placebo   C: Combination #>   MedDRA Preferred Term    (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   dcd B.2.2.3.1           8 (53.3%)   6 (40.0%)      7 (46.7%)    #>   dcd B.1.1.1.1           5 (33.3%)   6 (40.0%)      8 (53.3%)    #>   dcd C.2.1.2.1           6 (40.0%)   4 (26.7%)      8 (53.3%)    #>   dcd A.1.1.1.2           5 (33.3%)   6 (40.0%)      6 (40.0%)    #>   dcd B.2.1.2.1           5 (33.3%)   6 (40.0%)      5 (33.3%)    #>   dcd D.1.1.1.1           4 (26.7%)   4 (26.7%)      7 (46.7%)    #>   dcd D.1.1.4.2           6 (40.0%)   2 (13.3%)      7 (46.7%)    #>   dcd D.2.1.5.3           2 (13.3%)   5 (33.3%)      7 (46.7%)    #>   dcd C.1.1.1.3           4 (26.7%)   4 (26.7%)      5 (33.3%)    #>   dcd A.1.1.1.1           3 (20.0%)    1 (6.7%)      6 (40.0%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"most-common-8-adverse-events-setting-threshold","dir":"Articles","previous_headings":"TABLES > Most Common (>=5%) Adverse Events (AET10)","what":"2. Most Common (>=8%) Adverse Events (setting threshold)","title":"Chevron Catalog","text":"modify threshold displaying preferred terms, can achieved providing threshold argument atleast.","code":"run(aet10, syn_data, atleast = 0.08) #>                           A: Drug X   B: Placebo   C: Combination #>   MedDRA Preferred Term    (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   dcd B.2.2.3.1           8 (53.3%)   6 (40.0%)      7 (46.7%)    #>   dcd B.1.1.1.1           5 (33.3%)   6 (40.0%)      8 (53.3%)    #>   dcd C.2.1.2.1           6 (40.0%)   4 (26.7%)      8 (53.3%)    #>   dcd A.1.1.1.2           5 (33.3%)   6 (40.0%)      6 (40.0%)    #>   dcd B.2.1.2.1           5 (33.3%)   6 (40.0%)      5 (33.3%)    #>   dcd D.1.1.1.1           4 (26.7%)   4 (26.7%)      7 (46.7%)    #>   dcd D.1.1.4.2           6 (40.0%)   2 (13.3%)      7 (46.7%)    #>   dcd D.2.1.5.3           2 (13.3%)   5 (33.3%)      7 (46.7%)    #>   dcd C.1.1.1.3           4 (26.7%)   4 (26.7%)      5 (33.3%)    #>   dcd A.1.1.1.1           3 (20.0%)    1 (6.7%)      6 (40.0%)"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"absolute-value-and-change-from-baseline-by-visit","dir":"Articles","previous_headings":"TABLES > Absolute Value and Change from Baseline by Visit (CFBT01)","what":"1. Absolute Value and Change from Baseline by Visit","title":"Chevron Catalog","text":"default, cfbt01 template displays analysis value (AVAL) absolute change baseline (CHG) visit. template include column total default. parameter presented separate page. absolute change baseline baseline value displayed.","code":"proc_data <- log_filter(   syn_data,   PARAMCD %in% c(\"DIABP\", \"SYSBP\"), \"advs\" ) run(cfbt01, proc_data, dataset = \"advs\") #>                                          A: Drug X                            B: Placebo                          C: Combination            #>                                                   Change from                          Change from                           Change from    #>                               Value at Visit       Baseline        Value at Visit        Baseline        Value at Visit        Baseline     #>   Analysis Visit                  (N=15)            (N=15)             (N=15)             (N=15)             (N=15)             (N=15)      #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Diastolic Blood Pressure                                                                                                                  #>     SCREENING                                                                                                                               #>       n                             15                 0                 15                 0                  15                 0         #>       Mean (SD)              94.385 (17.067)        NE (NE)       106.381 (20.586)       NE (NE)        106.468 (12.628)       NE (NE)      #>       Median                      94.933              NE              111.133               NE              108.359               NE        #>       Min - Max               55.71 - 122.00        NE - NE        60.21 - 131.91        NE - NE         83.29 - 127.17        NE - NE      #>     BASELINE                                                                                                                                #>       n                             15                                   15                                    15                           #>       Mean (SD)              96.133 (22.458)                      108.111 (15.074)                      103.149 (19.752)                    #>       Median                      93.328                              108.951                               102.849                         #>       Min - Max               60.58 - 136.59                       83.44 - 131.62                        66.05 - 136.55                     #>     WEEK 1 DAY 8                                                                                                                            #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              98.977 (21.359)    2.844 (28.106)    104.110 (16.172)   -4.001 (21.867)    100.826 (19.027)   -2.323 (25.018)  #>       Median                      92.447            -4.066            107.703             3.227             103.058             -2.476      #>       Min - Max               67.55 - 130.37    -32.82 - 47.68     70.91 - 132.89     -52.94 - 28.63     70.04 - 128.68     -55.15 - 41.81  #>     WEEK 2 DAY 15                                                                                                                           #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              99.758 (14.477)    3.626 (21.189)    97.473 (17.296)    -10.638 (20.831)   94.272 (16.961)    -8.877 (27.229)  #>       Median                     101.498             1.731             99.501             -9.727             96.789            -10.155      #>       Min - Max               71.98 - 122.81    -39.50 - 47.57     53.80 - 125.81     -55.15 - 25.26     63.45 - 117.47     -73.10 - 46.54  #>     WEEK 3 DAY 22                                                                                                                           #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              99.101 (26.109)    2.968 (34.327)    91.984 (16.925)    -16.127 (21.881)   94.586 (13.560)    -8.563 (21.713)  #>       Median                     101.146            -0.271             91.244            -14.384             98.398            -16.075      #>       Min - Max               47.68 - 162.22    -47.87 - 76.64     67.80 - 119.72     -53.06 - 22.52     73.50 - 115.43     -37.90 - 32.66  #>     WEEK 4 DAY 29                                                                                                                           #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              103.400 (22.273)   7.267 (30.740)    96.467 (19.451)    -11.644 (25.922)   108.338 (18.417)    5.189 (21.881)  #>       Median                      98.168             2.510             97.385            -16.793            107.555             7.966       #>       Min - Max               63.09 - 148.25    -38.43 - 61.90     63.35 - 131.57     -57.11 - 48.13     68.78 - 132.52     -33.96 - 41.50  #>     WEEK 5 DAY 36                                                                                                                           #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              93.222 (18.536)    -2.911 (28.873)   97.890 (20.701)    -10.221 (27.593)   95.317 (16.401)    -7.832 (19.827)  #>       Median                      90.799            -3.385             99.049            -11.319             93.876             -4.665      #>       Min - Max               63.55 - 139.11    -48.63 - 47.35     69.47 - 137.64     -54.38 - 37.85     71.91 - 138.54     -44.47 - 29.11  #>   Systolic Blood Pressure                                                                                                                   #>     SCREENING                                                                                                                               #>       n                             15                 0                 15                 0                  15                 0         #>       Mean (SD)              154.073 (33.511)       NE (NE)       157.840 (34.393)       NE (NE)        152.407 (22.311)       NE (NE)      #>       Median                     156.169              NE              161.670               NE              149.556               NE        #>       Min - Max               78.31 - 210.70        NE - NE        79.76 - 210.40        NE - NE        108.21 - 184.88        NE - NE      #>     BASELINE                                                                                                                                #>       n                             15                                   15                                    15                           #>       Mean (SD)              145.925 (28.231)                     152.007 (28.664)                      154.173 (26.317)                    #>       Median                     142.705                              157.698                               155.282                         #>       Min - Max               85.21 - 195.68                       98.90 - 194.62                        86.65 - 192.68                     #>     WEEK 1 DAY 8                                                                                                                            #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              156.509 (21.097)   10.584 (34.598)   147.480 (33.473)   -4.527 (48.895)    143.319 (30.759)   -10.854 (34.553) #>       Median                     160.711             5.802            155.030             2.758             145.548             -5.636      #>       Min - Max              126.84 - 185.53    -53.28 - 91.52     85.22 - 189.88     -77.34 - 90.98     90.37 - 191.58     -65.71 - 49.04  #>     WEEK 2 DAY 15                                                                                                                           #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              144.202 (33.676)   -1.723 (27.067)   136.892 (30.178)   -15.115 (37.794)   148.622 (27.088)   -5.551 (44.670)  #>       Median                     144.253             5.325            142.679            -14.083            147.102            -11.512      #>       Min - Max               62.56 - 203.66    -53.89 - 44.16     70.34 - 174.27     -83.07 - 62.39    108.82 - 200.23    -69.54 - 113.59  #>     WEEK 3 DAY 22                                                                                                                           #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              154.887 (35.374)   8.962 (38.455)    149.761 (28.944)   -2.247 (44.835)    150.460 (21.352)   -3.712 (37.984)  #>       Median                     158.938            17.191            155.044             -1.796            156.505             -7.606      #>       Min - Max              112.32 - 218.83    -47.28 - 96.18     84.42 - 192.92    -110.20 - 94.02     94.70 - 180.41     -74.91 - 72.74  #>     WEEK 4 DAY 29                                                                                                                           #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              150.159 (32.249)   4.234 (32.965)    156.043 (22.863)    4.036 (42.494)    145.714 (22.980)   -8.458 (33.175)  #>       Median                     145.506             3.754            149.094            -10.000            150.797            -14.432      #>       Min - Max               69.37 - 210.43    -89.16 - 54.32    113.57 - 195.10     -71.44 - 77.75    106.91 - 188.09     -41.95 - 65.16  #>     WEEK 5 DAY 36                                                                                                                           #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              155.964 (30.945)   10.039 (42.252)   156.387 (35.274)    4.380 (51.782)    143.592 (33.170)   -10.581 (44.799) #>       Median                     158.142             1.448            164.552             7.060             148.501             -2.385      #>       Min - Max              110.61 - 212.47    -53.91 - 90.45     63.28 - 198.79    -131.34 - 86.84     92.18 - 191.05     -78.77 - 64.35"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"absolute-value-and-change-from-baseline-by-visit-without-screening","dir":"Articles","previous_headings":"TABLES > Absolute Value and Change from Baseline by Visit (CFBT01)","what":"2. Absolute Value and Change from Baseline by Visit without Screening","title":"Chevron Catalog","text":"skip arguments controls visit values displayed. instance, mask changes baseline ‚ÄúSCREENING‚Äù ‚ÄúBASELINE‚Äù visits.","code":"run(cfbt01, proc_data, dataset = \"advs\", skip = list(CHG = c(\"SCREENING\", \"BASELINE\"))) #>                                          A: Drug X                            B: Placebo                          C: Combination            #>                                                   Change from                          Change from                           Change from    #>                               Value at Visit       Baseline        Value at Visit        Baseline        Value at Visit        Baseline     #>   Analysis Visit                  (N=15)            (N=15)             (N=15)             (N=15)             (N=15)             (N=15)      #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Diastolic Blood Pressure                                                                                                                  #>     SCREENING                                                                                                                               #>       n                             15                                   15                                    15                           #>       Mean (SD)              94.385 (17.067)                      106.381 (20.586)                      106.468 (12.628)                    #>       Median                      94.933                              111.133                               108.359                         #>       Min - Max               55.71 - 122.00                       60.21 - 131.91                        83.29 - 127.17                     #>     BASELINE                                                                                                                                #>       n                             15                                   15                                    15                           #>       Mean (SD)              96.133 (22.458)                      108.111 (15.074)                      103.149 (19.752)                    #>       Median                      93.328                              108.951                               102.849                         #>       Min - Max               60.58 - 136.59                       83.44 - 131.62                        66.05 - 136.55                     #>     WEEK 1 DAY 8                                                                                                                            #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              98.977 (21.359)    2.844 (28.106)    104.110 (16.172)   -4.001 (21.867)    100.826 (19.027)   -2.323 (25.018)  #>       Median                      92.447            -4.066            107.703             3.227             103.058             -2.476      #>       Min - Max               67.55 - 130.37    -32.82 - 47.68     70.91 - 132.89     -52.94 - 28.63     70.04 - 128.68     -55.15 - 41.81  #>     WEEK 2 DAY 15                                                                                                                           #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              99.758 (14.477)    3.626 (21.189)    97.473 (17.296)    -10.638 (20.831)   94.272 (16.961)    -8.877 (27.229)  #>       Median                     101.498             1.731             99.501             -9.727             96.789            -10.155      #>       Min - Max               71.98 - 122.81    -39.50 - 47.57     53.80 - 125.81     -55.15 - 25.26     63.45 - 117.47     -73.10 - 46.54  #>     WEEK 3 DAY 22                                                                                                                           #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              99.101 (26.109)    2.968 (34.327)    91.984 (16.925)    -16.127 (21.881)   94.586 (13.560)    -8.563 (21.713)  #>       Median                     101.146            -0.271             91.244            -14.384             98.398            -16.075      #>       Min - Max               47.68 - 162.22    -47.87 - 76.64     67.80 - 119.72     -53.06 - 22.52     73.50 - 115.43     -37.90 - 32.66  #>     WEEK 4 DAY 29                                                                                                                           #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              103.400 (22.273)   7.267 (30.740)    96.467 (19.451)    -11.644 (25.922)   108.338 (18.417)    5.189 (21.881)  #>       Median                      98.168             2.510             97.385            -16.793            107.555             7.966       #>       Min - Max               63.09 - 148.25    -38.43 - 61.90     63.35 - 131.57     -57.11 - 48.13     68.78 - 132.52     -33.96 - 41.50  #>     WEEK 5 DAY 36                                                                                                                           #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              93.222 (18.536)    -2.911 (28.873)   97.890 (20.701)    -10.221 (27.593)   95.317 (16.401)    -7.832 (19.827)  #>       Median                      90.799            -3.385             99.049            -11.319             93.876             -4.665      #>       Min - Max               63.55 - 139.11    -48.63 - 47.35     69.47 - 137.64     -54.38 - 37.85     71.91 - 138.54     -44.47 - 29.11  #>   Systolic Blood Pressure                                                                                                                   #>     SCREENING                                                                                                                               #>       n                             15                                   15                                    15                           #>       Mean (SD)              154.073 (33.511)                     157.840 (34.393)                      152.407 (22.311)                    #>       Median                     156.169                              161.670                               149.556                         #>       Min - Max               78.31 - 210.70                       79.76 - 210.40                       108.21 - 184.88                     #>     BASELINE                                                                                                                                #>       n                             15                                   15                                    15                           #>       Mean (SD)              145.925 (28.231)                     152.007 (28.664)                      154.173 (26.317)                    #>       Median                     142.705                              157.698                               155.282                         #>       Min - Max               85.21 - 195.68                       98.90 - 194.62                        86.65 - 192.68                     #>     WEEK 1 DAY 8                                                                                                                            #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              156.509 (21.097)   10.584 (34.598)   147.480 (33.473)   -4.527 (48.895)    143.319 (30.759)   -10.854 (34.553) #>       Median                     160.711             5.802            155.030             2.758             145.548             -5.636      #>       Min - Max              126.84 - 185.53    -53.28 - 91.52     85.22 - 189.88     -77.34 - 90.98     90.37 - 191.58     -65.71 - 49.04  #>     WEEK 2 DAY 15                                                                                                                           #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              144.202 (33.676)   -1.723 (27.067)   136.892 (30.178)   -15.115 (37.794)   148.622 (27.088)   -5.551 (44.670)  #>       Median                     144.253             5.325            142.679            -14.083            147.102            -11.512      #>       Min - Max               62.56 - 203.66    -53.89 - 44.16     70.34 - 174.27     -83.07 - 62.39    108.82 - 200.23    -69.54 - 113.59  #>     WEEK 3 DAY 22                                                                                                                           #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              154.887 (35.374)   8.962 (38.455)    149.761 (28.944)   -2.247 (44.835)    150.460 (21.352)   -3.712 (37.984)  #>       Median                     158.938            17.191            155.044             -1.796            156.505             -7.606      #>       Min - Max              112.32 - 218.83    -47.28 - 96.18     84.42 - 192.92    -110.20 - 94.02     94.70 - 180.41     -74.91 - 72.74  #>     WEEK 4 DAY 29                                                                                                                           #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              150.159 (32.249)   4.234 (32.965)    156.043 (22.863)    4.036 (42.494)    145.714 (22.980)   -8.458 (33.175)  #>       Median                     145.506             3.754            149.094            -10.000            150.797            -14.432      #>       Min - Max               69.37 - 210.43    -89.16 - 54.32    113.57 - 195.10     -71.44 - 77.75    106.91 - 188.09     -41.95 - 65.16  #>     WEEK 5 DAY 36                                                                                                                           #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              155.964 (30.945)   10.039 (42.252)   156.387 (35.274)    4.380 (51.782)    143.592 (33.170)   -10.581 (44.799) #>       Median                     158.142             1.448            164.552             7.060             148.501             -2.385      #>       Min - Max              110.61 - 212.47    -53.91 - 90.45     63.28 - 198.79    -131.34 - 86.84     92.18 - 191.05     -78.77 - 64.35"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"absolute-value-by-visit","dir":"Articles","previous_headings":"TABLES","what":"3. Absolute Value by Visit","title":"Chevron Catalog","text":"display absolute value, specify summaryvars  = \"AVAL\".","code":"run(cfbt01, proc_data, dataset = \"advs\", summaryvars = \"AVAL\") #>                                 A: Drug X          B: Placebo       C: Combination  #>                               Value at Visit     Value at Visit     Value at Visit  #>   Analysis Visit                  (N=15)             (N=15)             (N=15)      #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Diastolic Blood Pressure                                                          #>     SCREENING                                                                       #>       n                             15                 15                 15        #>       Mean (SD)              94.385 (17.067)    106.381 (20.586)   106.468 (12.628) #>       Median                      94.933            111.133            108.359      #>       Min - Max               55.71 - 122.00     60.21 - 131.91     83.29 - 127.17  #>     BASELINE                                                                        #>       n                             15                 15                 15        #>       Mean (SD)              96.133 (22.458)    108.111 (15.074)   103.149 (19.752) #>       Median                      93.328            108.951            102.849      #>       Min - Max               60.58 - 136.59     83.44 - 131.62     66.05 - 136.55  #>     WEEK 1 DAY 8                                                                    #>       n                             15                 15                 15        #>       Mean (SD)              98.977 (21.359)    104.110 (16.172)   100.826 (19.027) #>       Median                      92.447            107.703            103.058      #>       Min - Max               67.55 - 130.37     70.91 - 132.89     70.04 - 128.68  #>     WEEK 2 DAY 15                                                                   #>       n                             15                 15                 15        #>       Mean (SD)              99.758 (14.477)    97.473 (17.296)    94.272 (16.961)  #>       Median                     101.498             99.501             96.789      #>       Min - Max               71.98 - 122.81     53.80 - 125.81     63.45 - 117.47  #>     WEEK 3 DAY 22                                                                   #>       n                             15                 15                 15        #>       Mean (SD)              99.101 (26.109)    91.984 (16.925)    94.586 (13.560)  #>       Median                     101.146             91.244             98.398      #>       Min - Max               47.68 - 162.22     67.80 - 119.72     73.50 - 115.43  #>     WEEK 4 DAY 29                                                                   #>       n                             15                 15                 15        #>       Mean (SD)              103.400 (22.273)   96.467 (19.451)    108.338 (18.417) #>       Median                      98.168             97.385            107.555      #>       Min - Max               63.09 - 148.25     63.35 - 131.57     68.78 - 132.52  #>     WEEK 5 DAY 36                                                                   #>       n                             15                 15                 15        #>       Mean (SD)              93.222 (18.536)    97.890 (20.701)    95.317 (16.401)  #>       Median                      90.799             99.049             93.876      #>       Min - Max               63.55 - 139.11     69.47 - 137.64     71.91 - 138.54  #>   Systolic Blood Pressure                                                           #>     SCREENING                                                                       #>       n                             15                 15                 15        #>       Mean (SD)              154.073 (33.511)   157.840 (34.393)   152.407 (22.311) #>       Median                     156.169            161.670            149.556      #>       Min - Max               78.31 - 210.70     79.76 - 210.40    108.21 - 184.88  #>     BASELINE                                                                        #>       n                             15                 15                 15        #>       Mean (SD)              145.925 (28.231)   152.007 (28.664)   154.173 (26.317) #>       Median                     142.705            157.698            155.282      #>       Min - Max               85.21 - 195.68     98.90 - 194.62     86.65 - 192.68  #>     WEEK 1 DAY 8                                                                    #>       n                             15                 15                 15        #>       Mean (SD)              156.509 (21.097)   147.480 (33.473)   143.319 (30.759) #>       Median                     160.711            155.030            145.548      #>       Min - Max              126.84 - 185.53     85.22 - 189.88     90.37 - 191.58  #>     WEEK 2 DAY 15                                                                   #>       n                             15                 15                 15        #>       Mean (SD)              144.202 (33.676)   136.892 (30.178)   148.622 (27.088) #>       Median                     144.253            142.679            147.102      #>       Min - Max               62.56 - 203.66     70.34 - 174.27    108.82 - 200.23  #>     WEEK 3 DAY 22                                                                   #>       n                             15                 15                 15        #>       Mean (SD)              154.887 (35.374)   149.761 (28.944)   150.460 (21.352) #>       Median                     158.938            155.044            156.505      #>       Min - Max              112.32 - 218.83     84.42 - 192.92     94.70 - 180.41  #>     WEEK 4 DAY 29                                                                   #>       n                             15                 15                 15        #>       Mean (SD)              150.159 (32.249)   156.043 (22.863)   145.714 (22.980) #>       Median                     145.506            149.094            150.797      #>       Min - Max               69.37 - 210.43    113.57 - 195.10    106.91 - 188.09  #>     WEEK 5 DAY 36                                                                   #>       n                             15                 15                 15        #>       Mean (SD)              155.964 (30.945)   156.387 (35.274)   143.592 (33.170) #>       Median                     158.142            164.552            148.501      #>       Min - Max              110.61 - 212.47     63.28 - 198.79     92.18 - 191.05"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"concomitant-medications-by-medication-class-and-preferred-name","dir":"Articles","previous_headings":"TABLES > Concomitant Medications by Medication Class and Preferred Name (CMT01A)","what":"1. Concomitant Medications by Medication Class and Preferred Name","title":"Chevron Catalog","text":"cmt01a template displays concomitant medications ATC Level 2 Preferred Name default. template include column total default. template sort medication class preferred name alphabetical order default.","code":"run(cmt01a, syn_data) #>   ATC Level 2 Text                                         A: Drug X    B: Placebo   C: Combination #>     Other Treatment                                          (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Total number of patients with at least one treatment     13 (86.7%)   14 (93.3%)     15 (100%)    #>   Total number of treatments                                   58           59             99       #>   ATCCLAS2 A                                                                                        #>     Total number of patients with at least one treatment   10 (66.7%)   11 (73.3%)     12 (80.0%)   #>     Total number of treatments                                 15           21             28       #>     medname A_3/3                                          5 (33.3%)    8 (53.3%)      6 (40.0%)    #>     medname A_2/3                                          5 (33.3%)    6 (40.0%)      7 (46.7%)    #>     medname A_1/3                                          4 (26.7%)    3 (20.0%)      8 (53.3%)    #>   ATCCLAS2 A p2                                                                                     #>     Total number of patients with at least one treatment   5 (33.3%)    8 (53.3%)      6 (40.0%)    #>     Total number of treatments                                 6            8              8        #>     medname A_3/3                                          5 (33.3%)    8 (53.3%)      6 (40.0%)    #>   ATCCLAS2 B                                                                                        #>     Total number of patients with at least one treatment   12 (80.0%)   10 (66.7%)     14 (93.3%)   #>     Total number of treatments                                 30           30             52       #>     medname B_3/4                                          8 (53.3%)    6 (40.0%)      8 (53.3%)    #>     medname B_2/4                                          6 (40.0%)    5 (33.3%)      10 (66.7%)   #>     medname B_1/4                                          7 (46.7%)    6 (40.0%)      6 (40.0%)    #>     medname B_4/4                                          4 (26.7%)    5 (33.3%)      8 (53.3%)    #>   ATCCLAS2 B p2                                                                                     #>     Total number of patients with at least one treatment   10 (66.7%)   8 (53.3%)      12 (80.0%)   #>     Total number of treatments                                 18           17             25       #>     medname B_2/4                                          6 (40.0%)    5 (33.3%)      10 (66.7%)   #>     medname B_1/4                                          7 (46.7%)    6 (40.0%)      6 (40.0%)    #>   ATCCLAS2 B p3                                                                                     #>     Total number of patients with at least one treatment   10 (66.7%)   8 (53.3%)      12 (80.0%)   #>     Total number of treatments                                 18           17             25       #>     medname B_2/4                                          6 (40.0%)    5 (33.3%)      10 (66.7%)   #>     medname B_1/4                                          7 (46.7%)    6 (40.0%)      6 (40.0%)    #>   ATCCLAS2 C                                                                                        #>     Total number of patients with at least one treatment   9 (60.0%)    7 (46.7%)      12 (80.0%)   #>     Total number of treatments                                 13           8              19       #>     medname C_2/2                                          4 (26.7%)    5 (33.3%)      7 (46.7%)    #>     medname C_1/2                                          6 (40.0%)    2 (13.3%)      6 (40.0%)    #>   ATCCLAS2 C p2                                                                                     #>     Total number of patients with at least one treatment   9 (60.0%)    7 (46.7%)      12 (80.0%)   #>     Total number of treatments                                 13           8              19       #>     medname C_2/2                                          4 (26.7%)    5 (33.3%)      7 (46.7%)    #>     medname C_1/2                                          6 (40.0%)    2 (13.3%)      6 (40.0%)    #>   ATCCLAS2 C p3                                                                                     #>     Total number of patients with at least one treatment   4 (26.7%)    5 (33.3%)      7 (46.7%)    #>     Total number of treatments                                 5            5              12       #>     medname C_2/2                                          4 (26.7%)    5 (33.3%)      7 (46.7%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"concomitant-medications-by-medication-class-and-preferred-name-changing-atc-class-level","dir":"Articles","previous_headings":"TABLES > Concomitant Medications by Medication Class and Preferred Name (CMT01A)","what":"2. Concomitant Medications by Medication Class and Preferred Name (changing ATC class level)","title":"Chevron Catalog","text":"","code":"run(cmt01a, syn_data, row_split_var = \"ATC1\") #>   ATC Level 1 Text                                         A: Drug X    B: Placebo   C: Combination #>     Other Treatment                                          (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Total number of patients with at least one treatment     13 (86.7%)   14 (93.3%)     15 (100%)    #>   Total number of treatments                                   58           59             99       #>   ATCCLAS1 A                                                                                        #>     Total number of patients with at least one treatment   10 (66.7%)   11 (73.3%)     12 (80.0%)   #>     Total number of treatments                                 15           21             28       #>     medname A_3/3                                          5 (33.3%)    8 (53.3%)      6 (40.0%)    #>     medname A_2/3                                          5 (33.3%)    6 (40.0%)      7 (46.7%)    #>     medname A_1/3                                          4 (26.7%)    3 (20.0%)      8 (53.3%)    #>   ATCCLAS1 A p2                                                                                     #>     Total number of patients with at least one treatment   5 (33.3%)    8 (53.3%)      6 (40.0%)    #>     Total number of treatments                                 6            8              8        #>     medname A_3/3                                          5 (33.3%)    8 (53.3%)      6 (40.0%)    #>   ATCCLAS1 B                                                                                        #>     Total number of patients with at least one treatment   12 (80.0%)   10 (66.7%)     14 (93.3%)   #>     Total number of treatments                                 30           30             52       #>     medname B_3/4                                          8 (53.3%)    6 (40.0%)      8 (53.3%)    #>     medname B_2/4                                          6 (40.0%)    5 (33.3%)      10 (66.7%)   #>     medname B_1/4                                          7 (46.7%)    6 (40.0%)      6 (40.0%)    #>     medname B_4/4                                          4 (26.7%)    5 (33.3%)      8 (53.3%)    #>   ATCCLAS1 B p2                                                                                     #>     Total number of patients with at least one treatment   10 (66.7%)   8 (53.3%)      12 (80.0%)   #>     Total number of treatments                                 18           17             25       #>     medname B_2/4                                          6 (40.0%)    5 (33.3%)      10 (66.7%)   #>     medname B_1/4                                          7 (46.7%)    6 (40.0%)      6 (40.0%)    #>   ATCCLAS1 B p3                                                                                     #>     Total number of patients with at least one treatment   10 (66.7%)   8 (53.3%)      12 (80.0%)   #>     Total number of treatments                                 18           17             25       #>     medname B_2/4                                          6 (40.0%)    5 (33.3%)      10 (66.7%)   #>     medname B_1/4                                          7 (46.7%)    6 (40.0%)      6 (40.0%)    #>   ATCCLAS1 C                                                                                        #>     Total number of patients with at least one treatment   9 (60.0%)    7 (46.7%)      12 (80.0%)   #>     Total number of treatments                                 13           8              19       #>     medname C_2/2                                          4 (26.7%)    5 (33.3%)      7 (46.7%)    #>     medname C_1/2                                          6 (40.0%)    2 (13.3%)      6 (40.0%)    #>   ATCCLAS1 C p2                                                                                     #>     Total number of patients with at least one treatment   9 (60.0%)    7 (46.7%)      12 (80.0%)   #>     Total number of treatments                                 13           8              19       #>     medname C_2/2                                          4 (26.7%)    5 (33.3%)      7 (46.7%)    #>     medname C_1/2                                          6 (40.0%)    2 (13.3%)      6 (40.0%)    #>   ATCCLAS1 C p3                                                                                     #>     Total number of patients with at least one treatment   4 (26.7%)    5 (33.3%)      7 (46.7%)    #>     Total number of treatments                                 5            5              12       #>     medname C_2/2                                          4 (26.7%)    5 (33.3%)      7 (46.7%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"concomitant-medications-by-medication-class-and-preferred-name-classes-sorted-by-frequency","dir":"Articles","previous_headings":"TABLES > Concomitant Medications by Medication Class and Preferred Name (CMT01A)","what":"3. Concomitant Medications by Medication Class and Preferred Name (classes sorted by frequency)","title":"Chevron Catalog","text":"argument sort_by_freq = TRUE sort medication class frequency.","code":"run(cmt01a, syn_data, sort_by_freq = TRUE) #>   ATC Level 2 Text                                         A: Drug X    B: Placebo   C: Combination #>     Other Treatment                                          (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Total number of patients with at least one treatment     13 (86.7%)   14 (93.3%)     15 (100%)    #>   Total number of treatments                                   58           59             99       #>   ATCCLAS2 B                                                                                        #>     Total number of patients with at least one treatment   12 (80.0%)   10 (66.7%)     14 (93.3%)   #>     Total number of treatments                                 30           30             52       #>     medname B_3/4                                          8 (53.3%)    6 (40.0%)      8 (53.3%)    #>     medname B_2/4                                          6 (40.0%)    5 (33.3%)      10 (66.7%)   #>     medname B_1/4                                          7 (46.7%)    6 (40.0%)      6 (40.0%)    #>     medname B_4/4                                          4 (26.7%)    5 (33.3%)      8 (53.3%)    #>   ATCCLAS2 A                                                                                        #>     Total number of patients with at least one treatment   10 (66.7%)   11 (73.3%)     12 (80.0%)   #>     Total number of treatments                                 15           21             28       #>     medname A_3/3                                          5 (33.3%)    8 (53.3%)      6 (40.0%)    #>     medname A_2/3                                          5 (33.3%)    6 (40.0%)      7 (46.7%)    #>     medname A_1/3                                          4 (26.7%)    3 (20.0%)      8 (53.3%)    #>   ATCCLAS2 B p2                                                                                     #>     Total number of patients with at least one treatment   10 (66.7%)   8 (53.3%)      12 (80.0%)   #>     Total number of treatments                                 18           17             25       #>     medname B_2/4                                          6 (40.0%)    5 (33.3%)      10 (66.7%)   #>     medname B_1/4                                          7 (46.7%)    6 (40.0%)      6 (40.0%)    #>   ATCCLAS2 B p3                                                                                     #>     Total number of patients with at least one treatment   10 (66.7%)   8 (53.3%)      12 (80.0%)   #>     Total number of treatments                                 18           17             25       #>     medname B_2/4                                          6 (40.0%)    5 (33.3%)      10 (66.7%)   #>     medname B_1/4                                          7 (46.7%)    6 (40.0%)      6 (40.0%)    #>   ATCCLAS2 C                                                                                        #>     Total number of patients with at least one treatment   9 (60.0%)    7 (46.7%)      12 (80.0%)   #>     Total number of treatments                                 13           8              19       #>     medname C_2/2                                          4 (26.7%)    5 (33.3%)      7 (46.7%)    #>     medname C_1/2                                          6 (40.0%)    2 (13.3%)      6 (40.0%)    #>   ATCCLAS2 C p2                                                                                     #>     Total number of patients with at least one treatment   9 (60.0%)    7 (46.7%)      12 (80.0%)   #>     Total number of treatments                                 13           8              19       #>     medname C_2/2                                          4 (26.7%)    5 (33.3%)      7 (46.7%)    #>     medname C_1/2                                          6 (40.0%)    2 (13.3%)      6 (40.0%)    #>   ATCCLAS2 A p2                                                                                     #>     Total number of patients with at least one treatment   5 (33.3%)    8 (53.3%)      6 (40.0%)    #>     Total number of treatments                                 6            8              8        #>     medname A_3/3                                          5 (33.3%)    8 (53.3%)      6 (40.0%)    #>   ATCCLAS2 C p3                                                                                     #>     Total number of patients with at least one treatment   4 (26.7%)    5 (33.3%)      7 (46.7%)    #>     Total number of treatments                                 5            5              12       #>     medname C_2/2                                          4 (26.7%)    5 (33.3%)      7 (46.7%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"concomitant-medications-by-medication-class-and-preferred-name-total-number-of-treatments-per-medication-class-suppressed","dir":"Articles","previous_headings":"TABLES > Concomitant Medications by Medication Class and Preferred Name (CMT01A)","what":"4. Concomitant Medications by Medication Class and Preferred Name (total number of treatments per medication class suppressed)","title":"Chevron Catalog","text":"cmt01a template includes analysis ‚Äòtotal number treatments‚Äô default, modify argument summary_labels change .","code":"run(cmt01a, syn_data, summary_labels = list(TOTAL = cmt01_label, ATC2 = cmt01_label[1])) #>   ATC Level 2 Text                                         A: Drug X    B: Placebo   C: Combination #>     Other Treatment                                          (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Total number of patients with at least one treatment     13 (86.7%)   14 (93.3%)     15 (100%)    #>   Total number of treatments                                   58           59             99       #>   ATCCLAS2 A                                                                                        #>     Total number of patients with at least one treatment   10 (66.7%)   11 (73.3%)     12 (80.0%)   #>     medname A_3/3                                          5 (33.3%)    8 (53.3%)      6 (40.0%)    #>     medname A_2/3                                          5 (33.3%)    6 (40.0%)      7 (46.7%)    #>     medname A_1/3                                          4 (26.7%)    3 (20.0%)      8 (53.3%)    #>   ATCCLAS2 A p2                                                                                     #>     Total number of patients with at least one treatment   5 (33.3%)    8 (53.3%)      6 (40.0%)    #>     medname A_3/3                                          5 (33.3%)    8 (53.3%)      6 (40.0%)    #>   ATCCLAS2 B                                                                                        #>     Total number of patients with at least one treatment   12 (80.0%)   10 (66.7%)     14 (93.3%)   #>     medname B_3/4                                          8 (53.3%)    6 (40.0%)      8 (53.3%)    #>     medname B_2/4                                          6 (40.0%)    5 (33.3%)      10 (66.7%)   #>     medname B_1/4                                          7 (46.7%)    6 (40.0%)      6 (40.0%)    #>     medname B_4/4                                          4 (26.7%)    5 (33.3%)      8 (53.3%)    #>   ATCCLAS2 B p2                                                                                     #>     Total number of patients with at least one treatment   10 (66.7%)   8 (53.3%)      12 (80.0%)   #>     medname B_2/4                                          6 (40.0%)    5 (33.3%)      10 (66.7%)   #>     medname B_1/4                                          7 (46.7%)    6 (40.0%)      6 (40.0%)    #>   ATCCLAS2 B p3                                                                                     #>     Total number of patients with at least one treatment   10 (66.7%)   8 (53.3%)      12 (80.0%)   #>     medname B_2/4                                          6 (40.0%)    5 (33.3%)      10 (66.7%)   #>     medname B_1/4                                          7 (46.7%)    6 (40.0%)      6 (40.0%)    #>   ATCCLAS2 C                                                                                        #>     Total number of patients with at least one treatment   9 (60.0%)    7 (46.7%)      12 (80.0%)   #>     medname C_2/2                                          4 (26.7%)    5 (33.3%)      7 (46.7%)    #>     medname C_1/2                                          6 (40.0%)    2 (13.3%)      6 (40.0%)    #>   ATCCLAS2 C p2                                                                                     #>     Total number of patients with at least one treatment   9 (60.0%)    7 (46.7%)      12 (80.0%)   #>     medname C_2/2                                          4 (26.7%)    5 (33.3%)      7 (46.7%)    #>     medname C_1/2                                          6 (40.0%)    2 (13.3%)      6 (40.0%)    #>   ATCCLAS2 C p3                                                                                     #>     Total number of patients with at least one treatment   4 (26.7%)    5 (33.3%)      7 (46.7%)    #>     medname C_2/2                                          4 (26.7%)    5 (33.3%)      7 (46.7%)"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"concomitant-medications-by-preferred-name","dir":"Articles","previous_headings":"TABLES > Concomitant Medications by Preferred Name (CMT02_PT)","what":"1. Concomitant Medications by Preferred Name","title":"Chevron Catalog","text":"cmt02_pt template displays concomitant medications Preferred Name default. template include column total default. template sorts preferred name alphabetical order default. Set argument sort_by_freq = TRUE sort preferred names frequency.","code":"run(cmt02_pt, syn_data) #>                                                          A: Drug X    B: Placebo   C: Combination #>   Other Treatment                                          (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Total number of patients with at least one treatment   13 (86.7%)   14 (93.3%)     15 (100%)    #>   Total number of treatments                                 58           59             99       #>   medname B_3/4                                          8 (53.3%)    6 (40.0%)      8 (53.3%)    #>   medname B_2/4                                          6 (40.0%)    5 (33.3%)      10 (66.7%)   #>   medname A_3/3                                          5 (33.3%)    8 (53.3%)      6 (40.0%)    #>   medname B_1/4                                          7 (46.7%)    6 (40.0%)      6 (40.0%)    #>   medname A_2/3                                          5 (33.3%)    6 (40.0%)      7 (46.7%)    #>   medname B_4/4                                          4 (26.7%)    5 (33.3%)      8 (53.3%)    #>   medname C_2/2                                          4 (26.7%)    5 (33.3%)      7 (46.7%)    #>   medname A_1/3                                          4 (26.7%)    3 (20.0%)      8 (53.3%)    #>   medname C_1/2                                          6 (40.0%)    2 (13.3%)      6 (40.0%)"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"cox-regression","dir":"Articles","previous_headings":"TABLES > Cox Regression (COXT01)","what":"1. Cox Regression","title":"Chevron Catalog","text":"coxt01 template produces standard Cox regression output. Users expected pre-process input analysis data selecting time--event parameter analyzed. example based time--event parameter ‚ÄúDuration Confirmed Response Investigator‚Äù. time variable model specified time_var argument. default, time_var set \"AVAL\", comes ADTTE.AVAL. event variable model specified event_var argument. default, event_var set \"EVENT\", derived based censoring indicator ADTTE.CNSR pre-processing function coxt01_pre. two treatment groups present input analysis data, users also expected select two treatment groups. example based treatment groups \"Arm \" \"Arm B\".","code":"proc_data <- log_filter(syn_data, PARAMCD == \"OS\", \"adtte\") proc_data <- log_filter(proc_data, ARMCD != \"ARM C\", \"adsl\") run(coxt01, proc_data, time_var = \"AVAL\", event_var = \"EVENT\") #>                                                Treatment Effect Adjusted for Covariate      #>   Effect/Covariate Included in the Model    n      Hazard Ratio       95% CI       p-value  #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Treatment:                                                                                #>     B: Placebo vs control (A: Drug X)       30         2.71        (0.93, 7.88)     0.0666  #>   Covariate:                                                                                #>     Sex                                     30         2.91        (0.97, 8.73)     0.0567  #>     RACE                                    30         3.09        (1.01, 9.50)     0.0487  #>     Age (yr)                                30         2.89        (0.97, 8.59)     0.0566"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"cox-regression-with-interaction-term","dir":"Articles","previous_headings":"TABLES > Cox Regression (COXT01)","what":"2. Cox Regression (with interaction term)","title":"Chevron Catalog","text":"add interaction term model, interaction = TRUE, passed tern::control_coxreg(), needs specified.","code":"run(coxt01, proc_data, covariates = \"AAGE\", interaction = TRUE) #>                                                        Treatment Effect Adjusted for Covariate              #>   Effect/Covariate Included in the Model   n    Hazard Ratio      95% CI      p-value   Interaction p-value #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Treatment:                                                                                                #>     B: Placebo vs control (A: Drug X)      30       2.71       (0.93, 7.88)   0.0666                        #>   Covariate:                                                                                                #>     Age (yr)                               30                                                 0.3666        #>       32                                            2.87       (0.98, 8.41)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"cox-regression-specifying-covariates","dir":"Articles","previous_headings":"TABLES > Cox Regression (COXT01)","what":"3. Cox Regression (specifying covariates)","title":"Chevron Catalog","text":"default, \"SEX\", \"RACE\" \"AAGE\" used covariates model. Users can specify different set covariates covariates argument. example , \"RACE\" \"AAGE\" used covariates.","code":"run(coxt01, proc_data, covariates = c(\"RACE\", \"AAGE\")) #>                                                Treatment Effect Adjusted for Covariate      #>   Effect/Covariate Included in the Model    n      Hazard Ratio       95% CI       p-value  #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Treatment:                                                                                #>     B: Placebo vs control (A: Drug X)       30         2.71        (0.93, 7.88)     0.0666  #>   Covariate:                                                                                #>     RACE                                    30         3.09        (1.01, 9.50)     0.0487  #>     Age (yr)                                30         2.89        (0.97, 8.59)     0.0566"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"cox-regression-setting-strata-ties-and-alpha-level","dir":"Articles","previous_headings":"TABLES > Cox Regression (COXT01)","what":"4. Cox Regression (setting strata, ties, and alpha level)","title":"Chevron Catalog","text":"default, strata = NULL (stratification), ties = \"exact\" (equivalent DISCRETE SAS), conf_level = 0.95 applied. Users can specify one stratification variables via strata argument. tie handling methods, .e., \"efron\" \"breslow\", can specified tie argument, passed tern::control_coxreg(). Users can also customize alpha level confidence intervals conf_level argument, passed tern::control_coxreg().","code":"run(coxt01, proc_data, covariates = c(\"SEX\", \"AAGE\"), strata = c(\"RACE\"), conf_level = 0.90) #>                                                Treatment Effect Adjusted for Covariate      #>   Effect/Covariate Included in the Model    n      Hazard Ratio       90% CI       p-value  #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Treatment:                                                                                #>     B: Placebo vs control (A: Drug X)       30         2.69        (1.07, 6.76)     0.0785  #>   Covariate:                                                                                #>     Sex                                     30         2.90        (1.12, 7.54)     0.0668  #>     Age (yr)                                30         2.72        (1.08, 6.85)     0.0755"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"multi-variable-cox-regression","dir":"Articles","previous_headings":"TABLES > Multi-variable Cox Regression (COXT02)","what":"1. Multi-variable Cox Regression","title":"Chevron Catalog","text":"coxt02 template produces standard multi-variable cox regression output. Users expected pre-process input analysis data selecting time--event parameter analyzed. example based time--event parameter ‚ÄúDuration Confirmed Response Investigator‚Äù. time variable model specified time_var argument. default, time_var set \"AVAL\", comes ADTTE.AVAL. event variable model specified event_var argument. default, event_var set \"EVENT\", derived based censoring indicator ADTTE.CNSR pre-processing function coxt01_pre.","code":"proc_data <- log_filter(syn_data, PARAMCD == \"OS\", \"adtte\") run(coxt02, proc_data, time_var = \"AVAL\", event_var = \"EVENT\") #>   Effect/Covariate Included in the Model                  Hazard Ratio      95% CI      p-value #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Treatment:                                                                                    #>     Description of Planned Arm (reference = A: Drug X)                                  0.1630  #>       B: Placebo                                              2.92       (0.93, 9.17)   0.0672  #>       C: Combination                                          1.56       (0.47, 5.10)   0.4659  #>   Covariate:                                                                                    #>     Sex (reference = F)                                                                         #>       M                                                       1.03       (0.41, 2.55)   0.9549  #>     RACE (reference = AMERICAN INDIAN OR ALASKA NATIVE)                                 0.8498  #>       ASIAN                                                   1.22       (0.27, 5.55)   0.7967  #>       BLACK OR AFRICAN AMERICAN                               0.81       (0.12, 5.70)   0.8340  #>       WHITE                                                   1.57       (0.26, 9.67)   0.6258  #>     Age (yr)                                                                                    #>       All                                                     0.99       (0.93, 1.05)   0.6650"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"multi-variable-cox-regression-specifying-covariates","dir":"Articles","previous_headings":"TABLES > Multi-variable Cox Regression (COXT02)","what":"2. Multi-variable Cox Regression (specifying covariates)","title":"Chevron Catalog","text":"default, \"SEX\", \"RACE\" \"AAGE\" used covariates model. Users can specify different set covariates covariates argument. example , \"RACE\" \"AAGE\" used covariates.","code":"run(coxt02, proc_data, covariates = c(\"RACE\", \"AAGE\")) #>   Effect/Covariate Included in the Model                  Hazard Ratio      95% CI      p-value #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Treatment:                                                                                    #>     Description of Planned Arm (reference = A: Drug X)                                  0.1390  #>       B: Placebo                                              2.94       (0.97, 8.92)   0.0570  #>       C: Combination                                          1.56       (0.48, 5.09)   0.4605  #>   Covariate:                                                                                    #>     RACE (reference = AMERICAN INDIAN OR ALASKA NATIVE)                                 0.8504  #>       ASIAN                                                   1.22       (0.27, 5.54)   0.7972  #>       BLACK OR AFRICAN AMERICAN                               0.81       (0.12, 5.65)   0.8306  #>       WHITE                                                   1.56       (0.26, 9.53)   0.6279  #>     Age (yr)                                                                                    #>       All                                                     0.99       (0.93, 1.05)   0.6633"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"multi-variable-cox-regression-setting-strata-ties-and-alpha-level","dir":"Articles","previous_headings":"TABLES > Multi-variable Cox Regression (COXT02)","what":"3. Multi-variable Cox Regression (setting strata, ties, and alpha level)","title":"Chevron Catalog","text":"default, strata = NULL (stratification), ties = \"exact\" (equivalent DISCRETE SAS), conf_level = 0.95 applied. Users can specify one stratification variables via strata argument. tie handling methods, .e., \"efron\" \"breslow\", can specified tie argument, passed tern::control_coxreg(). Users can also customize alpha level confidence intervals conf_level argument, passed tern::control_coxreg().","code":"run(coxt02, proc_data, covariates = c(\"SEX\", \"AAGE\"), strata = c(\"RACE\"), conf_level = 0.90, ties = \"efron\") #>   Effect/Covariate Included in the Model                 Hazard Ratio      90% CI      p-value #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Treatment:                                                                                   #>     Description of Planned Arm (reference = A: Drug X)                                 0.1680  #>       B: Placebo                                             2.85       (1.09, 7.46)   0.0743  #>       C: Combination                                         1.47       (0.54, 4.02)   0.5254  #>   Covariate:                                                                                   #>     Sex (reference = F)                                                                        #>       M                                                      0.98       (0.45, 2.13)   0.9700  #>     Age (yr)                                                                                   #>       All                                                    0.99       (0.94, 1.04)   0.6571"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"demographics-and-baseline-characteristics-with-all-patients","dir":"Articles","previous_headings":"TABLES > Demographics and Baseline Characteristics (DMT01)","what":"1. Demographics and Baseline Characteristics with All Patients","title":"Chevron Catalog","text":"dmt01 template produces standard demographics baseline characteristics summary. template includes column total default.","code":"run(dmt01, syn_data) #>                                        A: Drug X    B: Placebo   C: Combination   All Patients #>                                          (N=15)       (N=15)         (N=15)          (N=45)    #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Age (yr)                                                                                     #>     n                                      15           15             15              45      #>     Mean (SD)                          31.3 (5.3)   35.1 (9.0)     36.6 (6.4)      34.3 (7.3)  #>     Median                                31.0         35.0           35.0            34.0     #>     Min - Max                           24 - 40      24 - 57        24 - 49         24 - 57    #>   Age Group                                                                                    #>     n                                      15           15             15              45      #>     <65                                15 (100%)    15 (100%)      15 (100%)       45 (100%)   #>   Sex                                                                                          #>     n                                      15           15             15              45      #>     Male                               3 (20.0%)    7 (46.7%)      5 (33.3%)       15 (33.3%)  #>     Female                             12 (80.0%)   8 (53.3%)      10 (66.7%)      30 (66.7%)  #>   Ethnicity                                                                                    #>     n                                      15           15             15              45      #>     HISPANIC OR LATINO                 2 (13.3%)        0              0            2 (4.4%)   #>     NOT HISPANIC OR LATINO             13 (86.7%)   15 (100%)      13 (86.7%)      41 (91.1%)  #>     NOT REPORTED                           0            0          2 (13.3%)        2 (4.4%)   #>   RACE                                                                                         #>     n                                      15           15             15              45      #>     AMERICAN INDIAN OR ALASKA NATIVE       0        2 (13.3%)       1 (6.7%)        3 (6.7%)   #>     ASIAN                              8 (53.3%)    10 (66.7%)     8 (53.3%)       26 (57.8%)  #>     BLACK OR AFRICAN AMERICAN          4 (26.7%)     1 (6.7%)      4 (26.7%)       9 (20.0%)   #>     WHITE                              3 (20.0%)    2 (13.3%)      2 (13.3%)       7 (15.6%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"demographics-and-baseline-characteristics-without-all-patients","dir":"Articles","previous_headings":"TABLES > Demographics and Baseline Characteristics (DMT01)","what":"2. Demographics and Baseline Characteristics without All Patients","title":"Chevron Catalog","text":"remove column total, set argument lbl_overall NULL.","code":"run(dmt01, syn_data, lbl_overall = NULL) #>                                        A: Drug X    B: Placebo   C: Combination #>                                          (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Age (yr)                                                                      #>     n                                      15           15             15       #>     Mean (SD)                          31.3 (5.3)   35.1 (9.0)     36.6 (6.4)   #>     Median                                31.0         35.0           35.0      #>     Min - Max                           24 - 40      24 - 57        24 - 49     #>   Age Group                                                                     #>     n                                      15           15             15       #>     <65                                15 (100%)    15 (100%)      15 (100%)    #>   Sex                                                                           #>     n                                      15           15             15       #>     Male                               3 (20.0%)    7 (46.7%)      5 (33.3%)    #>     Female                             12 (80.0%)   8 (53.3%)      10 (66.7%)   #>   Ethnicity                                                                     #>     n                                      15           15             15       #>     HISPANIC OR LATINO                 2 (13.3%)        0              0        #>     NOT HISPANIC OR LATINO             13 (86.7%)   15 (100%)      13 (86.7%)   #>     NOT REPORTED                           0            0          2 (13.3%)    #>   RACE                                                                          #>     n                                      15           15             15       #>     AMERICAN INDIAN OR ALASKA NATIVE       0        2 (13.3%)       1 (6.7%)    #>     ASIAN                              8 (53.3%)    10 (66.7%)     8 (53.3%)    #>     BLACK OR AFRICAN AMERICAN          4 (26.7%)     1 (6.7%)      4 (26.7%)    #>     WHITE                              3 (20.0%)    2 (13.3%)      2 (13.3%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"demographics-and-baseline-characteristics-with-an-additional-study-specific-continuous-variable","dir":"Articles","previous_headings":"TABLES > Demographics and Baseline Characteristics (DMT01)","what":"3. Demographics and Baseline Characteristics with an additional study specific continuous variable","title":"Chevron Catalog","text":"Study specific continuous variables can added standard demographics baseline characteristics summary editing argument summaryvars. add remove analyses, need pass variables like include argument. CHEVRON performs analysis based type variable defined input data.","code":"run(dmt01, syn_data, summaryvars = c(\"AGE\", \"AGEGR1\", \"SEX\", \"ETHNIC\", \"RACE\", \"BBMISI\"), lbl_overall = NULL) #>                                          A: Drug X      B: Placebo     C: Combination #>                                           (N=15)          (N=15)           (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Age                                                                                 #>     n                                       15              15               15       #>     Mean (SD)                           31.3 (5.3)      35.1 (9.0)       36.6 (6.4)   #>     Median                                 31.0            35.0             35.0      #>     Min - Max                             24 - 40         24 - 57         24 - 49     #>   Age Group                                                                           #>     n                                       15              15               15       #>     <65                                  15 (100%)       15 (100%)       15 (100%)    #>   Sex                                                                                 #>     n                                       15              15               15       #>     Male                                 3 (20.0%)       7 (46.7%)       5 (33.3%)    #>     Female                              12 (80.0%)       8 (53.3%)       10 (66.7%)   #>   Ethnicity                                                                           #>     n                                       15              15               15       #>     HISPANIC OR LATINO                   2 (13.3%)           0               0        #>     NOT HISPANIC OR LATINO              13 (86.7%)       15 (100%)       13 (86.7%)   #>     NOT REPORTED                             0               0           2 (13.3%)    #>   RACE                                                                                #>     n                                       15              15               15       #>     AMERICAN INDIAN OR ALASKA NATIVE         0           2 (13.3%)        1 (6.7%)    #>     ASIAN                                8 (53.3%)      10 (66.7%)       8 (53.3%)    #>     BLACK OR AFRICAN AMERICAN            4 (26.7%)       1 (6.7%)        4 (26.7%)    #>     WHITE                                3 (20.0%)       2 (13.3%)       2 (13.3%)    #>   Baseline BMI                                                                        #>     n                                       15              15               15       #>     Mean (SD)                          29.75 (15.10)   41.08 (26.65)   33.90 (15.39)  #>     Median                                 37.00           33.70           37.80      #>     Min - Max                           6.4 - 47.9      5.3 - 117.9     -3.5 - 59.0"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"demographics-and-baseline-characteristics-with-an-additional-study-specific-categorical-variable","dir":"Articles","previous_headings":"TABLES > Demographics and Baseline Characteristics (DMT01)","what":"4. Demographics and Baseline Characteristics with an additional study specific categorical variable","title":"Chevron Catalog","text":"Study specific categorical variables can added standard demographics baseline characteristics summary editing argument summaryvars. display values within categorical variable pre-specified order, categorical variable need factorized pre-specified order provided levels.","code":"proc_data <- syn_data proc_data$adsl <- proc_data$adsl %>%   mutate(     SEX = reformat(.data$SEX, rule(Male = \"M\", Female = \"F\")),     BBMIGR1 = factor(case_when(       BBMISI < 15 ~ \"Very severely underweight\",       BBMISI >= 15 & BBMISI < 16 ~ \"Severely underweight\",       BBMISI >= 16 & BBMISI < 18.5 ~ \"Underweight\",       BBMISI >= 18.5 & BBMISI < 25 ~ \"Normal (healthy weight)\",       BBMISI >= 25 & BBMISI < 30 ~ \"Overweight\",       BBMISI >= 30 & BBMISI < 35 ~ \"Obese Class I (Moderately obese)\",       BBMISI >= 35 & BBMISI < 40 ~ \"Obese Class II (Severely obese)\",       BBMISI >= 40 ~ \"Obese Class III (Very severely obese)\"     ), levels = c(       \"Very severely underweight\",       \"Severely underweight\",       \"Underweight\",       \"Normal (healthy weight)\",       \"Overweight\",       \"Obese Class I (Moderately obese)\",       \"Obese Class II (Severely obese)\",       \"Obese Class III (Very severely obese)\"     ))   )  run(dmt01, proc_data, summaryvars = c(\"AGE\", \"AGEGR1\", \"SEX\", \"ETHNIC\", \"RACE\", \"BBMIGR1\"), auto_pre = FALSE) #>                                             A: Drug X    B: Placebo   C: Combination   All Patients #>                                               (N=15)       (N=15)         (N=15)          (N=45)    #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Age                                                                                               #>     n                                           15           15             15              45      #>     Mean (SD)                               31.3 (5.3)   35.1 (9.0)     36.6 (6.4)      34.3 (7.3)  #>     Median                                     31.0         35.0           35.0            34.0     #>     Min - Max                                24 - 40      24 - 57        24 - 49         24 - 57    #>   Age Group                                                                                         #>     n                                           15           15             15              45      #>     <65                                     15 (100%)    15 (100%)      15 (100%)       45 (100%)   #>   Sex                                                                                               #>     n                                           15           15             15              45      #>     Male                                    3 (20.0%)    7 (46.7%)      5 (33.3%)       15 (33.3%)  #>     Female                                  12 (80.0%)   8 (53.3%)      10 (66.7%)      30 (66.7%)  #>   Ethnicity                                                                                         #>     n                                           15           15             15              45      #>     HISPANIC OR LATINO                      2 (13.3%)        0              0            2 (4.4%)   #>     NOT HISPANIC OR LATINO                  13 (86.7%)   15 (100%)      13 (86.7%)      41 (91.1%)  #>     NOT REPORTED                                0            0          2 (13.3%)        2 (4.4%)   #>   RACE                                                                                              #>     n                                           15           15             15              45      #>     AMERICAN INDIAN OR ALASKA NATIVE            0        2 (13.3%)       1 (6.7%)        3 (6.7%)   #>     ASIAN                                   8 (53.3%)    10 (66.7%)     8 (53.3%)       26 (57.8%)  #>     BLACK OR AFRICAN AMERICAN               4 (26.7%)     1 (6.7%)      4 (26.7%)       9 (20.0%)   #>     WHITE                                   3 (20.0%)    2 (13.3%)      2 (13.3%)       7 (15.6%)   #>   BBMIGR1                                                                                           #>     n                                           15           15             15              45      #>     Very severely underweight               4 (26.7%)     1 (6.7%)       1 (6.7%)       6 (13.3%)   #>     Underweight                              1 (6.7%)        0              0            1 (2.2%)   #>     Normal (healthy weight)                  1 (6.7%)    3 (20.0%)      4 (26.7%)       8 (17.8%)   #>     Overweight                                  0         1 (6.7%)       1 (6.7%)        2 (4.4%)   #>     Obese Class I (Moderately obese)            0        3 (20.0%)          0            3 (6.7%)   #>     Obese Class II (Severely obese)         4 (26.7%)     1 (6.7%)      3 (20.0%)       8 (17.8%)   #>     Obese Class III (Very severely obese)   5 (33.3%)    6 (40.0%)      6 (40.0%)       17 (37.8%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"demographics-and-baseline-characteristics-with-additional-vital-signs-baseline-values-from-advs-or-adsub","dir":"Articles","previous_headings":"TABLES > Demographics and Baseline Characteristics (DMT01)","what":"5. Demographics and Baseline Characteristics with additional vital signs baseline values from ADVS or ADSUB","title":"Chevron Catalog","text":"add baseline vital signs baseline characteristics demographics baseline characteristics summary, manual preprocess input adsl dataset expected merge vital signs baseline values advs (ADVS.ABLFL == \"Y\") adsub adsl unique subject identifier.","code":"proc_data <- syn_data diabpbl <- proc_data$advs %>%   filter(ABLFL == \"Y\" & PARAMCD == \"DIABP\") %>%   mutate(DIABPBL = AVAL) %>%   select(\"STUDYID\", \"USUBJID\", \"DIABPBL\")  proc_data$adsl <- proc_data$adsl %>%   mutate(SEX = reformat(.data$SEX, rule(Male = \"M\", Female = \"F\"))) %>%   left_join(diabpbl, by = c(\"STUDYID\", \"USUBJID\"))  run(dmt01, proc_data, summaryvars = c(\"AGE\", \"AGEGR1\", \"SEX\", \"ETHNIC\", \"RACE\", \"DIABPBL\"), auto_pre = FALSE) #>                                              A: Drug X               B: Placebo             C: Combination            All Patients      #>                                               (N=15)                   (N=15)                   (N=15)                   (N=45)         #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Age                                                                                                                                   #>     n                                           15                       15                       15                       45           #>     Mean (SD)                               31.3 (5.3)               35.1 (9.0)               36.6 (6.4)               34.3 (7.3)       #>     Median                                     31.0                     35.0                     35.0                     34.0          #>     Min - Max                                 24 - 40                 24 - 57                  24 - 49                  24 - 57         #>   Age Group                                                                                                                             #>     n                                           15                       15                       15                       45           #>     <65                                      15 (100%)               15 (100%)                15 (100%)                45 (100%)        #>   Sex                                                                                                                                   #>     n                                           15                       15                       15                       45           #>     Male                                     3 (20.0%)               7 (46.7%)                5 (33.3%)                15 (33.3%)       #>     Female                                  12 (80.0%)               8 (53.3%)                10 (66.7%)               30 (66.7%)       #>   Ethnicity                                                                                                                             #>     n                                           15                       15                       15                       45           #>     HISPANIC OR LATINO                       2 (13.3%)                   0                        0                     2 (4.4%)        #>     NOT HISPANIC OR LATINO                  13 (86.7%)               15 (100%)                13 (86.7%)               41 (91.1%)       #>     NOT REPORTED                                 0                       0                    2 (13.3%)                 2 (4.4%)        #>   RACE                                                                                                                                  #>     n                                           15                       15                       15                       45           #>     AMERICAN INDIAN OR ALASKA NATIVE             0                   2 (13.3%)                 1 (6.7%)                 3 (6.7%)        #>     ASIAN                                    8 (53.3%)               10 (66.7%)               8 (53.3%)                26 (57.8%)       #>     BLACK OR AFRICAN AMERICAN                4 (26.7%)                1 (6.7%)                4 (26.7%)                9 (20.0%)        #>     WHITE                                    3 (20.0%)               2 (13.3%)                2 (13.3%)                7 (15.6%)        #>   Analysis Value                                                                                                                        #>     n                                           15                       15                       15                       45           #>     Mean (SD)                          96.132511 (22.458204)   108.110944 (15.074451)   103.148818 (19.751687)   102.464091 (19.534945) #>     Median                                   93.328321               108.951358               102.849019               102.396129       #>     Min - Max                          60.58490 - 136.59343     83.44277 - 131.61501     66.05223 - 136.55256     60.58490 - 136.59343"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"patient-disposition","dir":"Articles","previous_headings":"TABLES > Patient Disposition (DST01)","what":"1. Patient Disposition","title":"Chevron Catalog","text":"dst01 template produces standard patient disposition summary. template includes column total default. Use lbl_overall = NULL suppress default.","code":"run(dst01, syn_data, lbl_overall = NULL) #>                                     A: Drug X    B: Placebo   C: Combination #>                                       (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Completed                         10 (66.7%)   10 (66.7%)     10 (66.7%)   #>   Discontinued                      5 (33.3%)    5 (33.3%)      5 (33.3%)    #>     ADVERSE EVENT                       0            0           1 (6.7%)    #>     DEATH                           2 (13.3%)    4 (26.7%)      3 (20.0%)    #>     LACK OF EFFICACY                2 (13.3%)        0              0        #>     PHYSICIAN DECISION                  0            0           1 (6.7%)    #>     PROTOCOL VIOLATION                  0         1 (6.7%)          0        #>     WITHDRAWAL BY PARENT/GUARDIAN    1 (6.7%)        0              0"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"patient-disposition-with-grouping-of-reasons","dir":"Articles","previous_headings":"TABLES > Patient Disposition (DST01)","what":"2. Patient Disposition (with grouping of reasons)","title":"Chevron Catalog","text":"syntax produces standard patient disposition summary grouping discontinuation reasons. variable [ADSL.DCSREASGP] groups discontinuation reasons needs derived manually provided input adsl dataset.","code":"run(dst01, syn_data, detail_vars = list(Discontinued = c(\"DCSREASGP\", \"DCSREAS\")), lbl_overall = NULL) #>                                       A: Drug X    B: Placebo   C: Combination #>                                         (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Completed                           10 (66.7%)   10 (66.7%)     10 (66.7%)   #>   Discontinued                        5 (33.3%)    5 (33.3%)      5 (33.3%)    #>     Safety                                                                     #>       ADVERSE EVENT                       0            0           1 (6.7%)    #>       DEATH                           2 (13.3%)    4 (26.7%)      3 (20.0%)    #>     Non-Safety                                                                 #>       LACK OF EFFICACY                2 (13.3%)        0              0        #>       PHYSICIAN DECISION                  0            0           1 (6.7%)    #>       PROTOCOL VIOLATION                  0         1 (6.7%)          0        #>       WITHDRAWAL BY PARENT/GUARDIAN    1 (6.7%)        0              0"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"patient-disposition-adding-end-of-treatment-status","dir":"Articles","previous_headings":"TABLES > Patient Disposition (DST01)","what":"3. Patient Disposition (adding end of treatment status)","title":"Chevron Catalog","text":"syntax adds end treatment status standard patient disposition summary providing end treatment status variable argument trt_status_var.","code":"run(dst01, syn_data, trt_status_var = \"EOTSTT\", lbl_overall = NULL) #>                                     A: Drug X    B: Placebo   C: Combination #>                                       (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Completed                         10 (66.7%)   10 (66.7%)     10 (66.7%)   #>   Discontinued                      5 (33.3%)    5 (33.3%)      5 (33.3%)    #>     ADVERSE EVENT                       0            0           1 (6.7%)    #>     DEATH                           2 (13.3%)    4 (26.7%)      3 (20.0%)    #>     LACK OF EFFICACY                2 (13.3%)        0              0        #>     PHYSICIAN DECISION                  0            0           1 (6.7%)    #>     PROTOCOL VIOLATION                  0         1 (6.7%)          0        #>     WITHDRAWAL BY PARENT/GUARDIAN    1 (6.7%)        0              0        #>   Completed Treatment               8 (53.3%)    4 (26.7%)      5 (33.3%)    #>   Ongoing Treatment                 4 (26.7%)    6 (40.0%)      4 (26.7%)    #>   Discontinued Treatment            3 (20.0%)    5 (33.3%)      6 (40.0%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"patient-disposition-adding-details-of-study-ongoing-status","dir":"Articles","previous_headings":"TABLES > Patient Disposition (DST01)","what":"4. Patient Disposition (adding details of study ongoing status)","title":"Chevron Catalog","text":"syntax adds details study ongoing/alive status standard patient disposition summary modifying argument detail_vars.","code":"run(dst01, syn_data, detail_vars = list(Discontinued = \"DCSREAS\", Ongoing = \"STDONS\")) #>                                     A: Drug X    B: Placebo   C: Combination   All Patients #>                                       (N=15)       (N=15)         (N=15)          (N=45)    #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Completed                         10 (66.7%)   10 (66.7%)     10 (66.7%)      30 (66.7%)  #>   Discontinued                      5 (33.3%)    5 (33.3%)      5 (33.3%)       15 (33.3%)  #>     ADVERSE EVENT                       0            0           1 (6.7%)        1 (2.2%)   #>     DEATH                           2 (13.3%)    4 (26.7%)      3 (20.0%)       9 (20.0%)   #>     LACK OF EFFICACY                2 (13.3%)        0              0            2 (4.4%)   #>     PHYSICIAN DECISION                  0            0           1 (6.7%)        1 (2.2%)   #>     PROTOCOL VIOLATION                  0         1 (6.7%)          0            1 (2.2%)   #>     WITHDRAWAL BY PARENT/GUARDIAN    1 (6.7%)        0              0            1 (2.2%)"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"deaths","dir":"Articles","previous_headings":"TABLES > Deaths (DTHT01)","what":"1. Deaths","title":"Chevron Catalog","text":"dtht01 template produces standard deaths output.","code":"run(dst01, syn_data) #>                                     A: Drug X    B: Placebo   C: Combination   All Patients #>                                       (N=15)       (N=15)         (N=15)          (N=45)    #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Completed                         10 (66.7%)   10 (66.7%)     10 (66.7%)      30 (66.7%)  #>   Discontinued                      5 (33.3%)    5 (33.3%)      5 (33.3%)       15 (33.3%)  #>     ADVERSE EVENT                       0            0           1 (6.7%)        1 (2.2%)   #>     DEATH                           2 (13.3%)    4 (26.7%)      3 (20.0%)       9 (20.0%)   #>     LACK OF EFFICACY                2 (13.3%)        0              0            2 (4.4%)   #>     PHYSICIAN DECISION                  0            0           1 (6.7%)        1 (2.2%)   #>     PROTOCOL VIOLATION                  0         1 (6.7%)          0            1 (2.2%)   #>     WITHDRAWAL BY PARENT/GUARDIAN    1 (6.7%)        0              0            1 (2.2%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"deaths-adding-primary-cause-of-death-details-for-other-category","dir":"Articles","previous_headings":"TABLES > Deaths (DTHT01)","what":"2. Deaths (adding ‚ÄúPrimary Cause of Death‚Äù details for ‚ÄòOther‚Äô category)","title":"Chevron Catalog","text":"NOTE: order avoid warning display ‚Äò‚Äô last category ‚ÄúPrimary Cause Death‚Äù right detailed reasons ‚Äú‚Äù, user expected manually provide levels ADSL.DTHCAT based categories available dataset.","code":"run(dtht01, syn_data, other_category = TRUE) #>                            A: Drug X   B: Placebo   C: Combination #>                             (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Total number of deaths   2 (13.3%)   4 (26.7%)      3 (20.0%)    #>   Primary Cause of Death                                           #>     n                          2           4              3        #>     Adverse Event          1 (50.0%)   2 (50.0%)      1 (33.3%)    #>     Progressive Disease    1 (50.0%)       0          2 (66.7%)    #>     Other                      0       2 (50.0%)          0        #>       LOST TO FOLLOW UP        0        1 (50%)           0        #>       SUICIDE                  0        1 (50%)           0"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"deaths-adding-summary-by-days-from-last-study-drug-administration","dir":"Articles","previous_headings":"TABLES > Deaths (DTHT01)","what":"3. Deaths (adding summary by days from last study drug administration)","title":"Chevron Catalog","text":"Setting time_since_last_dose TRUE, syntax produces count deaths days last study drug administration well count deaths primary cause days last study drug administration.","code":"run(dtht01, syn_data, time_since_last_dose = TRUE) #>                                                               A: Drug X   B: Placebo   C: Combination #>                                                                (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Total number of deaths                                      2 (13.3%)   4 (26.7%)      3 (20.0%)    #>   Days from last drug administration                                                                  #>     n                                                             2           4              3        #>     <=30                                                      2 (100%)    1 (25.0%)      2 (66.7%)    #>     >30                                                           0       3 (75.0%)      1 (33.3%)    #>   Primary cause by days from last study drug administration                                           #>     <=30                                                                                              #>       n                                                           2           1              2        #>       Adverse Event                                           1 (50.0%)       0          1 (50.0%)    #>       Progressive Disease                                     1 (50.0%)       0          1 (50.0%)    #>       Other                                                       0        1 (100%)          0        #>     >30                                                                                               #>       n                                                           0           3              1        #>       Adverse Event                                               0       2 (66.7%)          0        #>       Progressive Disease                                         0           0           1 (100%)    #>       Other                                                       0       1 (33.3%)          0"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"ecg-results-and-change-from-baseline-by-visit","dir":"Articles","previous_headings":"TABLES > ECG Results and Change from Baseline by Visit (EGT01)","what":"1. ECG Results and Change from Baseline by Visit","title":"Chevron Catalog","text":"egt01 template produces standard ECG results change baseline visit summary.","code":"run(egt01, syn_data) #>                                    A: Drug X                                B: Placebo                             C: Combination              #>                                             Change from                               Change from                              Change from     #>                       Value at Visit          Baseline          Value at Visit         Baseline          Value at Visit          Baseline      #>   Analysis Visit          (N=15)               (N=15)               (N=15)              (N=15)               (N=15)               (N=15)       #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Heart Rate                                                                                                                                   #>     BASELINE                                                                                                                                   #>       n                     15                                        15                                       15                              #>       Mean (SD)      76.594 (17.889)                           69.899 (18.788)                          70.492 (18.175)                        #>       Median              77.531                                    77.174                                   74.111                            #>       Min - Max       46.50 - 106.68                            26.42 - 97.69                            45.37 - 115.49                        #>     WEEK 1 DAY 8                                                                                                                               #>       n                     15                   15                   15                  15                   15                   15         #>       Mean (SD)      71.140 (23.441)      -5.454 (25.128)      70.958 (14.877)      1.059 (23.345)      67.450 (18.932)      -3.043 (23.753)   #>       Median              77.210               -2.152               70.033              -8.403               68.471               0.181        #>       Min - Max       8.53 - 102.63        -50.97 - 36.54       44.85 - 93.79       -25.34 - 60.50       38.90 - 100.05       -52.20 - 33.13   #>     WEEK 2 DAY 15                                                                                                                              #>       n                     15                   15                   15                  15                   15                   15         #>       Mean (SD)      69.350 (16.083)      -7.244 (28.960)      76.096 (14.958)      6.198 (29.319)      63.694 (12.920)      -6.799 (23.949)   #>       Median              65.746              -11.369               75.323               0.255               61.076               -4.954       #>       Min - Max       47.22 - 101.44       -49.59 - 42.91       47.50 - 111.40      -37.51 - 69.34       43.25 - 86.13        -52.70 - 40.76   #>     WEEK 3 DAY 22                                                                                                                              #>       n                     15                   15                   15                  15                   15                   15         #>       Mean (SD)      73.894 (24.576)      -2.700 (32.079)      67.635 (19.114)      -2.263 (29.989)     72.054 (19.308)       1.562 (27.494)   #>       Median              69.296               5.492                68.468              -2.093               68.686               -5.848       #>       Min - Max       44.15 - 131.73       -62.53 - 38.19       31.89 - 108.87      -52.26 - 66.81       32.16 - 109.86       -49.61 - 35.23   #>     WEEK 4 DAY 29                                                                                                                              #>       n                     15                   15                   15                  15                   15                   15         #>       Mean (SD)      73.241 (19.256)      -3.353 (29.170)      66.524 (25.487)      -3.374 (36.024)     66.600 (22.839)      -3.892 (24.140)   #>       Median              68.689               0.232                66.397              -11.730              64.969               -6.827       #>       Min - Max       33.71 - 111.54       -55.14 - 65.04       19.66 - 111.29      -60.39 - 61.00       10.35 - 100.88       -50.72 - 26.77   #>     WEEK 5 DAY 36                                                                                                                              #>       n                     15                   15                   15                  15                   15                   15         #>       Mean (SD)      61.690 (22.182)      -14.904 (30.330)     60.712 (20.025)      -9.187 (24.587)     72.683 (23.495)       2.191 (26.654)   #>       Median              57.925              -12.660               60.454              -16.100              77.585               14.635       #>       Min - Max       23.89 - 103.74       -60.00 - 57.24       32.53 - 102.02      -52.56 - 50.96       31.21 - 105.05       -42.90 - 34.64   #>   QT Duration                                                                                                                                  #>     BASELINE                                                                                                                                   #>       n                     15                                        15                                       15                              #>       Mean (SD)     335.294 (123.231)                          363.104 (68.160)                         347.311 (86.236)                       #>       Median             372.731                                   386.316                                  348.254                            #>       Min - Max      121.28 - 554.97                           214.65 - 445.53                          170.80 - 508.54                        #>     WEEK 1 DAY 8                                                                                                                               #>       n                     15                   15                   15                  15                   15                   15         #>       Mean (SD)      357.361 (85.688)     22.067 (144.166)    415.225 (105.425)    52.121 (144.259)    321.078 (107.553)    -26.233 (129.135)  #>       Median             344.797               49.432              421.950              62.762              307.962              -17.006       #>       Min - Max      241.22 - 517.39      -207.23 - 245.36     234.11 - 604.72     -190.70 - 364.94     118.36 - 480.29      -363.11 - 163.67  #>     WEEK 2 DAY 15                                                                                                                              #>       n                     15                   15                   15                  15                   15                   15         #>       Mean (SD)     344.883 (106.793)     9.589 (174.797)      370.548 (80.862)     7.444 (91.301)      354.129 (95.133)     6.818 (142.397)   #>       Median             312.236               -9.264              388.515              -9.429              365.292               39.930       #>       Min - Max      187.77 - 501.87      -278.91 - 372.71     204.55 - 514.43     -190.58 - 173.87     200.19 - 493.40      -279.46 - 265.56  #>     WEEK 3 DAY 22                                                                                                                              #>       n                     15                   15                   15                  15                   15                   15         #>       Mean (SD)      342.062 (92.568)     6.768 (151.505)     326.684 (116.421)    -36.420 (145.415)    366.245 (99.106)     18.935 (168.417)  #>       Median             352.930              -22.771              298.353              -78.409             329.688              -21.584       #>       Min - Max      199.40 - 476.04      -230.25 - 303.00     151.05 - 561.23     -205.30 - 293.76     249.42 - 580.81      -252.73 - 410.01  #>     WEEK 4 DAY 29                                                                                                                              #>       n                     15                   15                   15                  15                   15                   15         #>       Mean (SD)      371.650 (44.805)     36.356 (139.308)    333.697 (110.377)    -29.407 (125.592)    333.181 (96.466)    -14.130 (107.622)  #>       Median             375.412               58.958              308.020              -40.987             330.911              -25.820       #>       Min - Max      302.32 - 451.62      -214.07 - 258.04     183.09 - 531.08     -241.72 - 134.12     126.95 - 488.57      -234.92 - 152.49  #>     WEEK 5 DAY 36                                                                                                                              #>       n                     15                   15                   15                  15                   15                   15         #>       Mean (SD)     345.504 (130.543)     10.210 (198.224)     309.919 (84.624)    -53.185 (105.730)    322.931 (67.801)    -24.380 (117.331)  #>       Median             355.730              -23.213              306.219              -12.373             341.988              -26.952       #>       Min - Max       88.38 - 661.12      -271.06 - 539.84     189.01 - 448.58      -256.52 - 91.57     217.51 - 427.16      -291.03 - 171.19  #>   RR Duration                                                                                                                                  #>     BASELINE                                                                                                                                   #>       n                     15                                        15                                       15                              #>       Mean (SD)     1086.908 (363.811)                        1050.034 (390.444)                       1102.659 (310.359)                      #>       Median             1116.849                                  1089.193                                 1250.037                           #>       Min - Max      626.19 - 1653.12                          414.61 - 1721.89                         385.51 - 1430.81                       #>     WEEK 1 DAY 8                                                                                                                               #>       n                     15                   15                   15                  15                   15                   15         #>       Mean (SD)     968.499 (287.811)    -118.409 (546.796)   1041.186 (211.201)   -8.848 (435.281)    948.491 (213.746)    -154.168 (442.882) #>       Median             961.296              -147.460             1013.786             24.754              965.429              -224.054      #>       Min - Max      358.92 - 1593.51    -1014.82 - 911.82     714.44 - 1417.52    -618.80 - 847.31     513.35 - 1229.09     -736.69 - 843.58  #>     WEEK 2 DAY 15                                                                                                                              #>       n                     15                   15                   15                  15                   15                   15         #>       Mean (SD)     932.717 (259.634)    -154.191 (331.884)   1139.332 (454.231)   89.298 (582.750)    1021.283 (233.529)   -81.376 (415.781)  #>       Median             950.533              -205.949             1068.007             -5.449              964.616              -142.180      #>       Min - Max      409.68 - 1269.35     -649.69 - 473.09     486.51 - 2048.73    -846.72 - 1148.61    667.36 - 1367.25     -647.47 - 616.15  #>     WEEK 3 DAY 22                                                                                                                              #>       n                     15                   15                   15                  15                   15                   15         #>       Mean (SD)     1068.865 (319.540)   -18.043 (513.412)    1110.882 (259.523)   60.848 (432.700)    1105.918 (306.185)    3.259 (516.734)   #>       Median             1201.998             -65.085              1163.690             51.200              1187.130              30.318       #>       Min - Max      380.49 - 1551.65     -832.86 - 703.74     621.41 - 1453.29    -887.06 - 822.18     446.02 - 1648.32     -984.79 - 816.30  #>     WEEK 4 DAY 29                                                                                                                              #>       n                     15                   15                   15                  15                   15                   15         #>       Mean (SD)     1087.915 (205.940)    1.008 (403.039)     1161.681 (293.257)   111.647 (460.979)   992.134 (283.177)    -110.525 (334.932) #>       Median             1084.658             146.611              1055.223             191.008             1028.997             -112.599      #>       Min - Max      697.59 - 1499.17     -801.16 - 402.97     722.35 - 1762.04    -528.27 - 1191.83    497.14 - 1382.12     -597.95 - 757.99  #>     WEEK 5 DAY 36                                                                                                                              #>       n                     15                   15                   15                  15                   15                   15         #>       Mean (SD)     1016.880 (424.428)   -70.027 (505.078)    1135.131 (224.684)   85.097 (497.679)    1089.527 (238.909)   -13.132 (362.606)  #>       Median             962.584              -142.925             1158.815             -9.553              1081.015              16.706       #>       Min - Max      352.97 - 1843.86    -894.83 - 1162.79     714.34 - 1436.68    -843.41 - 992.34     699.72 - 1611.38     -696.03 - 561.53"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"ecg-abnormalities-regardless-of-abnormality-at-baseline","dir":"Articles","previous_headings":"TABLES > ECG Abnormalities (Regardless of Abnormality at Baseline) (EGT02_1)","what":"1. ECG Abnormalities (Regardless of Abnormality at Baseline)","title":"Chevron Catalog","text":"egt02_1 template produces standard ECG abnormalities summary abnormalities summarized regardless abnormality baseline.","code":"run(egt02_1, syn_data) #>   Assessment      A: Drug X      B: Placebo    C: Combination #>    Abnormality      (N=15)         (N=15)          (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Heart Rate                                                  #>     Low          4/15 (26.7%)   4/15 (26.7%)    4/15 (26.7%)  #>     High         4/15 (26.7%)    3/15 (20%)      3/15 (20%)   #>   QT Duration                                                 #>     Low          2/15 (13.3%)   5/15 (33.3%)     3/15 (20%)   #>     High          3/15 (20%)     6/15 (40%)     2/15 (13.3%)  #>   RR Duration                                                 #>     Low           6/15 (40%)    2/15 (13.3%)    4/15 (26.7%)  #>     High         4/15 (26.7%)   5/15 (33.3%)    2/15 (13.3%)"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"ecg-abnormalities-among-subject-without-abnormality-at-baseline","dir":"Articles","previous_headings":"TABLES > ECG Abnormalities (Among Subject Without Abnormality at Baseline) (EGT02_2)","what":"1. ECG Abnormalities (Among Subject Without Abnormality at Baseline)","title":"Chevron Catalog","text":"egt02_2 template produces standard ECG abnormalities summary abnormalities summarized among subject without abnormality baseline.","code":"run(egt02_2, syn_data) #>   Assessment      A: Drug X      B: Placebo    C: Combination #>    Abnormality      (N=15)         (N=15)          (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Heart Rate                                                  #>     Low          4/15 (26.7%)   4/14 (28.6%)    4/15 (26.7%)  #>     High         3/13 (23.1%)    3/15 (20%)     2/14 (14.3%)  #>   QT Duration                                                 #>     Low          2/12 (16.7%)   5/15 (33.3%)    3/14 (21.4%)  #>     High         3/14 (21.4%)    6/15 (40%)     2/14 (14.3%)  #>   RR Duration                                                 #>     Low           6/15 (40%)    2/13 (15.4%)    4/14 (28.6%)  #>     High         4/13 (30.8%)   5/13 (38.5%)    2/15 (13.3%)"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"shift-table-of-ecg-interval-data---baseline-versus-minimum-post-baseline","dir":"Articles","previous_headings":"TABLES > Shift Table of ECG Interval Data - Baseline versus Minimum/Maximum Post-Baseline (EGT03)","what":"1. Shift Table of ECG Interval Data - Baseline versus Minimum Post-Baseline","title":"Chevron Catalog","text":"egt03 template produces standard shift table ECG interval data - baseline versus minimum post-baseline summary.","code":"proc_data <- log_filter(syn_data, PARAMCD == \"HR\", \"adeg\") run(egt03, proc_data) #>   Actual Arm Code                            Minimum Post-Baseline Assessment      #>     Baseline Reference Range Indicator      LOW         NORMAL      HIGH   Missing #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Heart Rate                                                                       #>     ARM A (N=15)                                                                   #>       LOW                                    0             0         0        0    #>       NORMAL                             4 (26.7%)     9 (60.0%)     0        0    #>       HIGH                                   0         2 (13.3%)     0        0    #>       Missing                                0             0         0        0    #>     ARM B (N=15)                                                                   #>       LOW                                    0         1 (6.7%)      0        0    #>       NORMAL                             4 (26.7%)    10 (66.7%)     0        0    #>       HIGH                                   0             0         0        0    #>       Missing                                0             0         0        0    #>     ARM C (N=15)                                                                   #>       LOW                                    0             0         0        0    #>       NORMAL                             4 (26.7%)    10 (66.7%)     0        0    #>       HIGH                                   0         1 (6.7%)      0        0    #>       Missing                                0             0         0        0"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"shift-table-of-ecg-interval-data---baseline-versus-maximum-post-baseline","dir":"Articles","previous_headings":"TABLES > Shift Table of ECG Interval Data - Baseline versus Minimum/Maximum Post-Baseline (EGT03)","what":"2. Shift Table of ECG Interval Data - Baseline versus Maximum Post-Baseline","title":"Chevron Catalog","text":"produce standard shift table ECG interval data - baseline versus maximum post-baseline summary‚Ä¶.TBA","code":""},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"ecg-actual-values-and-changes-from-baseline-by-visit","dir":"Articles","previous_headings":"TABLES > ECG Actual Values and Changes from Baseline by Visit (EGT05_QTCAT)","what":"1. ECG Actual Values and Changes from Baseline by Visit","title":"Chevron Catalog","text":"egt05_qtcat template produces standard ECG actual values changes baseline visit summary.","code":"run(egt05_qtcat, syn_data) #>   Parameter                                                           #>     Analysis Visit           A: Drug X    B: Placebo   C: Combination #>       Category                 (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   QT Duration                                                         #>     BASELINE                                                          #>       Value at Visit                                                  #>         n                        15           15             15       #>         <=450 msec           13 (86.7%)   15 (100%)      13 (86.7%)   #>         >450 to <=480 msec    1 (6.7%)        0              0        #>         >480 to <=500 msec       0            0           1 (6.7%)    #>         >500 msec             1 (6.7%)        0           1 (6.7%)    #>     WEEK 1 DAY 8                                                      #>       Value at Visit                                                  #>         n                        15           15             15       #>         <=450 msec           12 (80.0%)   9 (60.0%)      13 (86.7%)   #>         >450 to <=480 msec    1 (6.7%)     1 (6.7%)       1 (6.7%)    #>         >480 to <=500 msec    1 (6.7%)    3 (20.0%)       1 (6.7%)    #>         >500 msec             1 (6.7%)    2 (13.3%)          0        #>       Change from Baseline                                            #>         n                        15           15             15       #>         <=30 msec            7 (46.7%)    6 (40.0%)      9 (60.0%)    #>         >30 to <=60 msec     2 (13.3%)     1 (6.7%)       1 (6.7%)    #>         >60 msec             6 (40.0%)    8 (53.3%)      5 (33.3%)    #>     WEEK 2 DAY 15                                                     #>       Value at Visit                                                  #>         n                        15           15             15       #>         <=450 msec           11 (73.3%)   14 (93.3%)     12 (80.0%)   #>         >450 to <=480 msec   2 (13.3%)        0          2 (13.3%)    #>         >480 to <=500 msec    1 (6.7%)        0           1 (6.7%)    #>         >500 msec             1 (6.7%)     1 (6.7%)          0        #>       Change from Baseline                                            #>         n                        15           15             15       #>         <=30 msec            9 (60.0%)    12 (80.0%)     7 (46.7%)    #>         >30 to <=60 msec     2 (13.3%)        0          3 (20.0%)    #>         >60 msec             4 (26.7%)    3 (20.0%)      5 (33.3%)    #>     WEEK 3 DAY 22                                                     #>       Value at Visit                                                  #>         n                        15           15             15       #>         <=450 msec           12 (80.0%)   12 (80.0%)     12 (80.0%)   #>         >450 to <=480 msec   3 (20.0%)     1 (6.7%)       1 (6.7%)    #>         >500 msec                0        2 (13.3%)      2 (13.3%)    #>       Change from Baseline                                            #>         n                        15           15             15       #>         <=30 msec            9 (60.0%)    11 (73.3%)     9 (60.0%)    #>         >30 to <=60 msec      1 (6.7%)     1 (6.7%)          0        #>         >60 msec             5 (33.3%)    3 (20.0%)      6 (40.0%)    #>     WEEK 4 DAY 29                                                     #>       Value at Visit                                                  #>         n                        15           15             15       #>         <=450 msec           14 (93.3%)   12 (80.0%)     13 (86.7%)   #>         >450 to <=480 msec    1 (6.7%)     1 (6.7%)       1 (6.7%)    #>         >480 to <=500 msec       0            0           1 (6.7%)    #>         >500 msec                0        2 (13.3%)          0        #>       Change from Baseline                                            #>         n                        15           15             15       #>         <=30 msec            6 (40.0%)    9 (60.0%)      9 (60.0%)    #>         >30 to <=60 msec     2 (13.3%)     1 (6.7%)      2 (13.3%)    #>         >60 msec             7 (46.7%)    5 (33.3%)      4 (26.7%)    #>     WEEK 5 DAY 36                                                     #>       Value at Visit                                                  #>         n                        15           15             15       #>         <=450 msec           12 (80.0%)   15 (100%)      15 (100%)    #>         >450 to <=480 msec   2 (13.3%)        0              0        #>         >500 msec             1 (6.7%)        0              0        #>       Change from Baseline                                            #>         n                        15           15             15       #>         <=30 msec            9 (60.0%)    11 (73.3%)     9 (60.0%)    #>         >30 to <=60 msec         0        3 (20.0%)      2 (13.3%)    #>         >60 msec             6 (40.0%)     1 (6.7%)      4 (26.7%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"ecg-actual-values-and-changes-from-baseline-by-visit-removing-default-analyses","dir":"Articles","previous_headings":"TABLES > ECG Actual Values and Changes from Baseline by Visit (EGT05_QTCAT)","what":"2. ECG Actual Values and Changes from Baseline by Visit (removing default analyses)","title":"Chevron Catalog","text":"template two default analyses ADEG.AVALCAT1 ADEG.CHGCAT1. keep analyses needed, can achieved modifying parameter summaryvars.","code":"run(egt05_qtcat, syn_data, summaryvars = c(\"AVALCAT1\")) #>   Parameter                                                         #>     Analysis Visit         A: Drug X    B: Placebo   C: Combination #>       Category               (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   QT Duration                                                       #>     BASELINE                                                        #>       n                        15           15             15       #>       <=450 msec           13 (86.7%)   15 (100%)      13 (86.7%)   #>       >450 to <=480 msec    1 (6.7%)        0              0        #>       >480 to <=500 msec       0            0           1 (6.7%)    #>       >500 msec             1 (6.7%)        0           1 (6.7%)    #>     WEEK 1 DAY 8                                                    #>       n                        15           15             15       #>       <=450 msec           12 (80.0%)   9 (60.0%)      13 (86.7%)   #>       >450 to <=480 msec    1 (6.7%)     1 (6.7%)       1 (6.7%)    #>       >480 to <=500 msec    1 (6.7%)    3 (20.0%)       1 (6.7%)    #>       >500 msec             1 (6.7%)    2 (13.3%)          0        #>     WEEK 2 DAY 15                                                   #>       n                        15           15             15       #>       <=450 msec           11 (73.3%)   14 (93.3%)     12 (80.0%)   #>       >450 to <=480 msec   2 (13.3%)        0          2 (13.3%)    #>       >480 to <=500 msec    1 (6.7%)        0           1 (6.7%)    #>       >500 msec             1 (6.7%)     1 (6.7%)          0        #>     WEEK 3 DAY 22                                                   #>       n                        15           15             15       #>       <=450 msec           12 (80.0%)   12 (80.0%)     12 (80.0%)   #>       >450 to <=480 msec   3 (20.0%)     1 (6.7%)       1 (6.7%)    #>       >500 msec                0        2 (13.3%)      2 (13.3%)    #>     WEEK 4 DAY 29                                                   #>       n                        15           15             15       #>       <=450 msec           14 (93.3%)   12 (80.0%)     13 (86.7%)   #>       >450 to <=480 msec    1 (6.7%)     1 (6.7%)       1 (6.7%)    #>       >480 to <=500 msec       0            0           1 (6.7%)    #>       >500 msec                0        2 (13.3%)          0        #>     WEEK 5 DAY 36                                                   #>       n                        15           15             15       #>       <=450 msec           12 (80.0%)   15 (100%)      15 (100%)    #>       >450 to <=480 msec   2 (13.3%)        0              0        #>       >500 msec             1 (6.7%)        0              0"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"study-drug-exposure","dir":"Articles","previous_headings":"TABLES > Study Drug Exposure (EXT01)","what":"1. Study Drug Exposure","title":"Chevron Catalog","text":"ext01 template displays total number doses administered total dose administered default template include column total default","code":"run(ext01, syn_data) #>                                  A: Drug X        B: Placebo      C: Combination  #>   PARCAT2                         (N=15)            (N=15)            (N=15)      #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Drug A                                                                          #>     Overall duration (days)                                                       #>       n                             11                 7                 7        #>       Mean (SD)                157.5 (67.4)      115.4 (62.8)       98.6 (68.8)   #>       Median                       174.0             119.0             89.0       #>       Min - Max                53.0 - 239.0      22.0 - 219.0       1.0 - 182.0   #>     Total dose administered                                                       #>       n                             11                 7                 7        #>       Mean (SD)               6567.3 (1127.1)   7028.6 (1626.1)   6377.1 (863.7)  #>       Median                      6720.0            7200.0            6480.0      #>       Min - Max               4800.0 - 8400.0   5280.0 - 9360.0   5280.0 - 7440.0 #>   Drug B                                                                          #>     Overall duration (days)                                                       #>       n                              4                 8                 8        #>       Mean (SD)                142.2 (100.3)     105.9 (60.0)      158.2 (96.2)   #>       Median                       160.0             95.0              203.0      #>       Min - Max                17.0 - 232.0      37.0 - 211.0      27.0 - 249.0   #>     Total dose administered                                                       #>       n                              4                 8                 8        #>       Mean (SD)               7020.0 (1148.9)   5250.0 (864.7)    5940.0 (1187.9) #>       Median                      6960.0            5160.0            5880.0      #>       Min - Max               5760.0 - 8400.0   4080.0 - 6480.0   4320.0 - 7680.0"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"laboratory-test-results-and-change-from-baseline-by-visit","dir":"Articles","previous_headings":"TABLES > Laboratory Test Results and Change from Baseline by Visit (LBT01)","what":"1. Laboratory Test Results and Change from Baseline by Visit","title":"Chevron Catalog","text":"lbt01 template produces standard laboratory test results change baseline visit. select SI/CV/LS results panel (chemistry/hematology/urinalysis/coagulation etc.) display, user defines individual filters apply input datasets prior running CHEVRON.","code":"t_lb_chg <- run(lbt01, syn_data) head(t_lb_chg, 20) #>                                                      A: Drug X                          B: Placebo                       C: Combination           #>                                                              Change from                        Change from                        Change from    #>                                          Value at Visit       Baseline       Value at Visit       Baseline      Value at Visit       Baseline     #>                                              (N=15)            (N=15)            (N=15)            (N=15)           (N=15)            (N=15)      #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Alanine Aminotransferase Measurement                                                                                                            #>     BASELINE                                                                                                                                      #>       n                                        15                                  15                                 15                          #>       Mean (SD)                          18.655 (12.455)                     16.835 (11.080)                    22.385 (9.452)                    #>       Median                                 16.040                              17.453                             25.250                        #>       Min - Max                           2.43 - 44.06                        1.48 - 31.99                       0.57 - 37.23                     #>     WEEK 1 DAY 8                                                                                                                                  #>       n                                        15                15                15                15               15                15        #>       Mean (SD)                          16.308 (10.850)   -2.348 (17.558)   22.055 (7.537)    5.220 (16.359)   19.574 (9.876)   -2.811 (10.902)  #>       Median                                 14.664            -5.369            22.476            7.252            19.425            -0.995      #>       Min - Max                           0.10 - 36.30     -30.18 - 22.66     9.72 - 33.81     -16.82 - 32.33    1.03 - 36.28     -19.61 - 18.45  #>     WEEK 2 DAY 15                                                                                                                                 #>       n                                        15                15                15                15               15                15        #>       Mean (SD)                          16.646 (10.528)   -2.010 (15.773)   20.758 (9.578)    3.923 (14.084)   10.911 (7.721)   -11.474 (11.002) #>       Median                                 15.470            -6.427            18.499            6.248            9.850             -8.657      #>       Min - Max                           0.40 - 35.29     -29.99 - 32.86     1.56 - 42.84     -24.92 - 29.85    0.35 - 25.01     -27.38 - 2.52   #>     WEEK 3 DAY 22                                                                                                                                 #>       n                                        15                15                15                15               15                15        #>       Mean (SD)                          17.488 (10.679)   -1.167 (15.759)   20.055 (8.086)    3.219 (16.285)   18.413 (9.513)    -3.973 (9.966)  #>       Median                                 14.224             1.355            21.852            5.345            19.529            -7.194"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"laboratory-test-results-and-change-from-baseline-by-visit-customized-precision","dir":"Articles","previous_headings":"TABLES > Laboratory Test Results and Change from Baseline by Visit (LBT01)","what":"2. Laboratory Test Results and Change from Baseline by Visit (customized precision)","title":"Chevron Catalog","text":"TBA","code":""},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"laboratory-abnormalities","dir":"Articles","previous_headings":"TABLES > Laboratory Abnormalities (LBT04)","what":"1. Laboratory Abnormalities","title":"Chevron Catalog","text":"lbt04 template produces standard laboratory abnormalities summary. template subsets SI results default. laboratory tests directions abnormality template data-driven. Table entries provide number patients treatment laboratory value abnormality direction specified among patients without abnormality baseline.","code":"run(lbt04, syn_data) #>   Laboratory Test                           A: Drug X    B: Placebo    C: Combination #>       Direction of Abnormality               (N=15)        (N=15)          (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   CHEMISTRY                                                                           #>     Alanine Aminotransferase Measurement                                              #>       Low                                      0/7           0/2        1/7 (14.3%)   #>       High                                     0/7           0/3            0/8       #>     C-Reactive Protein Measurement                                                    #>       Low                                      0/8       1/2 (50.0%)        0/6       #>       High                                 3/8 (37.5%)       0/2            0/7       #>     Immunoglobulin A Measurement                                                      #>       Low                                      0/5           0/8            0/7       #>       High                                 1/3 (33.3%)   1/8 (12.5%)        0/6       #>   COAGULATION                                                                         #>     Alanine Aminotransferase Measurement                                              #>       Low                                      0/3           0/6            0/4       #>       High                                     0/5           0/7            0/4       #>     C-Reactive Protein Measurement                                                    #>       Low                                      0/5           0/5        1/3 (33.3%)   #>       High                                     0/5       1/6 (16.7%)    1/4 (25.0%)   #>     Immunoglobulin A Measurement                                                      #>       Low                                      0/8           0/9            0/6       #>       High                                     0/8           0/9        1/6 (16.7%)   #>   HEMATOLOGY                                                                          #>     Alanine Aminotransferase Measurement                                              #>       Low                                      0/4           0/5            0/4       #>       High                                     0/6           0/5            0/4       #>     C-Reactive Protein Measurement                                                    #>       Low                                      0/5           0/4            0/3       #>       High                                     0/5           0/4            0/5       #>     Immunoglobulin A Measurement                                                      #>       Low                                      0/3           0/4            0/8       #>       High                                     0/3           0/4            0/7"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"laboratory-abnormalities-with-single-and-replicated-marked","dir":"Articles","previous_headings":"TABLES > Laboratory Abnormalities with Single and Replicated Marked (LBT05)","what":"1. Laboratory Abnormalities with Single and Replicated Marked","title":"Chevron Catalog","text":"lbt05 template produces standard laboratory abnormalities summary marked abnormalities. laboratory tests directions abnormality template currently data-driven. standard metadata Safety Lab Standardization incorporated future release.","code":"run(lbt05, syn_data) #>   Laboratory Test                            A: Drug X   B: Placebo   C: Combination #>       Direction of Abnormality                (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Alanine Aminotransferase Measurement (n)      15           14             14       #>     Low                                                                              #>       Single, not last                       1 (6.7%)        0          4 (28.6%)    #>       Last or replicated                     5 (33.3%)   4 (28.6%)      4 (28.6%)    #>       Any Abnormality                        6 (40.0%)   4 (28.6%)      8 (57.1%)    #>     High                                                                             #>       Single, not last                           0           0              0        #>       Last or replicated                         0           0              0        #>       Any Abnormality                            0           0              0        #>   C-Reactive Protein Measurement (n)            15           15             15       #>     Low                                                                              #>       Single, not last                       4 (26.7%)       0          3 (20.0%)    #>       Last or replicated                     3 (20.0%)   5 (33.3%)      6 (40.0%)    #>       Any Abnormality                        7 (46.7%)   5 (33.3%)      9 (60.0%)    #>     High                                                                             #>       Single, not last                       1 (6.7%)    3 (20.0%)          0        #>       Last or replicated                     4 (26.7%)   3 (20.0%)      6 (40.0%)    #>       Any Abnormality                        5 (33.3%)   6 (40.0%)      6 (40.0%)    #>   Immunoglobulin A Measurement (n)              13           14             14       #>     Low                                                                              #>       Single, not last                           0           0              0        #>       Last or replicated                         0           0              0        #>       Any Abnormality                            0           0              0        #>     High                                                                             #>       Single, not last                       6 (46.2%)    1 (7.1%)      2 (14.3%)    #>       Last or replicated                     3 (23.1%)   4 (28.6%)      3 (21.4%)    #>       Any Abnormality                        9 (69.2%)   5 (35.7%)      5 (35.7%)"},{"path":[]},{"path":[]},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"laboratory-abnormalities-by-visit-and-baseline-status","dir":"Articles","previous_headings":"TABLES > Laboratory Abnormalities by Visit and Baseline Status (LBT06)","what":"1. Laboratory Abnormalities by Visit and Baseline Status","title":"Chevron Catalog","text":"lbt06 template produces standard laboratory abnormalities visit baseline status summary.","code":"run(lbt06, syn_data) #>   Visit                                                                             #>     Abnormality at Visit                  A: Drug X    B: Placebo    C: Combination #>               Baseline Status              (N=15)        (N=15)          (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Alanine Aminotransferase Measurement                                              #>     WEEK 1 DAY 8                                                                    #>       Low                                                                           #>                 Not low                      0/1           0/6            0/1       #>                 Low                          0/1           0/1            0/1       #>                 Total                        0/2           0/7            0/2       #>       High                                                                          #>                 Not high                     0/2           0/7            0/2       #>                 High                         0/0           0/0            0/0       #>                 Total                        0/2           0/7            0/2       #>     WEEK 2 DAY 15                                                                   #>       Low                                                                           #>                 Not low                      0/3           0/2            0/2       #>                 Low                          0/0           0/0            0/0       #>                 Total                        0/3           0/2            0/2       #>       High                                                                          #>                 Not high                     0/3           0/2            0/2       #>                 High                         0/0           0/0            0/0       #>                 Total                        0/3           0/2            0/2       #>     WEEK 3 DAY 22                                                                   #>       Low                                                                           #>                 Not low                      0/5           0/3        1/6 (16.7%)   #>                 Low                          0/0           0/0            0/0       #>                 Total                        0/5           0/3        1/6 (16.7%)   #>       High                                                                          #>                 Not high                     0/5           0/3            0/6       #>                 High                         0/0           0/0            0/0       #>                 Total                        0/5           0/3            0/6       #>     WEEK 4 DAY 29                                                                   #>       Low                                                                           #>                 Not low                      0/3           0/1            0/1       #>                 Low                          0/3           0/2            0/0       #>                 Total                        0/6           0/3            0/1       #>       High                                                                          #>                 Not high                     0/6           0/3            0/1       #>                 High                         0/0           0/0            0/0       #>                 Total                        0/6           0/3            0/1       #>     WEEK 5 DAY 36                                                                   #>       Low                                                                           #>                 Not low                      0/2           0/2            0/5       #>                 Low                          0/1           0/1            0/0       #>                 Total                        0/3           0/3            0/5       #>       High                                                                          #>                 Not high                     0/3           0/3            0/5       #>                 High                         0/0           0/0            0/0       #>                 Total                        0/3           0/3            0/5       #>   C-Reactive Protein Measurement                                                    #>     WEEK 1 DAY 8                                                                    #>       Low                                                                           #>                 Not low                      0/5           0/3            0/3       #>                 Low                          0/0           0/1            0/0       #>                 Total                        0/5           0/4            0/3       #>       High                                                                          #>                 Not high                     0/5           0/3        1/3 (33.3%)   #>                 High                         0/0           0/1            0/0       #>                 Total                        0/5           0/4        1/3 (33.3%)   #>     WEEK 2 DAY 15                                                                   #>       Low                                                                           #>                 Not low                      0/8           0/2            0/0       #>                 Low                          0/0           0/0            0/1       #>                 Total                        0/8           0/2            0/1       #>       High                                                                          #>                 Not high                 1/8 (12.5%)       0/1            0/1       #>                 High                         0/0           0/1            0/0       #>                 Total                    1/8 (12.5%)       0/2            0/1       #>     WEEK 3 DAY 22                                                                   #>       Low                                                                           #>                 Not low                      0/5           0/4            0/4       #>                 Low                          0/0       1/1 (100%)         0/2       #>                 Total                        0/5        1/5 (20%)         0/6       #>       High                                                                          #>                 Not high                  1/5 (20%)     1/5 (20%)         0/6       #>                 High                         0/0           0/0            0/0       #>                 Total                     1/5 (20%)     1/5 (20%)         0/6       #>     WEEK 4 DAY 29                                                                   #>       Low                                                                           #>                 Not low                      0/2        1/2 (50%)     1/3 (33.3%)   #>                 Low                          0/0           0/0            0/0       #>                 Total                        0/2        1/2 (50%)     1/3 (33.3%)   #>       High                                                                          #>                 Not high                     0/2           0/2            0/3       #>                 High                         0/0           0/0            0/0       #>                 Total                        0/2           0/2            0/3       #>     WEEK 5 DAY 36                                                                   #>       Low                                                                           #>                 Not low                      0/2           0/2            0/5       #>                 Low                          0/0       1/1 (100%)         0/1       #>                 Total                        0/2       1/3 (33.3%)        0/6       #>       High                                                                          #>                 Not high                  1/2 (50%)        0/3            0/6       #>                 High                         0/0           0/0            0/0       #>                 Total                     1/2 (50%)        0/3            0/6       #>   Immunoglobulin A Measurement                                                      #>     WEEK 1 DAY 8                                                                    #>       Low                                                                           #>                 Not low                      0/6           0/6            0/2       #>                 Low                          0/0           0/0            0/0       #>                 Total                        0/6           0/6            0/2       #>       High                                                                          #>                 Not high                     0/5       1/6 (16.7%)        0/2       #>                 High                         0/1           0/0            0/0       #>                 Total                        0/6       1/6 (16.7%)        0/2       #>     WEEK 2 DAY 15                                                                   #>       Low                                                                           #>                 Not low                      0/3           0/7            0/4       #>                 Low                          0/0           0/0            0/0       #>                 Total                        0/3           0/7            0/4       #>       High                                                                          #>                 Not high                     0/3           0/7         1/4 (25%)    #>                 High                         0/0           0/0            0/0       #>                 Total                        0/3           0/7         1/4 (25%)    #>     WEEK 3 DAY 22                                                                   #>       Low                                                                           #>                 Not low                      0/4           0/5            0/9       #>                 Low                          0/0           0/0            0/0       #>                 Total                        0/4           0/5            0/9       #>       High                                                                          #>                 Not high                     0/3           0/5            0/8       #>                 High                         0/1           0/0            0/1       #>                 Total                        0/4           0/5            0/9       #>     WEEK 4 DAY 29                                                                   #>       Low                                                                           #>                 Not low                      0/2           0/6            0/4       #>                 Low                          0/0           0/0            0/0       #>                 Total                        0/2           0/6            0/4       #>       High                                                                          #>                 Not high                 1/1 (100%)        0/6            0/3       #>                 High                         0/1           0/0            0/1       #>                 Total                     1/2 (50%)        0/6            0/4       #>     WEEK 5 DAY 36                                                                   #>       Low                                                                           #>                 Not low                      0/6           0/5            0/5       #>                 Low                          0/0           0/0            0/0       #>                 Total                        0/6           0/5            0/5       #>       High                                                                          #>                 Not high                     0/5           0/5            0/5       #>                 High                         0/1           0/0            0/0       #>                 Total                        0/6           0/5            0/5"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"laboratory-test-results-with-highest-nci-ctcae-grade-post-baseline","dir":"Articles","previous_headings":"TABLES > Laboratory Test Results with Highest NCI CTCAE Grade Post-Baseline (LBT07)","what":"1. Laboratory Test Results with Highest NCI CTCAE Grade Post-Baseline","title":"Chevron Catalog","text":"lbt07 template produces standard laboratory test results highest NCI CTCAE grade post-baseline summary. laboratory tests grades template currently data-driven. standard metadata possible lab tests corresponding NCI CTCAE grade incorporated future release.","code":"run(lbt07, syn_data) #>   Parameter                                                                           #>     Direction of Abnormality                 A: Drug X    B: Placebo   C: Combination #>               Highest NCI CTCAE Grade          (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Alanine Aminotransferase Measurement (n)       15           15             15       #>     LOW                                                                               #>               1                              3 (20.0%)        0              0        #>               2                              2 (13.3%)     1 (6.7%)       1 (6.7%)    #>               3                               1 (6.7%)     1 (6.7%)      6 (40.0%)    #>               4                              3 (20.0%)    2 (13.3%)      3 (20.0%)    #>               Any                            9 (60.0%)    4 (26.7%)      10 (66.7%)   #>   C-Reactive Protein Measurement (n)             15           15             15       #>     LOW                                                                               #>               1                              2 (13.3%)     1 (6.7%)      2 (13.3%)    #>               2                              5 (33.3%)    2 (13.3%)      5 (33.3%)    #>               3                              3 (20.0%)    4 (26.7%)      3 (20.0%)    #>               4                                  0         1 (6.7%)          0        #>               Any                            10 (66.7%)   8 (53.3%)      10 (66.7%)   #>     HIGH                                                                              #>               1                              3 (20.0%)     1 (6.7%)       1 (6.7%)    #>               2                              4 (26.7%)    4 (26.7%)      2 (13.3%)    #>               3                               1 (6.7%)    2 (13.3%)      4 (26.7%)    #>               4                                  0         1 (6.7%)          0        #>               Any                            8 (53.3%)    8 (53.3%)      7 (46.7%)    #>   Immunoglobulin A Measurement (n)               15           15             15       #>     HIGH                                                                              #>               1                              3 (20.0%)     1 (6.7%)       1 (6.7%)    #>               2                              5 (33.3%)    4 (26.7%)      2 (13.3%)    #>               3                              3 (20.0%)    3 (20.0%)      2 (13.3%)    #>               4                                  0            0           1 (6.7%)    #>               Any                            11 (73.3%)   8 (53.3%)      6 (40.0%)"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"laboratory-test-results-shift-table---highest-nci-ctcae-grade-post-baseline-by-baseline-nci-ctcae-grade-high","dir":"Articles","previous_headings":"TABLES > Laboratory Test Results Shift Table - Highest NCI-CTCAE Grade Post-Baseline by Baseline NCI-CTCAE Grade (LBT14)","what":"1. Laboratory Test Results Shift Table - Highest NCI-CTCAE Grade Post-Baseline by Baseline NCI-CTCAE Grade (High)","title":"Chevron Catalog","text":"produce standard laboratory test results shift table - highest NCI-CTCAE grade post-baseline baseline NCI-CTCAE grade summary high abnormalities, use lbt14 template set parameter direction high.","code":"run(lbt14, syn_data, direction = \"high\") #>   Baseline Toxicity Grade                 A: Drug X   B: Placebo   C: Combination #>           Post-baseline NCI-CTCAE Grade    (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Alanine Aminotransferase Measurement                                            #>     Not High                                 15           15             15       #>             Not High                      15 (100%)   15 (100%)      15 (100%)    #>   C-Reactive Protein Measurement                                                  #>     Not High                                 15           13             14       #>             Not High                      7 (46.7%)   7 (53.8%)      8 (57.1%)    #>             1                             3 (20.0%)    1 (7.7%)       1 (7.1%)    #>             2                             4 (26.7%)   3 (23.1%)       1 (7.1%)    #>             3                             1 (6.7%)     1 (7.7%)      4 (28.6%)    #>             4                                 0        1 (7.7%)          0        #>     1                                         0           0              1        #>             2                                 0           0           1 (100%)    #>     3                                         0           1              0        #>             2                                 0        1 (100%)          0        #>     4                                         0           1              0        #>             3                                 0        1 (100%)          0        #>   Immunoglobulin A Measurement                                                    #>     Not High                                 12           14             13       #>             Not High                      3 (25.0%)   7 (50.0%)      8 (61.5%)    #>             1                             3 (25.0%)    1 (7.1%)       1 (7.7%)    #>             2                             3 (25.0%)   3 (21.4%)      2 (15.4%)    #>             3                             3 (25.0%)   3 (21.4%)      2 (15.4%)    #>     1                                         2           0              1        #>             Not High                      1 (50.0%)       0           1 (100%)    #>             2                             1 (50.0%)       0              0        #>     3                                         0           0              1        #>             4                                 0           0           1 (100%)    #>     4                                         1           1              0        #>             2                             1 (100%)     1 (100%)          0"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"laboratory-test-results-shift-table---highest-nci-ctcae-grade-post-baseline-by-baseline-nci-ctcae-grade-low","dir":"Articles","previous_headings":"TABLES > Laboratory Test Results Shift Table - Highest NCI-CTCAE Grade Post-Baseline by Baseline NCI-CTCAE Grade (LBT14)","what":"2. Laboratory Test Results Shift Table - Highest NCI-CTCAE Grade Post-Baseline by Baseline NCI-CTCAE Grade (Low)","title":"Chevron Catalog","text":"produce standard laboratory test results shift table - highest NCI-CTCAE grade post-baseline baseline NCI-CTCAE grade summary high abnormalities, use lbt14 template argument direction low default.","code":"run(lbt14, syn_data) #>   Baseline Toxicity Grade                 A: Drug X   B: Placebo   C: Combination #>           Post-baseline NCI-CTCAE Grade    (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Alanine Aminotransferase Measurement                                            #>     Not Low                                  12           12             14       #>             Not Low                       5 (41.7%)   8 (66.7%)      5 (35.7%)    #>             1                             3 (25.0%)       0              0        #>             2                             2 (16.7%)    1 (8.3%)       1 (7.1%)    #>             3                                 0        1 (8.3%)      5 (35.7%)    #>             4                             2 (16.7%)   2 (16.7%)      3 (21.4%)    #>     1                                         1           2              0        #>             Not Low                       1 (100%)     2 (100%)          0        #>     2                                         1           1              0        #>             Not Low                           0        1 (100%)          0        #>             4                             1 (100%)        0              0        #>     3                                         1           0              1        #>             3                             1 (100%)        0           1 (100%)    #>   C-Reactive Protein Measurement                                                  #>     Not Low                                  14           13             12       #>             Not Low                       5 (35.7%)   7 (53.8%)      4 (33.3%)    #>             1                             2 (14.3%)       0          2 (16.7%)    #>             2                             5 (35.7%)   2 (15.4%)      4 (33.3%)    #>             3                             2 (14.3%)   3 (23.1%)      2 (16.7%)    #>             4                                 0        1 (7.7%)          0        #>     1                                         0           0              2        #>             Not Low                           0           0          1 (50.0%)    #>             2                                 0           0          1 (50.0%)    #>     2                                         0           1              0        #>             1                                 0        1 (100%)          0        #>     3                                         1           1              1        #>             3                             1 (100%)     1 (100%)       1 (100%)    #>   Immunoglobulin A Measurement                                                    #>     Not Low                                  15           15             15       #>             Not Low                       15 (100%)   15 (100%)      15 (100%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"laboratory-test-results-shift-table---highest-nci-ctcae-grade-post-baseline-by-baseline-nci-ctcae-grade-high-without-patients-with-missing-baseline","dir":"Articles","previous_headings":"TABLES > Laboratory Test Results Shift Table - Highest NCI-CTCAE Grade Post-Baseline by Baseline NCI-CTCAE Grade (LBT14)","what":"3. Laboratory Test Results Shift Table - Highest NCI-CTCAE Grade Post-Baseline by Baseline NCI-CTCAE Grade (High) Without Patients with Missing Baseline","title":"Chevron Catalog","text":"exclude patients missing baseline grade, set argument gr_missing excl.","code":"run(lbt14, syn_data, direction = \"high\", gr_missing = \"excl\") #>   Baseline Toxicity Grade                 A: Drug X   B: Placebo   C: Combination #>           Post-baseline NCI-CTCAE Grade    (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Alanine Aminotransferase Measurement                                            #>     Not High                                 15           15             15       #>             Not High                      15 (100%)   15 (100%)      15 (100%)    #>   C-Reactive Protein Measurement                                                  #>     Not High                                 15           13             14       #>             Not High                      7 (46.7%)   7 (53.8%)      8 (57.1%)    #>             1                             3 (20.0%)    1 (7.7%)       1 (7.1%)    #>             2                             4 (26.7%)   3 (23.1%)       1 (7.1%)    #>             3                             1 (6.7%)     1 (7.7%)      4 (28.6%)    #>             4                                 0        1 (7.7%)          0        #>     1                                         0           0              1        #>             2                                 0           0           1 (100%)    #>     3                                         0           1              0        #>             2                                 0        1 (100%)          0        #>     4                                         0           1              0        #>             3                                 0        1 (100%)          0        #>   Immunoglobulin A Measurement                                                    #>     Not High                                 12           14             13       #>             Not High                      3 (25.0%)   7 (50.0%)      8 (61.5%)    #>             1                             3 (25.0%)    1 (7.1%)       1 (7.7%)    #>             2                             3 (25.0%)   3 (21.4%)      2 (15.4%)    #>             3                             3 (25.0%)   3 (21.4%)      2 (15.4%)    #>     1                                         2           0              1        #>             Not High                      1 (50.0%)       0           1 (100%)    #>             2                             1 (50.0%)       0              0        #>     3                                         0           0              1        #>             4                                 0           0           1 (100%)    #>     4                                         1           1              0        #>             2                             1 (100%)     1 (100%)          0"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"laboratory-test-results-shift-table---highest-nci-ctcae-grade-post-baseline-by-baseline-nci-ctcae-grade-low-with-missing-baseline-considered-as-grade-0","dir":"Articles","previous_headings":"TABLES > Laboratory Test Results Shift Table - Highest NCI-CTCAE Grade Post-Baseline by Baseline NCI-CTCAE Grade (LBT14)","what":"4. Laboratory Test Results Shift Table - Highest NCI-CTCAE Grade Post-Baseline by Baseline NCI-CTCAE Grade (Low) with Missing Baseline Considered as Grade 0","title":"Chevron Catalog","text":"count patients missing baseline grade grade 0, set argument gr_missing gr_0.","code":"run(lbt14, syn_data, gr_missing = \"gr_0\") #>   Baseline Toxicity Grade                 A: Drug X   B: Placebo   C: Combination #>           Post-baseline NCI-CTCAE Grade    (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Alanine Aminotransferase Measurement                                            #>     1                                         1           2              0        #>             Not Low                       1 (100%)     2 (100%)          0        #>     2                                         1           1              0        #>             Not Low                           0        1 (100%)          0        #>             4                             1 (100%)        0              0        #>     3                                         1           0              1        #>             3                             1 (100%)        0           1 (100%)    #>     Not Low                                  12           12             14       #>             Not Low                       5 (41.7%)   8 (66.7%)      5 (35.7%)    #>             1                             3 (25.0%)       0              0        #>             2                             2 (16.7%)    1 (8.3%)       1 (7.1%)    #>             3                                 0        1 (8.3%)      5 (35.7%)    #>             4                             2 (16.7%)   2 (16.7%)      3 (21.4%)    #>   C-Reactive Protein Measurement                                                  #>     1                                         0           0              2        #>             1                                 0           0          1 (50.0%)    #>             3                                 0           0          1 (50.0%)    #>     2                                         0           1              0        #>             2                                 0        1 (100%)          0        #>     3                                         1           1              1        #>             3                             1 (100%)     1 (100%)       1 (100%)    #>     Not Low                                  14           13             12       #>             Not Low                       5 (35.7%)   7 (53.8%)      4 (33.3%)    #>             1                             2 (14.3%)       0          2 (16.7%)    #>             2                             5 (35.7%)   2 (15.4%)      4 (33.3%)    #>             3                             2 (14.3%)   3 (23.1%)      2 (16.7%)    #>             4                                 0        1 (7.7%)          0        #>   Immunoglobulin A Measurement                                                    #>     Not Low                                  15           15             15       #>             Not Low                       15 (100%)   15 (100%)      15 (100%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"laboratory-test-results-shift-table---highest-nci-ctcae-grade-post-baseline-by-baseline-nci-ctcae-grade-with-fill-in-of-grades","dir":"Articles","previous_headings":"TABLES > Laboratory Test Results Shift Table - Highest NCI-CTCAE Grade Post-Baseline by Baseline NCI-CTCAE Grade (LBT14)","what":"4. Laboratory Test Results Shift Table - Highest NCI-CTCAE Grade Post-Baseline by Baseline NCI-CTCAE Grade (with fill in of grades)","title":"Chevron Catalog","text":"display possible grades even occur data, set argument prune_0 FALSE.","code":"run(lbt14, syn_data, direction = \"high\", prune_0 = FALSE) #>   Baseline Toxicity Grade                 A: Drug X   B: Placebo   C: Combination #>           Post-baseline NCI-CTCAE Grade    (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Alanine Aminotransferase Measurement                                            #>     Not High                                 15           15             15       #>             Not High                      15 (100%)   15 (100%)      15 (100%)    #>             1                                 0           0              0        #>             2                                 0           0              0        #>             3                                 0           0              0        #>             4                                 0           0              0        #>             Missing                           0           0              0        #>     1                                         0           0              0        #>             Not High                          0           0              0        #>             1                                 0           0              0        #>             2                                 0           0              0        #>             3                                 0           0              0        #>             4                                 0           0              0        #>             Missing                           0           0              0        #>     2                                         0           0              0        #>             Not High                          0           0              0        #>             1                                 0           0              0        #>             2                                 0           0              0        #>             3                                 0           0              0        #>             4                                 0           0              0        #>             Missing                           0           0              0        #>     3                                         0           0              0        #>             Not High                          0           0              0        #>             1                                 0           0              0        #>             2                                 0           0              0        #>             3                                 0           0              0        #>             4                                 0           0              0        #>             Missing                           0           0              0        #>     4                                         0           0              0        #>             Not High                          0           0              0        #>             1                                 0           0              0        #>             2                                 0           0              0        #>             3                                 0           0              0        #>             4                                 0           0              0        #>             Missing                           0           0              0        #>     Missing                                   0           0              0        #>             Not High                          0           0              0        #>             1                                 0           0              0        #>             2                                 0           0              0        #>             3                                 0           0              0        #>             4                                 0           0              0        #>             Missing                           0           0              0        #>   C-Reactive Protein Measurement                                                  #>     Not High                                 15           13             14       #>             Not High                      7 (46.7%)   7 (53.8%)      8 (57.1%)    #>             1                             3 (20.0%)    1 (7.7%)       1 (7.1%)    #>             2                             4 (26.7%)   3 (23.1%)       1 (7.1%)    #>             3                             1 (6.7%)     1 (7.7%)      4 (28.6%)    #>             4                                 0        1 (7.7%)          0        #>             Missing                           0           0              0        #>     1                                         0           0              1        #>             Not High                          0           0              0        #>             1                                 0           0              0        #>             2                                 0           0           1 (100%)    #>             3                                 0           0              0        #>             4                                 0           0              0        #>             Missing                           0           0              0        #>     2                                         0           0              0        #>             Not High                          0           0              0        #>             1                                 0           0              0        #>             2                                 0           0              0        #>             3                                 0           0              0        #>             4                                 0           0              0        #>             Missing                           0           0              0        #>     3                                         0           1              0        #>             Not High                          0           0              0        #>             1                                 0           0              0        #>             2                                 0        1 (100%)          0        #>             3                                 0           0              0        #>             4                                 0           0              0        #>             Missing                           0           0              0        #>     4                                         0           1              0        #>             Not High                          0           0              0        #>             1                                 0           0              0        #>             2                                 0           0              0        #>             3                                 0        1 (100%)          0        #>             4                                 0           0              0        #>             Missing                           0           0              0        #>     Missing                                   0           0              0        #>             Not High                          0           0              0        #>             1                                 0           0              0        #>             2                                 0           0              0        #>             3                                 0           0              0        #>             4                                 0           0              0        #>             Missing                           0           0              0        #>   Immunoglobulin A Measurement                                                    #>     Not High                                 12           14             13       #>             Not High                      3 (25.0%)   7 (50.0%)      8 (61.5%)    #>             1                             3 (25.0%)    1 (7.1%)       1 (7.7%)    #>             2                             3 (25.0%)   3 (21.4%)      2 (15.4%)    #>             3                             3 (25.0%)   3 (21.4%)      2 (15.4%)    #>             4                                 0           0              0        #>             Missing                           0           0              0        #>     1                                         2           0              1        #>             Not High                      1 (50.0%)       0           1 (100%)    #>             1                                 0           0              0        #>             2                             1 (50.0%)       0              0        #>             3                                 0           0              0        #>             4                                 0           0              0        #>             Missing                           0           0              0        #>     2                                         0           0              0        #>             Not High                          0           0              0        #>             1                                 0           0              0        #>             2                                 0           0              0        #>             3                                 0           0              0        #>             4                                 0           0              0        #>             Missing                           0           0              0        #>     3                                         0           0              1        #>             Not High                          0           0              0        #>             1                                 0           0              0        #>             2                                 0           0              0        #>             3                                 0           0              0        #>             4                                 0           0           1 (100%)    #>             Missing                           0           0              0        #>     4                                         1           1              0        #>             Not High                          0           0              0        #>             1                                 0           0              0        #>             2                             1 (100%)     1 (100%)          0        #>             3                                 0           0              0        #>             4                                 0           0              0        #>             Missing                           0           0              0        #>     Missing                                   0           0              0        #>             Not High                          0           0              0        #>             1                                 0           0              0        #>             2                                 0           0              0        #>             3                                 0           0              0        #>             4                                 0           0              0        #>             Missing                           0           0              0"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"medical-history","dir":"Articles","previous_headings":"TABLES > Medical History (MHT01)","what":"1. Medical History","title":"Chevron Catalog","text":"mht01 template displays medical conditions MedDRA system organ class Preferred Name default. default treatment variable \"ADSL.ARM\". user expected use filter subset medical conditions prior entering study. default, template produces overall ‚Äòtotal number conditions‚Äô well ‚Äòtotal number conditions‚Äô per body system summary patients. 5Ôºâtemplate currently support sorting MedDRA system organ class preferred names order frequency.","code":"run(mht01, syn_data) #>   MedDRA System Organ Class                                A: Drug X    B: Placebo   C: Combination #>     MedDRA Preferred Term                                    (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Total number of patients with at least one condition     13 (86.7%)   14 (93.3%)     15 (100%)    #>   Total number of conditions                                   58           59             99       #>   cl A                                                                                              #>     Total number of patients with at least one condition   7 (46.7%)    6 (40.0%)      10 (66.7%)   #>     Total number of conditions                                 8            11             16       #>     trm A_2/2                                              5 (33.3%)    6 (40.0%)      6 (40.0%)    #>     trm A_1/2                                              3 (20.0%)     1 (6.7%)      6 (40.0%)    #>   cl B                                                                                              #>     Total number of patients with at least one condition   12 (80.0%)   11 (73.3%)     12 (80.0%)   #>     Total number of conditions                                 24           21             32       #>     trm B_3/3                                              8 (53.3%)    6 (40.0%)      7 (46.7%)    #>     trm B_1/3                                              5 (33.3%)    6 (40.0%)      8 (53.3%)    #>     trm B_2/3                                              5 (33.3%)    6 (40.0%)      5 (33.3%)    #>   cl C                                                                                              #>     Total number of patients with at least one condition   8 (53.3%)    6 (40.0%)      11 (73.3%)   #>     Total number of conditions                                 10           13             22       #>     trm C_2/2                                              6 (40.0%)    4 (26.7%)      8 (53.3%)    #>     trm C_1/2                                              4 (26.7%)    4 (26.7%)      5 (33.3%)    #>   cl D                                                                                              #>     Total number of patients with at least one condition   10 (66.7%)   7 (46.7%)      13 (86.7%)   #>     Total number of conditions                                 16           14             29       #>     trm D_1/3                                              4 (26.7%)    4 (26.7%)      7 (46.7%)    #>     trm D_2/3                                              6 (40.0%)    2 (13.3%)      7 (46.7%)    #>     trm D_3/3                                              2 (13.3%)    5 (33.3%)      7 (46.7%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"medical-history-showing-additional-column-all-patients","dir":"Articles","previous_headings":"TABLES > Medical History (MHT01)","what":"2. Medical History showing additional column ‚ÄòAll Patients‚Äô","title":"Chevron Catalog","text":"","code":"run(mht01, syn_data, lbl_overall = \"All Patients\") #>   MedDRA System Organ Class                                A: Drug X    B: Placebo   C: Combination   All Patients #>     MedDRA Preferred Term                                    (N=15)       (N=15)         (N=15)          (N=45)    #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Total number of patients with at least one condition     13 (86.7%)   14 (93.3%)     15 (100%)       42 (93.3%)  #>   Total number of conditions                                   58           59             99             216      #>   cl A                                                                                                             #>     Total number of patients with at least one condition   7 (46.7%)    6 (40.0%)      10 (66.7%)      23 (51.1%)  #>     Total number of conditions                                 8            11             16              35      #>     trm A_2/2                                              5 (33.3%)    6 (40.0%)      6 (40.0%)       17 (37.8%)  #>     trm A_1/2                                              3 (20.0%)     1 (6.7%)      6 (40.0%)       10 (22.2%)  #>   cl B                                                                                                             #>     Total number of patients with at least one condition   12 (80.0%)   11 (73.3%)     12 (80.0%)      35 (77.8%)  #>     Total number of conditions                                 24           21             32              77      #>     trm B_3/3                                              8 (53.3%)    6 (40.0%)      7 (46.7%)       21 (46.7%)  #>     trm B_1/3                                              5 (33.3%)    6 (40.0%)      8 (53.3%)       19 (42.2%)  #>     trm B_2/3                                              5 (33.3%)    6 (40.0%)      5 (33.3%)       16 (35.6%)  #>   cl C                                                                                                             #>     Total number of patients with at least one condition   8 (53.3%)    6 (40.0%)      11 (73.3%)      25 (55.6%)  #>     Total number of conditions                                 10           13             22              45      #>     trm C_2/2                                              6 (40.0%)    4 (26.7%)      8 (53.3%)       18 (40.0%)  #>     trm C_1/2                                              4 (26.7%)    4 (26.7%)      5 (33.3%)       13 (28.9%)  #>   cl D                                                                                                             #>     Total number of patients with at least one condition   10 (66.7%)   7 (46.7%)      13 (86.7%)      30 (66.7%)  #>     Total number of conditions                                 16           14             29              59      #>     trm D_1/3                                              4 (26.7%)    4 (26.7%)      7 (46.7%)       15 (33.3%)  #>     trm D_2/3                                              6 (40.0%)    2 (13.3%)      7 (46.7%)       15 (33.3%)  #>     trm D_3/3                                              2 (13.3%)    5 (33.3%)      7 (46.7%)       14 (31.1%)"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"major-protocol-deviations","dir":"Articles","previous_headings":"TABLES > Major Protocol Deviations (PDT01)","what":"1. Major Protocol Deviations","title":"Chevron Catalog","text":"pdt01 template produces standard major protocol deviations output. Users expected filter addv include records DVCAT == \"MAJOR\" pre-processing.","code":"proc_data <- syn_data proc_data$addv <- proc_data$addv %>%   filter(DVCAT == \"MAJOR\")  run(pdt01, proc_data) #>   Category                                                              A: Drug X   B: Placebo   C: Combination #>     Description                                                          (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Total number of patients with at least one major protocol deviation   2 (13.3%)   4 (26.7%)          0        #>   Total number of major protocol deviations                                 2           5              0        #>   EXCLUSION CRITERIA                                                                                            #>     Active or untreated or other excluded cns metastases                    0        1 (6.7%)          0        #>     Pregnancy criteria                                                      0        1 (6.7%)          0        #>   INCLUSION CRITERIA                                                                                            #>     Ineligible cancer type or current cancer stage                      1 (6.7%)        0              0        #>   MEDICATION                                                                                                    #>     Discontinued study drug for unspecified reason                          0        1 (6.7%)          0        #>     Received prohibited concomitant medication                              0        1 (6.7%)          0        #>   PROCEDURAL                                                                                                    #>     Eligibility-related test not done/out of window                         0        1 (6.7%)          0        #>     Failure to sign updated ICF within two visits                       1 (6.7%)        0              0"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"reasons-for-major-protocol-deviations-related-to-epidemicpandemic","dir":"Articles","previous_headings":"TABLES > Reasons for Major Protocol Deviations Related to Epidemic/Pandemic (PDT02)","what":"1. Reasons for Major Protocol Deviations Related to Epidemic/Pandemic","title":"Chevron Catalog","text":"pdt02 template produces reasons major protocol deviations related epidemic/pandemic summary. default, ADDV.DVREAS provides reason ADDV.DVTERM provides description. default, addv filtered include records meet condition AEPRELFL == \"Y\" & DVCAT == \"MAJOR\".","code":"run(pdt02, syn_data) #>   Primary Reason                                                                                     A: Drug X   B: Placebo   C: Combination #>     Description                                                                                       (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Total number of patients with at least one major protocol deviation related to epidemic/pandemic   1 (6.7%)        0              0        #>   Total number of major protocol deviations related to epidemic/pandemic                                 1           0              0        #>   Site action due to epidemic/pandemic                                                               1 (6.7%)        0              0        #>     Failure to sign updated ICF within two visits                                                    1 (6.7%)        0              0"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"duration-of-exposure-for-risk-management-plan","dir":"Articles","previous_headings":"TABLES > Duration of Exposure for Risk Management Plan (RMPT01)","what":"1. Duration of Exposure for Risk Management Plan","title":"Chevron Catalog","text":"rmpt01 template produces standard duration exposure output Risk Management Plan (RMP). Person time sum exposure across patients days.","code":"run(rmpt01, syn_data) #>                                        Patients     Person time #>   Duration of exposure                  (N=45)        (N=45)    #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   < 1 month                            4 (8.9%)         67      #>   1 to <3 months                      13 (28.9%)        837     #>   3 to <6 months                      13 (28.9%)       1728     #>   >=6 months                          15 (33.3%)       3281     #>   Total patients number/person time   45 (100.0%)      5913"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"extent-of-exposure-by-age-group-and-gender-for-risk-management-plan","dir":"Articles","previous_headings":"TABLES > Extent of Exposure by Age Group and Gender for Risk Management Plan (RMPT03)","what":"1. Extent of Exposure by Age Group and Gender for Risk Management Plan","title":"Chevron Catalog","text":"rmpt03 template produces standard extent exposure age group gender output Risk Management Plan (RMP). default, AGEGR1 variable used age group. AGEGR1 available ADSL ADEX, needs added ADEX first. study specific age group can used editing parameter summaryvars. RMP tables, variable specified per summaryvars unavailable ADEX, needs added ADEX first.","code":"proc_data <- syn_data proc_data <- propagate(proc_data, \"adsl\", \"AGEGR1\", \"USUBJID\") #>  #> Updating: adae with: AGEGR1 #> Updating: adsaftte with: AGEGR1 #> Updating: adcm with: AGEGR1 #> Updating: addv with: AGEGR1 #> Updating: adeg with: AGEGR1 #> Updating: adex with: AGEGR1 #> Updating: adlb with: AGEGR1 #> Updating: admh with: AGEGR1 #> Skipping: adrs #> Updating: adsub with: AGEGR1 #> Skipping: adtte #> Updating: advs with: AGEGR1 run(rmpt03, proc_data) #>                                                   F                           M                      All Genders        #>                                        Patients     Person time    Patients     Person time    Patients     Person time #>   Age Group                             (N=30)        (N=30)        (N=15)        (N=15)        (N=45)        (N=45)    #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   <65                                 30 (100.0%)      4088       15 (100.0%)      1825       45 (100.0%)      5913     #>   Total patients number/person time   30 (100.0%)      4088       15 (100.0%)      1825       45 (100.0%)      5913 proc_data <- syn_data proc_data$adsl <- proc_data$adsl %>%   mutate(     AGEGR2 = with_label(       factor(case_when(         AAGE < 18 ~ \"<18\",         AAGE >= 18 & AAGE <= 65 ~ \"18 - 65\",         AAGE > 65 ~ \">65\",       ), levels = c(\"<18\", \"18 - 65\", \">65\")),       \"Age Group 2\"     )   ) proc_data <- propagate(proc_data, \"adsl\", \"AGEGR2\", \"USUBJID\") #>  #> Updating: adae with: AGEGR2 #> Updating: adsaftte with: AGEGR2 #> Updating: adcm with: AGEGR2 #> Updating: addv with: AGEGR2 #> Updating: adeg with: AGEGR2 #> Updating: adex with: AGEGR2 #> Updating: adlb with: AGEGR2 #> Updating: admh with: AGEGR2 #> Updating: adrs with: AGEGR2 #> Updating: adsub with: AGEGR2 #> Updating: adtte with: AGEGR2 #> Updating: advs with: AGEGR2 run(rmpt03, proc_data, summaryvars = \"AGEGR2\") #>                                                   F                           M                      All Genders        #>                                        Patients     Person time    Patients     Person time    Patients     Person time #>   Age Group 2                           (N=30)        (N=30)        (N=15)        (N=15)        (N=45)        (N=45)    #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   18 - 65                             30 (100.0%)      4088       15 (100.0%)      1825       45 (100.0%)      5913     #>   Total patients number/person time   30 (100.0%)      4088       15 (100.0%)      1825       45 (100.0%)      5913"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"extent-of-exposure-by-ethnic-origin-for-risk-management-plan","dir":"Articles","previous_headings":"TABLES > Extent of Exposure by Ethnic Origin for Risk Management Plan (RMPT04)","what":"1. Extent of Exposure by Ethnic Origin for Risk Management Plan","title":"Chevron Catalog","text":"rmpt04 template produces standard extent exposure ethnic origin output Risk Management Plan (RMP).","code":"run(rmpt04, syn_data) #>                                        Patients     Person time #>   ETHNIC                                (N=45)        (N=45)    #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   HISPANIC OR LATINO                   2 (4.4%)         309     #>   NOT HISPANIC OR LATINO              41 (91.1%)       5555     #>   NOT REPORTED                         2 (4.4%)         49      #>   Total patients number/person time   45 (100.0%)      5913"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"extent-of-exposure-by-race-for-risk-management-plan","dir":"Articles","previous_headings":"TABLES > Extent of Exposure by Race for Risk Management Plan (RMPT05)","what":"1. Extent of Exposure by Race for Risk Management Plan","title":"Chevron Catalog","text":"rmpt05 template produces standard extent exposure race output Risk Management Plan (RMP).","code":"run(rmpt05, syn_data) #>                                        Patients     Person time #>   RACE                                  (N=45)        (N=45)    #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   ASIAN                               26 (57.8%)       3309     #>   BLACK OR AFRICAN AMERICAN            9 (20.0%)       1139     #>   WHITE                                7 (15.6%)       1231     #>   AMERICAN INDIAN OR ALASKA NATIVE     3 (6.7%)         234     #>   Total patients number/person time   45 (100.0%)      5913"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"best-overall-response","dir":"Articles","previous_headings":"TABLES > Best Overall Response (RSPT01)","what":"1. Best Overall Response","title":"Chevron Catalog","text":"rspt01 template produces standard best overall response output. template syntax built based RECIST 1.1. default, subjects response results \"CR\" \"PR\" considered responders. Users expected pre-process input analysis data select parameter analyzed, .e., best overall response investigator best overall response BICR. Unstratified analysis provided default.","code":"proc_data <- log_filter(syn_data, PARAMCD == \"BESRSPI\", \"adrs\")  run(rspt01, proc_data, ref_group = NULL, perform_analysis = \"unstrat\", strata = NULL) #> Warning in stats::prop.test(tbl, correct = FALSE): Chi-squared approximation #> may be incorrect #>                                          A: Drug X          B: Placebo         C: Combination   #>                                            (N=15)             (N=15)               (N=15)       #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Responders                             10 (66.7%)         9 (60.0%)            11 (73.3%)     #>   95% CI (Wald, with correction)        (39.5, 93.9)       (31.9, 88.1)         (47.6, 99.0)    #>   Unstratified Analysis                                                                         #>     Difference in Response rate (%)                            -6.7                 6.7         #>       95% CI (Wald, with correction)                      (-47.7, 34.4)        (-32.7, 46.0)    #>     p-value (Chi-Squared Test)                                0.7048               0.6903       #>   Odds Ratio (95% CI)                                   0.75 (0.17 - 3.33)   1.37 (0.29 - 6.60) #>   Complete Response (CR)                 4 (26.7%)          4 (26.7%)            7 (46.7%)      #>     95% CI (Wald, with correction)     (0.95, 52.38)      (0.95, 52.38)        (18.09, 75.25)   #>   Partial Response (PR)                  6 (40.0%)          5 (33.3%)            4 (26.7%)      #>     95% CI (Wald, with correction)     (11.87, 68.13)     (6.14, 60.52)        (0.95, 52.38)    #>   Stable Disease (SD)                    5 (33.3%)          6 (40.0%)            4 (26.7%)      #>     95% CI (Wald, with correction)     (6.14, 60.52)      (11.87, 68.13)       (0.95, 52.38)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"id_1","dir":"Articles","previous_headings":"TABLES > Best Overall Response (RSPT01)","what":"2. Best Overall Response (Ordering of treatment groups)","title":"Chevron Catalog","text":"default, first level value arm_var (default \"ADSL.ARM\" unless specified) treated reference group without specification. apply user-defined reference group, please provide value treatment variable argument ref_group, e.g., ref_group = \"PLACEBO\". Since rtables displays reference group left column, order displayed treatment groups may exactly order factorized, depending group selected reference group. See examples:","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"best-overall-response-selecting-sections-to-display","dir":"Articles","previous_headings":"TABLES > Best Overall Response (RSPT01)","what":"3. Best Overall Response (selecting sections to display)","title":"Chevron Catalog","text":"section Odds Ratio can suppressed argument odds_ratio = FALSE. section Difference response rate can suppressed argument perform_analysis = NULL.","code":"proc_data <- log_filter(syn_data, PARAMCD == \"BESRSPI\", \"adrs\")  run(rspt01, proc_data, odds_ratio = FALSE, perform_analysis = NULL) #>                                        A: Drug X        B: Placebo     C: Combination #>                                          (N=15)           (N=15)           (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Responders                           10 (66.7%)       9 (60.0%)        11 (73.3%)   #>   95% CI (Wald, with correction)      (39.5, 93.9)     (31.9, 88.1)     (47.6, 99.0)  #>   Complete Response (CR)               4 (26.7%)        4 (26.7%)        7 (46.7%)    #>     95% CI (Wald, with correction)   (0.95, 52.38)    (0.95, 52.38)    (18.09, 75.25) #>   Partial Response (PR)                6 (40.0%)        5 (33.3%)        4 (26.7%)    #>     95% CI (Wald, with correction)   (11.87, 68.13)   (6.14, 60.52)    (0.95, 52.38)  #>   Stable Disease (SD)                  5 (33.3%)        6 (40.0%)        4 (26.7%)    #>     95% CI (Wald, with correction)   (6.14, 60.52)    (11.87, 68.13)   (0.95, 52.38)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"best-overall-response-with-stratified-analysis","dir":"Articles","previous_headings":"TABLES > Best Overall Response (RSPT01)","what":"4. Best Overall Response (with stratified analysis)","title":"Chevron Catalog","text":"stratified analysis can added specifying argument perform_analysis = \"strat\" providing stratification variable argument strata . argument strata expected perform_analysis set include stratified analysis. stratification variables expected available adrs. unstratified stratified analysis required, use perform_analysis = c(\"unstrat\", \"strat\")","code":"proc_data <- log_filter(syn_data, PARAMCD == \"BESRSPI\", \"adrs\")  run(rspt01, proc_data, perform_analysis = \"strat\", strata = c(\"STRATA1\", \"STRATA2\")) #> Warning in prop_diff_cmh(rsp, grp, strata, conf_level): Less than 5 #> observations in some strata. #> Warning in prop_diff_cmh(rsp, grp, strata, conf_level): Less than 5 #> observations in some strata. #> Warning in prop_cmh(tbl): <5 data points in some strata. CMH test may be #> incorrect. #> Warning in prop_cmh(tbl): <5 data points in some strata. CMH test may be #> incorrect. #>                                                A: Drug X          B: Placebo         C: Combination   #>                                                  (N=15)             (N=15)               (N=15)       #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Responders                                   10 (66.7%)         9 (60.0%)            11 (73.3%)     #>   95% CI (Wald, with correction)              (39.5, 93.9)       (31.9, 88.1)         (47.6, 99.0)    #>   Stratified Analysis                                                                                 #>     Difference in Response rate (%)                                 -11.0                 22.5        #>       95% CI (CMH, without correction)                          (-42.7, 20.7)         (-3.5, 48.5)    #>     p-value (Cochran-Mantel-Haenszel Test)                          0.5731               0.3088       #>   Odds Ratio (95% CI)                                         0.75 (0.17 - 3.33)   1.37 (0.29 - 6.60) #>   Complete Response (CR)                       4 (26.7%)          4 (26.7%)            7 (46.7%)      #>     95% CI (Wald, with correction)           (0.95, 52.38)      (0.95, 52.38)        (18.09, 75.25)   #>   Partial Response (PR)                        6 (40.0%)          5 (33.3%)            4 (26.7%)      #>     95% CI (Wald, with correction)           (11.87, 68.13)     (6.14, 60.52)        (0.95, 52.38)    #>   Stable Disease (SD)                          5 (33.3%)          6 (40.0%)            4 (26.7%)      #>     95% CI (Wald, with correction)           (6.14, 60.52)      (11.87, 68.13)       (0.95, 52.38)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"best-overall-response-modifying-analysis-details-like-type-of-confidence-interval-alpha-level-test-for-p-value","dir":"Articles","previous_headings":"TABLES > Best Overall Response (RSPT01)","what":"5. Best Overall Response (modifying analysis details like type of confidence interval, alpha level, test for p-value)","title":"Chevron Catalog","text":"level confidence intervals defined argument conf_level. methods construct confidence interval p-value controlled argument methods. named list five optional sub-arguments. example, methods = list(prop_conf_method = \"wald\", diff_conf_method = \"wald\", strat_diff_conf_method = \"ha\", diff_pval_method = \"fisher\", strat_diff_pval_method = \"schouten\") See table argument controls available method options: See table method options estimates proportions associated statistical methods: See table method options estimates proportion difference associated statistical methods: See table method options testing proportion difference associated statistical methods: example:","code":"proc_data <- log_filter(syn_data, PARAMCD == \"BESRSPI\", \"adrs\")  run(rspt01, proc_data,   conf_level = 0.90,   methods = list(     prop_conf_method = \"wald\",     diff_conf_method = \"wald\",     diff_pval_method = \"fisher\"   ) ) #>                                             A: Drug X          B: Placebo         C: Combination   #>                                               (N=15)             (N=15)               (N=15)       #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Responders                                10 (66.7%)         9 (60.0%)            11 (73.3%)     #>   90% CI (Wald, without correction)        (46.6, 86.7)       (39.2, 80.8)         (54.6, 92.1)    #>   Unstratified Analysis                                                                            #>     Difference in Response rate (%)                               -6.7                 6.7         #>       90% CI (Wald, without correction)                      (-35.5, 22.2)        (-20.8, 34.1)    #>     p-value (Fisher's Exact Test)                                1.0000               1.0000       #>   Odds Ratio (95% CI)                                      0.75 (0.17 - 3.33)   1.37 (0.29 - 6.60) #>   Complete Response (CR)                    4 (26.7%)          4 (26.7%)            7 (46.7%)      #>     90% CI (Wald, without correction)     (7.89, 45.45)      (7.89, 45.45)        (25.48, 67.85)   #>   Partial Response (PR)                     6 (40.0%)          5 (33.3%)            4 (26.7%)      #>     90% CI (Wald, without correction)     (19.19, 60.81)     (13.31, 53.35)       (7.89, 45.45)    #>   Stable Disease (SD)                       5 (33.3%)          6 (40.0%)            4 (26.7%)      #>     90% CI (Wald, without correction)     (13.31, 53.35)     (19.19, 60.81)       (7.89, 45.45)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"best-overall-response-modifying-the-definition-of-overall-response","dir":"Articles","previous_headings":"TABLES > Best Overall Response (RSPT01)","what":"6. Best Overall Response (modifying the definition of overall response)","title":"Chevron Catalog","text":"following example shows customize definition responder, e.g, consider complete response response.","code":"proc_data <- log_filter(syn_data, PARAMCD == \"BESRSPI\", \"adrs\")  preprocess(rspt01) <- function(adam_db, ...) {   adam_db$adrs <- adam_db$adrs %>%     mutate(RSP_LAB = tern::d_onco_rsp_label(.data$AVALC)) %>%     mutate(IS_RSP = .data$AVALC %in% c(\"CR\"))   adam_db }  run(rspt01, proc_data) #> Warning in stats::prop.test(tbl, correct = FALSE): Chi-squared approximation #> may be incorrect #>                                          A: Drug X          B: Placebo         C: Combination    #>                                            (N=15)             (N=15)               (N=15)        #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Responders                             4 (26.7%)          4 (26.7%)             7 (46.7%)      #>   95% CI (Wald, with correction)        (1.0, 52.4)        (1.0, 52.4)          (18.1, 75.2)     #>   Unstratified Analysis                                                                          #>     Difference in Response rate (%)                            0.0                  20.0         #>       95% CI (Wald, with correction)                      (-38.3, 38.3)         (-20.4, 60.4)    #>     p-value (Chi-Squared Test)                                1.0000               0.2557        #>   Odds Ratio (95% CI)                                   1.00 (0.20 - 5.04)   2.41 (0.52 - 11.10) #>   Complete Response (CR)                 4 (26.7%)          4 (26.7%)             7 (46.7%)      #>     95% CI (Wald, with correction)     (0.95, 52.38)      (0.95, 52.38)        (18.09, 75.25)    #>   Partial Response (PR)                  6 (40.0%)          5 (33.3%)             4 (26.7%)      #>     95% CI (Wald, with correction)     (11.87, 68.13)     (6.14, 60.52)         (0.95, 52.38)    #>   Stable Disease (SD)                    5 (33.3%)          6 (40.0%)             4 (26.7%)      #>     95% CI (Wald, with correction)     (6.14, 60.52)      (11.87, 68.13)        (0.95, 52.38)"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"time-to-event-summary","dir":"Articles","previous_headings":"TABLES > Time-to-event Summary (TTET01)","what":"1. Time-to-event Summary","title":"Chevron Catalog","text":"ttet01 template produces standard time--event summary. Users expected subset parameter interest (e.g.¬†PARAMCD == \"PFS\") pre-processing. Please see section Best Overall Response (Ordering treatment groups) find ordering treatment groups reference group. Unstratified analysis provided default. Survival estimations difference survival provided default.","code":"proc_data <- log_filter(syn_data, PARAMCD == \"PFS\", \"adtte\")  run(ttet01, proc_data) #>                                       A: Drug X        B: Placebo      C: Combination  #>                                         (N=15)           (N=15)            (N=15)      #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Patients with event (%)             7 (46.7%)         12 (80%)          8 (53.3%)    #>     Earliest contributing event                                                        #>       Death                               5                11                 7        #>       Disease Progression                 2                 1                 1        #>   Patients without event (%)          8 (53.3%)          3 (20%)          7 (46.7%)    #>   Time to Event (MONTHS)                                                               #>     Median                               8.6               6.2               8.4       #>       95% CI                          (7.3, NE)        (4.8, 7.6)         (7.0, NE)    #>     25% and 75%-ile                    3.8, NE          4.7, 8.4           5.8, NE     #>     Range                           1.2 to 9.5 {1}     0.9 to 9.1      0.9 to 9.5 {1}  #>   Unstratified Analysis                                                                #>     p-value (log-rank)                                   0.0973            0.9111      #>     Hazard Ratio                                          2.18              1.06       #>     95% CI                                            (0.85, 5.60)      (0.38, 2.94)   #>   6 MONTHS                                                                             #>     Patients remaining at risk            11                8                11        #>     Event Free Rate (%)                 73.33             53.33             73.33      #>     95% CI                          (50.95, 95.71)   (28.09, 78.58)    (50.95, 95.71)  #>     Difference in Event Free Rate                        -20.00             0.00       #>       95% CI                                         (-53.74, 13.74)   (-31.65, 31.65) #>       p-value (Z-test)                                   0.2453            1.0000      #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>  #>   {1} - Censored observation: range maximum #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"time-to-event-summary-selecting-sections-to-display","dir":"Articles","previous_headings":"TABLES > Time-to-event Summary (TTET01)","what":"2. Time-to-event Summary (selecting sections to display)","title":"Chevron Catalog","text":"suspend section earliest contributing events, use summarize_event = FALSE. select either survival estimations difference survival , please specify argument method. - surv calls analysis patients remaining risk, event free rate corresponding 95% confidence interval rates. - surv_diff calls analysis difference event free rate, 95% confidence interval difference corresponding p-value. - calls .","code":"proc_data <- log_filter(syn_data, PARAMCD == \"PFS\", \"adtte\")  run(ttet01, proc_data, summarize_event = FALSE) #>                                       A: Drug X        B: Placebo      C: Combination  #>                                         (N=15)           (N=15)            (N=15)      #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Patients with event (%)             7 (46.7%)         12 (80%)          8 (53.3%)    #>   Patients without event (%)          8 (53.3%)          3 (20%)          7 (46.7%)    #>   Time to Event (MONTHS)                                                               #>     Median                               8.6               6.2               8.4       #>       95% CI                          (7.3, NE)        (4.8, 7.6)         (7.0, NE)    #>     25% and 75%-ile                    3.8, NE          4.7, 8.4           5.8, NE     #>     Range                           1.2 to 9.5 {1}     0.9 to 9.1      0.9 to 9.5 {1}  #>   Unstratified Analysis                                                                #>     p-value (log-rank)                                   0.0973            0.9111      #>     Hazard Ratio                                          2.18              1.06       #>     95% CI                                            (0.85, 5.60)      (0.38, 2.94)   #>   6 MONTHS                                                                             #>     Patients remaining at risk            11                8                11        #>     Event Free Rate (%)                 73.33             53.33             73.33      #>     95% CI                          (50.95, 95.71)   (28.09, 78.58)    (50.95, 95.71)  #>     Difference in Event Free Rate                        -20.00             0.00       #>       95% CI                                         (-53.74, 13.74)   (-31.65, 31.65) #>       p-value (Z-test)                                   0.2453            1.0000      #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>  #>   {1} - Censored observation: range maximum #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî proc_data <- log_filter(syn_data, PARAMCD == \"PFS\", \"adtte\")  run(ttet01, proc_data, method = \"surv\") #>                                     A: Drug X        B: Placebo     C: Combination #>                                       (N=15)           (N=15)           (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Patients with event (%)           7 (46.7%)         12 (80%)        8 (53.3%)    #>     Earliest contributing event                                                    #>       Death                             5                11               7        #>       Disease Progression               2                1                1        #>   Patients without event (%)        8 (53.3%)         3 (20%)         7 (46.7%)    #>   Time to Event (MONTHS)                                                           #>     Median                             8.6              6.2              8.4       #>       95% CI                        (7.3, NE)        (4.8, 7.6)       (7.0, NE)    #>     25% and 75%-ile                  3.8, NE          4.7, 8.4         5.8, NE     #>     Range                         1.2 to 9.5 {1}     0.9 to 9.1     0.9 to 9.5 {1} #>   Unstratified Analysis                                                            #>     p-value (log-rank)                                 0.0973           0.9111     #>     Hazard Ratio                                        2.18             1.06      #>     95% CI                                          (0.85, 5.60)     (0.38, 2.94)  #>   6 MONTHS                                                                         #>     Patients remaining at risk          11               8                11       #>     Event Free Rate (%)               73.33            53.33            73.33      #>     95% CI                        (50.95, 95.71)   (28.09, 78.58)   (50.95, 95.71) #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>  #>   {1} - Censored observation: range maximum #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"time-to-event-summary-modifying-analysis-details-like-confidence-interval-type-ties-and-alpha-level","dir":"Articles","previous_headings":"TABLES > Time-to-event Summary (TTET01)","what":"3. Time-to-event Summary (modifying analysis details like confidence interval type, ties, and alpha level)","title":"Chevron Catalog","text":"level confidence intervals defined argument conf_level. type confidence interval defined argument conf_type. Options \"plain\" (default), \"log\" \"log-log\". Handling ties specified argument ties. Options \"efron\" (default),\"breslow\" \"exact\".","code":"proc_data <- log_filter(syn_data, PARAMCD == \"PFS\", \"adtte\")  run(ttet01, proc_data, conf_level = 0.90, conf_type = \"log-log\", ties = \"efron\") #>                                       A: Drug X        B: Placebo     C: Combination  #>                                         (N=15)           (N=15)           (N=15)      #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Patients with event (%)             7 (46.7%)         12 (80%)         8 (53.3%)    #>     Earliest contributing event                                                       #>       Death                               5                11                7        #>       Disease Progression                 2                1                 1        #>   Patients without event (%)          8 (53.3%)         3 (20%)          7 (46.7%)    #>   Time to Event (MONTHS)                                                              #>     Median                               8.6              6.2               8.4       #>       90% CI                          (3.8, NE)        (4.7, 7.6)        (5.8, NE)    #>     25% and 75%-ile                    3.8, NE          4.7, 8.4          5.8, NE     #>     Range                           1.2 to 9.5 {1}     0.9 to 9.1     0.9 to 9.5 {1}  #>   Unstratified Analysis                                                               #>     p-value (log-rank)                                   0.0973           0.9111      #>     Hazard Ratio                                          2.18             1.06       #>     90% CI                                            (0.99, 4.81)     (0.45, 2.50)   #>   6 MONTHS                                                                            #>     Patients remaining at risk            11               8                11        #>     Event Free Rate (%)                 73.33            53.33             73.33      #>     90% CI                          (49.25, 87.30)   (30.65, 71.60)   (49.25, 87.30)  #>     Difference in Event Free Rate                        -20.00            0.00       #>       90% CI                                         (-48.31, 8.31)   (-26.56, 26.56) #>       p-value (Z-test)                                   0.2453           1.0000      #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>  #>   {1} - Censored observation: range maximum #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"time-to-event-summary-with-stratified-analysis","dir":"Articles","previous_headings":"TABLES > Time-to-event Summary (TTET01)","what":"4. Time-to-event Summary (with stratified analysis)","title":"Chevron Catalog","text":"stratified analysis can added specifying argument perform_analysis = \"strat\" providing stratification variable argument strata . argument strata expected perform_analysis set include stratified analysis. stratification variables expected available adrs. unstratified stratified analysis required, users can use perform_analysis = c(\"unstrat\", \"strat\").","code":"proc_data <- log_filter(syn_data, PARAMCD == \"PFS\", \"adtte\")  run(ttet01, proc_data, perform_analysis = \"strat\", strata = \"STRATA1\") #>                                       A: Drug X        B: Placebo      C: Combination  #>                                         (N=15)           (N=15)            (N=15)      #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Patients with event (%)             7 (46.7%)         12 (80%)          8 (53.3%)    #>     Earliest contributing event                                                        #>       Death                               5                11                 7        #>       Disease Progression                 2                 1                 1        #>   Patients without event (%)          8 (53.3%)          3 (20%)          7 (46.7%)    #>   Time to Event (MONTHS)                                                               #>     Median                               8.6               6.2               8.4       #>       95% CI                          (7.3, NE)        (4.8, 7.6)         (7.0, NE)    #>     25% and 75%-ile                    3.8, NE          4.7, 8.4           5.8, NE     #>     Range                           1.2 to 9.5 {1}     0.9 to 9.1      0.9 to 9.5 {1}  #>   Stratified Analysis                                                                  #>     p-value (log-rank)                                   0.0649            0.8901      #>     Hazard Ratio                                          2.52              1.08       #>     95% CI                                            (0.92, 6.93)      (0.36, 3.22)   #>   6 MONTHS                                                                             #>     Patients remaining at risk            11                8                11        #>     Event Free Rate (%)                 73.33             53.33             73.33      #>     95% CI                          (50.95, 95.71)   (28.09, 78.58)    (50.95, 95.71)  #>     Difference in Event Free Rate                        -20.00             0.00       #>       95% CI                                         (-53.74, 13.74)   (-31.65, 31.65) #>       p-value (Z-test)                                   0.2453            1.0000      #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>  #>   {1} - Censored observation: range maximum #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"time-to-event-summary-modifying-time-point-for-the-survival-at-xx-months-analysis","dir":"Articles","previous_headings":"TABLES > Time-to-event Summary (TTET01)","what":"5. Time-to-event Summary (modifying time point for the ‚Äúsurvival at xx months‚Äù analysis)","title":"Chevron Catalog","text":"time point ‚Äúsurvival xx months‚Äù analysis can modified specifying argument time_point. default, function takes AVAL adtte days converts months. survival estimates summarized month, numeric values provided months time_point. following example shows specify time point user-defined unit.","code":"proc_data <- log_filter(syn_data, PARAMCD == \"PFS\", \"adtte\")  run(ttet01, proc_data, perform_analysis = \"unstrat\", time_point = c(3, 6)) #>                                        A: Drug X        B: Placebo      C: Combination  #>                                         (N=15)            (N=15)            (N=15)      #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Patients with event (%)              7 (46.7%)         12 (80%)          8 (53.3%)    #>     Earliest contributing event                                                         #>       Death                                5                11                 7        #>       Disease Progression                  2                 1                 1        #>   Patients without event (%)           8 (53.3%)          3 (20%)          7 (46.7%)    #>   Time to Event (MONTHS)                                                                #>     Median                                8.6               6.2               8.4       #>       95% CI                           (7.3, NE)        (4.8, 7.6)         (7.0, NE)    #>     25% and 75%-ile                     3.8, NE          4.7, 8.4           5.8, NE     #>     Range                           1.2 to 9.5 {1}      0.9 to 9.1      0.9 to 9.5 {1}  #>   Unstratified Analysis                                                                 #>     p-value (log-rank)                                    0.0973            0.9111      #>     Hazard Ratio                                           2.18              1.06       #>     95% CI                                             (0.85, 5.60)      (0.38, 2.94)   #>   3 MONTHS                                                                              #>     Patients remaining at risk            12                12                13        #>     Event Free Rate (%)                  80.00             80.00             86.67      #>     95% CI                          (59.76, 100.00)   (59.76, 100.00)   (69.46, 100.00) #>     Difference in Event Free Rate                          0.00              6.67       #>       95% CI                                          (-28.63, 28.63)   (-19.90, 33.23) #>       p-value (Z-test)                                    1.0000            0.6228      #>   6 MONTHS                                                                              #>     Patients remaining at risk            11                 8                11        #>     Event Free Rate (%)                  73.33             53.33             73.33      #>     95% CI                          (50.95, 95.71)    (28.09, 78.58)    (50.95, 95.71)  #>     Difference in Event Free Rate                         -20.00             0.00       #>       95% CI                                          (-53.74, 13.74)   (-31.65, 31.65) #>       p-value (Z-test)                                    0.2453            1.0000      #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>  #>   {1} - Censored observation: range maximum #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî proc_data <- log_filter(syn_data, PARAMCD == \"PFS\", \"adtte\")  preprocess(ttet01) <- function(adam_db, dataset = \"adtte\",                                ...) {   adam_db[[dataset]] <- adam_db[[dataset]] %>%     mutate(       AVALU = \"DAYS\",       IS_EVENT = .data$CNSR == 0,       IS_NOT_EVENT = .data$CNSR == 1,       EVNT1 = factor(         case_when(           IS_EVENT == TRUE ~ render_safe(\"{Patient_label} with event (%)\"),           IS_EVENT == FALSE ~ render_safe(\"{Patient_label} without event (%)\")         ),         levels = render_safe(c(\"{Patient_label} with event (%)\", \"{Patient_label} without event (%)\"))       ),       EVNTDESC = factor(.data$EVNTDESC)     )    adam_db }  run(ttet01, proc_data, perform_analysis = \"unstrat\", time_point = c(91, 183)) #>                                         A: Drug X         B: Placebo       C: Combination   #>                                          (N=15)             (N=15)             (N=15)       #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Patients with event (%)               7 (46.7%)          12 (80%)           8 (53.3%)     #>     Earliest contributing event                                                             #>       Death                                 5                 11                  7         #>       Disease Progression                   2                  1                  1         #>   Patients without event (%)            8 (53.3%)           3 (20%)           7 (46.7%)     #>   Time to Event (DAYS)                                                                      #>     Median                                261.9              187.7              256.3       #>       95% CI                           (221.9, NE)      (144.7, 232.2)       (212.0, NE)    #>     25% and 75%-ile                     114.9, NE        141.9, 254.4         175.0, NE     #>     Range                           37.2 to 288.3 {1}    28.0 to 276.6    26.4 to 288.1 {1} #>   Unstratified Analysis                                                                     #>     p-value (log-rank)                                      0.0973             0.9111       #>     Hazard Ratio                                             2.18               1.06        #>     95% CI                                               (0.85, 5.60)       (0.38, 2.94)    #>   91 DAYS                                                                                   #>     Patients remaining at risk             12                 12                 13         #>     Event Free Rate (%)                   80.00              80.00              86.67       #>     95% CI                           (59.76, 100.00)    (59.76, 100.00)    (69.46, 100.00)  #>     Difference in Event Free Rate                            0.00               6.67        #>       95% CI                                            (-28.63, 28.63)    (-19.90, 33.23)  #>       p-value (Z-test)                                      1.0000             0.6228       #>   183 DAYS                                                                                  #>     Patients remaining at risk             11                  8                 11         #>     Event Free Rate (%)                   73.33              53.33              73.33       #>     95% CI                           (50.95, 95.71)     (28.09, 78.58)     (50.95, 95.71)   #>     Difference in Event Free Rate                           -20.00              0.00        #>       95% CI                                            (-53.74, 13.74)    (-31.65, 31.65)  #>       p-value (Z-test)                                      0.2453             1.0000       #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>  #>   {1} - Censored observation: range maximum #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"time-to-event-summary-modifying-the-p-value-method-for-testing-hazard-ratio","dir":"Articles","previous_headings":"TABLES > Time-to-event Summary (TTET01)","what":"6. Time-to-event Summary (modifying the p-value method for testing hazard ratio)","title":"Chevron Catalog","text":"default p-value method testing hazard ratio ‚Äúlog-rank‚Äù. Alternative methods can requested specifying argument pval_method options include, log-rank (default), wald likelihood. syntax currently allow requesting one p-value. Note ttet01 modified previous example (.e., preprocess(ttet01) overridden); access default template, try chevron::ttet01.","code":"proc_data <- log_filter(syn_data, PARAMCD == \"PFS\", \"adtte\")  run(ttet01, proc_data, pval_method = \"wald\") #>                                       A: Drug X          B: Placebo       C: Combination   #>                                        (N=15)              (N=15)             (N=15)       #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Patients with event (%)             7 (46.7%)           12 (80%)           8 (53.3%)     #>     Earliest contributing event                                                            #>       Death                               5                  11                  7         #>       Disease Progression                 2                  1                   1         #>   Patients without event (%)          8 (53.3%)           3 (20%)            7 (46.7%)     #>   Time to Event (DAYS)                                                                     #>     Median                              261.9              187.7               256.3       #>       95% CI                         (221.9, NE)       (144.7, 232.2)       (212.0, NE)    #>     25% and 75%-ile                   114.9, NE         141.9, 254.4         175.0, NE     #>     Range                         37.2 to 288.3 {1}    28.0 to 276.6     26.4 to 288.1 {1} #>   Unstratified Analysis                                                                    #>     p-value (wald)                                         0.1053             0.9111       #>     Hazard Ratio                                            2.18               1.06        #>     95% CI                                              (0.85, 5.60)       (0.38, 2.94)    #>   6 DAYS                                                                                   #>     Patients remaining at risk           15                  15                 15         #>     Event Free Rate (%)                100.00              100.00             100.00       #>     95% CI                        (100.00, 100.00)    (100.00, 100.00)   (100.00, 100.00)  #>   12 DAYS                                                                                  #>     Patients remaining at risk           15                  15                 15         #>     Event Free Rate (%)                100.00              100.00             100.00       #>     95% CI                        (100.00, 100.00)    (100.00, 100.00)   (100.00, 100.00)  #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>  #>   {1} - Censored observation: range maximum #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"vital-sign-results-and-change-from-baseline-by-visit","dir":"Articles","previous_headings":"TABLES > Vital Signs (VST01)","what":"1. Vital Sign Results and Change from Baseline by Visit","title":"Chevron Catalog","text":"","code":"t_vs_chg <- run(vst01, syn_data) head(t_vs_chg, 20) #>                                         A: Drug X                           B: Placebo                          C: Combination           #>                                                 Change from                          Change from                           Change from   #>                              Value at Visit       Baseline       Value at Visit        Baseline        Value at Visit       Baseline     #>                                  (N=15)            (N=15)            (N=15)             (N=15)             (N=15)            (N=15)      #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Diastolic Blood Pressure                                                                                                               #>     SCREENING                                                                                                                            #>       n                            15                0                 15                 0                  15                 0        #>       Mean (SD)              94.385 (17.067)      NE (NE)       106.381 (20.586)       NE (NE)        106.468 (12.628)       NE (NE)     #>       Median                     94.933              NE             111.133               NE              108.359              NE        #>       Min - Max              55.71 - 122.00       NE - NE        60.21 - 131.91        NE - NE         83.29 - 127.17        NE - NE     #>     BASELINE                                                                                                                             #>       n                            15                                  15                                    15                          #>       Mean (SD)              96.133 (22.458)                    108.111 (15.074)                      103.149 (19.752)                   #>       Median                     93.328                             108.951                               102.849                        #>       Min - Max              60.58 - 136.59                      83.44 - 131.62                        66.05 - 136.55                    #>     WEEK 1 DAY 8                                                                                                                         #>       n                            15                15                15                 15                 15                15        #>       Mean (SD)              98.977 (21.359)   2.844 (28.106)   104.110 (16.172)   -4.001 (21.867)    100.826 (19.027)   -2.323 (25.018) #>       Median                     92.447            -4.066           107.703             3.227             103.058            -2.476      #>       Min - Max              67.55 - 130.37    -32.82 - 47.68    70.91 - 132.89     -52.94 - 28.63     70.04 - 128.68    -55.15 - 41.81  #>     WEEK 2 DAY 15                                                                                                                        #>       n                            15                15                15                 15                 15                15        #>       Mean (SD)              99.758 (14.477)   3.626 (21.189)   97.473 (17.296)    -10.638 (20.831)   94.272 (16.961)    -8.877 (27.229) #>       Median                     101.498           1.731             99.501             -9.727             96.789            -10.155"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"vital-sign-abnormalities-regardless-of-abnormality-at-baseline","dir":"Articles","previous_headings":"TABLES > Vital Signs Abnormalities (Regardless of Abnormality at Baseline) (VST02_1)","what":"1. Vital Sign Abnormalities (Regardless of Abnormality at Baseline)","title":"Chevron Catalog","text":"","code":"run(vst02_1, syn_data) #>   Assessment                   A: Drug X      B: Placebo     C: Combination #>    Abnormality                  (N=15)          (N=15)           (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Diastolic Blood Pressure                                                  #>     Low                      8/15 (53.3%)     9/15 (60%)      8/15 (53.3%)  #>     High                     10/15 (66.7%)   5/15 (33.3%)     8/15 (53.3%)  #>   Pulse Rate                                                                #>     Low                       9/15 (60%)      3/15 (20%)      5/15 (33.3%)  #>     High                     2/15 (13.3%)     6/15 (40%)      5/15 (33.3%)  #>   Respiratory Rate                                                          #>     Low                      13/15 (86.7%)   10/15 (66.7%)   13/15 (86.7%)  #>     High                     7/15 (46.7%)    10/15 (66.7%)   11/15 (73.3%)  #>   Systolic Blood Pressure                                                   #>     Low                      7/15 (46.7%)     9/15 (60%)     11/15 (73.3%)  #>     High                     10/15 (66.7%)    9/15 (60%)       9/15 (60%)   #>   Temperature                                                               #>     Low                       12/15 (80%)    13/15 (86.7%)   11/15 (73.3%)  #>     High                     14/15 (93.3%)    12/15 (80%)    14/15 (93.3%)  #>   Weight                                                                    #>     Low                       3/15 (20%)      3/15 (20%)      4/15 (26.7%)  #>     High                     4/15 (26.7%)    4/15 (26.7%)     5/15 (33.3%)"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"vital-sign-abnormalities-among-subject-without-abnormality-at-baseline","dir":"Articles","previous_headings":"TABLES > Vital Signs Abnormalities (Among Subject Without Abnormality at Baseline) (VST02_2)","what":"1. Vital Sign Abnormalities (Among Subject Without Abnormality at Baseline)","title":"Chevron Catalog","text":"","code":"run(vst02_2, syn_data) #>   Assessment                  A: Drug X      B: Placebo    C: Combination #>    Abnormality                  (N=15)         (N=15)          (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Diastolic Blood Pressure                                                #>     Low                      6/11 (54.5%)    9/15 (60%)      6/12 (50%)   #>     High                     8/12 (66.7%)   4/11 (36.4%)    7/13 (53.8%)  #>   Pulse Rate                                                              #>     Low                       9/15 (60%)     3/15 (20%)     5/13 (38.5%)  #>     High                     2/14 (14.3%)   4/12 (33.3%)    5/15 (33.3%)  #>   Respiratory Rate                                                        #>     Low                      7/9 (77.8%)    7/11 (63.6%)   11/12 (91.7%)  #>     High                     6/14 (42.9%)   7/11 (63.6%)    9/13 (69.2%)  #>   Systolic Blood Pressure                                                 #>     Low                      5/13 (38.5%)   8/12 (66.7%)   10/14 (71.4%)  #>     High                     8/13 (61.5%)   8/13 (61.5%)    8/13 (61.5%)  #>   Temperature                                                             #>     Low                       8/10 (80%)    7/9 (77.8%)      8/10 (80%)   #>     High                      8/8 (100%)    7/8 (87.5%)    12/13 (92.3%)  #>   Weight                                                                  #>     Low                       3/15 (20%)     3/15 (20%)     3/14 (21.4%)  #>     High                     4/14 (28.6%)   4/15 (26.7%)    5/14 (35.7%)"},{"path":[]},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"glossary-of-adverse-event-preferred-terms-and-investigator-specified-terms","dir":"Articles","previous_headings":"LISTINGS > Glossary of Adverse Event Preferred Terms and Investigator-Specified Terms (AEL01_NOLLT)","what":"1. Glossary of Adverse Event Preferred Terms and Investigator-Specified Terms","title":"Chevron Catalog","text":"ael01_nollt template produces standard glossary adverse event preferred terms investigator-specified terms. example uses head function print first 10 lines output.","code":"l_ae_nollt <- run(ael01_nollt, syn_data) head(l_ae_nollt, 10) #> MedDRA System Organ Class   MedDRA Preferred Term   Reported Term for the Adverse Event #> ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #> cl A.1                      dcd A.1.1.1.1           trm A.1.1.1.1                       #>                             dcd A.1.1.1.2           trm A.1.1.1.2                       #> cl B.1                      dcd B.1.1.1.1           trm B.1.1.1.1                       #> cl B.2                      dcd B.2.1.2.1           trm B.2.1.2.1                       #>                             dcd B.2.2.3.1           trm B.2.2.3.1                       #> cl C.1                      dcd C.1.1.1.3           trm C.1.1.1.3                       #> cl C.2                      dcd C.2.1.2.1           trm C.2.1.2.1                       #> cl D.1                      dcd D.1.1.1.1           trm D.1.1.1.1                       #>                             dcd D.1.1.4.2           trm D.1.1.4.2                       #> cl D.2                      dcd D.2.1.5.3           trm D.2.1.5.3"},{"path":[]},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"forest-plot-for-odds-ratio-with-subgroup-analysis","dir":"Articles","previous_headings":"Graphics > Forest Plot for Odds Ratio (FSTG01)","what":"1. Forest Plot for Odds Ratio (with subgroup analysis)","title":"Chevron Catalog","text":"fstg01 template produces standard forest plot odds ratio. Users expected subset parameter interest (e.g.¬†PARAMCD == \"BESRSPI\") pre-processing. Users expected subset arm variable keep two arms compare (e.g.¬†ARM %% c(\": Drug X\", \"B: Placebo\")). default, plots displays subgroup analysis \"SEX\", \"AGEGR1\" \"RACE\". Unstratified analysis provided default. plots displays default Total number subjects, odd ratio 95% confidence interval, , arm, number subject, number responders proportion responders.","code":"proc_data <- log_filter(   syn_data,   PARAMCD == \"BESRSPI\" & ARM %in% c(\"A: Drug X\", \"B: Placebo\"), \"adrs\" ) run(fstg01, proc_data)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"forest-plot-for-odds-ratio-with-a-user-defined-confidence-level","dir":"Articles","previous_headings":"Graphics > Forest Plot for Odds Ratio (FSTG01)","what":"2. Forest Plot for Odds Ratio (with a user-defined confidence level)","title":"Chevron Catalog","text":"confidence level confidence interval can adjusted conf_level argument.","code":"run(fstg01, proc_data, conf_level = 0.90)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"forest-plot-for-odds-ratio-with-p-values-andor-different-statistics","dir":"Articles","previous_headings":"Graphics > Forest Plot for Odds Ratio (FSTG01)","what":"3. Forest Plot for Odds Ratio (with p-values and/or different statistics)","title":"Chevron Catalog","text":"interaction p-values different set statistics can displayed using stat_var argument. Note users expected select method p-value computation. see [tern::prop_diff_test].","code":"run(fstg01, proc_data, method = \"fisher\", stat_var = c(\"n_tot\", \"n\", \"ci\", \"or\", \"pval\"))"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"forest-plot-for-odds-ratio-with-user-defined-subgroup-analysis","dir":"Articles","previous_headings":"Graphics > Forest Plot for Odds Ratio (FSTG01)","what":"4. Forest Plot for Odds Ratio (with user-defined subgroup analysis)","title":"Chevron Catalog","text":"subgroups arguments controls variables used subgroup analysis. NULLthe subgroup analysis removed.","code":"run(fstg01, proc_data, subgroups = NULL)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"forest-plot-for-odds-ratio-with-stratified-analysis","dir":"Articles","previous_headings":"Graphics > Forest Plot for Odds Ratio (FSTG01)","what":"5. Forest Plot for Odds Ratio (with stratified analysis)","title":"Chevron Catalog","text":"strata_var argument used pass columns used stratified analysis.","code":"run(fstg01, proc_data, strata_var = \"STRATA1\") #> Warning in coxexact.fit(X, Y, istrat, offset, init, control, weights = weights, #> : Ran out of iterations and did not converge #> Warning in s_odds_ratio(df = l_df[[2]], .var = \"rsp\", .ref_group = l_df[[1]], : #> Unable to compute the odds ratio estimate. Please try re-running the function #> with parameter `method` set to \"approximate\". #> Warning in coxexact.fit(X, Y, istrat, offset, init, control, weights = weights, #> : Ran out of iterations and did not converge"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"forest-plot-for-odds-ratio-without-proportional-sizing-of-the-odds-ratio-symbol","dir":"Articles","previous_headings":"Graphics > Forest Plot for Odds Ratio (FSTG01)","what":"6. Forest Plot for Odds Ratio (without proportional sizing of the odds ratio symbol)","title":"Chevron Catalog","text":"col_symbol_size argument controls size odds ratio symbols default proportional size sample size subgroup. NULL symbol size used subgroups.","code":"run(fstg01, proc_data, col_symbol_size = NULL)"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"forest-plot-for-hazard-ratio-with-subgroup-analysis","dir":"Articles","previous_headings":"Graphics > Forest Plot for Hazard Ratio (FSTG02)","what":"1. Forest Plot for Hazard Ratio (with subgroup analysis)","title":"Chevron Catalog","text":"fstg02 template produces standard forest plot hazard ratio. Users expected subset parameter interest (e.g.¬†PARAMCD == \"OS\") pre-processing. Users expected subset arm variable keep two arms compare (e.g.¬†ARM %% c(\": Drug X\", \"B: Placebo\")). default, plots displays subgroup analysis \"SEX\", \"AGEGR1\" \"RACE\". Unstratified analysis provided default. plots displays default Total number events, hazard ratio 95% confidence interval, , arm, number events median time event month.","code":"proc_data <- log_filter(   syn_data,   PARAMCD == \"OS\" & ARM %in% c(\"A: Drug X\", \"B: Placebo\"), \"adtte\" ) run(fstg02, proc_data)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"forest-plot-for-hazard-ratio-with-p-values-andor-different-statistics","dir":"Articles","previous_headings":"Graphics > Forest Plot for Hazard Ratio (FSTG02)","what":"2. Forest Plot for Hazard Ratio (with p-values and/or different statistics)","title":"Chevron Catalog","text":"interaction p-values different set statistics can displayed using control argument. details control options available [tern::extract_survival_subgroups]","code":"run(   fstg02,   proc_data,   stat_var = c(\"n_tot\", \"n\", \"ci\", \"hr\", \"pval\"),   control = list(conf_level = 0.9, pval_method = \"likelihood\") )"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"forest-plot-for-hazard-ratio-with-user-defined-subgroup-analysis","dir":"Articles","previous_headings":"Graphics > Forest Plot for Hazard Ratio (FSTG02)","what":"3. Forest Plot for Hazard Ratio (with user-defined subgroup analysis)","title":"Chevron Catalog","text":"subgroups arguments controls variables used subgroup analysis. NULLthe subgroup analysis removed.","code":"run(fstg02, proc_data, subgroups = NULL)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"forest-plot-for-hazard-ratio-with-stratified-analysis","dir":"Articles","previous_headings":"Graphics > Forest Plot for Hazard Ratio (FSTG02)","what":"4. Forest Plot for Hazard Ratio (with stratified analysis)","title":"Chevron Catalog","text":"strata_var argument used pass columns used stratified analysis.","code":"run(fstg02, proc_data, strata_var = \"STRATA1\") #> Warning in coxph.fit(X, Y, istrat, offset, init, control, weights = weights, : #> Loglik converged before variable 1 ; coefficient may be infinite."},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"forest-plot-for-hazard-ratio-without-proportional-sizing-of-the-hazard-ratio-symbol","dir":"Articles","previous_headings":"Graphics > Forest Plot for Hazard Ratio (FSTG02)","what":"5. Forest Plot for Hazard Ratio (without proportional sizing of the hazard ratio symbol)","title":"Chevron Catalog","text":"col_symbol_size argument controls size hazard ratio symbols default proportional size number events subgroup. NULL symbol size used subgroups.","code":"run(fstg02, proc_data, col_symbol_size = NULL)"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"kaplan-meier-plot-without-comparative-statistics","dir":"Articles","previous_headings":"Graphics > Kaplan-Meier Plot (KMG01)","what":"1. Kaplan-Meier Plot (without comparative statistics)","title":"Chevron Catalog","text":"kmg01 template produces standard Kaplan-Meier Plot. Users expected select particular parameter analysis. Users expected select treatment groups compare, otherwise, treatment groups available input datasets plotted. comparative statistics included default. estimation median survival time per treatment group default. arguments g_km control_coxph functions can passed , please use Help find information.","code":"proc_data <- log_filter(syn_data, PARAMCD == \"OS\", \"adtte\") run(kmg01, proc_data, dataset = \"adtte\")"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"kaplan-meier-plot-with-comparative-statistics","dir":"Articles","previous_headings":"Graphics > Kaplan-Meier Plot (KMG01)","what":"2. Kaplan-Meier Plot (with comparative statistics)","title":"Chevron Catalog","text":"enable comparative statistics (hazard ratio p-value), argument annot_coxph needs set TRUE. compare group determined levels factorized variable treatment group first level used reference group statistics.","code":"proc_data <- log_filter(syn_data, PARAMCD == \"OS\", \"adtte\") run(   kmg01,   proc_data,   dataset = \"adtte\",   annot_coxph = TRUE,   control_annot_coxph = tern::control_coxph_annot(x = 0.33, y = 0.42) )"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"kaplan-meier-plot-without-censoring-marks","dir":"Articles","previous_headings":"Graphics > Kaplan-Meier Plot (KMG01)","what":"3. Kaplan-Meier Plot (without censoring marks)","title":"Chevron Catalog","text":"suppress censoring marks, set argument cencor_show FALSE.","code":"proc_data <- log_filter(syn_data, PARAMCD == \"OS\", \"adtte\") run(kmg01, proc_data, dataset = \"adtte\", censor_show = FALSE)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"kaplan-meier-plot-without-estimation-of-median-survival-time","dir":"Articles","previous_headings":"Graphics > Kaplan-Meier Plot (KMG01)","what":"4. Kaplan-Meier Plot (without estimation of median survival time)","title":"Chevron Catalog","text":"","code":"proc_data <- log_filter(syn_data, PARAMCD == \"OS\", \"adtte\") run(kmg01, proc_data, dataset = \"adtte\", annot_surv_med = FALSE)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"kaplan-meier-plot-with-statistical-annotation-of-either-median-or-min-of-survival-time","dir":"Articles","previous_headings":"Graphics > Kaplan-Meier Plot (KMG01)","what":"5. Kaplan-Meier Plot (with statistical annotation of either median or min of survival time)","title":"Chevron Catalog","text":"add statistics annotation, use function annot_stats. Options min median.","code":"proc_data <- log_filter(syn_data, PARAMCD == \"OS\", \"adtte\") run(kmg01, proc_data, dataset = \"adtte\", annot_stats = \"median\") run(kmg01, proc_data, dataset = \"adtte\", annot_stats = c(\"min\", \"median\"))"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"kaplan-meier-plot-without-the-table-of-patients-at-risk","dir":"Articles","previous_headings":"Graphics > Kaplan-Meier Plot (KMG01)","what":"6. Kaplan-Meier Plot (without the table of patients at risk)","title":"Chevron Catalog","text":"","code":"proc_data <- log_filter(syn_data, PARAMCD == \"OS\", \"adtte\") run(kmg01, proc_data, dataset = \"adtte\", annot_at_risk = FALSE)"},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"plot-of-mean-and-confidence-interval-with-table-section","dir":"Articles","previous_headings":"Graphics > Mean Plot (MNG01)","what":"1. Plot of Mean and Confidence Interval (with Table Section)","title":"Chevron Catalog","text":"mng01 template produces standard mean plot. Note template mng01 quite general. users expected specify analysis dataset visit variable run function, select parameters prior run function. table summary statistics included default. variable Analysis Value AVAL used plotting default. input dataset contains results analyses multiple units,(e.g.¬†SI/CV units ADLB), please make sure parameters appropriate units selected advance.","code":"proc_data <- log_filter(syn_data, PARAMCD == \"DIABP\", \"advs\") run(mng01, proc_data, dataset = \"advs\", x_var = c(\"AVISIT\", \"AVISITN\")) #> $`Diastolic Blood Pressure`"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"plot-of-mean-and-confidence-interval-of-change-from-baseline-of-vital-signs","dir":"Articles","previous_headings":"Graphics > Mean Plot (MNG01)","what":"2. Plot of Mean and Confidence Interval of Change from Baseline of Vital Signs","title":"Chevron Catalog","text":"","code":"proc_data <- log_filter(syn_data, PARAMCD == \"DIABP\", \"advs\") run(mng01, proc_data, dataset = \"advs\", x_var = c(\"AVISIT\", \"AVISITN\"), y_var = \"CHG\") #> `geom_line()`: Each group consists of only one observation. #> ‚Ñπ Do you need to adjust the group aesthetic? #> $`Diastolic Blood Pressure`"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"plot-of-mean--sd-changing-the-statistics","dir":"Articles","previous_headings":"Graphics > Mean Plot (MNG01)","what":"3. Plot of Mean (+/-SD) (Changing the Statistics)","title":"Chevron Catalog","text":"change statistics, use argument interval_fun. Options mean_ci, mean_sei, mean_sdi, median_ci, quantiles,range.","code":"proc_data <- log_filter(syn_data, PARAMCD == \"DIABP\", \"advs\") run(mng01, proc_data, dataset = \"advs\", x_var = c(\"AVISIT\", \"AVISITN\"), interval_fun = \"mean_sdi\") #> $`Diastolic Blood Pressure`"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"plot-of-mean-and-confidence-interval-modify-alpha-level","dir":"Articles","previous_headings":"Graphics > Mean Plot (MNG01)","what":"4. Plot of Mean and Confidence Interval (Modify Alpha Level)","title":"Chevron Catalog","text":"change alpha level confidence interval, use argument control = control_analyze_vars(conf_level = <0.xx>). Note effect interval_fun set mean_ci.","code":"proc_data <- log_filter(syn_data, PARAMCD == \"DIABP\", \"advs\") run(   mng01, proc_data,   dataset = \"advs\", x_var = c(\"AVISIT\", \"AVISITN\"),   interval_fun = \"mean_ci\", control = tern::control_analyze_vars(conf_level = 0.80) ) #> $`Diastolic Blood Pressure`"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"plot-of-mean-and-confidence-interval-with-number-of-patients-only","dir":"Articles","previous_headings":"Graphics > Mean Plot (MNG01)","what":"5. Plot of Mean and Confidence Interval ÔºàWith Number of Patients Only)","title":"Chevron Catalog","text":"","code":"proc_data <- log_filter(syn_data, PARAMCD == \"DIABP\", \"advs\") run(mng01, proc_data, dataset = \"advs\", x_var = c(\"AVISIT\", \"AVISITN\"), table = \"n\") #> $`Diastolic Blood Pressure`"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/chevron_catalog.html","id":"plot-of-mean-and-confidence-interval-without-table-section","dir":"Articles","previous_headings":"Graphics > Mean Plot (MNG01)","what":"6. Plot of Mean and Confidence Interval (without Table Section)","title":"Chevron Catalog","text":"new argument added control theme (e.g.¬†setting angle axis); see example :","code":"proc_data <- log_filter(syn_data, PARAMCD == \"DIABP\", \"advs\") run(mng01, proc_data, dataset = \"advs\", x_var = c(\"AVISIT\", \"AVISITN\"), table = NULL) #> $`Diastolic Blood Pressure` ggtheme <- ggplot2::theme(   panel.grid = ggplot2::element_line(colour = \"black\", linetype = 3),   panel.background = ggplot2::element_rect(fill = \"white\"),   legend.position = \"top\",   axis.text.x = ggplot2::element_text(angle = 22, hjust = 1, vjust = 1) ) run(mng01, syn_data, dataset = \"adlb\", ggtheme = ggtheme) #> $`Alanine Aminotransferase Measurement` #>  #> $`C-Reactive Protein Measurement` #>  #> $`Immunoglobulin A Measurement`"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/script_generator.html","id":"introduction","dir":"Articles","previous_headings":"","what":"Introduction","title":"Script_Generator","text":"addition embedded run() method create tlg, chevron offers script-based approach allows user quickly edit chevron workflow without need modifying chevron_tlg object. script generated script_funs method default output script corresponding preprocessing function generated script.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/script_generator.html","id":"using-a-chevron-defined-object","dir":"Articles","previous_headings":"","what":"Using a chevron-defined object","title":"Script_Generator","text":"object returned script methods vectors character one element per line script, can easily rendered.","code":"res <- script_funs(aet01, adam_db = \"syn_data\", args = \"args_list\") writeLines(res) #> # Edit Preprocessing Function. #> preprocess(aet01) <-  #> function (adam_db, ...)  #> { #>     adam_db$adae <- adam_db$adae %>% filter(.data$ANL01FL ==  #>         \"Y\") %>% mutate(FATAL = with_label(.data$AESDTH == \"Y\",  #>         \"AE with fatal outcome\"), SER = with_label(.data$AESER ==  #>         \"Y\", \"Serious AE\"), SEV = with_label(.data$ASEV == \"SEVERE\",  #>         \"Severe AE (at greatest intensity)\"), REL = with_label(.data$AREL ==  #>         \"Y\", \"Related AE\"), WD = with_label(.data$AEACN == \"DRUG WITHDRAWN\",  #>         \"AE leading to withdrawal from treatment\"), DSM = with_label(.data$AEACN %in%  #>         c(\"DRUG INTERRUPTED\", \"DOSE INCREASED\", \"DOSE REDUCED\"),  #>         \"AE leading to dose modification/interruption\"), SERWD = with_label(.data$SER &  #>         .data$WD, \"Serious AE leading to withdrawal from treatment\"),  #>         SERDSM = with_label(.data$SER & .data$DSM, \"Serious AE leading to dose modification/interruption\"),  #>         RELSER = with_label(.data$SER & .data$REL, \"Related Serious AE\"),  #>         RELWD = with_label(.data$REL & .data$WD, \"Related AE leading to withdrawal from treatment\"),  #>         RELDSM = with_label(.data$REL & .data$DSM, \"Related AE leading to dose modification/interruption\"),  #>         CTC35 = with_label(.data$ATOXGR %in% c(\"3\", \"4\", \"5\"),  #>             \"Grade 3-5 AE\"), CTC45 = with_label(.data$ATOXGR %in%  #>             c(\"4\", \"5\"), \"Grade 4/5 AE\")) #>     adam_db$adsl <- adam_db$adsl %>% mutate(DCSREAS = reformat(.data$DCSREAS,  #>         missing_rule)) #>     adam_db #> } #>  #> # Create TLG #> tlg_output <- run(object = aet01, adam_db = syn_data, verbose = TRUE, user_args = args_list)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/articles/script_generator.html","id":"with-a-modified-chevron-object","dir":"Articles","previous_headings":"","what":"With a modified chevron object","title":"Script_Generator","text":"script generator depends functions actually stored object. Modifying chevron_tlg object can lead different script. Print generated scripts. Note new argument new_format added pre processing function modified.","code":"aet01_custom <- aet01 preprocess(aet01_custom) <- function(adam_db, new_format, ...) {   reformat(adam_db, new_format) }  res_funs <- script_funs(aet01_custom, adam_db = \"syn_data\", args = \"args_list\") writeLines(res_funs) #> # Edit Preprocessing Function. #> preprocess(aet01_custom) <-  #> function (adam_db, new_format, ...)  #> { #>     reformat(adam_db, new_format) #> } #>  #> # Create TLG #> tlg_output <- run(object = aet01_custom, adam_db = syn_data, verbose = TRUE, user_args = args_list)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/authors.html","id":null,"dir":"","previous_headings":"","what":"Authors","title":"Authors and Citation","text":"Liming Li. Author, maintainer. Benoit Falquet. Author. Xiaoli Duan. Author. Adrian Waddell. Contributor. Chenkai Lv. Contributor. Pawel Rucki. Contributor. Tim Barnett. Contributor. Tian Fang. Contributor. F. Hoffmann-La Roche AG. Copyright holder, funder.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/authors.html","id":"citation","dir":"","previous_headings":"","what":"Citation","title":"Authors and Citation","text":"Li L, Falquet B, Duan X (2024). chevron: Standard TLGs Clinical Trials Reporting. R package version 0.2.8, https://github.com/insightsengineering/chevron/, https://insightsengineering.github.io/chevron/v0.2.8/.","code":"@Manual{,   title = {chevron: Standard TLGs for Clinical Trials Reporting},   author = {Liming Li and Benoit Falquet and Xiaoli Duan},   year = {2024},   note = {R package version 0.2.8,     https://github.com/insightsengineering/chevron/},   url = {https://insightsengineering.github.io/chevron/v0.2.8/}, }"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/index.html","id":"chevron-standard-tlgs-for-clinical-trials-reporting-","dir":"","previous_headings":"","what":"Standard TLGs for Clinical Trials Reporting","title":"Standard TLGs for Clinical Trials Reporting","text":"chevron collection high-level functions create standard outputs clinical trials reporting limited parameterisation. outputs includes: Safety Summary (AET01) Adverse Events (AET02) Adverse Events Greatest Intensity (AET03) Common (>=5%) Adverse Events (AET10) Demographics Baseline Characteristics (DMT01) ECG Results Change Baseline Visit (EGT01) ECG Abnormalities (Regardless Abnormality Baseline) (EGT02_1) ECG Abnormalities (Among Subject Without Abnormality Baseline) (EGT02_2) Laboratory Test Results Change Baseline Visit (LBT01) Laboratory Abnormalities (LBT04) Laboratory Abnormalities Single Replicated Marked (LBT05) Medical History (MHT01) Best Overall Response (RSPT01) Time--event Summary (TTET01) Vital Signs (VST01) Vital Signs Abnormalities (Regardless Abnormality Baseline) (VST02_1) Vital Signs Abnormalities (Among Subject Without Abnormality Baseline) (VST02_2) Listings Kaplan-Meier Plot (KMG01) Mean Plot (MNG01) Please visit catalog see full list available outputs. want new output, please create issue. need flexibility please refer tern TLG Catalog.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/index.html","id":"installation","dir":"","previous_headings":"","what":"Installation","title":"Standard TLGs for Clinical Trials Reporting","text":"chevron available CRAN can install latest released version : Alternatively, might also use development version.","code":"install.packages(\"chevron\") # install.packages(\"pak\") pak::pak(\"insightsengineering/chevron\")"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/index.html","id":"usage","dir":"","previous_headings":"","what":"Usage","title":"Standard TLGs for Clinical Trials Reporting","text":"understand use package, please refer Introduction chevron article, provides multiple examples code implementation. showcase example usage. returns","code":"library(chevron)  data(syn_data) run(aet02, syn_data) MedDRA System Organ Class                                     A: Drug X    B: Placebo    C: Combination     MedDRA Preferred Term                                        (N=134)       (N=134)        (N=132)   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî   Total number of patients with at least one adverse event     122 (91.0%)   123 (91.8%)    120 (90.9%)   Overall total number of events                                   609           622            703   cl A.1     Total number of patients with at least one adverse event   78 (58.2%)    75 (56.0%)      89 (67.4%)     Total number of events                                         132           130            160     dcd A.1.1.1.1                                              50 (37.3%)    45 (33.6%)      63 (47.7%)     dcd A.1.1.1.2                                              48 (35.8%)    48 (35.8%)      50 (37.9%)   cl B.2     Total number of patients with at least one adverse event   79 (59.0%)    74 (55.2%)      85 (64.4%)     Total number of events                                         129           138            143     dcd B.2.2.3.1                                              48 (35.8%)    54 (40.3%)      51 (38.6%)     dcd B.2.1.2.1                                              49 (36.6%)    44 (32.8%)      52 (39.4%)   cl D.1     Total number of patients with at least one adverse event   79 (59.0%)    67 (50.0%)      80 (60.6%)     Total number of events                                         127           106            135     dcd D.1.1.1.1                                              50 (37.3%)    42 (31.3%)      51 (38.6%)     dcd D.1.1.4.2                                              48 (35.8%)    42 (31.3%)      50 (37.9%)   cl D.2     Total number of patients with at least one adverse event   47 (35.1%)    58 (43.3%)      57 (43.2%)     Total number of events                                         62            72              74     dcd D.2.1.5.3                                              47 (35.1%)    58 (43.3%)      57 (43.2%)   cl B.1     Total number of patients with at least one adverse event   47 (35.1%)    49 (36.6%)      43 (32.6%)     Total number of events                                         56            60              62     dcd B.1.1.1.1                                              47 (35.1%)    49 (36.6%)      43 (32.6%)   cl C.2     Total number of patients with at least one adverse event   35 (26.1%)    48 (35.8%)      55 (41.7%)     Total number of events                                         48            53              65     dcd C.2.1.2.1                                              35 (26.1%)    48 (35.8%)      55 (41.7%)   cl C.1     Total number of patients with at least one adverse event   43 (32.1%)    46 (34.3%)      43 (32.6%)     Total number of events                                         55            63              64     dcd C.1.1.1.3                                              43 (32.1%)    46 (34.3%)      43 (32.6%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/index.html","id":"related","dir":"","previous_headings":"","what":"Related","title":"Standard TLGs for Clinical Trials Reporting","text":"rtables - table engine used tern - analysis function used","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/index.html","id":"acknowledgment","dir":"","previous_headings":"","what":"Acknowledgment","title":"Standard TLGs for Clinical Trials Reporting","text":"package result joint efforts many developers stakeholders. like thank everyone contributed far!","code":""},{"path":[]},{"path":[]},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ael01_nollt.html","id":null,"dir":"Reference","previous_headings":"","what":"AEL01_NOLLT Listing 1 (Default) Glossary of Preferred Terms and Investigator-Specified Terms. ‚Äî ael01_nollt_main","title":"AEL01_NOLLT Listing 1 (Default) Glossary of Preferred Terms and Investigator-Specified Terms. ‚Äî ael01_nollt_main","text":"AEL01_NOLLT Listing 1 (Default) Glossary Preferred Terms Investigator-Specified Terms.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ael01_nollt.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"AEL01_NOLLT Listing 1 (Default) Glossary of Preferred Terms and Investigator-Specified Terms. ‚Äî ael01_nollt_main","text":"","code":"ael01_nollt_main(   adam_db,   dataset = \"adae\",   key_cols = c(\"AEBODSYS\", \"AEDECOD\"),   disp_cols = \"AETERM\",   split_into_pages_by_var = NULL,   unique_rows = TRUE,   ... )  ael01_nollt_pre(   adam_db,   dataset = \"adae\",   key_cols = c(\"AEBODSYS\", \"AEDECOD\"),   disp_cols = \"AETERM\",   ... )  ael01_nollt"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ael01_nollt.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"AEL01_NOLLT Listing 1 (Default) Glossary of Preferred Terms and Investigator-Specified Terms. ‚Äî ael01_nollt_main","text":"object class chevron_l length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ael01_nollt.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"AEL01_NOLLT Listing 1 (Default) Glossary of Preferred Terms and Investigator-Specified Terms. ‚Äî ael01_nollt_main","text":"adam_db (list data.frames) object containing ADaM datasets dataset (string) name table adam_db object. key_cols (character) names columns treated key columns rendering listing. Key columns allow group repeat occurrences. disp_cols (character) names non-key columns displayed listing rendered. split_into_pages_by_var (character NULL) name variable split listing . unique_rows (flag) whether keep unique rows listing. ... additional arguments passed rlistings::as_listing.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ael01_nollt.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"AEL01_NOLLT Listing 1 (Default) Glossary of Preferred Terms and Investigator-Specified Terms. ‚Äî ael01_nollt_main","text":"main function returns rlistings list object. preprocessing function returns list data.frame.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ael01_nollt.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"AEL01_NOLLT Listing 1 (Default) Glossary of Preferred Terms and Investigator-Specified Terms. ‚Äî ael01_nollt_main","text":"Removes duplicate rows. default, uses dataset adae, sorting key columns AEBODSYS AEDECOD. using dataset adae, sure specify desired labels variables key_cols disp_cols, pre-process missing data.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ael01_nollt.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"AEL01_NOLLT Listing 1 (Default) Glossary of Preferred Terms and Investigator-Specified Terms. ‚Äî ael01_nollt_main","text":"ael01_nollt_main(): Main TLG function ael01_nollt_pre(): Preprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ael01_nollt.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"AEL01_NOLLT Listing 1 (Default) Glossary of Preferred Terms and Investigator-Specified Terms. ‚Äî ael01_nollt_main","text":"adam_db object must contain dataset table columns specified key_cols disp_cols.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ael01_nollt.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"AEL01_NOLLT Listing 1 (Default) Glossary of Preferred Terms and Investigator-Specified Terms. ‚Äî ael01_nollt_main","text":"","code":"run(ael01_nollt, syn_data) #> MedDRA System Organ Class   MedDRA Preferred Term   Reported Term for the Adverse Event #> ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #> cl A.1                      dcd A.1.1.1.1           trm A.1.1.1.1                       #>                             dcd A.1.1.1.2           trm A.1.1.1.2                       #> cl B.1                      dcd B.1.1.1.1           trm B.1.1.1.1                       #> cl B.2                      dcd B.2.1.2.1           trm B.2.1.2.1                       #>                             dcd B.2.2.3.1           trm B.2.2.3.1                       #> cl C.1                      dcd C.1.1.1.3           trm C.1.1.1.3                       #> cl C.2                      dcd C.2.1.2.1           trm C.2.1.2.1                       #> cl D.1                      dcd D.1.1.1.1           trm D.1.1.1.1                       #>                             dcd D.1.1.4.2           trm D.1.1.4.2                       #> cl D.2                      dcd D.2.1.5.3           trm D.2.1.5.3"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ael02.html","id":null,"dir":"Reference","previous_headings":"","what":"AEL02 Listing 1 (Default) Listing of Adverse Events. ‚Äî ael02_main","title":"AEL02 Listing 1 (Default) Listing of Adverse Events. ‚Äî ael02_main","text":"AEL02 Listing 1 (Default) Listing Adverse Events.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ael02.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"AEL02 Listing 1 (Default) Listing of Adverse Events. ‚Äî ael02_main","text":"","code":"ael02_main(   adam_db,   dataset = \"adae\",   key_cols = c(\"ID\", \"ASR\"),   disp_cols = c(\"AEDECOD\", \"TRTSDTM\", \"ASTDY\", \"ADURN\", \"AESER\", \"ASEV\", \"AREL\", \"AEOUT\",     \"AECONTRT\", \"AEACN\"),   split_into_pages_by_var = \"ACTARM\",   unique_rows = FALSE,   ... )  ael02_pre(adam_db, dataset = \"adae\", arm_var = \"ACTARM\", ...)  ael02"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ael02.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"AEL02 Listing 1 (Default) Listing of Adverse Events. ‚Äî ael02_main","text":"object class chevron_l length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ael02.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"AEL02 Listing 1 (Default) Listing of Adverse Events. ‚Äî ael02_main","text":"adam_db (list data.frames) object containing ADaM datasets dataset (string) name table adam_db object. key_cols (character) names columns treated key columns rendering listing. Key columns allow group repeat occurrences. disp_cols (character) names non-key columns displayed listing rendered. split_into_pages_by_var (character NULL) name variable split listing . unique_rows (flag) whether keep unique rows listing. ... used. arm_var (string) variable used column splitting","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ael02.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"AEL02 Listing 1 (Default) Listing of Adverse Events. ‚Äî ael02_main","text":"main function returns rlistings list object. preprocessing function returns list data.frame.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ael02.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"AEL02 Listing 1 (Default) Listing of Adverse Events. ‚Äî ael02_main","text":"ael02_main(): Main TLG function ael02_pre(): Preprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ael02.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"AEL02 Listing 1 (Default) Listing of Adverse Events. ‚Äî ael02_main","text":"","code":"res <- run(ael02, syn_data)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ael03.html","id":null,"dir":"Reference","previous_headings":"","what":"AEL03 Listing 1 (Default) Listing of Serious Adverse Events. ‚Äî ael03_main","title":"AEL03 Listing 1 (Default) Listing of Serious Adverse Events. ‚Äî ael03_main","text":"AEL03 Listing 1 (Default) Listing Serious Adverse Events.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ael03.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"AEL03 Listing 1 (Default) Listing of Serious Adverse Events. ‚Äî ael03_main","text":"","code":"ael03_main(   adam_db,   dataset = \"adae\",   key_cols = c(\"ID\", \"ASR\"),   disp_cols = c(\"AEDECOD\", \"TRTSDTM\", \"ASTDY\", \"ADURN\", \"ASEV\", \"AREL\", \"AEOUT\",     \"AECONTRT\", \"AEACN\", \"SERREAS\"),   split_into_pages_by_var = \"ACTARM\",   unique_rows = FALSE,   ... )  ael03_pre(adam_db, dataset = \"adae\", arm_var = \"ACTARM\", ...)  ael03"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ael03.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"AEL03 Listing 1 (Default) Listing of Serious Adverse Events. ‚Äî ael03_main","text":"object class chevron_l length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ael03.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"AEL03 Listing 1 (Default) Listing of Serious Adverse Events. ‚Äî ael03_main","text":"adam_db (list data.frames) object containing ADaM datasets dataset (string) name table adam_db object. key_cols (character) names columns treated key columns rendering listing. Key columns allow group repeat occurrences. disp_cols (character) names non-key columns displayed listing rendered. split_into_pages_by_var (character NULL) name variable split listing . unique_rows (flag) whether keep unique rows listing. ... used. arm_var (string) variable used column splitting","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ael03.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"AEL03 Listing 1 (Default) Listing of Serious Adverse Events. ‚Äî ael03_main","text":"main function returns rlistings list object.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ael03.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"AEL03 Listing 1 (Default) Listing of Serious Adverse Events. ‚Äî ael03_main","text":"ael03_main(): Main TLG function ael03_pre(): Preprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ael03.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"AEL03 Listing 1 (Default) Listing of Serious Adverse Events. ‚Äî ael03_main","text":"","code":"res <- run(ael03, syn_data)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet01.html","id":null,"dir":"Reference","previous_headings":"","what":"AET01 Table 1 (Default) Overview of Deaths and Adverse Events Summary Table 1. ‚Äî aet01_main","title":"AET01 Table 1 (Default) Overview of Deaths and Adverse Events Summary Table 1. ‚Äî aet01_main","text":"AET01 Table 1 (Default) Overview Deaths Adverse Events Summary Table 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet01.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"AET01 Table 1 (Default) Overview of Deaths and Adverse Events Summary Table 1. ‚Äî aet01_main","text":"","code":"aet01_main(   adam_db,   arm_var = \"ACTARM\",   lbl_overall = NULL,   anl_vars = list(safety_var = c(\"FATAL\", \"SER\", \"SERWD\", \"SERDSM\", \"RELSER\", \"WD\",     \"DSM\", \"REL\", \"RELWD\", \"RELDSM\", \"SEV\")),   anl_lbls = \"Total number of {patient_label} with at least one\",   show_wd = TRUE,   ... )  aet01_pre(adam_db, ...)  aet01_post(tlg, prune_0 = FALSE, ...)  aet01"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet01.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"AET01 Table 1 (Default) Overview of Deaths and Adverse Events Summary Table 1. ‚Äî aet01_main","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet01.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"AET01 Table 1 (Default) Overview of Deaths and Adverse Events Summary Table 1. ‚Äî aet01_main","text":"adam_db (list data.frames) object containing ADaM datasets arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted anl_vars Named (list) (character) variables safety variables summarized. anl_lbls (character) analysis labels. show_wd (flag) whether display number patients withdrawn study due adverse event number death. ... used. tlg (TableTree, Listing ggplot) object typically produced main function. prune_0 (flag) remove 0 count rows","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet01.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"AET01 Table 1 (Default) Overview of Deaths and Adverse Events Summary Table 1. ‚Äî aet01_main","text":"main function returns rtables object. preprocessing function returns list data.frame. postprocessing function returns rtables object ElementaryTable (null report).","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet01.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"AET01 Table 1 (Default) Overview of Deaths and Adverse Events Summary Table 1. ‚Äî aet01_main","text":"remove rows zero counts default.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet01.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"AET01 Table 1 (Default) Overview of Deaths and Adverse Events Summary Table 1. ‚Äî aet01_main","text":"aet01_main(): Main TLG function aet01_pre(): Preprocessing aet01_post(): Postprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet01.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"AET01 Table 1 (Default) Overview of Deaths and Adverse Events Summary Table 1. ‚Äî aet01_main","text":"adam_db object must contain adsl table \"DTHFL\" \"DCSREAS\" columns. adam_db object must contain adae table columns passed anl_vars.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet01.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"AET01 Table 1 (Default) Overview of Deaths and Adverse Events Summary Table 1. ‚Äî aet01_main","text":"","code":"run(aet01, syn_data, arm_var = \"ARM\") #>                                                                A: Drug X    B: Placebo   C: Combination #>                                                                  (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Total number of patients with at least one AE                13 (86.7%)   14 (93.3%)     15 (100%)    #>   Total number of AEs                                              58           59             99       #>   Total number of deaths                                       2 (13.3%)    4 (26.7%)      3 (20.0%)    #>   Total number of patients withdrawn from study due to an AE       0            0           1 (6.7%)    #>   Total number of patients with at least one                                                            #>     AE with fatal outcome                                      8 (53.3%)    8 (53.3%)      10 (66.7%)   #>     Serious AE                                                 12 (80.0%)   12 (80.0%)     11 (73.3%)   #>     Serious AE leading to withdrawal from treatment                0            0          2 (13.3%)    #>     Serious AE leading to dose modification/interruption       4 (26.7%)    3 (20.0%)      4 (26.7%)    #>     Related Serious AE                                         8 (53.3%)    8 (53.3%)      10 (66.7%)   #>     AE leading to withdrawal from treatment                    2 (13.3%)    3 (20.0%)      3 (20.0%)    #>     AE leading to dose modification/interruption               6 (40.0%)    9 (60.0%)      11 (73.3%)   #>     Related AE                                                 11 (73.3%)   10 (66.7%)     13 (86.7%)   #>     Related AE leading to withdrawal from treatment                0        3 (20.0%)          0        #>     Related AE leading to dose modification/interruption        1 (6.7%)    4 (26.7%)      9 (60.0%)    #>     Severe AE (at greatest intensity)                          11 (73.3%)   10 (66.7%)     12 (80.0%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet01_aesi.html","id":null,"dir":"Reference","previous_headings":"","what":"AET01_AESI Table 1 (Default) Adverse Event of Special Interest Summary Table. ‚Äî aet01_aesi_main","title":"AET01_AESI Table 1 (Default) Adverse Event of Special Interest Summary Table. ‚Äî aet01_aesi_main","text":"AET01_AESI Table 1 (Default) Adverse Event Special Interest Summary Table.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet01_aesi.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"AET01_AESI Table 1 (Default) Adverse Event of Special Interest Summary Table. ‚Äî aet01_aesi_main","text":"","code":"aet01_aesi_main(   adam_db,   arm_var = \"ACTARM\",   lbl_overall = NULL,   aesi_vars = NULL,   grade_groups = NULL,   ... )  aet01_aesi_pre(adam_db, ...)  aet01_aesi_post(tlg, prune_0 = FALSE, ...)  aet01_aesi"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet01_aesi.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"AET01_AESI Table 1 (Default) Adverse Event of Special Interest Summary Table. ‚Äî aet01_aesi_main","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet01_aesi.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"AET01_AESI Table 1 (Default) Adverse Event of Special Interest Summary Table. ‚Äî aet01_aesi_main","text":"adam_db (list data.frames) object containing ADaM datasets arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted aesi_vars (character) AESI variables included summary. Defaults NA. grade_groups (list) grade groups displayed. ... used. tlg (TableTree, Listing ggplot) object typically produced main function. prune_0 (flag) remove 0 count rows","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet01_aesi.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"AET01_AESI Table 1 (Default) Adverse Event of Special Interest Summary Table. ‚Äî aet01_aesi_main","text":"main function returns rtables object. preprocessing function returns list data.frame. postprocessing function returns rtables object ElementaryTable (null report).","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet01_aesi.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"AET01_AESI Table 1 (Default) Adverse Event of Special Interest Summary Table. ‚Äî aet01_aesi_main","text":"remove rows zero counts default.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet01_aesi.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"AET01_AESI Table 1 (Default) Adverse Event of Special Interest Summary Table. ‚Äî aet01_aesi_main","text":"aet01_aesi_main(): Main TLG function aet01_aesi_pre(): Preprocessing aet01_aesi_post(): Postprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet01_aesi.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"AET01_AESI Table 1 (Default) Adverse Event of Special Interest Summary Table. ‚Äî aet01_aesi_main","text":"adam_db object must contain adae table columns \"AEOUT\", \"AEACN\", \"AECONTRT\", \"AESER\", \"AREL\", column specified arm_var. aesi_vars may contain /following variables display: \"ALLRESWD\", \"ALLRESDSM\", \"ALLRESCONTRT\", \"NOTRESWD\", \"NOTRESDSM\", \"NOTRESCONTRT\", \"SERWD\", \"SERDSM\", \"SERCONTRT\", \"RELWD\", \"RELDSM\", \"RELCONTRT\", \"RELSER\". aesi_vars variable prefixes defined follows: \"ALLRES\" = \"non-fatal adverse events resolved\" \"NOTRES\" = \"least one unresolved ongoing non-fatal adverse event\" \"SER\" = \"serious adverse event\" \"REL\" = \"related adverse event\" aesi_vars variable suffixes defined follows: \"WD\" = \"patients study drug withdrawn\" \"DSM\" = \"patients dose modified/interrupted\" \"CONTRT\" = \"patients treatment received\" Several aesi_vars can added table : aesi_vars = \"\" include possible aesi_vars. Including \"ALL_XXX\" aesi_vars XXX one prefixes listed include aesi_vars prefix.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet01_aesi.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"AET01_AESI Table 1 (Default) Adverse Event of Special Interest Summary Table. ‚Äî aet01_aesi_main","text":"","code":"run(aet01_aesi, syn_data) #>                                                                                   A: Drug X    B: Placebo   C: Combination #>                                                                                     (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Total number of patients with at least one AE                                   13 (86.7%)   14 (93.3%)     15 (100%)    #>   Total number of AEs                                                                 58           59             99       #>   Total number of patients with at least one AE by worst grade                                                             #>     Grade 1                                                                           0         1 (6.7%)       1 (6.7%)    #>     Grade 2                                                                        1 (6.7%)     1 (6.7%)       1 (6.7%)    #>     Grade 3                                                                        1 (6.7%)    2 (13.3%)       1 (6.7%)    #>     Grade 4                                                                       3 (20.0%)    2 (13.3%)      2 (13.3%)    #>     Grade 5 (fatal outcome)                                                       8 (53.3%)    8 (53.3%)      10 (66.7%)   #>   Total number of patients with study drug withdrawn due to AE                    2 (13.3%)    3 (20.0%)      3 (20.0%)    #>   Total number of patients with dose modified/interrupted due to AE               6 (40.0%)    9 (60.0%)      11 (73.3%)   #>   Total number of patients with treatment received for AE                         10 (66.7%)   10 (66.7%)     14 (93.3%)   #>   Total number of patients with all non-fatal AEs resolved                        9 (60.0%)    10 (66.7%)     12 (80.0%)   #>   Total number of patients with at least one unresolved or ongoing non-fatal AE   10 (66.7%)   9 (60.0%)      14 (93.3%)   #>   Total number of patients with at least one serious AE                           12 (80.0%)   12 (80.0%)     11 (73.3%)   #>   Total number of patients with at least one related AE                           11 (73.3%)   10 (66.7%)     13 (86.7%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet01_aesi_lyt.html","id":null,"dir":"Reference","previous_headings":"","what":"aet01_aesi Layout ‚Äî aet01_aesi_lyt","title":"aet01_aesi Layout ‚Äî aet01_aesi_lyt","text":"aet01_aesi Layout","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet01_aesi_lyt.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"aet01_aesi Layout ‚Äî aet01_aesi_lyt","text":"","code":"aet01_aesi_lyt(arm_var, aesi_vars, lbl_overall, lbl_aesi_vars, grade_groups)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet01_aesi_lyt.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"aet01_aesi Layout ‚Äî aet01_aesi_lyt","text":"arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted lbl_aesi_vars (character) labels AESI variables summarized.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet01_aesi_lyt.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"aet01_aesi Layout ‚Äî aet01_aesi_lyt","text":"PreDataTableLayouts object.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet01_lyt.html","id":null,"dir":"Reference","previous_headings":"","what":"aet01 Layout ‚Äî aet01_lyt","title":"aet01 Layout ‚Äî aet01_lyt","text":"aet01 Layout","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet01_lyt.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"aet01 Layout ‚Äî aet01_lyt","text":"","code":"aet01_lyt(arm_var, lbl_overall, anl_vars, anl_lbls, lbl_vars)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet01_lyt.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"aet01 Layout ‚Äî aet01_lyt","text":"arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted anl_vars Named (list) analysis variables. anl_lbls (character) labels. lbl_vars Named (list) analysis labels.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet01_lyt.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"aet01 Layout ‚Äî aet01_lyt","text":"PreDataTableLayouts object.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet02.html","id":null,"dir":"Reference","previous_headings":"","what":"AET02 Table 1 (Default) Adverse Events by System Organ Class and Preferred Term Table 1. ‚Äî aet02_label","title":"AET02 Table 1 (Default) Adverse Events by System Organ Class and Preferred Term Table 1. ‚Äî aet02_label","text":"AET02 table provides overview number subjects experiencing adverse events number advert events categorized Body System Dictionary-Derived Term.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet02.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"AET02 Table 1 (Default) Adverse Events by System Organ Class and Preferred Term Table 1. ‚Äî aet02_label","text":"","code":"aet02_label  aet02_main(   adam_db,   arm_var = \"ACTARM\",   row_split_var = \"AEBODSYS\",   lbl_overall = NULL,   summary_labels = list(all = aet02_label, TOTAL = c(nonunique =     \"Overall total number of events\")),   ... )  aet02_pre(adam_db, row_split_var = \"AEBODSYS\", ...)  aet02_post(tlg, row_split_var = \"AEBODSYS\", prune_0 = TRUE, ...)  aet02"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet02.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"AET02 Table 1 (Default) Adverse Events by System Organ Class and Preferred Term Table 1. ‚Äî aet02_label","text":"object class character length 2. object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet02.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"AET02 Table 1 (Default) Adverse Events by System Organ Class and Preferred Term Table 1. ‚Äî aet02_label","text":"adam_db (list data.frames) object containing ADaM datasets arm_var (string) variable used column splitting row_split_var (character) additional row split variables. lbl_overall (string) label used overall column, set NULL overall column omitted summary_labels (list) summarize labels. See details. ... used. tlg (TableTree, Listing ggplot) object typically produced main function. prune_0 (flag) remove 0 count rows","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet02.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"AET02 Table 1 (Default) Adverse Events by System Organ Class and Preferred Term Table 1. ‚Äî aet02_label","text":"main function returns rtables object. preprocessing function returns list data.frame. postprocessing function returns rtables object ElementaryTable (null report).","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet02.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"AET02 Table 1 (Default) Adverse Events by System Organ Class and Preferred Term Table 1. ‚Äî aet02_label","text":"Numbers represent absolute numbers subject fraction N, absolute number event specified. Remove zero-count rows unless overridden prune_0 = FALSE. Split columns arm. include total column default. Sort Dictionary-Derived Code (AEDECOD) highest overall frequencies. Missing values AEBODSYS, AEDECOD labeled Coding Available. summary_labels used control summary level. \"\" used, split summary statistic labels. One special case \"TOTAL\", overall population.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet02.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"AET02 Table 1 (Default) Adverse Events by System Organ Class and Preferred Term Table 1. ‚Äî aet02_label","text":"aet02_label: Default labels aet02_main(): Main TLG function aet02_pre(): Preprocessing aet02_post(): Postprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet02.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"AET02 Table 1 (Default) Adverse Events by System Organ Class and Preferred Term Table 1. ‚Äî aet02_label","text":"adam_db object must contain adae table columns \"AEBODSYS\" \"AEDECOD\".","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet02.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"AET02 Table 1 (Default) Adverse Events by System Organ Class and Preferred Term Table 1. ‚Äî aet02_label","text":"","code":"run(aet02, syn_data) #>   MedDRA System Organ Class                                    A: Drug X    B: Placebo   C: Combination #>     MedDRA Preferred Term                                        (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Total number of patients with at least one adverse event     13 (86.7%)   14 (93.3%)     15 (100%)    #>   Overall total number of events                                   58           59             99       #>   cl B.2                                                                                                #>     Total number of patients with at least one adverse event   11 (73.3%)   8 (53.3%)      10 (66.7%)   #>     Total number of events                                         18           15             20       #>     dcd B.2.2.3.1                                              8 (53.3%)    6 (40.0%)      7 (46.7%)    #>     dcd B.2.1.2.1                                              5 (33.3%)    6 (40.0%)      5 (33.3%)    #>   cl D.1                                                                                                #>     Total number of patients with at least one adverse event   9 (60.0%)    5 (33.3%)      11 (73.3%)   #>     Total number of events                                         13           9              19       #>     dcd D.1.1.1.1                                              4 (26.7%)    4 (26.7%)      7 (46.7%)    #>     dcd D.1.1.4.2                                              6 (40.0%)    2 (13.3%)      7 (46.7%)    #>   cl A.1                                                                                                #>     Total number of patients with at least one adverse event   7 (46.7%)    6 (40.0%)      10 (66.7%)   #>     Total number of events                                         8            11             16       #>     dcd A.1.1.1.2                                              5 (33.3%)    6 (40.0%)      6 (40.0%)    #>     dcd A.1.1.1.1                                              3 (20.0%)     1 (6.7%)      6 (40.0%)    #>   cl B.1                                                                                                #>     Total number of patients with at least one adverse event   5 (33.3%)    6 (40.0%)      8 (53.3%)    #>     Total number of events                                         6            6              12       #>     dcd B.1.1.1.1                                              5 (33.3%)    6 (40.0%)      8 (53.3%)    #>   cl C.2                                                                                                #>     Total number of patients with at least one adverse event   6 (40.0%)    4 (26.7%)      8 (53.3%)    #>     Total number of events                                         6            4              12       #>     dcd C.2.1.2.1                                              6 (40.0%)    4 (26.7%)      8 (53.3%)    #>   cl D.2                                                                                                #>     Total number of patients with at least one adverse event   2 (13.3%)    5 (33.3%)      7 (46.7%)    #>     Total number of events                                         3            5              10       #>     dcd D.2.1.5.3                                              2 (13.3%)    5 (33.3%)      7 (46.7%)    #>   cl C.1                                                                                                #>     Total number of patients with at least one adverse event   4 (26.7%)    4 (26.7%)      5 (33.3%)    #>     Total number of events                                         4            9              10       #>     dcd C.1.1.1.3                                              4 (26.7%)    4 (26.7%)      5 (33.3%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet03.html","id":null,"dir":"Reference","previous_headings":"","what":"AET03 Table 1 (Default) Advert Events by Greatest Intensity Table 1. ‚Äî aet03_main","title":"AET03 Table 1 (Default) Advert Events by Greatest Intensity Table 1. ‚Äî aet03_main","text":"adverse events table categorized System Organ Class, Dictionary-Derived Term Greatest intensity.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet03.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"AET03 Table 1 (Default) Advert Events by Greatest Intensity Table 1. ‚Äî aet03_main","text":"","code":"aet03_main(adam_db, arm_var = \"ACTARM\", lbl_overall = NULL, ...)  aet03_pre(adam_db, ...)  aet03_post(tlg, prune_0 = TRUE, ...)  aet03"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet03.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"AET03 Table 1 (Default) Advert Events by Greatest Intensity Table 1. ‚Äî aet03_main","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet03.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"AET03 Table 1 (Default) Advert Events by Greatest Intensity Table 1. ‚Äî aet03_main","text":"adam_db (list data.frames) object containing ADaM datasets arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted ... used. tlg (TableTree, Listing ggplot) object typically produced main function. prune_0 (flag) remove 0 count rows","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet03.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"AET03 Table 1 (Default) Advert Events by Greatest Intensity Table 1. ‚Äî aet03_main","text":"main function returns rtables object. preprocessing function returns list data.frame. postprocessing function returns rtables object ElementaryTable (null report).","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet03.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"AET03 Table 1 (Default) Advert Events by Greatest Intensity Table 1. ‚Äî aet03_main","text":"Default Adverse Events Greatest Intensity table. Numbers represent absolute numbers patients fraction N. Remove zero-count rows unless overridden prune_0 = FALSE. Split columns arm. include total column default. Sort Body System Organ Class (SOC) Dictionary-Derived Term (PT).","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet03.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"AET03 Table 1 (Default) Advert Events by Greatest Intensity Table 1. ‚Äî aet03_main","text":"aet03_main(): Main TLG function aet03_pre(): Preprocessing aet03_post(): Postprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet03.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"AET03 Table 1 (Default) Advert Events by Greatest Intensity Table 1. ‚Äî aet03_main","text":"adam_db object must contain adae table columns \"AEBODSYS\", \"AEDECOD\" \"ASEV\".","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet03.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"AET03 Table 1 (Default) Advert Events by Greatest Intensity Table 1. ‚Äî aet03_main","text":"","code":"run(aet03, syn_data) #>   MedDRA System Organ Class   A: Drug X    B: Placebo   C: Combination #>     MedDRA Preferred Term       (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   - Any Intensity -           13 (86.7%)   14 (93.3%)     15 (100%)    #>   MILD                            0         1 (6.7%)       1 (6.7%)    #>   MODERATE                    2 (13.3%)    3 (20.0%)      2 (13.3%)    #>   SEVERE                      11 (73.3%)   10 (66.7%)     12 (80.0%)   #>   cl B.2                                                               #>     - Any Intensity -         11 (73.3%)   8 (53.3%)      10 (66.7%)   #>     MILD                      6 (40.0%)    2 (13.3%)      5 (33.3%)    #>     MODERATE                  5 (33.3%)    6 (40.0%)      5 (33.3%)    #>     dcd B.2.2.3.1                                                      #>       - Any Intensity -       8 (53.3%)    6 (40.0%)      7 (46.7%)    #>       MILD                    8 (53.3%)    6 (40.0%)      7 (46.7%)    #>     dcd B.2.1.2.1                                                      #>       - Any Intensity -       5 (33.3%)    6 (40.0%)      5 (33.3%)    #>       MODERATE                5 (33.3%)    6 (40.0%)      5 (33.3%)    #>   cl D.1                                                               #>     - Any Intensity -         9 (60.0%)    5 (33.3%)      11 (73.3%)   #>     MODERATE                  5 (33.3%)     1 (6.7%)      4 (26.7%)    #>     SEVERE                    4 (26.7%)    4 (26.7%)      7 (46.7%)    #>     dcd D.1.1.1.1                                                      #>       - Any Intensity -       4 (26.7%)    4 (26.7%)      7 (46.7%)    #>       SEVERE                  4 (26.7%)    4 (26.7%)      7 (46.7%)    #>     dcd D.1.1.4.2                                                      #>       - Any Intensity -       6 (40.0%)    2 (13.3%)      7 (46.7%)    #>       MODERATE                6 (40.0%)    2 (13.3%)      7 (46.7%)    #>   cl A.1                                                               #>     - Any Intensity -         7 (46.7%)    6 (40.0%)      10 (66.7%)   #>     MILD                      2 (13.3%)        0          4 (26.7%)    #>     MODERATE                  5 (33.3%)    6 (40.0%)      6 (40.0%)    #>     dcd A.1.1.1.2                                                      #>       - Any Intensity -       5 (33.3%)    6 (40.0%)      6 (40.0%)    #>       MODERATE                5 (33.3%)    6 (40.0%)      6 (40.0%)    #>     dcd A.1.1.1.1                                                      #>       - Any Intensity -       3 (20.0%)     1 (6.7%)      6 (40.0%)    #>       MILD                    3 (20.0%)     1 (6.7%)      6 (40.0%)    #>   cl B.1                                                               #>     - Any Intensity -         5 (33.3%)    6 (40.0%)      8 (53.3%)    #>     SEVERE                    5 (33.3%)    6 (40.0%)      8 (53.3%)    #>     dcd B.1.1.1.1                                                      #>       - Any Intensity -       5 (33.3%)    6 (40.0%)      8 (53.3%)    #>       SEVERE                  5 (33.3%)    6 (40.0%)      8 (53.3%)    #>   cl C.2                                                               #>     - Any Intensity -         6 (40.0%)    4 (26.7%)      8 (53.3%)    #>     MODERATE                  6 (40.0%)    4 (26.7%)      8 (53.3%)    #>     dcd C.2.1.2.1                                                      #>       - Any Intensity -       6 (40.0%)    4 (26.7%)      8 (53.3%)    #>       MODERATE                6 (40.0%)    4 (26.7%)      8 (53.3%)    #>   cl D.2                                                               #>     - Any Intensity -         2 (13.3%)    5 (33.3%)      7 (46.7%)    #>     MILD                      2 (13.3%)    5 (33.3%)      7 (46.7%)    #>     dcd D.2.1.5.3                                                      #>       - Any Intensity -       2 (13.3%)    5 (33.3%)      7 (46.7%)    #>       MILD                    2 (13.3%)    5 (33.3%)      7 (46.7%)    #>   cl C.1                                                               #>     - Any Intensity -         4 (26.7%)    4 (26.7%)      5 (33.3%)    #>     SEVERE                    4 (26.7%)    4 (26.7%)      5 (33.3%)    #>     dcd C.1.1.1.3                                                      #>       - Any Intensity -       4 (26.7%)    4 (26.7%)      5 (33.3%)    #>       SEVERE                  4 (26.7%)    4 (26.7%)      5 (33.3%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet03_lyt.html","id":null,"dir":"Reference","previous_headings":"","what":"aet03 Layout ‚Äî aet03_lyt","title":"aet03 Layout ‚Äî aet03_lyt","text":"aet03 Layout","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet03_lyt.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"aet03 Layout ‚Äî aet03_lyt","text":"","code":"aet03_lyt(arm_var, lbl_overall, lbl_aebodsys, lbl_aedecod, intensity_grade)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet03_lyt.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"aet03 Layout ‚Äî aet03_lyt","text":"arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted lbl_aebodsys (string) text label AEBODSYS. lbl_aedecod (string) text label AEDECOD. intensity_grade (character) describing intensity levels present dataset.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet03_lyt.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"aet03 Layout ‚Äî aet03_lyt","text":"PreDataTableLayouts object.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet04.html","id":null,"dir":"Reference","previous_headings":"","what":"AET04 Table 1 (Default) Adverse Events by Highest NCI CTACAE AE Grade Table 1. ‚Äî aet04_main","title":"AET04 Table 1 (Default) Adverse Events by Highest NCI CTACAE AE Grade Table 1. ‚Äî aet04_main","text":"AET04 table provides overview adverse event highest NCI CTCAE grade per individual.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet04.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"AET04 Table 1 (Default) Adverse Events by Highest NCI CTACAE AE Grade Table 1. ‚Äî aet04_main","text":"","code":"aet04_main(   adam_db,   arm_var = \"ACTARM\",   lbl_overall = NULL,   grade_groups = NULL,   ... )  aet04_pre(adam_db, ...)  aet04_post(tlg, prune_0 = TRUE, ...)  aet04"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet04.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"AET04 Table 1 (Default) Adverse Events by Highest NCI CTACAE AE Grade Table 1. ‚Äî aet04_main","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet04.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"AET04 Table 1 (Default) Adverse Events by Highest NCI CTACAE AE Grade Table 1. ‚Äî aet04_main","text":"adam_db (list data.frames) object containing ADaM datasets arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted grade_groups (list) putting correspondence toxicity grades labels. ... used. tlg (TableTree, Listing ggplot) object typically produced main function. prune_0 (flag) remove 0 count rows","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet04.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"AET04 Table 1 (Default) Adverse Events by Highest NCI CTACAE AE Grade Table 1. ‚Äî aet04_main","text":"main function returns rtables object. preprocessing function returns list data.frame. postprocessing function returns rtables object ElementaryTable (null report).","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet04.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"AET04 Table 1 (Default) Adverse Events by Highest NCI CTACAE AE Grade Table 1. ‚Äî aet04_main","text":"Numbers represent absolute numbers patients fraction N, absolute number event specified. Remove zero-count rows unless overridden prune_0 = FALSE. Events missing grading values excluded. Split columns arm, typically ACTARM. include total column default. Sort Body System Organ Class Dictionary-Derived Term highest overall frequencies. Analysis Toxicity Grade sorted severity.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet04.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"AET04 Table 1 (Default) Adverse Events by Highest NCI CTACAE AE Grade Table 1. ‚Äî aet04_main","text":"aet04_main(): Main TLG function aet04_pre(): Preprocessing aet04_post(): Postprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet04.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"AET04 Table 1 (Default) Adverse Events by Highest NCI CTACAE AE Grade Table 1. ‚Äî aet04_main","text":"adam_db object must contain adae table columns \"AEBODSYS\", \"AEDECOD\" \"ATOXGR\".","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet04.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"AET04 Table 1 (Default) Adverse Events by Highest NCI CTACAE AE Grade Table 1. ‚Äî aet04_main","text":"","code":"grade_groups <- list(   \"Grade 1-2\" = c(\"1\", \"2\"),   \"Grade 3-4\" = c(\"3\", \"4\"),   \"Grade 5\" = c(\"5\") ) proc_data <- dunlin::log_filter(syn_data, AEBODSYS == \"cl A.1\", \"adae\") run(aet04, proc_data, grade_groups = grade_groups) #>   MedDRA System Organ Class                                                           #>     MedDRA Preferred Term                     A: Drug X   B: Placebo   C: Combination #>                               Grade            (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   - Any adverse events -                                                              #>                               - Any Grade -   7 (46.7%)   6 (40.0%)      10 (66.7%)   #>                               Grade 1-2       7 (46.7%)   6 (40.0%)      10 (66.7%)   #>                               1               2 (13.3%)       0          4 (26.7%)    #>                               2               5 (33.3%)   6 (40.0%)      6 (40.0%)    #>   cl A.1                                                                              #>     - Overall -                                                                       #>                               - Any Grade -   7 (46.7%)   6 (40.0%)      10 (66.7%)   #>                               Grade 1-2       7 (46.7%)   6 (40.0%)      10 (66.7%)   #>                               1               2 (13.3%)       0          4 (26.7%)    #>                               2               5 (33.3%)   6 (40.0%)      6 (40.0%)    #>     dcd A.1.1.1.2                                                                     #>                               - Any Grade -   5 (33.3%)   6 (40.0%)      6 (40.0%)    #>                               Grade 1-2       5 (33.3%)   6 (40.0%)      6 (40.0%)    #>                               2               5 (33.3%)   6 (40.0%)      6 (40.0%)    #>     dcd A.1.1.1.1                                                                     #>                               - Any Grade -   3 (20.0%)    1 (6.7%)      6 (40.0%)    #>                               Grade 1-2       3 (20.0%)    1 (6.7%)      6 (40.0%)    #>                               1               3 (20.0%)    1 (6.7%)      6 (40.0%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet04_lyt.html","id":null,"dir":"Reference","previous_headings":"","what":"aet04 Layout ‚Äî aet04_lyt","title":"aet04 Layout ‚Äî aet04_lyt","text":"aet04 Layout","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet04_lyt.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"aet04 Layout ‚Äî aet04_lyt","text":"","code":"aet04_lyt(   arm_var,   total_var,   lbl_overall,   lbl_aebodsys,   lbl_aedecod,   grade_groups )"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet04_lyt.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"aet04 Layout ‚Äî aet04_lyt","text":"arm_var (string) variable used column splitting total_var (string) variable create summary variables. lbl_overall (string) label used overall column, set NULL overall column omitted lbl_aebodsys (string) text label AEBODSYS. lbl_aedecod (string) text label AEDECOD. grade_groups (list) putting correspondence toxicity grades labels.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet04_lyt.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"aet04 Layout ‚Äî aet04_lyt","text":"PreDataTableLayouts object.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet05.html","id":null,"dir":"Reference","previous_headings":"","what":"AET05 Table 1 (Default) Adverse Event Rate Adjusted for Patient-Years at Risk - First Occurrence. ‚Äî aet05_main","title":"AET05 Table 1 (Default) Adverse Event Rate Adjusted for Patient-Years at Risk - First Occurrence. ‚Äî aet05_main","text":"AET05 table produces standard adverse event rate adjusted patient-years risk summary considering first occurrence.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet05.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"AET05 Table 1 (Default) Adverse Event Rate Adjusted for Patient-Years at Risk - First Occurrence. ‚Äî aet05_main","text":"","code":"aet05_main(   adam_db,   dataset = \"adsaftte\",   arm_var = \"ACTARM\",   lbl_overall = NULL,   ... )  aet05_pre(adam_db, dataset = \"adsaftte\", ...)  aet05_post(tlg, prune_0 = FALSE, ...)  aet05"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet05.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"AET05 Table 1 (Default) Adverse Event Rate Adjusted for Patient-Years at Risk - First Occurrence. ‚Äî aet05_main","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet05.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"AET05 Table 1 (Default) Adverse Event Rate Adjusted for Patient-Years at Risk - First Occurrence. ‚Äî aet05_main","text":"adam_db (list data.frames) object containing ADaM datasets dataset (string) name table adam_db object. arm_var (string) arm variable used arm splitting. lbl_overall (string) label used overall column, set NULL overall column omitted ... arguments passed tern::control_incidence_rate(). tlg (TableTree, Listing ggplot) object typically produced main function. prune_0 (flag) remove 0 count rows","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet05.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"AET05 Table 1 (Default) Adverse Event Rate Adjusted for Patient-Years at Risk - First Occurrence. ‚Äî aet05_main","text":"main function returns rtables object. preprocessing function returns list data.frame. postprocessing function returns rtables object ElementaryTable (null report).","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet05.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"AET05 Table 1 (Default) Adverse Event Rate Adjusted for Patient-Years at Risk - First Occurrence. ‚Äî aet05_main","text":"Total patient-years risk sum patients time intervals (years). Split columns arm, typically ACTARM. Split rows parameter code. AVAL patient-years risk. N_EVENTS number adverse events observed. table allows confidence level adjusted, default 95%. Keep zero count rows default.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet05.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"AET05 Table 1 (Default) Adverse Event Rate Adjusted for Patient-Years at Risk - First Occurrence. ‚Äî aet05_main","text":"aet05_main(): Main TLG function aet05_pre(): Preprocessing aet05_post(): Postprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet05.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"AET05 Table 1 (Default) Adverse Event Rate Adjusted for Patient-Years at Risk - First Occurrence. ‚Äî aet05_main","text":"adam_db object must contain table named dataset columns \"PARAMCD\", \"PARAM\", \"AVAL\", \"CNSR\".","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet05.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"AET05 Table 1 (Default) Adverse Event Rate Adjusted for Patient-Years at Risk - First Occurrence. ‚Äî aet05_main","text":"","code":"library(dplyr) #>  #> Attaching package: ‚Äòdplyr‚Äô #> The following object is masked from ‚Äòpackage:testthat‚Äô: #>  #>     matches #> The following objects are masked from ‚Äòpackage:stats‚Äô: #>  #>     filter, lag #> The following objects are masked from ‚Äòpackage:base‚Äô: #>  #>     intersect, setdiff, setequal, union library(dunlin)  proc_data <- log_filter(syn_data, PARAMCD == \"AETTE1\", \"adsaftte\")  run(aet05, proc_data) #>                                                     A: Drug X       B: Placebo      C: Combination #>                                                      (N=15)           (N=15)            (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Time to first occurrence of any adverse event                                                    #>     Total patient-years at risk                       31.0              9.0              22.0      #>     Number of adverse events observed                   5               13                8        #>     AE rate per 100 patient-years                     16.13           143.75            36.30      #>     95% CI                                        (1.99, 30.27)   (65.61, 221.89)   (11.15, 61.45)  run(aet05, proc_data, conf_level = 0.90, conf_type = \"exact\") #>                                                     A: Drug X       B: Placebo      C: Combination #>                                                      (N=15)           (N=15)            (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Time to first occurrence of any adverse event                                                    #>     Total patient-years at risk                       31.0              9.0              22.0      #>     Number of adverse events observed                   5               13                8        #>     AE rate per 100 patient-years                     16.13           143.75            36.30      #>     90% CI                                        (6.36, 33.91)   (85.03, 228.55)   (18.06, 65.50)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet05_all.html","id":null,"dir":"Reference","previous_headings":"","what":"AET05_ALL Table 1 (Default) Adverse Event Rate Adjusted for Patient-Years at Risk - All Occurrences. ‚Äî aet05_all_pre","title":"AET05_ALL Table 1 (Default) Adverse Event Rate Adjusted for Patient-Years at Risk - All Occurrences. ‚Äî aet05_all_pre","text":"AET05_ALL table produces standard adverse event rate adjusted patient-years risk summary considering occurrences.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet05_all.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"AET05_ALL Table 1 (Default) Adverse Event Rate Adjusted for Patient-Years at Risk - All Occurrences. ‚Äî aet05_all_pre","text":"","code":"aet05_all_pre(adam_db, dataset = \"adsaftte\", ...)  aet05_all"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet05_all.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"AET05_ALL Table 1 (Default) Adverse Event Rate Adjusted for Patient-Years at Risk - All Occurrences. ‚Äî aet05_all_pre","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet05_all.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"AET05_ALL Table 1 (Default) Adverse Event Rate Adjusted for Patient-Years at Risk - All Occurrences. ‚Äî aet05_all_pre","text":"adam_db (list data.frames) object containing ADaM datasets dataset (string) name table adam_db object. ... used.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet05_all.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"AET05_ALL Table 1 (Default) Adverse Event Rate Adjusted for Patient-Years at Risk - All Occurrences. ‚Äî aet05_all_pre","text":"preprocessing function returns list data.frame.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet05_all.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"AET05_ALL Table 1 (Default) Adverse Event Rate Adjusted for Patient-Years at Risk - All Occurrences. ‚Äî aet05_all_pre","text":"aet05_all_pre(): Preprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet05_all.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"AET05_ALL Table 1 (Default) Adverse Event Rate Adjusted for Patient-Years at Risk - All Occurrences. ‚Äî aet05_all_pre","text":"","code":"library(dplyr) library(dunlin)  proc_data <- log_filter(syn_data, PARAMCD == \"AETOT1\" | PARAMCD == \"AEREPTTE\", \"adsaftte\")  run(aet05_all, proc_data) #>                                                  A: Drug X        B: Placebo      C: Combination  #>                                                    (N=15)           (N=15)            (N=15)      #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Number of occurrences of any adverse event                                                      #>     Total patient-years at risk                     44.4             44.2              44.4       #>     Number of adverse events observed                29               49                56        #>     AE rate per 100 patient-years                  65.32            110.76            126.15      #>     95% CI                                     (41.54, 89.09)   (79.75, 141.77)   (93.11, 159.19)  run(aet05_all, proc_data, conf_level = 0.90, conf_type = \"exact\") #>                                                  A: Drug X        B: Placebo      C: Combination  #>                                                    (N=15)           (N=15)            (N=15)      #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Number of occurrences of any adverse event                                                      #>     Total patient-years at risk                     44.4             44.2              44.4       #>     Number of adverse events observed                29               49                56        #>     AE rate per 100 patient-years                  65.32            110.76            126.15      #>     90% CI                                     (46.73, 89.06)   (86.08, 140.53)   (99.76, 157.60)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet05_lyt.html","id":null,"dir":"Reference","previous_headings":"","what":"aet05 Layout ‚Äî aet05_lyt","title":"aet05 Layout ‚Äî aet05_lyt","text":"aet05 Layout","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet05_lyt.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"aet05 Layout ‚Äî aet05_lyt","text":"","code":"aet05_lyt(arm_var, lbl_overall, param_label, vars, n_events, control)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet05_lyt.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"aet05 Layout ‚Äî aet05_lyt","text":"arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted param_label (string) variable parameter code. vars (string) variable primary analysis variable iterated . n_events (string) variable count number events observed. control (list) parameters estimation details, specified using helper function control_incidence_rate().","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet05_lyt.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"aet05 Layout ‚Äî aet05_lyt","text":"PreDataTableLayouts object.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet10.html","id":null,"dir":"Reference","previous_headings":"","what":"AET10 Table 1 (Default) Most Common (xx%) Adverse Events Preferred Terms Table 1. ‚Äî aet10_main","title":"AET10 Table 1 (Default) Most Common (xx%) Adverse Events Preferred Terms Table 1. ‚Äî aet10_main","text":"AET10 table Include Adverse Events occurring user-specified threshold X% least one treatment groups. Standard table summarized preferred term (PT). Order data total column frequency least frequently reported PT (regardless SOC).","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet10.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"AET10 Table 1 (Default) Most Common (xx%) Adverse Events Preferred Terms Table 1. ‚Äî aet10_main","text":"","code":"aet10_main(adam_db, arm_var = \"ACTARM\", lbl_overall = NULL, ...)  aet10_pre(adam_db, ...)  aet10_post(tlg, atleast = 0.05, ...)  aet10"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet10.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"AET10 Table 1 (Default) Most Common (xx%) Adverse Events Preferred Terms Table 1. ‚Äî aet10_main","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet10.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"AET10 Table 1 (Default) Most Common (xx%) Adverse Events Preferred Terms Table 1. ‚Äî aet10_main","text":"adam_db (list data.frames) object containing ADaM datasets arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted ... used. tlg (TableTree, Listing ggplot) object typically produced main function. atleast given cut-numeric format, default 0.05","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet10.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"AET10 Table 1 (Default) Most Common (xx%) Adverse Events Preferred Terms Table 1. ‚Äî aet10_main","text":"main function returns rtables object preprocessing function returns list data.frame. postprocessing function returns rtables object ElementaryTable (null report).","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet10.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"AET10 Table 1 (Default) Most Common (xx%) Adverse Events Preferred Terms Table 1. ‚Äî aet10_main","text":"Numbers represent absolute numbers subject fraction N, absolute number event specified. Remove zero-count rows unless overridden prune_0 = FALSE. Split columns arm. include total column default. Sort Dictionary-Derived Code (AEDECOD) highest overall frequencies. Missing values AEDECOD labeled Coding Available.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet10.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"AET10 Table 1 (Default) Most Common (xx%) Adverse Events Preferred Terms Table 1. ‚Äî aet10_main","text":"aet10_main(): Main TLG function aet10_pre(): Preprocessing aet10_post(): Postprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet10.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"AET10 Table 1 (Default) Most Common (xx%) Adverse Events Preferred Terms Table 1. ‚Äî aet10_main","text":"adam_db object must contain adae table columns \"AEDECOD\".","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet10.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"AET10 Table 1 (Default) Most Common (xx%) Adverse Events Preferred Terms Table 1. ‚Äî aet10_main","text":"","code":"run(aet10, syn_data) #>                           A: Drug X   B: Placebo   C: Combination #>   MedDRA Preferred Term    (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   dcd B.2.2.3.1           8 (53.3%)   6 (40.0%)      7 (46.7%)    #>   dcd B.1.1.1.1           5 (33.3%)   6 (40.0%)      8 (53.3%)    #>   dcd C.2.1.2.1           6 (40.0%)   4 (26.7%)      8 (53.3%)    #>   dcd A.1.1.1.2           5 (33.3%)   6 (40.0%)      6 (40.0%)    #>   dcd B.2.1.2.1           5 (33.3%)   6 (40.0%)      5 (33.3%)    #>   dcd D.1.1.1.1           4 (26.7%)   4 (26.7%)      7 (46.7%)    #>   dcd D.1.1.4.2           6 (40.0%)   2 (13.3%)      7 (46.7%)    #>   dcd D.2.1.5.3           2 (13.3%)   5 (33.3%)      7 (46.7%)    #>   dcd C.1.1.1.3           4 (26.7%)   4 (26.7%)      5 (33.3%)    #>   dcd A.1.1.1.1           3 (20.0%)    1 (6.7%)      6 (40.0%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet10_lyt.html","id":null,"dir":"Reference","previous_headings":"","what":"aet10 Layout ‚Äî aet10_lyt","title":"aet10 Layout ‚Äî aet10_lyt","text":"aet10 Layout","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet10_lyt.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"aet10 Layout ‚Äî aet10_lyt","text":"","code":"aet10_lyt(arm_var, lbl_overall, lbl_aedecod)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet10_lyt.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"aet10 Layout ‚Äî aet10_lyt","text":"arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted lbl_aedecod (character) text label AEDECOD.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/aet10_lyt.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"aet10 Layout ‚Äî aet10_lyt","text":"PreDataTableLayouts object.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/afun_p.html","id":null,"dir":"Reference","previous_headings":"","what":"Analyze with defined precision ‚Äî afun_p","title":"Analyze with defined precision ‚Äî afun_p","text":"Analyze defined precision","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/afun_p.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Analyze with defined precision ‚Äî afun_p","text":"","code":"afun_p(   x,   .N_col,   .spl_context,   precision,   .N_row,   .var = NULL,   .df_row = NULL,   .stats = NULL,   .labels = NULL,   .indent_mods = NULL,   ... )"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/afun_p.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Analyze with defined precision ‚Äî afun_p","text":"x value analyze .N_col (int) See tern::analyze_variables. .spl_context split context. precision (named list integer) names columns found .df_row values indicate number digits statistics numeric value. default set, parameter precision specified, value default used. neither provided, auto determination used. See tern::format_auto. .N_row (int) See tern::analyze_variables. .var variable name. .stats (named list character)  names columns found .df_row values indicate statistical analysis perform. default set, parameter precision specified, value default used. .labels (character) See tern::analyze_variables. .indent_mods (integer) See tern::analyze_variables. ... additional arguments tern::a_summary.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/afun_skip.html","id":null,"dir":"Reference","previous_headings":"","what":"Analyze skip baseline ‚Äî afun_skip","title":"Analyze skip baseline ‚Äî afun_skip","text":"Analyze skip baseline","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/afun_skip.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Analyze skip baseline ‚Äî afun_skip","text":"","code":"afun_skip(   x,   .var,   .spl_context,   paramcdvar,   visitvar,   skip,   precision,   .stats,   .labels = NULL,   .indent_mods = NULL,   .N_col,   .N_row,   ... )"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/afun_skip.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Analyze skip baseline ‚Äî afun_skip","text":"x value analyze .var variable name. .spl_context split context. paramcdvar (string) name parameter code. visitvar (string) name visit variable. skip Named (character) indicating pairs skip analyze. precision (named list integer) names values found PARAMCD column values indicate number digits statistics. default set, parameter precision specified, value default used. .stats (character) See tern::analyze_variables. .labels (character) See tern::analyze_variables. .indent_mods (integer) See tern::analyze_variables. .N_col (int) See tern::analyze_variables. .N_row (int) See tern::analyze_variables. ... additional arguments tern::a_summary.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/args_ls.html","id":null,"dir":"Reference","previous_headings":"","what":"Get Arguments List ‚Äî args_ls","title":"Get Arguments List ‚Äî args_ls","text":"Get Arguments List","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/args_ls.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Get Arguments List ‚Äî args_ls","text":"","code":"args_ls(x, simplify = FALSE, omit = NULL)  # S4 method for class 'chevron_tlg' args_ls(x, simplify = FALSE, omit = NULL)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/args_ls.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Get Arguments List ‚Äî args_ls","text":"x (chevron_tlg) input. simplify (flag) whether simplify output, coalescing values parameters. order priority value parameters : main, preprocess postprocess. omit (character) names argument omit output.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/args_ls.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Get Arguments List ‚Äî args_ls","text":"list formal arguments default functions stored chevron_tlg object passed x argument.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/args_ls.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Get Arguments List ‚Äî args_ls","text":"","code":"args_ls(aet01, simplify = TRUE) #> $adam_db #>  #>  #> $arm_var #> [1] \"ACTARM\" #>  #> $lbl_overall #> NULL #>  #> $anl_vars #> list(safety_var = c(\"FATAL\", \"SER\", \"SERWD\", \"SERDSM\", \"RELSER\",  #>     \"WD\", \"DSM\", \"REL\", \"RELWD\", \"RELDSM\", \"SEV\")) #>  #> $anl_lbls #> [1] \"Total number of {patient_label} with at least one\" #>  #> $show_wd #> [1] TRUE #>  #> $... #>  #>  #> $tlg #>  #>  #> $prune_0 #> [1] FALSE #>"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/assert_single_value.html","id":null,"dir":"Reference","previous_headings":"","what":"Check variable only has one unique value. ‚Äî assert_single_value","title":"Check variable only has one unique value. ‚Äî assert_single_value","text":"Check variable one unique value.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/assert_single_value.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Check variable only has one unique value. ‚Äî assert_single_value","text":"","code":"assert_single_value(x, label = deparse(substitute(x)))"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/assert_single_value.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Check variable only has one unique value. ‚Äî assert_single_value","text":"x value vector. label (string) label input.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/assert_single_value.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Check variable only has one unique value. ‚Äî assert_single_value","text":"invisible NULL error message criteria fulfilled.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/assert_valid_type.html","id":null,"dir":"Reference","previous_headings":"","what":"Check variable is of correct type ‚Äî assert_valid_type","title":"Check variable is of correct type ‚Äî assert_valid_type","text":"Check variable correct type","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/assert_valid_type.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Check variable is of correct type ‚Äî assert_valid_type","text":"","code":"assert_valid_type(x, types, label = deparse(substitute(x)))"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/assert_valid_type.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Check variable is of correct type ‚Äî assert_valid_type","text":"x Object check type. types (character) possible types check. label (string) label.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/assert_valid_type.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Check variable is of correct type ‚Äî assert_valid_type","text":"invisible NULL error message criteria fulfilled.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/assert_valid_var.html","id":null,"dir":"Reference","previous_headings":"","what":"Check whether var is valid ‚Äî assert_valid_var","title":"Check whether var is valid ‚Äî assert_valid_var","text":"Check whether var valid","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/assert_valid_var.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Check whether var is valid ‚Äî assert_valid_var","text":"","code":"assert_valid_var(x, label, na_ok, empty_ok, ...)  # S3 method for class 'character' assert_valid_var(   x,   label = deparse(substitute(x)),   na_ok = FALSE,   empty_ok = FALSE,   min_chars = 1L,   ... )  # S3 method for class 'factor' assert_valid_var(   x,   label = deparse(substitute(x)),   na_ok = FALSE,   empty_ok = FALSE,   min_chars = 1L,   ... )  # S3 method for class 'logical' assert_valid_var(   x,   label = deparse(substitute(x)),   na_ok = TRUE,   empty_ok = FALSE,   ... )  # S3 method for class 'numeric' assert_valid_var(   x,   label = deparse(substitute(x)),   na_ok = TRUE,   empty_ok = FALSE,   integerish = FALSE,   ... )  # S3 method for class 'POSIXct' assert_valid_var(   x,   label = deparse(substitute(x)),   na_ok = TRUE,   empty_ok = FALSE,   tzs = OlsonNames(),   ... )  # Default S3 method assert_valid_var(   x,   label = deparse(substitute(x)),   na_ok = FALSE,   empty_ok = FALSE,   ... )"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/assert_valid_var.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Check whether var is valid ‚Äî assert_valid_var","text":"x value col_split variable label (string) hints. na_ok (flag) whether NA value allowed empty_ok (flag) whether length 0 value allowed. ... arguments methods. min_chars (integer) minimum length characters. integerish (flag) whether number treated integerish. tzs (character) time zones.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/assert_valid_var.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Check whether var is valid ‚Äî assert_valid_var","text":"invisible NULL error message criteria fulfilled.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/assert_valid_var.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Check whether var is valid ‚Äî assert_valid_var","text":"function checks variable values valid .","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/assert_valid_var_pair.html","id":null,"dir":"Reference","previous_headings":"","what":"Check variables are of same levels ‚Äî assert_valid_var_pair","title":"Check variables are of same levels ‚Äî assert_valid_var_pair","text":"Check variables levels","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/assert_valid_var_pair.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Check variables are of same levels ‚Äî assert_valid_var_pair","text":"","code":"assert_valid_var_pair(   df1,   df2,   var,   lab1 = deparse(substitute(df1)),   lab2 = deparse(substitute(df2)) )"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/assert_valid_var_pair.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Check variables are of same levels ‚Äî assert_valid_var_pair","text":"df1 (data.frame) input. df2 (data.frame) input. var (string) variable check. lab1 (string) label hint df1. lab2 (string) label hint df2.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/assert_valid_var_pair.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Check variables are of same levels ‚Äî assert_valid_var_pair","text":"invisible NULL error message criteria fulfilled.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/assert_valid_variable.html","id":null,"dir":"Reference","previous_headings":"","what":"Check variables in a data frame are valid character or factor. ‚Äî assert_valid_variable","title":"Check variables in a data frame are valid character or factor. ‚Äî assert_valid_variable","text":"Check variables data frame valid character factor.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/assert_valid_variable.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Check variables in a data frame are valid character or factor. ‚Äî assert_valid_variable","text":"","code":"assert_valid_variable(   df,   vars,   label = deparse(substitute(df)),   types = NULL,   ... )"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/assert_valid_variable.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Check variables in a data frame are valid character or factor. ‚Äî assert_valid_variable","text":"df (data.frame) input dataset. vars (character) variables check. label (string) labels data frame. types Named (list) type input. ... arguments assert_valid_var. Please note different methods different arguments provided make sure variables check class.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/assert_valid_variable.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Check variables in a data frame are valid character or factor. ‚Äî assert_valid_variable","text":"invisible TRUE error message criteria fulfilled.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cfbt01.html","id":null,"dir":"Reference","previous_headings":"","what":"CFBT01 Change from Baseline By Visit Table. ‚Äî cfbt01_main","title":"CFBT01 Change from Baseline By Visit Table. ‚Äî cfbt01_main","text":"CFBT01 table provides overview actual values change baseline respective arm course trial.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cfbt01.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"CFBT01 Change from Baseline By Visit Table. ‚Äî cfbt01_main","text":"","code":"cfbt01_main(   adam_db,   dataset,   arm_var = \"ACTARM\",   lbl_overall = NULL,   row_split_var = NULL,   summaryvars = c(\"AVAL\", \"CHG\"),   visitvar = \"AVISIT\",   precision = list(default = 2L),   page_var = \"PARAMCD\",   .stats = c(\"n\", \"mean_sd\", \"median\", \"range\"),   skip = list(CHG = \"BASELINE\"),   ... )  cfbt01_pre(adam_db, dataset, ...)  cfbt01_post(tlg, prune_0 = TRUE, ...)  cfbt01"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cfbt01.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"CFBT01 Change from Baseline By Visit Table. ‚Äî cfbt01_main","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cfbt01.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"CFBT01 Change from Baseline By Visit Table. ‚Äî cfbt01_main","text":"adam_db (list data.frames) object containing ADaM datasets dataset (string) name table adam_db object. arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted row_split_var (character) additional row split variables. summaryvars (character) variables analyzed. label attribute corresponding column table adam_db used label. visitvar (string) typically one \"AVISIT\" user-defined visit incorporating \"ATPT\". precision (named list integer) names values found PARAMCD column values indicate number digits statistics. default set, parameter precision specified, value default used. page_var (string) variable name prior row split page. .stats (character) statistics names, see tern::analyze_vars(). skip Named (list) visit values need inhibited. ... additional arguments like .indent_mods, .labels. tlg (TableTree, Listing ggplot) object typically produced main function. prune_0 (flag) remove 0 count rows","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cfbt01.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"CFBT01 Change from Baseline By Visit Table. ‚Äî cfbt01_main","text":"main function returns rtables object. preprocessing function returns list data.frame. postprocessing function returns rtables object ElementaryTable (null report).","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cfbt01.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"CFBT01 Change from Baseline By Visit Table. ‚Äî cfbt01_main","text":"Analysis Value column, displays number patients, mean, standard deviation, median range analysis value visit. Change Baseline column, displays number patient mean, standard deviation, median range changes relative baseline. Remove zero-count rows unless overridden prune_0 = FALSE. Split columns arm, typically ACTARM. include total column default. Sorted  based factor level; first PARAM labels alphabetic order chronological time point given AVISIT. Re-level customize order","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cfbt01.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"CFBT01 Change from Baseline By Visit Table. ‚Äî cfbt01_main","text":"cfbt01_main(): Main TLG function cfbt01_pre(): Preprocessing cfbt01_post(): Postprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cfbt01.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"CFBT01 Change from Baseline By Visit Table. ‚Äî cfbt01_main","text":"adam_db object must contain table named dataset columns specified summaryvars.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cfbt01.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"CFBT01 Change from Baseline By Visit Table. ‚Äî cfbt01_main","text":"","code":"library(dunlin)  proc_data <- log_filter(   syn_data,   PARAMCD %in% c(\"DIABP\", \"SYSBP\"), \"advs\" ) run(cfbt01, proc_data, dataset = \"advs\") #>                                          A: Drug X                            B: Placebo                          C: Combination            #>                                                   Change from                          Change from                           Change from    #>                               Value at Visit       Baseline        Value at Visit        Baseline        Value at Visit        Baseline     #>   Analysis Visit                  (N=15)            (N=15)             (N=15)             (N=15)             (N=15)             (N=15)      #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Diastolic Blood Pressure                                                                                                                  #>     SCREENING                                                                                                                               #>       n                             15                 0                 15                 0                  15                 0         #>       Mean (SD)              94.385 (17.067)        NE (NE)       106.381 (20.586)       NE (NE)        106.468 (12.628)       NE (NE)      #>       Median                      94.933              NE              111.133               NE              108.359               NE        #>       Min - Max               55.71 - 122.00        NE - NE        60.21 - 131.91        NE - NE         83.29 - 127.17        NE - NE      #>     BASELINE                                                                                                                                #>       n                             15                                   15                                    15                           #>       Mean (SD)              96.133 (22.458)                      108.111 (15.074)                      103.149 (19.752)                    #>       Median                      93.328                              108.951                               102.849                         #>       Min - Max               60.58 - 136.59                       83.44 - 131.62                        66.05 - 136.55                     #>     WEEK 1 DAY 8                                                                                                                            #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              98.977 (21.359)    2.844 (28.106)    104.110 (16.172)   -4.001 (21.867)    100.826 (19.027)   -2.323 (25.018)  #>       Median                      92.447            -4.066            107.703             3.227             103.058             -2.476      #>       Min - Max               67.55 - 130.37    -32.82 - 47.68     70.91 - 132.89     -52.94 - 28.63     70.04 - 128.68     -55.15 - 41.81  #>     WEEK 2 DAY 15                                                                                                                           #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              99.758 (14.477)    3.626 (21.189)    97.473 (17.296)    -10.638 (20.831)   94.272 (16.961)    -8.877 (27.229)  #>       Median                     101.498             1.731             99.501             -9.727             96.789            -10.155      #>       Min - Max               71.98 - 122.81    -39.50 - 47.57     53.80 - 125.81     -55.15 - 25.26     63.45 - 117.47     -73.10 - 46.54  #>     WEEK 3 DAY 22                                                                                                                           #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              99.101 (26.109)    2.968 (34.327)    91.984 (16.925)    -16.127 (21.881)   94.586 (13.560)    -8.563 (21.713)  #>       Median                     101.146            -0.271             91.244            -14.384             98.398            -16.075      #>       Min - Max               47.68 - 162.22    -47.87 - 76.64     67.80 - 119.72     -53.06 - 22.52     73.50 - 115.43     -37.90 - 32.66  #>     WEEK 4 DAY 29                                                                                                                           #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              103.400 (22.273)   7.267 (30.740)    96.467 (19.451)    -11.644 (25.922)   108.338 (18.417)    5.189 (21.881)  #>       Median                      98.168             2.510             97.385            -16.793            107.555             7.966       #>       Min - Max               63.09 - 148.25    -38.43 - 61.90     63.35 - 131.57     -57.11 - 48.13     68.78 - 132.52     -33.96 - 41.50  #>     WEEK 5 DAY 36                                                                                                                           #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              93.222 (18.536)    -2.911 (28.873)   97.890 (20.701)    -10.221 (27.593)   95.317 (16.401)    -7.832 (19.827)  #>       Median                      90.799            -3.385             99.049            -11.319             93.876             -4.665      #>       Min - Max               63.55 - 139.11    -48.63 - 47.35     69.47 - 137.64     -54.38 - 37.85     71.91 - 138.54     -44.47 - 29.11  #>   Systolic Blood Pressure                                                                                                                   #>     SCREENING                                                                                                                               #>       n                             15                 0                 15                 0                  15                 0         #>       Mean (SD)              154.073 (33.511)       NE (NE)       157.840 (34.393)       NE (NE)        152.407 (22.311)       NE (NE)      #>       Median                     156.169              NE              161.670               NE              149.556               NE        #>       Min - Max               78.31 - 210.70        NE - NE        79.76 - 210.40        NE - NE        108.21 - 184.88        NE - NE      #>     BASELINE                                                                                                                                #>       n                             15                                   15                                    15                           #>       Mean (SD)              145.925 (28.231)                     152.007 (28.664)                      154.173 (26.317)                    #>       Median                     142.705                              157.698                               155.282                         #>       Min - Max               85.21 - 195.68                       98.90 - 194.62                        86.65 - 192.68                     #>     WEEK 1 DAY 8                                                                                                                            #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              156.509 (21.097)   10.584 (34.598)   147.480 (33.473)   -4.527 (48.895)    143.319 (30.759)   -10.854 (34.553) #>       Median                     160.711             5.802            155.030             2.758             145.548             -5.636      #>       Min - Max              126.84 - 185.53    -53.28 - 91.52     85.22 - 189.88     -77.34 - 90.98     90.37 - 191.58     -65.71 - 49.04  #>     WEEK 2 DAY 15                                                                                                                           #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              144.202 (33.676)   -1.723 (27.067)   136.892 (30.178)   -15.115 (37.794)   148.622 (27.088)   -5.551 (44.670)  #>       Median                     144.253             5.325            142.679            -14.083            147.102            -11.512      #>       Min - Max               62.56 - 203.66    -53.89 - 44.16     70.34 - 174.27     -83.07 - 62.39    108.82 - 200.23    -69.54 - 113.59  #>     WEEK 3 DAY 22                                                                                                                           #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              154.887 (35.374)   8.962 (38.455)    149.761 (28.944)   -2.247 (44.835)    150.460 (21.352)   -3.712 (37.984)  #>       Median                     158.938            17.191            155.044             -1.796            156.505             -7.606      #>       Min - Max              112.32 - 218.83    -47.28 - 96.18     84.42 - 192.92    -110.20 - 94.02     94.70 - 180.41     -74.91 - 72.74  #>     WEEK 4 DAY 29                                                                                                                           #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              150.159 (32.249)   4.234 (32.965)    156.043 (22.863)    4.036 (42.494)    145.714 (22.980)   -8.458 (33.175)  #>       Median                     145.506             3.754            149.094            -10.000            150.797            -14.432      #>       Min - Max               69.37 - 210.43    -89.16 - 54.32    113.57 - 195.10     -71.44 - 77.75    106.91 - 188.09     -41.95 - 65.16  #>     WEEK 5 DAY 36                                                                                                                           #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              155.964 (30.945)   10.039 (42.252)   156.387 (35.274)    4.380 (51.782)    143.592 (33.170)   -10.581 (44.799) #>       Median                     158.142             1.448            164.552             7.060             148.501             -2.385      #>       Min - Max              110.61 - 212.47    -53.91 - 90.45     63.28 - 198.79    -131.34 - 86.84     92.18 - 191.05     -78.77 - 64.35"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cfbt01_lyt.html","id":null,"dir":"Reference","previous_headings":"","what":"cfbt01 Layout ‚Äî cfbt01_lyt","title":"cfbt01 Layout ‚Äî cfbt01_lyt","text":"cfbt01 Layout","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cfbt01_lyt.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"cfbt01 Layout ‚Äî cfbt01_lyt","text":"","code":"cfbt01_lyt(   arm_var,   lbl_overall,   lbl_avisit,   lbl_param,   summaryvars,   summaryvars_lbls,   row_split_var,   row_split_lbl,   visitvar,   precision,   page_var,   .stats,   skip,   ... )"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cfbt01_lyt.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"cfbt01 Layout ‚Äî cfbt01_lyt","text":"arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted lbl_avisit (string) label visitvar variable. lbl_param (string) label PARAM variable. summaryvars (character) variables analyzed. table, AVAL CHG default. summaryvars_lbls (character) label variables analyzed. row_split_var (character) additional row split variables. row_split_lbl (character) label row splits. visitvar (string) typically one \"AVISIT\" user-defined visit incorporating \"ATPT\". precision (named list integer) names values found PARAMCD column values indicate number digits statistics. default set, parameter precision specified, value default used. page_var (string) variable name prior row split page. .stats (character) statistics names, see tern::analyze_vars(). skip Named (list) visit values need inhibited. ... used.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cfbt01_lyt.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"cfbt01 Layout ‚Äî cfbt01_lyt","text":"PreDataTableLayouts object.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/check_all_colnames.html","id":null,"dir":"Reference","previous_headings":"","what":"Check that all names are among column names ‚Äî check_all_colnames","title":"Check that all names are among column names ‚Äî check_all_colnames","text":"Check names among column names","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/check_all_colnames.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Check that all names are among column names ‚Äî check_all_colnames","text":"","code":"check_all_colnames(df, x, null_ok = TRUE, qualifier = NULL)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/check_all_colnames.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Check that all names are among column names ‚Äî check_all_colnames","text":"df (data.frame) x (character) names columns checked. null_ok (flag) can x NULL. qualifier (string) returned check fails.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/check_all_colnames.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Check that all names are among column names ‚Äî check_all_colnames","text":"invisible NULL string criteria fulfilled.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/check_one_colnames.html","id":null,"dir":"Reference","previous_headings":"","what":"Check that at least one name is among column names ‚Äî check_one_colnames","title":"Check that at least one name is among column names ‚Äî check_one_colnames","text":"Check least one name among column names","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/check_one_colnames.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Check that at least one name is among column names ‚Äî check_one_colnames","text":"","code":"check_one_colnames(df, x, null_ok = TRUE, qualifier = NULL)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/check_one_colnames.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Check that at least one name is among column names ‚Äî check_one_colnames","text":"df (data.frame) x (character) names columns checked. null_ok (flag) can x NULL. qualifier (string) returned check fails.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/check_one_colnames.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Check that at least one name is among column names ‚Äî check_one_colnames","text":"invisible NULL string criteria fulfilled.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/chevron-package.html","id":null,"dir":"Reference","previous_headings":"","what":"chevron package ‚Äî chevron-package","title":"chevron package ‚Äî chevron-package","text":"Provide standard tables, listings, graphs (TLGs) libraries used clinical trials. package implements structure reformat data 'dunlin', create reporting tables using 'rtables' 'tern' standardized input arguments enable quick generation standard outputs. addition, also provides comprehensive data checks script generation functionality.","code":""},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/chevron-package.html","id":"author","dir":"Reference","previous_headings":"","what":"Author","title":"chevron package ‚Äî chevron-package","text":"Maintainer: Liming Li liming.li@roche.com Authors: Benoit Falquet benoit.falquet@roche.com Xiaoli Duan xiaoli.duan@roche.com contributors: Adrian Waddell waddell.adrian@gene.com [contributor] Chenkai Lv chenkai.lv@roche.com [contributor] Pawel Rucki pawel.rucki@roche.com [contributor] Tim Barnett timothy.barnett@roche.com [contributor] Tian Fang tian.fang@roche.com [contributor] F. Hoffmann-La Roche AG [copyright holder, funder]","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/chevron_tlg-class.html","id":null,"dir":"Reference","previous_headings":"","what":"chevron_t ‚Äî chevron_tlg-class","title":"chevron_t ‚Äî chevron_tlg-class","text":"chevron_t, subclass chevron_tlg specific validation criteria handle table creation chevron_l, subclass chevron_tlg specific validation criteria handle listing creation chevron_g, subclass chevron_tlg specific validation criteria handle graph creation chevron_simple, subclass chevron_tlg, main function simple call","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/chevron_tlg-class.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"chevron_t ‚Äî chevron_tlg-class","text":"","code":"chevron_t(   main = function(adam_db, ...) build_table(basic_table(), adam_db[[1]]),   preprocess = function(adam_db, ...) adam_db,   postprocess = std_postprocessing,   ... )  chevron_l(   main = function(adam_db, ...) data.frame(),   preprocess = function(adam_db, ...) adam_db,   postprocess = std_postprocessing,   ... )  chevron_g(   main = function(adam_db, ...) ggplot2::ggplot(),   preprocess = function(adam_db, ...) adam_db,   postprocess = std_postprocessing,   ... )  chevron_simple()"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/chevron_tlg-class.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"chevron_t ‚Äî chevron_tlg-class","text":"main (function) returning tlg, adam_db first argument. Typically one _main function chevron. preprocess (function) returning pre-processed list data.frames, adam_db first argument. Typically one _pre function chevron. postprocess (function) returning post-processed tlg, tlg first argument. ... used","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/chevron_tlg-class.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"chevron_t ‚Äî chevron_tlg-class","text":"chevron_t class object. chevron_l class object. chevron_g class object. chevron_simple class object.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/chevron_tlg-class.html","id":"slots","dir":"Reference","previous_headings":"","what":"Slots","title":"chevron_t ‚Äî chevron_tlg-class","text":"main (function) returning tlg. Typically one *_main function chevron. preprocess (function) returning pre-processed list data.frames amenable tlg creation. Typically one *_pre function chevron. postprocess (function) returning post-processed tlg. Typically one *_post function chevron.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/chevron_tlg-class.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"chevron_t ‚Äî chevron_tlg-class","text":"ensure correct execution workflow, additional validation criteria : first argument main function must adam_db, input list data.frames pre-process. ... argument mandatory. first argument preprocess function must adam_db, input list data.frames create tlg output. ... argument mandatory. first argument postprocess function must tlg, input TableTree object post-process. ... argument mandatory.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/chevron_tlg-class.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"chevron_t ‚Äî chevron_tlg-class","text":"","code":"chevron_t_obj <- chevron_t() chevron_t_obj <- chevron_t(postprocess = function(tlg, indent, ...) {   rtables::table_inset(tlg) <- indent   tlg })  chevron_l_obj <- chevron_l()  chevron_g_obj <- chevron_g() chevron_g_obj <- chevron_g(   postprocess = function(tlg, title, ...) tlg + ggplot2::labs(main = title) )  chevron_simple_obj <- chevron_simple()"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cml02a_gl.html","id":null,"dir":"Reference","previous_headings":"","what":"CML02A_GL Listing 1 (Default) Concomitant Medication Class Level 2, Preferred Name, and Investigator-Specified Terms. ‚Äî cml02a_gl_main","title":"CML02A_GL Listing 1 (Default) Concomitant Medication Class Level 2, Preferred Name, and Investigator-Specified Terms. ‚Äî cml02a_gl_main","text":"CML02A_GL Listing 1 (Default) Concomitant Medication Class Level 2, Preferred Name, Investigator-Specified Terms.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cml02a_gl.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"CML02A_GL Listing 1 (Default) Concomitant Medication Class Level 2, Preferred Name, and Investigator-Specified Terms. ‚Äî cml02a_gl_main","text":"","code":"cml02a_gl_main(   adam_db,   dataset = \"adcm\",   key_cols = c(\"ATC2\", \"CMDECOD\"),   disp_cols = c(\"ATC2\", \"CMDECOD\", \"CMTRT\"),   split_into_pages_by_var = NULL,   unique_rows = TRUE,   ... )  cml02a_gl_pre(   adam_db,   dataset = \"adcm\",   disp_cols = c(\"ATC2\", \"CMDECOD\", \"CMTRT\"),   ... )  cml02a_gl"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cml02a_gl.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"CML02A_GL Listing 1 (Default) Concomitant Medication Class Level 2, Preferred Name, and Investigator-Specified Terms. ‚Äî cml02a_gl_main","text":"object class chevron_l length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cml02a_gl.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"CML02A_GL Listing 1 (Default) Concomitant Medication Class Level 2, Preferred Name, and Investigator-Specified Terms. ‚Äî cml02a_gl_main","text":"adam_db (list data.frames) object containing ADaM datasets dataset (string) name table adam_db object. key_cols (character) names columns treated key columns rendering listing. Key columns allow group repeat occurrences. disp_cols (character) names non-key columns displayed listing rendered. split_into_pages_by_var (character NULL) name variable split listing . unique_rows (flag) whether keep unique rows listing. ... used.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cml02a_gl.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"CML02A_GL Listing 1 (Default) Concomitant Medication Class Level 2, Preferred Name, and Investigator-Specified Terms. ‚Äî cml02a_gl_main","text":"main function returns rlistings list object. preprocessing function returns list data.frame.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cml02a_gl.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"CML02A_GL Listing 1 (Default) Concomitant Medication Class Level 2, Preferred Name, and Investigator-Specified Terms. ‚Äî cml02a_gl_main","text":"cml02a_gl_main(): Main TLG function cml02a_gl_pre(): Preprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cml02a_gl.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"CML02A_GL Listing 1 (Default) Concomitant Medication Class Level 2, Preferred Name, and Investigator-Specified Terms. ‚Äî cml02a_gl_main","text":"","code":"run(cml02a_gl, syn_data) #> ATC Class Level 2   WHODrug Preferred Name   Investigator-Specified Treatment Term #> ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #> ATCCLAS2 A          medname A_1/3            A_1/3                                 #>                     medname A_2/3            A_2/3                                 #>                     medname A_3/3            A_3/3                                 #> ATCCLAS2 A p2       medname A_3/3            A_3/3                                 #> ATCCLAS2 B          medname B_1/4            B_1/4                                 #>                     medname B_2/4            B_2/4                                 #>                     medname B_3/4            B_3/4                                 #>                     medname B_4/4            B_4/4                                 #> ATCCLAS2 B p2       medname B_1/4            B_1/4                                 #>                     medname B_2/4            B_2/4                                 #> ATCCLAS2 B p3       medname B_1/4            B_1/4                                 #>                     medname B_2/4            B_2/4                                 #> ATCCLAS2 C          medname C_1/2            C_1/2                                 #>                     medname C_2/2            C_2/2                                 #> ATCCLAS2 C p2       medname C_1/2            C_1/2                                 #>                     medname C_2/2            C_2/2                                 #> ATCCLAS2 C p3       medname C_2/2            C_2/2"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cmt01a.html","id":null,"dir":"Reference","previous_headings":"","what":"CMT01A Concomitant Medication by Medication Class and Preferred Name. ‚Äî cmt01_label","title":"CMT01A Concomitant Medication by Medication Class and Preferred Name. ‚Äî cmt01_label","text":"concomitant medication table number subjects total number treatments medication class.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cmt01a.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"CMT01A Concomitant Medication by Medication Class and Preferred Name. ‚Äî cmt01_label","text":"","code":"cmt01_label  cmt01a_main(   adam_db,   arm_var = \"ARM\",   lbl_overall = NULL,   row_split_var = \"ATC2\",   medname_var = \"CMDECOD\",   summary_labels = setNames(rep(list(cmt01_label), length(row_split_var) + 1L),     c(\"TOTAL\", row_split_var)),   ... )  cmt01a_pre(adam_db, ...)  cmt01a_post(   tlg,   prune_0 = TRUE,   sort_by_freq = FALSE,   row_split_var = \"ATC2\",   medname_var = \"CMDECOD\",   ... )  cmt01a"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cmt01a.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"CMT01A Concomitant Medication by Medication Class and Preferred Name. ‚Äî cmt01_label","text":"object class character length 2. object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cmt01a.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"CMT01A Concomitant Medication by Medication Class and Preferred Name. ‚Äî cmt01_label","text":"adam_db (list data.frames) object containing ADaM datasets arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted row_split_var (character) variable defining medication category. default ATC2. medname_var (string) variable name medical treatment name. summary_labels (list) summarize labels. See details. ... used. tlg (TableTree, Listing ggplot) object typically produced main function. prune_0 (flag) remove 0 count rows sort_by_freq (flag) whether sort medication class frequency.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cmt01a.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"CMT01A Concomitant Medication by Medication Class and Preferred Name. ‚Äî cmt01_label","text":"main function returns rtables object. preprocessing function returns list data.frame. postprocessing function returns rtables object ElementaryTable (null report).","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cmt01a.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"CMT01A Concomitant Medication by Medication Class and Preferred Name. ‚Äî cmt01_label","text":"Data filtered concomitant medication. (ATIREL == \"CONCOMITANT\"). Numbers represent absolute numbers subjects fraction N, absolute numbers specified. Remove zero-count rows unless overridden prune_0 = FALSE. Split columns arm. include total column default. Sort medication class alphabetically within medication class decreasing total number patients specific medication. summary_labels used control summary level. \"\" used, split summary statistic labels. One special case \"TOTAL\", overall population.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cmt01a.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"CMT01A Concomitant Medication by Medication Class and Preferred Name. ‚Äî cmt01_label","text":"cmt01_label: Default labels cmt01a_main(): Main TLG function cmt01a_pre(): Preprocessing cmt01a_post(): Postprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cmt01a.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"CMT01A Concomitant Medication by Medication Class and Preferred Name. ‚Äî cmt01_label","text":"adam_db object must contain adcm table columns specified row_split_var medname_var well \"CMSEQ\".","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cmt01a.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"CMT01A Concomitant Medication by Medication Class and Preferred Name. ‚Äî cmt01_label","text":"","code":"library(dplyr)  proc_data <- syn_data proc_data$adcm <- proc_data$adcm %>%   filter(ATIREL == \"CONCOMITANT\")  run(cmt01a, proc_data) #>   ATC Level 2 Text                                         A: Drug X    B: Placebo   C: Combination #>     Other Treatment                                          (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Total number of patients with at least one treatment     13 (86.7%)   14 (93.3%)     14 (93.3%)   #>   Total number of treatments                                   40           40             61       #>   ATCCLAS2 A                                                                                        #>     Total number of patients with at least one treatment   7 (46.7%)    10 (66.7%)     10 (66.7%)   #>     Total number of treatments                                 11           17             19       #>     medname A_3/3                                          5 (33.3%)    8 (53.3%)      6 (40.0%)    #>     medname A_2/3                                          5 (33.3%)    6 (40.0%)      7 (46.7%)    #>   ATCCLAS2 A p2                                                                                     #>     Total number of patients with at least one treatment   5 (33.3%)    8 (53.3%)      6 (40.0%)    #>     Total number of treatments                                 6            8              8        #>     medname A_3/3                                          5 (33.3%)    8 (53.3%)      6 (40.0%)    #>   ATCCLAS2 B                                                                                        #>     Total number of patients with at least one treatment   10 (66.7%)   8 (53.3%)      10 (66.7%)   #>     Total number of treatments                                 16           15             23       #>     medname B_1/4                                          7 (46.7%)    6 (40.0%)      6 (40.0%)    #>     medname B_4/4                                          4 (26.7%)    5 (33.3%)      8 (53.3%)    #>   ATCCLAS2 B p2                                                                                     #>     Total number of patients with at least one treatment   7 (46.7%)    6 (40.0%)      6 (40.0%)    #>     Total number of treatments                                 12           8              10       #>     medname B_1/4                                          7 (46.7%)    6 (40.0%)      6 (40.0%)    #>   ATCCLAS2 B p3                                                                                     #>     Total number of patients with at least one treatment   7 (46.7%)    6 (40.0%)      6 (40.0%)    #>     Total number of treatments                                 12           8              10       #>     medname B_1/4                                          7 (46.7%)    6 (40.0%)      6 (40.0%)    #>   ATCCLAS2 C                                                                                        #>     Total number of patients with at least one treatment   9 (60.0%)    7 (46.7%)      12 (80.0%)   #>     Total number of treatments                                 13           8              19       #>     medname C_2/2                                          4 (26.7%)    5 (33.3%)      7 (46.7%)    #>     medname C_1/2                                          6 (40.0%)    2 (13.3%)      6 (40.0%)    #>   ATCCLAS2 C p2                                                                                     #>     Total number of patients with at least one treatment   9 (60.0%)    7 (46.7%)      12 (80.0%)   #>     Total number of treatments                                 13           8              19       #>     medname C_2/2                                          4 (26.7%)    5 (33.3%)      7 (46.7%)    #>     medname C_1/2                                          6 (40.0%)    2 (13.3%)      6 (40.0%)    #>   ATCCLAS2 C p3                                                                                     #>     Total number of patients with at least one treatment   4 (26.7%)    5 (33.3%)      7 (46.7%)    #>     Total number of treatments                                 5            5              12       #>     medname C_2/2                                          4 (26.7%)    5 (33.3%)      7 (46.7%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cmt02_pt.html","id":null,"dir":"Reference","previous_headings":"","what":"CMT02_PT Table 1 (Default) Concomitant Medications by Preferred Name. ‚Äî cmt02_pt_main","title":"CMT02_PT Table 1 (Default) Concomitant Medications by Preferred Name. ‚Äî cmt02_pt_main","text":"concomitant medication table number subjects total number treatments medication name sorted frequencies.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cmt02_pt.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"CMT02_PT Table 1 (Default) Concomitant Medications by Preferred Name. ‚Äî cmt02_pt_main","text":"","code":"cmt02_pt_main(   adam_db,   arm_var = \"ARM\",   lbl_overall = NULL,   row_split_var = NULL,   medname_var = \"CMDECOD\",   summary_labels = list(TOTAL = cmt01_label),   ... )  cmt02_pt_pre(adam_db, ...)  cmt02_pt_post(   tlg,   prune_0 = TRUE,   sort_by_freq = FALSE,   row_split_var = NULL,   medname_var = \"CMDECOD\",   ... )  cmt02_pt"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cmt02_pt.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"CMT02_PT Table 1 (Default) Concomitant Medications by Preferred Name. ‚Äî cmt02_pt_main","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cmt02_pt.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"CMT02_PT Table 1 (Default) Concomitant Medications by Preferred Name. ‚Äî cmt02_pt_main","text":"adam_db (list data.frames) object containing ADaM datasets arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted row_split_var (character) variable defining medication category. default ATC2. medname_var (string) variable name medical treatment name. summary_labels (list) summarize labels. See details. ... used. tlg (TableTree, Listing ggplot) object typically produced main function. prune_0 (flag) remove 0 count rows sort_by_freq (flag) whether sort medication class frequency.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cmt02_pt.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"CMT02_PT Table 1 (Default) Concomitant Medications by Preferred Name. ‚Äî cmt02_pt_main","text":"main function returns rtables object. preprocessing function returns list data.frame. postprocessing function returns rtables object ElementaryTable (null report).","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cmt02_pt.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"CMT02_PT Table 1 (Default) Concomitant Medications by Preferred Name. ‚Äî cmt02_pt_main","text":"Data filtered concomitant medication. (ATIREL == \"CONCOMITANT\"). Numbers represent absolute numbers subjects fraction N, absolute numbers specified. Remove zero-count rows unless overridden prune_0 = FALSE. Split columns arm. include total column default. Sort medication class alphabetically within medication class decreasing total number patients specific medication. summary_labels used control summary level. \"\" used, split summary statistic labels. One special case \"TOTAL\", overall population.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cmt02_pt.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"CMT02_PT Table 1 (Default) Concomitant Medications by Preferred Name. ‚Äî cmt02_pt_main","text":"cmt02_pt_main(): Main TLG function cmt02_pt_pre(): Preprocessing cmt02_pt_post(): Postprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cmt02_pt.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"CMT02_PT Table 1 (Default) Concomitant Medications by Preferred Name. ‚Äî cmt02_pt_main","text":"adam_db object must contain adcm table columns specified row_split_var medname_var well \"CMSEQ\".","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/cmt02_pt.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"CMT02_PT Table 1 (Default) Concomitant Medications by Preferred Name. ‚Äî cmt02_pt_main","text":"","code":"run(cmt02_pt, syn_data) #>                                                          A: Drug X    B: Placebo   C: Combination #>   Other Treatment                                          (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Total number of patients with at least one treatment   13 (86.7%)   14 (93.3%)     15 (100%)    #>   Total number of treatments                                 58           59             99       #>   medname B_3/4                                          8 (53.3%)    6 (40.0%)      8 (53.3%)    #>   medname B_2/4                                          6 (40.0%)    5 (33.3%)      10 (66.7%)   #>   medname A_3/3                                          5 (33.3%)    8 (53.3%)      6 (40.0%)    #>   medname B_1/4                                          7 (46.7%)    6 (40.0%)      6 (40.0%)    #>   medname A_2/3                                          5 (33.3%)    6 (40.0%)      7 (46.7%)    #>   medname B_4/4                                          4 (26.7%)    5 (33.3%)      8 (53.3%)    #>   medname C_2/2                                          4 (26.7%)    5 (33.3%)      7 (46.7%)    #>   medname A_1/3                                          4 (26.7%)    3 (20.0%)      8 (53.3%)    #>   medname C_1/2                                          6 (40.0%)    2 (13.3%)      6 (40.0%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/convert_to_month.html","id":null,"dir":"Reference","previous_headings":"","what":"Helper function to convert to months if needed ‚Äî convert_to_month","title":"Helper function to convert to months if needed ‚Äî convert_to_month","text":"Helper function convert months needed","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/convert_to_month.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Helper function to convert to months if needed ‚Äî convert_to_month","text":"","code":"convert_to_month(x, unit)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/convert_to_month.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Helper function to convert to months if needed ‚Äî convert_to_month","text":"x (numeric) time. unit (character) (factor) time unit.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/convert_to_month.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Helper function to convert to months if needed ‚Äî convert_to_month","text":"numeric vector time months.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/count_children.html","id":null,"dir":"Reference","previous_headings":"","what":"Count Children ‚Äî count_children","title":"Count Children ‚Äî count_children","text":"Count Children","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/count_children.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Count Children ‚Äî count_children","text":"","code":"count_children(x)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/count_or_summarize.html","id":null,"dir":"Reference","previous_headings":"","what":"Count or summarize by groups ‚Äî count_or_summarize","title":"Count or summarize by groups ‚Äî count_or_summarize","text":"Count summarize groups","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/count_or_summarize.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Count or summarize by groups ‚Äî count_or_summarize","text":"","code":"count_or_summarize(lyt, var, level, detail_vars, indent_mod = 0L, ...)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/count_or_summarize.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Count or summarize by groups ‚Äî count_or_summarize","text":"lyt (PreDataTableLayouts) rtable layout. var (string) analysis variable. level (string) level displayed. detail_vars (character) variables detail information.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/count_patients_recursive.html","id":null,"dir":"Reference","previous_headings":"","what":"Count patients recursively ‚Äî count_patients_recursive","title":"Count patients recursively ‚Äî count_patients_recursive","text":"Count patients recursively","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/count_patients_recursive.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Count patients recursively ‚Äî count_patients_recursive","text":"","code":"count_patients_recursive(lyt, anl_vars, anl_lbls, lbl_vars)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/count_patients_recursive.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Count patients recursively ‚Äî count_patients_recursive","text":"lyt (PreDataTableLayouts) rtable layout. anl_vars Named (list) analysis variables. anl_lbls (character) labels. lbl_vars Named (list) analysis labels.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/coxt01.html","id":null,"dir":"Reference","previous_headings":"","what":"COXT01 (Default) Cox Regression Model Table. ‚Äî coxt01_main","title":"COXT01 (Default) Cox Regression Model Table. ‚Äî coxt01_main","text":"Cox models commonly used methods estimate magnitude effect survival analyses. assumes proportional hazards; , assumes ratio hazards two groups (e.g. two arms) constant time. ratio referred \"hazard ratio\" one commonly reported metrics describe effect size survival analysis.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/coxt01.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"COXT01 (Default) Cox Regression Model Table. ‚Äî coxt01_main","text":"","code":"coxt01_main(   adam_db,   arm_var = \"ARM\",   time_var = \"AVAL\",   event_var = \"EVENT\",   covariates = c(\"SEX\", \"RACE\", \"AAGE\"),   strata = NULL,   lbl_vars = \"Effect/Covariate Included in the Model\",   multivar = FALSE,   ... )  coxt01_pre(adam_db, arm_var = \"ARM\", ...)  coxt01_post(tlg, prune_0 = FALSE, ...)  coxt01"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/coxt01.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"COXT01 (Default) Cox Regression Model Table. ‚Äî coxt01_main","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/coxt01.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"COXT01 (Default) Cox Regression Model Table. ‚Äî coxt01_main","text":"adam_db (list data.frames) object containing ADaM datasets arm_var (string) arm variable used arm splitting. time_var (string) time variable Cox proportional hazards regression model. event_var (string) event variable Cox proportional hazards regression model. covariates (character) fitted corresponding effect estimated. strata (character) fitted stratified analysis. lbl_vars (string) text label Cox regression model variables. multivar (flag) indicator whether multivariate cox regression conducted. ... arguments passed tern::control_coxreg(). tlg (TableTree, Listing ggplot) object typically produced main function. prune_0 (flag) remove 0 count rows","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/coxt01.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"COXT01 (Default) Cox Regression Model Table. ‚Äî coxt01_main","text":"main function returns rtables object preprocessing function returns list data.frame. postprocessing function returns rtables object ElementaryTable (null report).","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/coxt01.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"COXT01 (Default) Cox Regression Model Table. ‚Äî coxt01_main","text":"reference arm always first level arm_var. Please change level want change reference arms. table allows confidence level adjusted, default two-sided 95%. stratified analysis DISCRETE tie handling (equivalent tern::control_coxreg(ties = \"exact\") R). Model includes treatment plus specified covariate(s) factor(s) numeric(s), \"SEX\", \"RACE\" \"AAGE\" default candidates. selection covariates whether selection process (vs. fixed, pre-specified list) needs pre-specified. pairwise comparisons using hazard ratio, value control group denominator. Keep zero-count rows unless overridden prune_0 = TRUE.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/coxt01.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"COXT01 (Default) Cox Regression Model Table. ‚Äî coxt01_main","text":"coxt01_main(): Main TLG function coxt01_pre(): Preprocessing coxt01_post(): Postprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/coxt01.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"COXT01 (Default) Cox Regression Model Table. ‚Äî coxt01_main","text":"adam_db object must contain adtte table \"PARAMCD\", \"ARM\", \"AVAL\", \"CNSR, columns specified \"covariates\" denoted c(\"SEX\", \"RACE\", \"AAGE\") default.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/coxt01.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"COXT01 (Default) Cox Regression Model Table. ‚Äî coxt01_main","text":"","code":"library(dunlin)  proc_data <- log_filter(syn_data, PARAMCD == \"CRSD\", \"adtte\") proc_data <- log_filter(proc_data, ARMCD != \"ARM C\", \"adsl\") run(coxt01, proc_data) #>                                                Treatment Effect Adjusted for Covariate      #>   Effect/Covariate Included in the Model    n      Hazard Ratio       95% CI       p-value  #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Treatment:                                                                                #>     B: Placebo vs control (A: Drug X)       30         0.68        (0.25, 1.89)     0.4638  #>   Covariate:                                                                                #>     Sex                                     30         0.53        (0.18, 1.58)     0.2553  #>     RACE                                    30         0.79        (0.28, 2.17)     0.6415  #>     Age (yr)                                30         0.67        (0.24, 1.89)     0.4526   run(coxt01, proc_data, covariates = c(\"SEX\", \"AAGE\"), strata = c(\"RACE\"), conf_level = 0.90) #>                                                Treatment Effect Adjusted for Covariate      #>   Effect/Covariate Included in the Model    n      Hazard Ratio       90% CI       p-value  #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Treatment:                                                                                #>     B: Placebo vs control (A: Drug X)       30         1.03        (0.44, 2.42)     0.9578  #>   Covariate:                                                                                #>     Sex                                     30         0.81        (0.31, 2.10)     0.7214  #>     Age (yr)                                30         1.01        (0.42, 2.40)     0.9856"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/coxt01_lyt.html","id":null,"dir":"Reference","previous_headings":"","what":"COXT01 Layout ‚Äî coxt01_lyt","title":"COXT01 Layout ‚Äî coxt01_lyt","text":"COXT01 Layout","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/coxt01_lyt.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"COXT01 Layout ‚Äî coxt01_lyt","text":"","code":"coxt01_lyt(variables, col_split, lbl_vars, control, multivar, ...)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/coxt01_lyt.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"COXT01 Layout ‚Äî coxt01_lyt","text":"variables (list) list variables Cox proportional hazards regression model. lbl_vars (string) text label Cox regression model variables. multivar (flag) indicator whether multivariate cox regression conducted. ... arguments passed tern::control_coxreg().","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/coxt01_lyt.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"COXT01 Layout ‚Äî coxt01_lyt","text":"PreDataTableLayouts object.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/coxt02.html","id":null,"dir":"Reference","previous_headings":"","what":"COXT02 Multi-Variable Cox Regression Model Table. ‚Äî coxt02_main","title":"COXT02 Multi-Variable Cox Regression Model Table. ‚Äî coxt02_main","text":"COXT02 table follows principles general Cox model analysis produces estimates covariates included model (usually main effects without interaction terms).","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/coxt02.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"COXT02 Multi-Variable Cox Regression Model Table. ‚Äî coxt02_main","text":"","code":"coxt02_main(   adam_db,   arm_var = \"ARM\",   time_var = \"AVAL\",   event_var = \"EVENT\",   covariates = c(\"SEX\", \"RACE\", \"AAGE\"),   strata = NULL,   lbl_vars = \"Effect/Covariate Included in the Model\",   multivar = TRUE,   ... )  coxt02"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/coxt02.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"COXT02 Multi-Variable Cox Regression Model Table. ‚Äî coxt02_main","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/coxt02.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"COXT02 Multi-Variable Cox Regression Model Table. ‚Äî coxt02_main","text":"adam_db (list data.frames) object containing ADaM datasets arm_var (string) arm variable used arm splitting. time_var (string) time variable Cox proportional hazards regression model. event_var (string) event variable Cox proportional hazards regression model. covariates (character) fitted corresponding effect estimated. strata (character) fitted stratified analysis. lbl_vars (string) text label Cox regression model variables. multivar (flag) indicator whether multivariate cox regression conducted. ... arguments passed tern::control_coxreg().","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/coxt02.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"COXT02 Multi-Variable Cox Regression Model Table. ‚Äî coxt02_main","text":"main function returns rtables object.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/coxt02.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"COXT02 Multi-Variable Cox Regression Model Table. ‚Äî coxt02_main","text":"reference arm always first level arm_var. Please change level want change reference arms. table allows confidence level adjusted, default two-sided 95%. stratified analysis DISCRETE tie handling (equivalent tern::control_coxreg(ties = \"exact\") R). Model includes treatment plus specified covariate(s) factor(s) numeric(s), \"SEX\", \"RACE\" \"AAGE\" default candidates. selection covariates whether selection process (vs. fixed, pre-specified list) needs pre-specified. pairwise comparisons using hazard ratio, value control group denominator. Keep zero-count rows unless overridden prune_0 = TRUE.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/coxt02.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"COXT02 Multi-Variable Cox Regression Model Table. ‚Äî coxt02_main","text":"coxt02_main(): Main TLG function","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/coxt02.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"COXT02 Multi-Variable Cox Regression Model Table. ‚Äî coxt02_main","text":"adam_db object must contain adtte table \"PARAMCD\", \"ARM\", \"AVAL\", \"CNSR, columns specified \"covariates\" denoted c(\"SEX\", \"RACE\", \"AAGE\") default.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/coxt02.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"COXT02 Multi-Variable Cox Regression Model Table. ‚Äî coxt02_main","text":"","code":"library(dunlin)  proc_data <- log_filter(syn_data, PARAMCD == \"CRSD\", \"adtte\")  run(coxt02, proc_data) #>   Effect/Covariate Included in the Model                  Hazard Ratio      95% CI       p-value #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Treatment:                                                                                     #>     Description of Planned Arm (reference = A: Drug X)                                   0.6859  #>       B: Placebo                                              0.77       (0.29, 2.08)    0.6113  #>       C: Combination                                          0.62       (0.21, 1.82)    0.3853  #>   Covariate:                                                                                     #>     Sex (reference = F)                                                                          #>       M                                                       1.41       (0.61, 3.23)    0.4194  #>     RACE (reference = AMERICAN INDIAN OR ALASKA NATIVE)                                  0.8938  #>       ASIAN                                                   1.69       (0.36, 7.99)    0.5055  #>       BLACK OR AFRICAN AMERICAN                               1.86       (0.29, 11.72)   0.5109  #>       WHITE                                                   2.03       (0.34, 12.25)   0.4414  #>     Age (yr)                                                                                     #>       All                                                     1.00       (0.94, 1.08)    0.8951   run(coxt02, proc_data, covariates = c(\"SEX\", \"AAGE\"), strata = c(\"RACE\"), conf_level = 0.90) #>   Effect/Covariate Included in the Model                 Hazard Ratio      90% CI      p-value #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Treatment:                                                                                   #>     Description of Planned Arm (reference = A: Drug X)                                 0.7644  #>       B: Placebo                                             0.97       (0.40, 2.35)   0.9586  #>       C: Combination                                         0.70       (0.29, 1.73)   0.5199  #>   Covariate:                                                                                   #>     Sex (reference = F)                                                                        #>       M                                                      1.66       (0.81, 3.41)   0.2468  #>     Age (yr)                                                                                   #>       All                                                    1.01       (0.95, 1.06)   0.8541"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/create_id_listings.html","id":null,"dir":"Reference","previous_headings":"","what":"Concatenate Site and Subject ID ‚Äî create_id_listings","title":"Concatenate Site and Subject ID ‚Äî create_id_listings","text":"Concatenate Site Subject ID","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/create_id_listings.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Concatenate Site and Subject ID ‚Äî create_id_listings","text":"","code":"create_id_listings(site, subject, sep = \"/\")"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/create_id_listings.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Concatenate Site and Subject ID ‚Äî create_id_listings","text":"site (string) subject (string) sep (string)","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/create_id_listings.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"Concatenate Site and Subject ID ‚Äî create_id_listings","text":"{Patient_label} whisker placeholder used label.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/create_id_listings.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Concatenate Site and Subject ID ‚Äî create_id_listings","text":"","code":"create_id_listings(\"BRA-1\", \"xxx-1234\") #> [1] \"BRA-1/1234\" #> attr(,\"label\") #> [1] \"Center/Patients ID\""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ctcv4_dir.html","id":null,"dir":"Reference","previous_headings":"","what":"CTC version 4 Grade Direction Data ‚Äî ctcv4_dir","title":"CTC version 4 Grade Direction Data ‚Äî ctcv4_dir","text":"CTC version 4 Grade Direction Data","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ctcv4_dir.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"CTC version 4 Grade Direction Data ‚Äî ctcv4_dir","text":"","code":"ctcv4_dir"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ctcv4_dir.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"CTC version 4 Grade Direction Data ‚Äî ctcv4_dir","text":"object class data.frame 35 rows 3 columns.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ctcv5_dir.html","id":null,"dir":"Reference","previous_headings":"","what":"CTC version 5 Grade Direction Data ‚Äî ctcv5_dir","title":"CTC version 5 Grade Direction Data ‚Äî ctcv5_dir","text":"CTC version 5 Grade Direction Data","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ctcv5_dir.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"CTC version 5 Grade Direction Data ‚Äî ctcv5_dir","text":"","code":"ctcv5_dir"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ctcv5_dir.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"CTC version 5 Grade Direction Data ‚Äî ctcv5_dir","text":"object class data.frame 35 rows 3 columns.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/deparse_print.html","id":null,"dir":"Reference","previous_headings":"","what":"Deparse print ‚Äî deparse_print","title":"Deparse print ‚Äî deparse_print","text":"Deparse print","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/deparse_print.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Deparse print ‚Äî deparse_print","text":"","code":"deparse_print(x, indent, max_line = getOption(\"chevron.arg_max_line\", 5L))"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dmt01.html","id":null,"dir":"Reference","previous_headings":"","what":"DMT01 Table 1 (Default) Demographics and Baseline Characteristics Table 1. ‚Äî dmt01_main","title":"DMT01 Table 1 (Default) Demographics and Baseline Characteristics Table 1. ‚Äî dmt01_main","text":"variable, summary statistics default based number patients corresponding n row.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dmt01.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"DMT01 Table 1 (Default) Demographics and Baseline Characteristics Table 1. ‚Äî dmt01_main","text":"","code":"dmt01_main(   adam_db,   arm_var = \"ARM\",   lbl_overall = \"All {Patient_label}\",   summaryvars = c(\"AAGE\", \"AGEGR1\", \"SEX\", \"ETHNIC\", \"RACE\"),   stats = list(default = c(\"n\", \"mean_sd\", \"median\", \"range\", \"count_fraction\")),   precision = list(),   ... )  dmt01_pre(adam_db, ...)  dmt01_post(tlg, prune_0 = TRUE, ...)  dmt01"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dmt01.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"DMT01 Table 1 (Default) Demographics and Baseline Characteristics Table 1. ‚Äî dmt01_main","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dmt01.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"DMT01 Table 1 (Default) Demographics and Baseline Characteristics Table 1. ‚Äî dmt01_main","text":"adam_db (list data.frames) object containing ADaM datasets arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted summaryvars (character) variables summarized demographic table. label attribute corresponding column adsl table adam_db used label. stats (named list character)  names columns found .df_row values indicate statistical analysis perform. default set, parameter precision specified, value default used. precision (named list integer) names strings found summaryvars values indicate number digits statistics numeric variables. default set, parameter precision specified, value default used. neither provided, auto determination used. See tern::format_auto. ... used. tlg (TableTree, Listing ggplot) object typically produced main function. prune_0 (flag) remove 0 count rows","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dmt01.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"DMT01 Table 1 (Default) Demographics and Baseline Characteristics Table 1. ‚Äî dmt01_main","text":"main function returns rtables object. preprocessing function returns list data.frame. postprocessing function returns rtables object ElementaryTable (null report).","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dmt01.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"DMT01 Table 1 (Default) Demographics and Baseline Characteristics Table 1. ‚Äî dmt01_main","text":"Information ADSUB generally included ADSL analysis. Default demographic characteristics table specified otherwise, numbers represent absolute numbers patients fraction N Remove zero-count rows Split columns arm (planned actual / code description) Include total column default","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dmt01.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"DMT01 Table 1 (Default) Demographics and Baseline Characteristics Table 1. ‚Äî dmt01_main","text":"dmt01_main(): Main TLG function dmt01_pre(): Preprocessing dmt01_post(): Postprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dmt01.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"DMT01 Table 1 (Default) Demographics and Baseline Characteristics Table 1. ‚Äî dmt01_main","text":"adam_db object must contain adsl table columns specified summaryvars.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dmt01.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"DMT01 Table 1 (Default) Demographics and Baseline Characteristics Table 1. ‚Äî dmt01_main","text":"","code":"run(dmt01, syn_data) #>                                        A: Drug X    B: Placebo   C: Combination   All Patients #>                                          (N=15)       (N=15)         (N=15)          (N=45)    #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Age (yr)                                                                                     #>     n                                      15           15             15              45      #>     Mean (SD)                          31.3 (5.3)   35.1 (9.0)     36.6 (6.4)      34.3 (7.3)  #>     Median                                31.0         35.0           35.0            34.0     #>     Min - Max                           24 - 40      24 - 57        24 - 49         24 - 57    #>   Age Group                                                                                    #>     n                                      15           15             15              45      #>     <65                                15 (100%)    15 (100%)      15 (100%)       45 (100%)   #>   Sex                                                                                          #>     n                                      15           15             15              45      #>     Male                               3 (20.0%)    7 (46.7%)      5 (33.3%)       15 (33.3%)  #>     Female                             12 (80.0%)   8 (53.3%)      10 (66.7%)      30 (66.7%)  #>   Ethnicity                                                                                    #>     n                                      15           15             15              45      #>     HISPANIC OR LATINO                 2 (13.3%)        0              0            2 (4.4%)   #>     NOT HISPANIC OR LATINO             13 (86.7%)   15 (100%)      13 (86.7%)      41 (91.1%)  #>     NOT REPORTED                           0            0          2 (13.3%)        2 (4.4%)   #>   RACE                                                                                         #>     n                                      15           15             15              45      #>     AMERICAN INDIAN OR ALASKA NATIVE       0        2 (13.3%)       1 (6.7%)        3 (6.7%)   #>     ASIAN                              8 (53.3%)    10 (66.7%)     8 (53.3%)       26 (57.8%)  #>     BLACK OR AFRICAN AMERICAN          4 (26.7%)     1 (6.7%)      4 (26.7%)       9 (20.0%)   #>     WHITE                              3 (20.0%)    2 (13.3%)      2 (13.3%)       7 (15.6%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dmt01_lyt.html","id":null,"dir":"Reference","previous_headings":"","what":"dmt01 Layout ‚Äî dmt01_lyt","title":"dmt01 Layout ‚Äî dmt01_lyt","text":"dmt01 Layout","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dmt01_lyt.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"dmt01 Layout ‚Äî dmt01_lyt","text":"","code":"dmt01_lyt(   arm_var,   lbl_overall,   summaryvars,   summaryvars_lbls,   stats,   precision )"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dmt01_lyt.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"dmt01 Layout ‚Äî dmt01_lyt","text":"arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted summaryvars_lbls (character) labels corresponding analyzed variables.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dmt01_lyt.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"dmt01 Layout ‚Äî dmt01_lyt","text":"PreDataTableLayouts object.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/do_call.html","id":null,"dir":"Reference","previous_headings":"","what":"Execute a function call ‚Äî do_call","title":"Execute a function call ‚Äî do_call","text":"Execute function call","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/do_call.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Execute a function call ‚Äî do_call","text":"","code":"do_call(what, args)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dose_change_rule.html","id":null,"dir":"Reference","previous_headings":"","what":"Dose Change Rule ‚Äî dose_change_rule","title":"Dose Change Rule ‚Äî dose_change_rule","text":"Dose Change Rule","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dose_change_rule.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Dose Change Rule ‚Äî dose_change_rule","text":"","code":"dose_change_rule"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dose_change_rule.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Dose Change Rule ‚Äî dose_change_rule","text":"object class rule (inherits character) length 9.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dst01.html","id":null,"dir":"Reference","previous_headings":"","what":"DST01 Table 1 (Default) Patient Disposition Table 1. ‚Äî dst01_main","title":"DST01 Table 1 (Default) Patient Disposition Table 1. ‚Äî dst01_main","text":"DST01 Disposition Table provides overview patients study completion. patients discontinued study reason provided.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dst01.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"DST01 Table 1 (Default) Patient Disposition Table 1. ‚Äî dst01_main","text":"","code":"dst01_main(   adam_db,   arm_var = \"ARM\",   lbl_overall = \"All {Patient_label}\",   study_status_var = \"EOSSTT\",   detail_vars = list(Discontinued = c(\"DCSREAS\")),   trt_status_var = NULL,   ... )  dst01_pre(adam_db, ...)  dst01_post(tlg, prune_0 = TRUE, ...)  dst01"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dst01.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"DST01 Table 1 (Default) Patient Disposition Table 1. ‚Äî dst01_main","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dst01.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"DST01 Table 1 (Default) Patient Disposition Table 1. ‚Äî dst01_main","text":"adam_db (list data.frames) object containing ADaM datasets arm_var (string) variable. Usually one ARM, ACTARM, TRT01A, TRT01A. lbl_overall (string) label used overall column, set NULL overall column omitted study_status_var (string) variable used define patient status. Default EOSSTT, however can also variable name pattern EOPxxSTT xx must substituted 2 digits referring analysis period. detail_vars Named (list) grouped display study_status_var. names must subset unique levels study_status_var. trt_status_var (string) variable treatment status. ... used. tlg (TableTree, Listing ggplot) object typically produced main function. prune_0 (flag) remove 0 count rows","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dst01.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"DST01 Table 1 (Default) Patient Disposition Table 1. ‚Äî dst01_main","text":"main function returns rtables object. preprocessing function returns list data.frame. postprocessing function returns rtables object ElementaryTable (null report).","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dst01.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"DST01 Table 1 (Default) Patient Disposition Table 1. ‚Äî dst01_main","text":"Default patient disposition table summarizing reasons patients withdrawal. Numbers represent absolute numbers patients fraction N. Remove zero-count rows. Split columns arm. Include total column default. Sort withdrawal reasons alphabetic order.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dst01.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"DST01 Table 1 (Default) Patient Disposition Table 1. ‚Äî dst01_main","text":"dst01_main(): Main TLG function dst01_pre(): Preprocessing dst01_post(): Postprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dst01.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"DST01 Table 1 (Default) Patient Disposition Table 1. ‚Äî dst01_main","text":"adam_db object must contain adsl table columns specified status_var disc_reason_var.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dst01.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"DST01 Table 1 (Default) Patient Disposition Table 1. ‚Äî dst01_main","text":"","code":"run(dst01, syn_data, detail_vars = list(Ongoing = \"STDONS\")) #>               A: Drug X    B: Placebo   C: Combination   All Patients #>                 (N=15)       (N=15)         (N=15)          (N=45)    #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Completed   10 (66.7%)   10 (66.7%)     10 (66.7%)      30 (66.7%)   run(dst01, syn_data, detail_vars = list(Discontinued = \"DCSREAS\", Ongoing = \"STDONS\")) #>                                     A: Drug X    B: Placebo   C: Combination   All Patients #>                                       (N=15)       (N=15)         (N=15)          (N=45)    #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Completed                         10 (66.7%)   10 (66.7%)     10 (66.7%)      30 (66.7%)  #>   Discontinued                      5 (33.3%)    5 (33.3%)      5 (33.3%)       15 (33.3%)  #>     ADVERSE EVENT                       0            0           1 (6.7%)        1 (2.2%)   #>     DEATH                           2 (13.3%)    4 (26.7%)      3 (20.0%)       9 (20.0%)   #>     LACK OF EFFICACY                2 (13.3%)        0              0            2 (4.4%)   #>     PHYSICIAN DECISION                  0            0           1 (6.7%)        1 (2.2%)   #>     PROTOCOL VIOLATION                  0         1 (6.7%)          0            1 (2.2%)   #>     WITHDRAWAL BY PARENT/GUARDIAN    1 (6.7%)        0              0            1 (2.2%)    run(   dst01, syn_data,   detail_vars = list(     Discontinued = c(\"DCSREASGP\", \"DCSREAS\"),     Ongoing = \"STDONS\"   ) ) #>                                       A: Drug X    B: Placebo   C: Combination   All Patients #>                                         (N=15)       (N=15)         (N=15)          (N=45)    #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Completed                           10 (66.7%)   10 (66.7%)     10 (66.7%)      30 (66.7%)  #>   Discontinued                        5 (33.3%)    5 (33.3%)      5 (33.3%)       15 (33.3%)  #>     Safety                                                                                    #>       ADVERSE EVENT                       0            0           1 (6.7%)        1 (2.2%)   #>       DEATH                           2 (13.3%)    4 (26.7%)      3 (20.0%)       9 (20.0%)   #>     Non-Safety                                                                                #>       LACK OF EFFICACY                2 (13.3%)        0              0            2 (4.4%)   #>       PHYSICIAN DECISION                  0            0           1 (6.7%)        1 (2.2%)   #>       PROTOCOL VIOLATION                  0         1 (6.7%)          0            1 (2.2%)   #>       WITHDRAWAL BY PARENT/GUARDIAN    1 (6.7%)        0              0            1 (2.2%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dst01_lyt.html","id":null,"dir":"Reference","previous_headings":"","what":"dst01 Layout ‚Äî dst01_lyt","title":"dst01 Layout ‚Äî dst01_lyt","text":"dst01 Layout","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dst01_lyt.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"dst01 Layout ‚Äî dst01_lyt","text":"","code":"dst01_lyt(arm_var, lbl_overall, study_status_var, detail_vars, trt_status_var)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dst01_lyt.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"dst01 Layout ‚Äî dst01_lyt","text":"arm_var (string) variable. Usually one ARM, ACTARM, TRT01A, TRT01A. lbl_overall (string) label used overall column, set NULL overall column omitted study_status_var (string) variable used define patient status. Default EOSSTT, however can also variable name pattern EOPxxSTT xx must substituted 2 digits referring analysis period. detail_vars Named (list) grouped display study_status_var. trt_status_var (string) variable treatment status.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dst01_lyt.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"dst01 Layout ‚Äî dst01_lyt","text":"PreDataTableLayouts object.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dtht01.html","id":null,"dir":"Reference","previous_headings":"","what":"DTHT01 Table 1 (Default) Death Table. ‚Äî dtht01_main","title":"DTHT01 Table 1 (Default) Death Table. ‚Äî dtht01_main","text":"description causes death optionally breakdown category /post-study reporting death.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dtht01.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"DTHT01 Table 1 (Default) Death Table. ‚Äî dtht01_main","text":"","code":"dtht01_main(   adam_db,   arm_var = \"ACTARM\",   lbl_overall = NULL,   other_category = FALSE,   time_since_last_dose = FALSE,   ... )  dtht01_pre(adam_db, ...)  dtht01_post(tlg, prune_0 = TRUE, ...)  dtht01"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dtht01.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"DTHT01 Table 1 (Default) Death Table. ‚Äî dtht01_main","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dtht01.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"DTHT01 Table 1 (Default) Death Table. ‚Äî dtht01_main","text":"adam_db (list data.frames) object containing ADaM datasets arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted other_category (flag) breakdown category displayed. time_since_last_dose (flag) time event information displayed. ... used. tlg (TableTree, Listing ggplot) object typically produced main function. prune_0 (flag) remove 0 count rows","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dtht01.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"DTHT01 Table 1 (Default) Death Table. ‚Äî dtht01_main","text":"main function returns rtables object. preprocessing function returns list data.frame. postprocessing function returns rtables object ElementaryTable (null report).","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dtht01.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"DTHT01 Table 1 (Default) Death Table. ‚Äî dtht01_main","text":"Numbers represent absolute numbers subjects fraction N, absolute numbers specified. Remove zero-count rows unless overridden prune_0 = FALSE. include total column default.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dtht01.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"DTHT01 Table 1 (Default) Death Table. ‚Äî dtht01_main","text":"dtht01_main(): Main TLG function dtht01_pre(): Preprocessing dtht01_post(): Postprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dtht01.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"DTHT01 Table 1 (Default) Death Table. ‚Äî dtht01_main","text":"adam_db object must contain adsl table columns \"DTHFL\", \"DTHCAT\" well LDDTHGR1 time_since_last_dose TRUE.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dtht01.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"DTHT01 Table 1 (Default) Death Table. ‚Äî dtht01_main","text":"","code":"run(dtht01, syn_data) #>                            A: Drug X   B: Placebo   C: Combination #>                             (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Total number of deaths   2 (13.3%)   4 (26.7%)      3 (20.0%)    #>   Primary Cause of Death                                           #>     n                          2           4              3        #>     Adverse Event          1 (50.0%)   2 (50.0%)      1 (33.3%)    #>     Progressive Disease    1 (50.0%)       0          2 (66.7%)    #>     Other                      0       2 (50.0%)          0         run(dtht01, syn_data, other_category = TRUE, time_since_last_dose = TRUE) #>                                                               A: Drug X   B: Placebo   C: Combination #>                                                                (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Total number of deaths                                      2 (13.3%)   4 (26.7%)      3 (20.0%)    #>   Primary Cause of Death                                                                              #>     n                                                             2           4              3        #>     Adverse Event                                             1 (50.0%)   2 (50.0%)      1 (33.3%)    #>     Progressive Disease                                       1 (50.0%)       0          2 (66.7%)    #>     Other                                                         0       2 (50.0%)          0        #>       LOST TO FOLLOW UP                                           0        1 (50%)           0        #>       SUICIDE                                                     0        1 (50%)           0        #>   Days from last drug administration                                                                  #>     n                                                             2           4              3        #>     <=30                                                      2 (100%)    1 (25.0%)      2 (66.7%)    #>     >30                                                           0       3 (75.0%)      1 (33.3%)    #>   Primary cause by days from last study drug administration                                           #>     <=30                                                                                              #>       n                                                           2           1              2        #>       Adverse Event                                           1 (50.0%)       0          1 (50.0%)    #>       Progressive Disease                                     1 (50.0%)       0          1 (50.0%)    #>       Other                                                       0        1 (100%)          0        #>     >30                                                                                               #>       n                                                           0           3              1        #>       Adverse Event                                               0       2 (66.7%)          0        #>       Progressive Disease                                         0           0           1 (100%)    #>       Other                                                       0       1 (33.3%)          0"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dtht01_lyt.html","id":null,"dir":"Reference","previous_headings":"","what":"dtht01 Layout ‚Äî dtht01_lyt","title":"dtht01 Layout ‚Äî dtht01_lyt","text":"dtht01 Layout","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dtht01_lyt.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"dtht01 Layout ‚Äî dtht01_lyt","text":"","code":"dtht01_lyt(   arm_var,   lbl_overall,   death_flag,   death_var,   other_level,   other_var,   dose_death_var )"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dtht01_lyt.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"dtht01 Layout ‚Äî dtht01_lyt","text":"arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted death_flag (string) variable name death flag. death_var (string) variable name death category. other_level (string) \"\" level death category. other_var (string) variable name death cause \"\". dose_death_var (string) variable name days last dose.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dtht01_lyt.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"dtht01 Layout ‚Äî dtht01_lyt","text":"PreDataTableLayouts object.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dummy_template.html","id":null,"dir":"Reference","previous_headings":"","what":"Dummy template. ‚Äî dummy_template","title":"Dummy template. ‚Äî dummy_template","text":"template creates dummy output.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dummy_template.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Dummy template. ‚Äî dummy_template","text":"","code":"dummy_template"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dummy_template.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Dummy template. ‚Äî dummy_template","text":"object class chevron_simple length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/dummy_template.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Dummy template. ‚Äî dummy_template","text":"","code":"run(dummy_template, syn_data) #>    all obs #> ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt01.html","id":null,"dir":"Reference","previous_headings":"","what":"EGT01 ECG Parameters and Change from Baseline By Visit Table. ‚Äî egt01_main","title":"EGT01 ECG Parameters and Change from Baseline By Visit Table. ‚Äî egt01_main","text":"EGT01 table provides overview ECG values change baseline respective arm course trial.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt01.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"EGT01 ECG Parameters and Change from Baseline By Visit Table. ‚Äî egt01_main","text":"","code":"egt01_main(   adam_db,   dataset = \"adeg\",   arm_var = \"ACTARM\",   lbl_overall = NULL,   row_split_var = NULL,   summaryvars = c(\"AVAL\", \"CHG\"),   visitvar = \"AVISIT\",   precision = list(default = 2L),   page_var = \"PARAMCD\",   .stats = c(\"n\", \"mean_sd\", \"median\", \"range\"),   skip = list(CHG = \"BASELINE\"),   ... )  egt01_pre(adam_db, dataset = \"adeg\", ...)  egt01"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt01.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"EGT01 ECG Parameters and Change from Baseline By Visit Table. ‚Äî egt01_main","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt01.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"EGT01 ECG Parameters and Change from Baseline By Visit Table. ‚Äî egt01_main","text":"adam_db (list data.frames) object containing ADaM datasets dataset (string) name table adam_db object. arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted row_split_var (character) additional row split variables. summaryvars (character) variables analyzed. label attribute corresponding column table adam_db used label. visitvar (string) typically one \"AVISIT\" user-defined visit incorporating \"ATPT\". precision (named list integer) names values found PARAMCD column values indicate number digits statistics. default set, parameter precision specified, value default used. page_var (string) variable name prior row split page. .stats (character) statistics names, see tern::analyze_vars(). skip Named (list) visit values need inhibited. ... additional arguments like .indent_mods, .labels.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt01.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"EGT01 ECG Parameters and Change from Baseline By Visit Table. ‚Äî egt01_main","text":"main function returns rtables object. preprocessing function returns list data.frame.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt01.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"EGT01 ECG Parameters and Change from Baseline By Visit Table. ‚Äî egt01_main","text":"Analysis Value column, displays number patients, mean, standard deviation, median range analysis value visit. Change Baseline column, displays number patient mean, standard deviation, median range changes relative baseline. Remove zero-count rows unless overridden prune_0 = FALSE. Split columns arm, typically ACTARM. include total column default. Sorted  based factor level; first PARAM labels alphabetic order chronological time point given AVISIT. Re-level customize order","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt01.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"EGT01 ECG Parameters and Change from Baseline By Visit Table. ‚Äî egt01_main","text":"egt01_main(): Main TLG function egt01_pre(): Preprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt01.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"EGT01 ECG Parameters and Change from Baseline By Visit Table. ‚Äî egt01_main","text":"adam_db object must contain table named dataset columns specified summaryvars.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt01.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"EGT01 ECG Parameters and Change from Baseline By Visit Table. ‚Äî egt01_main","text":"","code":"run(egt01, syn_data) #>                                    A: Drug X                                B: Placebo                             C: Combination              #>                                             Change from                               Change from                              Change from     #>                       Value at Visit          Baseline          Value at Visit         Baseline          Value at Visit          Baseline      #>   Analysis Visit          (N=15)               (N=15)               (N=15)              (N=15)               (N=15)               (N=15)       #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Heart Rate                                                                                                                                   #>     BASELINE                                                                                                                                   #>       n                     15                                        15                                       15                              #>       Mean (SD)      76.594 (17.889)                           69.899 (18.788)                          70.492 (18.175)                        #>       Median              77.531                                    77.174                                   74.111                            #>       Min - Max       46.50 - 106.68                            26.42 - 97.69                            45.37 - 115.49                        #>     WEEK 1 DAY 8                                                                                                                               #>       n                     15                   15                   15                  15                   15                   15         #>       Mean (SD)      71.140 (23.441)      -5.454 (25.128)      70.958 (14.877)      1.059 (23.345)      67.450 (18.932)      -3.043 (23.753)   #>       Median              77.210               -2.152               70.033              -8.403               68.471               0.181        #>       Min - Max       8.53 - 102.63        -50.97 - 36.54       44.85 - 93.79       -25.34 - 60.50       38.90 - 100.05       -52.20 - 33.13   #>     WEEK 2 DAY 15                                                                                                                              #>       n                     15                   15                   15                  15                   15                   15         #>       Mean (SD)      69.350 (16.083)      -7.244 (28.960)      76.096 (14.958)      6.198 (29.319)      63.694 (12.920)      -6.799 (23.949)   #>       Median              65.746              -11.369               75.323               0.255               61.076               -4.954       #>       Min - Max       47.22 - 101.44       -49.59 - 42.91       47.50 - 111.40      -37.51 - 69.34       43.25 - 86.13        -52.70 - 40.76   #>     WEEK 3 DAY 22                                                                                                                              #>       n                     15                   15                   15                  15                   15                   15         #>       Mean (SD)      73.894 (24.576)      -2.700 (32.079)      67.635 (19.114)      -2.263 (29.989)     72.054 (19.308)       1.562 (27.494)   #>       Median              69.296               5.492                68.468              -2.093               68.686               -5.848       #>       Min - Max       44.15 - 131.73       -62.53 - 38.19       31.89 - 108.87      -52.26 - 66.81       32.16 - 109.86       -49.61 - 35.23   #>     WEEK 4 DAY 29                                                                                                                              #>       n                     15                   15                   15                  15                   15                   15         #>       Mean (SD)      73.241 (19.256)      -3.353 (29.170)      66.524 (25.487)      -3.374 (36.024)     66.600 (22.839)      -3.892 (24.140)   #>       Median              68.689               0.232                66.397              -11.730              64.969               -6.827       #>       Min - Max       33.71 - 111.54       -55.14 - 65.04       19.66 - 111.29      -60.39 - 61.00       10.35 - 100.88       -50.72 - 26.77   #>     WEEK 5 DAY 36                                                                                                                              #>       n                     15                   15                   15                  15                   15                   15         #>       Mean (SD)      61.690 (22.182)      -14.904 (30.330)     60.712 (20.025)      -9.187 (24.587)     72.683 (23.495)       2.191 (26.654)   #>       Median              57.925              -12.660               60.454              -16.100              77.585               14.635       #>       Min - Max       23.89 - 103.74       -60.00 - 57.24       32.53 - 102.02      -52.56 - 50.96       31.21 - 105.05       -42.90 - 34.64   #>   QT Duration                                                                                                                                  #>     BASELINE                                                                                                                                   #>       n                     15                                        15                                       15                              #>       Mean (SD)     335.294 (123.231)                          363.104 (68.160)                         347.311 (86.236)                       #>       Median             372.731                                   386.316                                  348.254                            #>       Min - Max      121.28 - 554.97                           214.65 - 445.53                          170.80 - 508.54                        #>     WEEK 1 DAY 8                                                                                                                               #>       n                     15                   15                   15                  15                   15                   15         #>       Mean (SD)      357.361 (85.688)     22.067 (144.166)    415.225 (105.425)    52.121 (144.259)    321.078 (107.553)    -26.233 (129.135)  #>       Median             344.797               49.432              421.950              62.762              307.962              -17.006       #>       Min - Max      241.22 - 517.39      -207.23 - 245.36     234.11 - 604.72     -190.70 - 364.94     118.36 - 480.29      -363.11 - 163.67  #>     WEEK 2 DAY 15                                                                                                                              #>       n                     15                   15                   15                  15                   15                   15         #>       Mean (SD)     344.883 (106.793)     9.589 (174.797)      370.548 (80.862)     7.444 (91.301)      354.129 (95.133)     6.818 (142.397)   #>       Median             312.236               -9.264              388.515              -9.429              365.292               39.930       #>       Min - Max      187.77 - 501.87      -278.91 - 372.71     204.55 - 514.43     -190.58 - 173.87     200.19 - 493.40      -279.46 - 265.56  #>     WEEK 3 DAY 22                                                                                                                              #>       n                     15                   15                   15                  15                   15                   15         #>       Mean (SD)      342.062 (92.568)     6.768 (151.505)     326.684 (116.421)    -36.420 (145.415)    366.245 (99.106)     18.935 (168.417)  #>       Median             352.930              -22.771              298.353              -78.409             329.688              -21.584       #>       Min - Max      199.40 - 476.04      -230.25 - 303.00     151.05 - 561.23     -205.30 - 293.76     249.42 - 580.81      -252.73 - 410.01  #>     WEEK 4 DAY 29                                                                                                                              #>       n                     15                   15                   15                  15                   15                   15         #>       Mean (SD)      371.650 (44.805)     36.356 (139.308)    333.697 (110.377)    -29.407 (125.592)    333.181 (96.466)    -14.130 (107.622)  #>       Median             375.412               58.958              308.020              -40.987             330.911              -25.820       #>       Min - Max      302.32 - 451.62      -214.07 - 258.04     183.09 - 531.08     -241.72 - 134.12     126.95 - 488.57      -234.92 - 152.49  #>     WEEK 5 DAY 36                                                                                                                              #>       n                     15                   15                   15                  15                   15                   15         #>       Mean (SD)     345.504 (130.543)     10.210 (198.224)     309.919 (84.624)    -53.185 (105.730)    322.931 (67.801)    -24.380 (117.331)  #>       Median             355.730              -23.213              306.219              -12.373             341.988              -26.952       #>       Min - Max       88.38 - 661.12      -271.06 - 539.84     189.01 - 448.58      -256.52 - 91.57     217.51 - 427.16      -291.03 - 171.19  #>   RR Duration                                                                                                                                  #>     BASELINE                                                                                                                                   #>       n                     15                                        15                                       15                              #>       Mean (SD)     1086.908 (363.811)                        1050.034 (390.444)                       1102.659 (310.359)                      #>       Median             1116.849                                  1089.193                                 1250.037                           #>       Min - Max      626.19 - 1653.12                          414.61 - 1721.89                         385.51 - 1430.81                       #>     WEEK 1 DAY 8                                                                                                                               #>       n                     15                   15                   15                  15                   15                   15         #>       Mean (SD)     968.499 (287.811)    -118.409 (546.796)   1041.186 (211.201)   -8.848 (435.281)    948.491 (213.746)    -154.168 (442.882) #>       Median             961.296              -147.460             1013.786             24.754              965.429              -224.054      #>       Min - Max      358.92 - 1593.51    -1014.82 - 911.82     714.44 - 1417.52    -618.80 - 847.31     513.35 - 1229.09     -736.69 - 843.58  #>     WEEK 2 DAY 15                                                                                                                              #>       n                     15                   15                   15                  15                   15                   15         #>       Mean (SD)     932.717 (259.634)    -154.191 (331.884)   1139.332 (454.231)   89.298 (582.750)    1021.283 (233.529)   -81.376 (415.781)  #>       Median             950.533              -205.949             1068.007             -5.449              964.616              -142.180      #>       Min - Max      409.68 - 1269.35     -649.69 - 473.09     486.51 - 2048.73    -846.72 - 1148.61    667.36 - 1367.25     -647.47 - 616.15  #>     WEEK 3 DAY 22                                                                                                                              #>       n                     15                   15                   15                  15                   15                   15         #>       Mean (SD)     1068.865 (319.540)   -18.043 (513.412)    1110.882 (259.523)   60.848 (432.700)    1105.918 (306.185)    3.259 (516.734)   #>       Median             1201.998             -65.085              1163.690             51.200              1187.130              30.318       #>       Min - Max      380.49 - 1551.65     -832.86 - 703.74     621.41 - 1453.29    -887.06 - 822.18     446.02 - 1648.32     -984.79 - 816.30  #>     WEEK 4 DAY 29                                                                                                                              #>       n                     15                   15                   15                  15                   15                   15         #>       Mean (SD)     1087.915 (205.940)    1.008 (403.039)     1161.681 (293.257)   111.647 (460.979)   992.134 (283.177)    -110.525 (334.932) #>       Median             1084.658             146.611              1055.223             191.008             1028.997             -112.599      #>       Min - Max      697.59 - 1499.17     -801.16 - 402.97     722.35 - 1762.04    -528.27 - 1191.83    497.14 - 1382.12     -597.95 - 757.99  #>     WEEK 5 DAY 36                                                                                                                              #>       n                     15                   15                   15                  15                   15                   15         #>       Mean (SD)     1016.880 (424.428)   -70.027 (505.078)    1135.131 (224.684)   85.097 (497.679)    1089.527 (238.909)   -13.132 (362.606)  #>       Median             962.584              -142.925             1158.815             -9.553              1081.015              16.706       #>       Min - Max      352.97 - 1843.86    -894.83 - 1162.79     714.34 - 1436.68    -843.41 - 992.34     699.72 - 1611.38     -696.03 - 561.53"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt02_1.html","id":null,"dir":"Reference","previous_headings":"","what":"EGT02 ECG Abnormalities Table. ‚Äî egt02_1_main","title":"EGT02 ECG Abnormalities Table. ‚Äî egt02_1_main","text":"ECG Parameters outside Normal Limits Regardless Abnormality Baseline Table.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt02_1.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"EGT02 ECG Abnormalities Table. ‚Äî egt02_1_main","text":"","code":"egt02_1_main(   adam_db,   arm_var = \"ACTARM\",   lbl_overall = NULL,   exclude_base_abn = FALSE,   ... )  egt02_pre(adam_db, ...)  egt02_post(tlg, ...)  egt02_1"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt02_1.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"EGT02 ECG Abnormalities Table. ‚Äî egt02_1_main","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt02_1.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"EGT02 ECG Abnormalities Table. ‚Äî egt02_1_main","text":"adam_db (list data.frames) object containing ADaM datasets arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted exclude_base_abn (flag) whether baseline abnormality excluded. ... used. tlg (TableTree, Listing ggplot) object typically produced main function.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt02_1.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"EGT02 ECG Abnormalities Table. ‚Äî egt02_1_main","text":"main function returns rtables object preprocessing function returns list data.frame. postprocessing function returns rtables object ElementaryTable (null report).","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt02_1.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"EGT02 ECG Abnormalities Table. ‚Äî egt02_1_main","text":"count LOW HIGH values. Results \"LOW LOW\" treated \"LOW\", \"HIGH HIGH\" \"HIGH\". include total column default. remove zero-count rows unless overridden prune_0 = TRUE.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt02_1.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"EGT02 ECG Abnormalities Table. ‚Äî egt02_1_main","text":"egt02_1_main(): Main TLG function egt02_pre(): Preprocessing egt02_post(): Postprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt02_1.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"EGT02 ECG Abnormalities Table. ‚Äî egt02_1_main","text":"adam_db object must contain adeg table \"PARAM\", \"ANRIND\" \"BNRIND\" columns.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt02_1.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"EGT02 ECG Abnormalities Table. ‚Äî egt02_1_main","text":"","code":"run(egt02_1, syn_data) #>   Assessment      A: Drug X      B: Placebo    C: Combination #>    Abnormality      (N=15)         (N=15)          (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Heart Rate                                                  #>     Low          4/15 (26.7%)   4/15 (26.7%)    4/15 (26.7%)  #>     High         4/15 (26.7%)    3/15 (20%)      3/15 (20%)   #>   QT Duration                                                 #>     Low          2/15 (13.3%)   5/15 (33.3%)     3/15 (20%)   #>     High          3/15 (20%)     6/15 (40%)     2/15 (13.3%)  #>   RR Duration                                                 #>     Low           6/15 (40%)    2/15 (13.3%)    4/15 (26.7%)  #>     High         4/15 (26.7%)   5/15 (33.3%)    2/15 (13.3%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt02_2.html","id":null,"dir":"Reference","previous_headings":"","what":"EGT02_2 ECG Abnormalities Table. ‚Äî egt02_2_main","title":"EGT02_2 ECG Abnormalities Table. ‚Äî egt02_2_main","text":"ECG Parameters outside Normal Limits Among Patients without Abnormality Baseline Table.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt02_2.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"EGT02_2 ECG Abnormalities Table. ‚Äî egt02_2_main","text":"","code":"egt02_2_main(   adam_db,   arm_var = \"ACTARM\",   lbl_overall = NULL,   exclude_base_abn = TRUE,   ... )  egt02_2"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt02_2.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"EGT02_2 ECG Abnormalities Table. ‚Äî egt02_2_main","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt02_2.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"EGT02_2 ECG Abnormalities Table. ‚Äî egt02_2_main","text":"adam_db (list data.frames) object containing ADaM datasets arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted exclude_base_abn (flag) whether baseline abnormality excluded. ... used.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt02_2.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"EGT02_2 ECG Abnormalities Table. ‚Äî egt02_2_main","text":"main function returns rtables object preprocessing function returns list data.frame. postprocessing function returns rtables object ElementaryTable (null report).","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt02_2.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"EGT02_2 ECG Abnormalities Table. ‚Äî egt02_2_main","text":"count LOW HIGH values. Results \"LOW LOW\" treated \"LOW\", \"HIGH HIGH\" \"HIGH\". include total column default. remove zero-count rows unless overridden prune_0 = TRUE.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt02_2.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"EGT02_2 ECG Abnormalities Table. ‚Äî egt02_2_main","text":"egt02_2_main(): Main TLG function","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt02_2.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"EGT02_2 ECG Abnormalities Table. ‚Äî egt02_2_main","text":"adam_db object must contain adeg table \"PARAM\", \"ANRIND\" \"BNRIND\" columns.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt02_2.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"EGT02_2 ECG Abnormalities Table. ‚Äî egt02_2_main","text":"","code":"run(egt02_2, syn_data) #>   Assessment      A: Drug X      B: Placebo    C: Combination #>    Abnormality      (N=15)         (N=15)          (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Heart Rate                                                  #>     Low          4/15 (26.7%)   4/14 (28.6%)    4/15 (26.7%)  #>     High         3/13 (23.1%)    3/15 (20%)     2/14 (14.3%)  #>   QT Duration                                                 #>     Low          2/12 (16.7%)   5/15 (33.3%)    3/14 (21.4%)  #>     High         3/14 (21.4%)    6/15 (40%)     2/14 (14.3%)  #>   RR Duration                                                 #>     Low           6/15 (40%)    2/13 (15.4%)    4/14 (28.6%)  #>     High         4/13 (30.8%)   5/13 (38.5%)    2/15 (13.3%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt02_lyt.html","id":null,"dir":"Reference","previous_headings":"","what":"egt02 Layout ‚Äî egt02_lyt","title":"egt02 Layout ‚Äî egt02_lyt","text":"egt02 Layout","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt02_lyt.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"egt02 Layout ‚Äî egt02_lyt","text":"","code":"egt02_lyt(   arm_var = \"ACTARM\",   lbl_overall,   lbl_vs_assessment = \"Assessment\",   lbl_vs_abnormality = \"Abnormality\",   exclude_base_abn )"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt02_lyt.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"egt02 Layout ‚Äî egt02_lyt","text":"arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted lbl_vs_assessment (string) label assessment variable. lbl_vs_abnormality (string) label abnormality variable. exclude_base_abn (flag) whether exclude subjects baseline abnormality numerator denominator.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt02_lyt.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"egt02 Layout ‚Äî egt02_lyt","text":"PreDataTableLayouts object.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt03.html","id":null,"dir":"Reference","previous_headings":"","what":"EGT03 Shift Table of ECG Interval Data - Baseline versus Minimum or Maximum Post-Baseline. ‚Äî egt03_main","title":"EGT03 Shift Table of ECG Interval Data - Baseline versus Minimum or Maximum Post-Baseline. ‚Äî egt03_main","text":"EGT03 Table entries provide number patients baseline assessment minimum maximum post-baseline assessment. Percentages based total number patients treatment group. Baseline patient's last observation prior initiation study drug.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt03.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"EGT03 Shift Table of ECG Interval Data - Baseline versus Minimum or Maximum Post-Baseline. ‚Äî egt03_main","text":"","code":"egt03_main(   adam_db,   arm_var = \"ACTARMCD\",   summaryvar = \"BNRIND\",   splitvar = \"ANRIND\",   visitvar = \"AVISIT\",   page_var = \"PARAMCD\",   ... )  egt03_pre(adam_db, ...)  egt03_post(tlg, prune_0 = FALSE, ...)  egt03"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt03.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"EGT03 Shift Table of ECG Interval Data - Baseline versus Minimum or Maximum Post-Baseline. ‚Äî egt03_main","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt03.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"EGT03 Shift Table of ECG Interval Data - Baseline versus Minimum or Maximum Post-Baseline. ‚Äî egt03_main","text":"adam_db (list data.frames) object containing ADaM datasets arm_var (character) arm variables used row split, typically \"ACTARMCD\". summaryvar (character) variables analyzed, typically \"BNRIND\". Labels corresponding columns used subtitles. splitvar (character) variables analyzed, typically \"ANRIND\". Labels corresponding columns used subtitles. visitvar (string) typically \"AVISIT\" user-defined visit incorporating \"ATPT\". page_var (string) variable name prior row split page. ... used. tlg (TableTree, Listing ggplot) object typically produced main function. prune_0 (flag) remove 0 count rows","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt03.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"EGT03 Shift Table of ECG Interval Data - Baseline versus Minimum or Maximum Post-Baseline. ‚Äî egt03_main","text":"main function returns rtables object. preprocessing function returns list data.frame. postprocessing function returns rtables object ElementaryTable (null report).","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt03.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"EGT03 Shift Table of ECG Interval Data - Baseline versus Minimum or Maximum Post-Baseline. ‚Äî egt03_main","text":"ADEG data subsetted contain \"POST-BASELINE MINIMUM\"/\"POST-BASELINE MAXIMUM\" visit according preprocessing. Percentages based total number patients treatment group. Split columns Analysis Reference Range Indicator, typically ANRIND. include total column default. Sorted  based factor level.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt03.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"EGT03 Shift Table of ECG Interval Data - Baseline versus Minimum or Maximum Post-Baseline. ‚Äî egt03_main","text":"egt03_main(): Main TLG function egt03_pre(): Preprocessing egt03_post(): Postprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt03.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"EGT03 Shift Table of ECG Interval Data - Baseline versus Minimum or Maximum Post-Baseline. ‚Äî egt03_main","text":"adam_db object must contain adeg table \"ACTARMCD\" column well columns specified summaryvar splitvar.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt03.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"EGT03 Shift Table of ECG Interval Data - Baseline versus Minimum or Maximum Post-Baseline. ‚Äî egt03_main","text":"","code":"library(dunlin)  proc_data <- log_filter(syn_data, PARAMCD == \"HR\", \"adeg\") run(egt03, proc_data) #>   Actual Arm Code                            Minimum Post-Baseline Assessment      #>     Baseline Reference Range Indicator      LOW         NORMAL      HIGH   Missing #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Heart Rate                                                                       #>     ARM A (N=15)                                                                   #>       LOW                                    0             0         0        0    #>       NORMAL                             4 (26.7%)     9 (60.0%)     0        0    #>       HIGH                                   0         2 (13.3%)     0        0    #>       Missing                                0             0         0        0    #>     ARM B (N=15)                                                                   #>       LOW                                    0         1 (6.7%)      0        0    #>       NORMAL                             4 (26.7%)    10 (66.7%)     0        0    #>       HIGH                                   0             0         0        0    #>       Missing                                0             0         0        0    #>     ARM C (N=15)                                                                   #>       LOW                                    0             0         0        0    #>       NORMAL                             4 (26.7%)    10 (66.7%)     0        0    #>       HIGH                                   0         1 (6.7%)      0        0    #>       Missing                                0             0         0        0"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt03_lyt.html","id":null,"dir":"Reference","previous_headings":"","what":"egt03 Layout ‚Äî egt03_lyt","title":"egt03 Layout ‚Äî egt03_lyt","text":"egt03 Layout","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt03_lyt.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"egt03 Layout ‚Äî egt03_lyt","text":"","code":"egt03_lyt(   arm_var,   splitvar,   summaryvar,   lbl_armvar,   lbl_summaryvars,   lbl_param,   page_var )"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt03_lyt.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"egt03 Layout ‚Äî egt03_lyt","text":"arm_var (string) variable used column splitting splitvar (character) variables analyzed, typically \"ANRIND\". Labels corresponding columns used subtitles. summaryvar (character) variables analyzed, typically \"BNRIND\". Labels corresponding columns used subtitles. lbl_armvar (string) label arm_var variable. lbl_summaryvars (string) label summaryvar variable. page_var (string) variable name prior row split page.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt03_lyt.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"egt03 Layout ‚Äî egt03_lyt","text":"PreDataTableLayouts object.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt05_qtcat.html","id":null,"dir":"Reference","previous_headings":"","what":"EGT05_QTCAT ECG Actual Values and Changes from Baseline by Visit Table. ‚Äî egt05_qtcat_main","title":"EGT05_QTCAT ECG Actual Values and Changes from Baseline by Visit Table. ‚Äî egt05_qtcat_main","text":"EGT05_QTCAT table summarizes several electrocardiogram parameters evolution throughout study.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt05_qtcat.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"EGT05_QTCAT ECG Actual Values and Changes from Baseline by Visit Table. ‚Äî egt05_qtcat_main","text":"","code":"egt05_qtcat_main(   adam_db,   arm_var = \"ACTARM\",   lbl_overall = NULL,   summaryvars = c(\"AVALCAT1\", \"CHGCAT1\"),   row_split_var = NULL,   visitvar = \"AVISIT\",   page_var = NULL,   ... )  egt05_qtcat_pre(adam_db, ...)  egt05_qtcat_post(tlg, prune_0 = TRUE, ...)  egt05_qtcat"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt05_qtcat.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"EGT05_QTCAT ECG Actual Values and Changes from Baseline by Visit Table. ‚Äî egt05_qtcat_main","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt05_qtcat.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"EGT05_QTCAT ECG Actual Values and Changes from Baseline by Visit Table. ‚Äî egt05_qtcat_main","text":"adam_db (list data.frames) object containing ADaM datasets arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted summaryvars (character) variables analyzed. label attribute corresponding column adeg table adam_db used name. row_split_var (character) additional row split variables. visitvar (string) typically \"AVISIT\" user-defined visit incorporating \"ATPT\". page_var (string) variable name prior row split page. ... used. tlg (TableTree, Listing ggplot) object typically produced main function. prune_0 (flag) remove 0 count rows","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt05_qtcat.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"EGT05_QTCAT ECG Actual Values and Changes from Baseline by Visit Table. ‚Äî egt05_qtcat_main","text":"main function returns rtables object. preprocessing function returns list data.frame. postprocessing function returns rtables object ElementaryTable (null report).","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt05_qtcat.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"EGT05_QTCAT ECG Actual Values and Changes from Baseline by Visit Table. ‚Äî egt05_qtcat_main","text":"Value Visit column, displays categories specific \"PARAMCD\" value patients. Change Baseline column, displays categories specific \"PARAMCD\" value change baseline patients. Remove zero-count rows unless overridden prune_0 = FALSE. Split columns arm, typically \"ACTARM\". include total column default. Sorted based factor level; chronological time point given \"AVISIT\" user-defined visit incorporating \"ATPT\". Re-level customize order. Please note preferable convert summaryvars factor.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt05_qtcat.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"EGT05_QTCAT ECG Actual Values and Changes from Baseline by Visit Table. ‚Äî egt05_qtcat_main","text":"egt05_qtcat_main(): Main TLG function egt05_qtcat_pre(): Preprocessing egt05_qtcat_post(): Postprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt05_qtcat.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"EGT05_QTCAT ECG Actual Values and Changes from Baseline by Visit Table. ‚Äî egt05_qtcat_main","text":"adam_db object must contain adeg table column specified visitvar. summaryvars, please make sure AVALCAT1 CHGCAT1 columns existed input data sets.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt05_qtcat.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"EGT05_QTCAT ECG Actual Values and Changes from Baseline by Visit Table. ‚Äî egt05_qtcat_main","text":"","code":"run(egt05_qtcat, syn_data) #>   Parameter                                                           #>     Analysis Visit           A: Drug X    B: Placebo   C: Combination #>       Category                 (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   QT Duration                                                         #>     BASELINE                                                          #>       Value at Visit                                                  #>         n                        15           15             15       #>         <=450 msec           13 (86.7%)   15 (100%)      13 (86.7%)   #>         >450 to <=480 msec    1 (6.7%)        0              0        #>         >480 to <=500 msec       0            0           1 (6.7%)    #>         >500 msec             1 (6.7%)        0           1 (6.7%)    #>     WEEK 1 DAY 8                                                      #>       Value at Visit                                                  #>         n                        15           15             15       #>         <=450 msec           12 (80.0%)   9 (60.0%)      13 (86.7%)   #>         >450 to <=480 msec    1 (6.7%)     1 (6.7%)       1 (6.7%)    #>         >480 to <=500 msec    1 (6.7%)    3 (20.0%)       1 (6.7%)    #>         >500 msec             1 (6.7%)    2 (13.3%)          0        #>       Change from Baseline                                            #>         n                        15           15             15       #>         <=30 msec            7 (46.7%)    6 (40.0%)      9 (60.0%)    #>         >30 to <=60 msec     2 (13.3%)     1 (6.7%)       1 (6.7%)    #>         >60 msec             6 (40.0%)    8 (53.3%)      5 (33.3%)    #>     WEEK 2 DAY 15                                                     #>       Value at Visit                                                  #>         n                        15           15             15       #>         <=450 msec           11 (73.3%)   14 (93.3%)     12 (80.0%)   #>         >450 to <=480 msec   2 (13.3%)        0          2 (13.3%)    #>         >480 to <=500 msec    1 (6.7%)        0           1 (6.7%)    #>         >500 msec             1 (6.7%)     1 (6.7%)          0        #>       Change from Baseline                                            #>         n                        15           15             15       #>         <=30 msec            9 (60.0%)    12 (80.0%)     7 (46.7%)    #>         >30 to <=60 msec     2 (13.3%)        0          3 (20.0%)    #>         >60 msec             4 (26.7%)    3 (20.0%)      5 (33.3%)    #>     WEEK 3 DAY 22                                                     #>       Value at Visit                                                  #>         n                        15           15             15       #>         <=450 msec           12 (80.0%)   12 (80.0%)     12 (80.0%)   #>         >450 to <=480 msec   3 (20.0%)     1 (6.7%)       1 (6.7%)    #>         >500 msec                0        2 (13.3%)      2 (13.3%)    #>       Change from Baseline                                            #>         n                        15           15             15       #>         <=30 msec            9 (60.0%)    11 (73.3%)     9 (60.0%)    #>         >30 to <=60 msec      1 (6.7%)     1 (6.7%)          0        #>         >60 msec             5 (33.3%)    3 (20.0%)      6 (40.0%)    #>     WEEK 4 DAY 29                                                     #>       Value at Visit                                                  #>         n                        15           15             15       #>         <=450 msec           14 (93.3%)   12 (80.0%)     13 (86.7%)   #>         >450 to <=480 msec    1 (6.7%)     1 (6.7%)       1 (6.7%)    #>         >480 to <=500 msec       0            0           1 (6.7%)    #>         >500 msec                0        2 (13.3%)          0        #>       Change from Baseline                                            #>         n                        15           15             15       #>         <=30 msec            6 (40.0%)    9 (60.0%)      9 (60.0%)    #>         >30 to <=60 msec     2 (13.3%)     1 (6.7%)      2 (13.3%)    #>         >60 msec             7 (46.7%)    5 (33.3%)      4 (26.7%)    #>     WEEK 5 DAY 36                                                     #>       Value at Visit                                                  #>         n                        15           15             15       #>         <=450 msec           12 (80.0%)   15 (100%)      15 (100%)    #>         >450 to <=480 msec   2 (13.3%)        0              0        #>         >500 msec             1 (6.7%)        0              0        #>       Change from Baseline                                            #>         n                        15           15             15       #>         <=30 msec            9 (60.0%)    11 (73.3%)     9 (60.0%)    #>         >30 to <=60 msec         0        3 (20.0%)      2 (13.3%)    #>         >60 msec             6 (40.0%)     1 (6.7%)      4 (26.7%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt05_qtcat_lyt.html","id":null,"dir":"Reference","previous_headings":"","what":"EGT05_QTCAT Layout ‚Äî egt05_qtcat_lyt","title":"EGT05_QTCAT Layout ‚Äî egt05_qtcat_lyt","text":"EGT05_QTCAT Layout","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt05_qtcat_lyt.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"EGT05_QTCAT Layout ‚Äî egt05_qtcat_lyt","text":"","code":"egt05_qtcat_lyt(   arm_var,   lbl_overall,   lbl_avisit,   lbl_param,   lbl_cat,   summaryvars,   summaryvars_lbls,   row_split_var,   row_split_lbl,   visitvar,   page_var )"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt05_qtcat_lyt.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"EGT05_QTCAT Layout ‚Äî egt05_qtcat_lyt","text":"arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted lbl_avisit (string) label visitvar variable. lbl_param (string) label PARAM variable. lbl_cat (string) label Category summaryvars variable. Default Category. summaryvars (character) variables analyzed. AVALCAT1 CHGCAT1 default. summaryvars_lbls (character) label variables analyzed. row_split_var (character) additional row split variables. visitvar (string) typically \"AVISIT\" user-defined visit incorporating \"ATPT\". page_var (string) variable name prior row split page.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/egt05_qtcat_lyt.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"EGT05_QTCAT Layout ‚Äî egt05_qtcat_lyt","text":"PreDataTableLayouts object.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/empty_rule.html","id":null,"dir":"Reference","previous_headings":"","what":"Empty rule ‚Äî empty_rule","title":"Empty rule ‚Äî empty_rule","text":"Empty rule","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/empty_rule.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Empty rule ‚Äî empty_rule","text":"","code":"empty_rule"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/empty_rule.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Empty rule ‚Äî empty_rule","text":"object class rule (inherits character) length 0.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/execute_with_args.html","id":null,"dir":"Reference","previous_headings":"","what":"Execute function with given arguments ‚Äî execute_with_args","title":"Execute function with given arguments ‚Äî execute_with_args","text":"Execute function given arguments","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/execute_with_args.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Execute function with given arguments ‚Äî execute_with_args","text":"","code":"execute_with_args(fun, ...)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/execute_with_args.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Execute function with given arguments ‚Äî execute_with_args","text":"function ..., function pass arguments .... named arguments passed.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/expand_list.html","id":null,"dir":"Reference","previous_headings":"","what":"Expand list to each split ‚Äî expand_list","title":"Expand list to each split ‚Äî expand_list","text":"Expand list split","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/expand_list.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Expand list to each split ‚Äî expand_list","text":"","code":"expand_list(lst, split)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ext01.html","id":null,"dir":"Reference","previous_headings":"","what":"EXT01 Exposure Summary Table. ‚Äî ext01_main","title":"EXT01 Exposure Summary Table. ‚Äî ext01_main","text":"EXT01 table provides overview exposure patients terms Total dose administered missed, treatment duration.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ext01.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"EXT01 Exposure Summary Table. ‚Äî ext01_main","text":"","code":"ext01_main(   adam_db,   arm_var = \"ACTARM\",   lbl_overall = NULL,   summaryvars = \"AVAL\",   row_split_var = \"PARCAT2\",   page_var = NULL,   map = NULL,   ... )  ext01_pre(adam_db, ...)  ext01_post(tlg, prune_0 = TRUE, ...)  ext01"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ext01.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"EXT01 Exposure Summary Table. ‚Äî ext01_main","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ext01.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"EXT01 Exposure Summary Table. ‚Äî ext01_main","text":"adam_db (list data.frames) object containing ADaM datasets arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted summaryvars (character) variables analyzed. label attribute corresponding column adex table adam_db used label. row_split_var (character) additional row split variables. page_var (string) variable name prior row split page. map (data.frame) mapping split rows. ... used. tlg (TableTree, Listing ggplot) object typically produced main function. prune_0 (flag) remove 0 count rows","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ext01.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"EXT01 Exposure Summary Table. ‚Äî ext01_main","text":"main function returns rtables object. preprocessing function returns list data.frame. postprocessing function returns rtables object ElementaryTable (null report).","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ext01.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"EXT01 Exposure Summary Table. ‚Äî ext01_main","text":"Default Exposure table n row provides number non-missing values. percentages categorical variables based n. percentages Total number patients least one dose modification based number patients corresponding analysis population given N. Split columns arm, typically ACTARM. include total column default. Sorted alphabetic order PARAM value. Transform factor re-level custom order. ANL01FL relevant subset.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ext01.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"EXT01 Exposure Summary Table. ‚Äî ext01_main","text":"ext01_main(): Main TLG function ext01_pre(): Preprocessing ext01_post(): Postprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ext01.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"EXT01 Exposure Summary Table. ‚Äî ext01_main","text":"adam_db object must contain adex table columns specified summaryvars.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ext01.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"EXT01 Exposure Summary Table. ‚Äî ext01_main","text":"","code":"run(ext01, syn_data) #>                                  A: Drug X        B: Placebo      C: Combination  #>   PARCAT2                         (N=15)            (N=15)            (N=15)      #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Drug A                                                                          #>     Overall duration (days)                                                       #>       n                             11                 7                 7        #>       Mean (SD)                157.5 (67.4)      115.4 (62.8)       98.6 (68.8)   #>       Median                       174.0             119.0             89.0       #>       Min - Max                53.0 - 239.0      22.0 - 219.0       1.0 - 182.0   #>     Total dose administered                                                       #>       n                             11                 7                 7        #>       Mean (SD)               6567.3 (1127.1)   7028.6 (1626.1)   6377.1 (863.7)  #>       Median                      6720.0            7200.0            6480.0      #>       Min - Max               4800.0 - 8400.0   5280.0 - 9360.0   5280.0 - 7440.0 #>   Drug B                                                                          #>     Overall duration (days)                                                       #>       n                              4                 8                 8        #>       Mean (SD)                142.2 (100.3)     105.9 (60.0)      158.2 (96.2)   #>       Median                       160.0             95.0              203.0      #>       Min - Max                17.0 - 232.0      37.0 - 211.0      27.0 - 249.0   #>     Total dose administered                                                       #>       n                              4                 8                 8        #>       Mean (SD)               7020.0 (1148.9)   5250.0 (864.7)    5940.0 (1187.9) #>       Median                      6960.0            5160.0            5880.0      #>       Min - Max               5760.0 - 8400.0   4080.0 - 6480.0   4320.0 - 7680.0  run(ext01, syn_data, summaryvars = c(\"AVAL\", \"AVALCAT1\"), prune_0 = FALSE) #>                                  A: Drug X        B: Placebo      C: Combination  #>   PARCAT2                         (N=15)            (N=15)            (N=15)      #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Drug A                                                                          #>     Overall duration (days)                                                       #>       n                             11                 7                 7        #>       Mean (SD)                157.5 (67.4)      115.4 (62.8)       98.6 (68.8)   #>       Median                       174.0             119.0             89.0       #>       Min - Max                53.0 - 239.0      22.0 - 219.0       1.0 - 182.0   #>       n                             11                 7                 7        #>       < 1 month                      0             1 (14.3%)         1 (14.3%)    #>       1 to <3 months             3 (27.3%)         1 (14.3%)         3 (42.9%)    #>       3 to <6 months             3 (27.3%)         4 (57.1%)         2 (28.6%)    #>       >=6 months                 5 (45.5%)         1 (14.3%)         1 (14.3%)    #>       <700                           0                 0                 0        #>       700-900                        0                 0                 0        #>       900-1200                       0                 0                 0        #>       >1200                          0                 0                 0        #>       <5000                          0                 0                 0        #>       5000-7000                      0                 0                 0        #>       7000-9000                      0                 0                 0        #>       >9000                          0                 0                 0        #>       7                              0                 0                 0        #>     Total dose administered                                                       #>       n                             11                 7                 7        #>       Mean (SD)               6567.3 (1127.1)   7028.6 (1626.1)   6377.1 (863.7)  #>       Median                      6720.0            7200.0            6480.0      #>       Min - Max               4800.0 - 8400.0   5280.0 - 9360.0   5280.0 - 7440.0 #>       n                             11                 7                 7        #>       < 1 month                      0                 0                 0        #>       1 to <3 months                 0                 0                 0        #>       3 to <6 months                 0                 0                 0        #>       >=6 months                     0                 0                 0        #>       <700                           0                 0                 0        #>       700-900                        0                 0                 0        #>       900-1200                       0                 0                 0        #>       >1200                          0                 0                 0        #>       <5000                      1 (9.1%)              0                 0        #>       5000-7000                  6 (54.5%)         3 (42.9%)         5 (71.4%)    #>       7000-9000                  4 (36.4%)         3 (42.9%)         2 (28.6%)    #>       >9000                          0             1 (14.3%)             0        #>       7                              0                 0                 0        #>   Drug B                                                                          #>     Overall duration (days)                                                       #>       n                              4                 8                 8        #>       Mean (SD)                142.2 (100.3)     105.9 (60.0)      158.2 (96.2)   #>       Median                       160.0             95.0              203.0      #>       Min - Max                17.0 - 232.0      37.0 - 211.0      27.0 - 249.0   #>       n                              4                 8                 8        #>       < 1 month                  1 (25.0%)             0             1 (12.5%)    #>       1 to <3 months                 0             4 (50.0%)         2 (25.0%)    #>       3 to <6 months             1 (25.0%)         3 (37.5%)             0        #>       >=6 months                 2 (50.0%)         1 (12.5%)         5 (62.5%)    #>       <700                           0                 0                 0        #>       700-900                        0                 0                 0        #>       900-1200                       0                 0                 0        #>       >1200                          0                 0                 0        #>       <5000                          0                 0                 0        #>       5000-7000                      0                 0                 0        #>       7000-9000                      0                 0                 0        #>       >9000                          0                 0                 0        #>       7                              0                 0                 0        #>     Total dose administered                                                       #>       n                              4                 8                 8        #>       Mean (SD)               7020.0 (1148.9)   5250.0 (864.7)    5940.0 (1187.9) #>       Median                      6960.0            5160.0            5880.0      #>       Min - Max               5760.0 - 8400.0   4080.0 - 6480.0   4320.0 - 7680.0 #>       n                              4                 8                 8        #>       < 1 month                      0                 0                 0        #>       1 to <3 months                 0                 0                 0        #>       3 to <6 months                 0                 0                 0        #>       >=6 months                     0                 0                 0        #>       <700                           0                 0                 0        #>       700-900                        0                 0                 0        #>       900-1200                       0                 0                 0        #>       >1200                          0                 0                 0        #>       <5000                          0             4 (50.0%)         2 (25.0%)    #>       5000-7000                  2 (50.0%)         4 (50.0%)         4 (50.0%)    #>       7000-9000                  2 (50.0%)             0             2 (25.0%)    #>       >9000                          0                 0                 0        #>       7                              0                 0                 0         levels(syn_data$adex$AVALCAT1) <- c(levels(syn_data$adex$AVALCAT1), \"12 months\") map <- data.frame(   PARAMCD = \"TDURD\",   AVALCAT1 = c(\"< 1 month\", \"1 to <3 months\", \">=6 months\", \"3 to <6 months\", \"12 months\") ) run(ext01, syn_data, summaryvars = c(\"AVAL\", \"AVALCAT1\"), prune_0 = FALSE, map = map) #>                                  A: Drug X        B: Placebo      C: Combination  #>   PARCAT2                         (N=15)            (N=15)            (N=15)      #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Drug A                                                                          #>     Overall duration (days)                                                       #>       n                             11                 7                 7        #>       Mean (SD)                157.5 (67.4)      115.4 (62.8)       98.6 (68.8)   #>       Median                       174.0             119.0             89.0       #>       Min - Max                53.0 - 239.0      22.0 - 219.0       1.0 - 182.0   #>       n                             11                 7                 7        #>       < 1 month                      0             1 (14.3%)         1 (14.3%)    #>       1 to <3 months             3 (27.3%)         1 (14.3%)         3 (42.9%)    #>       >=6 months                 5 (45.5%)         1 (14.3%)         1 (14.3%)    #>       3 to <6 months             3 (27.3%)         4 (57.1%)         2 (28.6%)    #>       12 months                      0                 0                 0        #>     Total dose administered                                                       #>       n                             11                 7                 7        #>       Mean (SD)               6567.3 (1127.1)   7028.6 (1626.1)   6377.1 (863.7)  #>       Median                      6720.0            7200.0            6480.0      #>       Min - Max               4800.0 - 8400.0   5280.0 - 9360.0   5280.0 - 7440.0 #>       n                             11                 7                 7        #>       <5000                      1 (9.1%)              0                 0        #>       5000-7000                  6 (54.5%)         3 (42.9%)         5 (71.4%)    #>       7000-9000                  4 (36.4%)         3 (42.9%)         2 (28.6%)    #>       >9000                          0             1 (14.3%)             0        #>   Drug B                                                                          #>     Overall duration (days)                                                       #>       n                              4                 8                 8        #>       Mean (SD)                142.2 (100.3)     105.9 (60.0)      158.2 (96.2)   #>       Median                       160.0             95.0              203.0      #>       Min - Max                17.0 - 232.0      37.0 - 211.0      27.0 - 249.0   #>       n                              4                 8                 8        #>       < 1 month                  1 (25.0%)             0             1 (12.5%)    #>       1 to <3 months                 0             4 (50.0%)         2 (25.0%)    #>       >=6 months                 2 (50.0%)         1 (12.5%)         5 (62.5%)    #>       3 to <6 months             1 (25.0%)         3 (37.5%)             0        #>       12 months                      0                 0                 0        #>     Total dose administered                                                       #>       n                              4                 8                 8        #>       Mean (SD)               7020.0 (1148.9)   5250.0 (864.7)    5940.0 (1187.9) #>       Median                      6960.0            5160.0            5880.0      #>       Min - Max               5760.0 - 8400.0   4080.0 - 6480.0   4320.0 - 7680.0 #>       n                              4                 8                 8        #>       <5000                          0             4 (50.0%)         2 (25.0%)    #>       5000-7000                  2 (50.0%)         4 (50.0%)         4 (50.0%)    #>       7000-9000                  2 (50.0%)             0             2 (25.0%)    #>       >9000                          0                 0                 0"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ext01_lyt.html","id":null,"dir":"Reference","previous_headings":"","what":"ext01 Layout ‚Äî ext01_lyt","title":"ext01 Layout ‚Äî ext01_lyt","text":"ext01 Layout","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ext01_lyt.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"ext01 Layout ‚Äî ext01_lyt","text":"","code":"ext01_lyt(   arm_var,   lbl_overall,   summaryvars,   summaryvars_lbls,   row_split_var,   row_split_lbl,   page_var,   map )"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ext01_lyt.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"ext01 Layout ‚Äî ext01_lyt","text":"arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted summaryvars (character) name variable analyzed. default \"AVAL\". summaryvars_lbls (character) label associated analyzed variable. row_split_var (character) additional row split variables. page_var (string) variable name prior row split page.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ext01_lyt.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"ext01 Layout ‚Äî ext01_lyt","text":"PreDataTableLayouts object.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/format_date.html","id":null,"dir":"Reference","previous_headings":"","what":"Formatting of date ‚Äî format_date","title":"Formatting of date ‚Äî format_date","text":"Formatting date","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/format_date.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Formatting of date ‚Äî format_date","text":"","code":"format_date(date_format = \"%d%b%Y\")"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/format_date.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Formatting of date ‚Äî format_date","text":"date_format (string) output format.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/format_date.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Formatting of date ‚Äî format_date","text":"function converting date string.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/format_date.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"Formatting of date ‚Äî format_date","text":"date extracted location measure, location system.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/format_date.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Formatting of date ‚Äî format_date","text":"","code":"format_date(\"%d%b%Y\")(as.Date(\"2021-01-01\")) #> [1] \"01JAN2021\" if (\"NZ\" %in% OlsonNames()) {   format_date(\"%d%b%Y\")(as.POSIXct(\"2021-01-01 00:00:01\", tz = \"NZ\")) } #> [1] \"01JAN2021\" if (\"US/Pacific\" %in% OlsonNames()) {   format_date(\"%d%b%Y\")(as.POSIXct(\"2021-01-01 00:00:01\", tz = \"US/Pacific\")) } #> [1] \"01JAN2021\""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/fstg01.html","id":null,"dir":"Reference","previous_headings":"","what":"FSTG01 Subgroup Analysis of Best Overall Response. ‚Äî fstg01_main","title":"FSTG01 Subgroup Analysis of Best Overall Response. ‚Äî fstg01_main","text":"template produces subgroup analysis best overall response graphic.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/fstg01.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"FSTG01 Subgroup Analysis of Best Overall Response. ‚Äî fstg01_main","text":"","code":"fstg01_main(   adam_db,   dataset = \"adrs\",   arm_var = \"ARM\",   rsp_var = \"IS_RSP\",   subgroups = c(\"SEX\", \"AGEGR1\", \"RACE\"),   strata_var = NULL,   stat_var = c(\"n_tot\", \"n\", \"n_rsp\", \"prop\", \"or\", \"ci\"),   ... )  fstg01_pre(adam_db, ...)  fstg01"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/fstg01.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"FSTG01 Subgroup Analysis of Best Overall Response. ‚Äî fstg01_main","text":"object class chevron_g length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/fstg01.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"FSTG01 Subgroup Analysis of Best Overall Response. ‚Äî fstg01_main","text":"adam_db (list data.frames) object containing ADaM datasets dataset (string) name table adam_db object. arm_var (string) arm variable name used group splitting. rsp_var (string) response variable name flag whether subject binary response . subgroups (character) subgroups variable name list baseline risk factors. strata_var (character) required stratified analysis performed. stat_var (character) names statistics reported tabulate_rsp_subgroups. ... arguments passed g_forest extract_rsp_subgroups (wrapper h_odds_ratio_subgroups_df h_proportion_subgroups_df). details, see documentation tern. Commonly used arguments include col_symbol_size, col, vline, groups_lists, conf_level, method, label_all, etc.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/fstg01.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"FSTG01 Subgroup Analysis of Best Overall Response. ‚Äî fstg01_main","text":"main function returns grob object. gTree object. preprocessing function returns list data.frame.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/fstg01.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"FSTG01 Subgroup Analysis of Best Overall Response. ‚Äî fstg01_main","text":"overall value. Keep zero count rows default.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/fstg01.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"FSTG01 Subgroup Analysis of Best Overall Response. ‚Äî fstg01_main","text":"fstg01_main(): Main TLG Function fstg01_pre(): Preprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/fstg01.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"FSTG01 Subgroup Analysis of Best Overall Response. ‚Äî fstg01_main","text":"adam_db object must contain table specified dataset \"PARAMCD\", \"ARM\", \"AVALC\", columns specified subgroups denoted c(\"SEX\", \"AGEGR1\", \"RACE\") default. plot large rendered output, please provide gp, width_row_names, width_columns width_forest manually make fit. See tern::g_forest details.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/fstg01.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"FSTG01 Subgroup Analysis of Best Overall Response. ‚Äî fstg01_main","text":"","code":"library(dplyr) library(dunlin)  proc_data <- log_filter(   syn_data,   PARAMCD == \"BESRSPI\" & ARM %in% c(\"A: Drug X\", \"B: Placebo\"), \"adrs\" ) run(fstg01, proc_data,   subgroups = c(\"SEX\", \"AGEGR1\", \"RACE\"),   conf_level = 0.90, dataset = \"adrs\" )"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/fstg02.html","id":null,"dir":"Reference","previous_headings":"","what":"FSTG02 Subgroup Analysis of Survival Duration. ‚Äî fstg02_main","title":"FSTG02 Subgroup Analysis of Survival Duration. ‚Äî fstg02_main","text":"template produces subgroup analysis survival duration graphic.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/fstg02.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"FSTG02 Subgroup Analysis of Survival Duration. ‚Äî fstg02_main","text":"","code":"fstg02_main(   adam_db,   dataset = \"adtte\",   arm_var = \"ARM\",   subgroups = c(\"SEX\", \"AGEGR1\", \"RACE\"),   strata_var = NULL,   stat_var = c(\"n_tot\", \"n\", \"median\", \"hr\", \"ci\"),   ... )  fstg02_pre(adam_db, ...)  fstg02"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/fstg02.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"FSTG02 Subgroup Analysis of Survival Duration. ‚Äî fstg02_main","text":"object class chevron_g length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/fstg02.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"FSTG02 Subgroup Analysis of Survival Duration. ‚Äî fstg02_main","text":"adam_db (list data.frames) object containing ADaM datasets dataset (string) name table adam_db object. arm_var (string) arm variable name used group splitting. subgroups (character) subgroups variable name list baseline risk factors. strata_var (character) required stratified analysis performed. stat_var (character) names statistics reported tabulate_survival_subgroups. ... arguments passed g_forest extract_rsp_subgroups (wrapper h_odds_ratio_subgroups_df h_proportion_subgroups_df). details, see documentation tern. Commonly used arguments include gp, col_symbol_size, col, vline, groups_lists, conf_level, method, label_all, etc.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/fstg02.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"FSTG02 Subgroup Analysis of Survival Duration. ‚Äî fstg02_main","text":"main function returns gTree object. gTree object. preprocessing function returns list data.frame.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/fstg02.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"FSTG02 Subgroup Analysis of Survival Duration. ‚Äî fstg02_main","text":"overall value. Keep zero count rows default.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/fstg02.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"FSTG02 Subgroup Analysis of Survival Duration. ‚Äî fstg02_main","text":"fstg02_main(): Main TLG Function fstg02_pre(): Preprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/fstg02.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"FSTG02 Subgroup Analysis of Survival Duration. ‚Äî fstg02_main","text":"adam_db object must contain table specified dataset \"PARAMCD\", \"ARM\", \"AVAL\", \"AVALU\", \"CNSR\", columns specified subgroups denoted c(\"SEX\", \"AGEGR1\", \"RACE\") default. plot large rendered output, please refer FSTG01.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/fstg02.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"FSTG02 Subgroup Analysis of Survival Duration. ‚Äî fstg02_main","text":"","code":"library(dplyr) library(dunlin)  proc_data <- log_filter(   syn_data,   PARAMCD == \"OS\" & ARM %in% c(\"A: Drug X\", \"B: Placebo\"), \"adtte\" ) run(fstg02, proc_data,   subgroups = c(\"SEX\", \"AGEGR1\", \"RACE\"),   conf_level = 0.90, dataset = \"adtte\" )"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/fuse_sequentially.html","id":null,"dir":"Reference","previous_headings":"","what":"Fuse list elements ‚Äî fuse_sequentially","title":"Fuse list elements ‚Äî fuse_sequentially","text":"Fuse list elements","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/fuse_sequentially.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Fuse list elements ‚Äî fuse_sequentially","text":"","code":"fuse_sequentially(x, y)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/fuse_sequentially.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Fuse list elements ‚Äî fuse_sequentially","text":"x (list) fuse. y (list) fuse. Elements names already existing x discarded.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/gen_args.html","id":null,"dir":"Reference","previous_headings":"","what":"General Argument Name Convention ‚Äî gen_args","title":"General Argument Name Convention ‚Äî gen_args","text":"General Argument Name Convention","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/gen_args.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"General Argument Name Convention ‚Äî gen_args","text":"","code":"gen_args(   adam_db,   main,   preprocess,   postprocess,   dataset,   type,   arm_var,   lbl_overall,   prune_0,   req_tables,   deco,   group,   tlg,   visitvar,   visit_value,   paramcd_value,   key_cols,   disp_cols,   row_split_var,   split_into_pages_by_var,   page_var,   unique_rows,   ... )"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/gen_args.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"General Argument Name Convention ‚Äî gen_args","text":"adam_db (list data.frames) object containing ADaM datasets main (function) returning tlg, adam_db first argument. Typically one _main function chevron. preprocess (function) returning pre-processed list data.frames, adam_db first argument. Typically one _pre function chevron. postprocess (function) returning post-processed tlg, tlg first argument. dataset (string) name table adam_db object. type (string) indicating subclass. arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted prune_0 (flag) remove 0 count rows req_tables (character) names required tables. deco (character) decoration title, subtitles main_footer content group (list lists) group-dependent data binning tlg (TableTree, Listing ggplot) object typically produced main function. visitvar (string) typically \"AVISIT\" user-defined visit incorporating \"ATPT\". visit_value Value visit variable. paramcd_value Value PARAMCD variable. key_cols (character) names columns treated key columns rendering listing. Key columns allow group repeat occurrences. disp_cols (character) names non-key columns displayed listing rendered. row_split_var (character) additional row split variables. split_into_pages_by_var (character NULL) name variable split listing . page_var (string) variable name prior row split page. unique_rows (flag) whether keep unique rows listing. ... used.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/gen_args.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"General Argument Name Convention ‚Äî gen_args","text":"invisible NULL. function documentation purpose .","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/gen_args.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"General Argument Name Convention ‚Äî gen_args","text":"following arguments better provided study object: lbl_overall, arm_var.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/get_grade_rule.html","id":null,"dir":"Reference","previous_headings":"","what":"Get grade rule ‚Äî get_grade_rule","title":"Get grade rule ‚Äî get_grade_rule","text":"Get grade rule","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/get_grade_rule.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Get grade rule ‚Äî get_grade_rule","text":"","code":"get_grade_rule(direction = \"high\", missing = \"incl\")"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/get_grade_rule.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Get grade rule ‚Äî get_grade_rule","text":"direction (string) abnormality direction. missing (string) method deal missing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/get_grade_rule.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Get grade rule ‚Äî get_grade_rule","text":"rule object.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/get_page_by.html","id":null,"dir":"Reference","previous_headings":"","what":"Get page by value ‚Äî get_page_by","title":"Get page by value ‚Äî get_page_by","text":"Get page value","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/get_page_by.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Get page by value ‚Äî get_page_by","text":"","code":"get_page_by(var, vars)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/get_section_div.html","id":null,"dir":"Reference","previous_headings":"","what":"Get Section dividers ‚Äî get_section_div","title":"Get Section dividers ‚Äî get_section_div","text":"Get Section dividers","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/get_section_div.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Get Section dividers ‚Äî get_section_div","text":"","code":"get_section_div()"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/get_section_div.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Get Section dividers ‚Äî get_section_div","text":"(character) value section dividers corresponding section.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/get_subset.html","id":null,"dir":"Reference","previous_headings":"","what":"Subset Arguments and Merge ‚Äî get_subset","title":"Subset Arguments and Merge ‚Äî get_subset","text":"Subset Arguments Merge","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/get_subset.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Subset Arguments and Merge ‚Äî get_subset","text":"","code":"get_subset(x, y)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/get_x_hjust.html","id":null,"dir":"Reference","previous_headings":"","what":"Get a harmonious value of horizontal justification for x axis ‚Äî get_x_hjust","title":"Get a harmonious value of horizontal justification for x axis ‚Äî get_x_hjust","text":"Get harmonious value horizontal justification x axis","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/get_x_hjust.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Get a harmonious value of horizontal justification for x axis ‚Äî get_x_hjust","text":"","code":"get_x_hjust(x)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/get_x_hjust.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Get a harmonious value of horizontal justification for x axis ‚Äî get_x_hjust","text":"x (numeric) angle -90 90 degree.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/get_x_vjust.html","id":null,"dir":"Reference","previous_headings":"","what":"Get a harmonious value of vertical justification for x axis ‚Äî get_x_vjust","title":"Get a harmonious value of vertical justification for x axis ‚Äî get_x_vjust","text":"Get harmonious value vertical justification x axis","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/get_x_vjust.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Get a harmonious value of vertical justification for x axis ‚Äî get_x_vjust","text":"","code":"get_x_vjust(x)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/get_x_vjust.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Get a harmonious value of vertical justification for x axis ‚Äî get_x_vjust","text":"x (numeric) angle -90 90 degree.","code":""},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/gg_list.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"List of gg object ‚Äî gg_list","text":"","code":"gg_list(...)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/gg_list.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"List of gg object ‚Äî gg_list","text":"... (ggplot) objects.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/gg_list.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"List of gg object ‚Äî gg_list","text":"gg_list object.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/gg_theme_chevron.html","id":null,"dir":"Reference","previous_headings":"","what":"Theme for Chevron Plot ‚Äî gg_theme_chevron","title":"Theme for Chevron Plot ‚Äî gg_theme_chevron","text":"Theme Chevron Plot","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/gg_theme_chevron.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Theme for Chevron Plot ‚Äî gg_theme_chevron","text":"","code":"gg_theme_chevron(   grid_y = TRUE,   grid_x = FALSE,   legend_position = \"top\",   text_axis_x_rot = 45 )"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/gg_theme_chevron.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Theme for Chevron Plot ‚Äî gg_theme_chevron","text":"grid_y (flag) horizontal grid displayed. grid_x (flag) vertical grid displayed. legend_position (string) position legend. text_axis_x_rot (numeric) x axis text rotation angle.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/gg_theme_chevron.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Theme for Chevron Plot ‚Äî gg_theme_chevron","text":"theme object.","code":""},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/grob_list.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"List of grob object ‚Äî grob_list","text":"","code":"grob_list(...)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/grob_list.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"List of grob object ‚Äî grob_list","text":"... (grob) objects.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/grob_list.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"List of grob object ‚Äî grob_list","text":"grob_list object.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/h_format_dec.html","id":null,"dir":"Reference","previous_headings":"","what":"Decimal formatting ‚Äî h_format_dec","title":"Decimal formatting ‚Äî h_format_dec","text":"Decimal formatting","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/h_format_dec.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Decimal formatting ‚Äî h_format_dec","text":"","code":"h_format_dec(digits, format, ne = NULL)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/h_format_dec.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Decimal formatting ‚Äî h_format_dec","text":"digits (integer) number digits. format (string) describing numbers formatted following sprintf syntax. ne (string) replace actual value. NULL, replacement performed.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/h_format_dec.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Decimal formatting ‚Äî h_format_dec","text":"function formatting numbers defined format.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/h_format_dec.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Decimal formatting ‚Äî h_format_dec","text":"","code":"fun <- h_format_dec(c(1, 1), \"%s - %s\") fun(c(123, 567.89)) #> [1] \"123.0 - 567.9\""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/h_unwrap_layout.html","id":null,"dir":"Reference","previous_headings":"","what":"Helper Function Extracting Layout Functions ‚Äî h_unwrap_layout","title":"Helper Function Extracting Layout Functions ‚Äî h_unwrap_layout","text":"Helper Function Extracting Layout Functions","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/h_unwrap_layout.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Helper Function Extracting Layout Functions ‚Äî h_unwrap_layout","text":"","code":"h_unwrap_layout(x, pattern)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ifneeded_split_col.html","id":null,"dir":"Reference","previous_headings":"","what":"Helper function to add a column split if specified ‚Äî ifneeded_split_col","title":"Helper function to add a column split if specified ‚Äî ifneeded_split_col","text":"Helper function add column split specified","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ifneeded_split_col.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Helper function to add a column split if specified ‚Äî ifneeded_split_col","text":"","code":"ifneeded_split_col(lyt, var, ...)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ifneeded_split_col.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Helper function to add a column split if specified ‚Äî ifneeded_split_col","text":"lyt (rtables) object. var (string) name variable initiating new column split. ... Additional arguments split_cols_by.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ifneeded_split_col.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Helper function to add a column split if specified ‚Äî ifneeded_split_col","text":"rtables object.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ifneeded_split_row.html","id":null,"dir":"Reference","previous_headings":"","what":"Helper function to add a row split if specified ‚Äî ifneeded_split_row","title":"Helper function to add a row split if specified ‚Äî ifneeded_split_row","text":"Helper function add row split specified","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ifneeded_split_row.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Helper function to add a row split if specified ‚Äî ifneeded_split_row","text":"","code":"ifneeded_split_row(lyt, var, lbl_var)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ifneeded_split_row.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Helper function to add a row split if specified ‚Äî ifneeded_split_row","text":"lyt (PreDataTableLayouts) object. var (string) name variable initiating new row split. lbl_var (string)label variable var.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ifneeded_split_row.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Helper function to add a row split if specified ‚Äî ifneeded_split_row","text":"PreDataTableLayouts object.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/kmg01.html","id":null,"dir":"Reference","previous_headings":"","what":"KMG01 Kaplan-Meier Plot 1. ‚Äî kmg01_main","title":"KMG01 Kaplan-Meier Plot 1. ‚Äî kmg01_main","text":"KMG01 Kaplan-Meier Plot 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/kmg01.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"KMG01 Kaplan-Meier Plot 1. ‚Äî kmg01_main","text":"","code":"kmg01_main(   adam_db,   dataset = \"adtte\",   arm_var = \"ARM\",   strata = NULL,   strat = lifecycle::deprecated(),   ... )  kmg01_pre(adam_db, dataset = \"adtte\", ...)  kmg01"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/kmg01.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"KMG01 Kaplan-Meier Plot 1. ‚Äî kmg01_main","text":"object class chevron_g length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/kmg01.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"KMG01 Kaplan-Meier Plot 1. ‚Äî kmg01_main","text":"adam_db (list data.frames) object containing ADaM datasets dataset (string) name table adam_db object. arm_var (string) variable used column splitting strata (character) variable name stratification variables. strat (character) ; backwards compatibility . Use strata instead. ... arguments passed g_km control_coxph. details, see documentation tern. Commonly used arguments include col, pval_method, ties, conf_level, conf_type, annot_coxph, annot_stats, etc.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/kmg01.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"KMG01 Kaplan-Meier Plot 1. ‚Äî kmg01_main","text":"main function returns gTree object. gTree object. preprocessing function returns list data.frame.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/kmg01.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"KMG01 Kaplan-Meier Plot 1. ‚Äî kmg01_main","text":"overall value.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/kmg01.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"KMG01 Kaplan-Meier Plot 1. ‚Äî kmg01_main","text":"kmg01_main(): Main TLG Function kmg01_pre(): Preprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/kmg01.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"KMG01 Kaplan-Meier Plot 1. ‚Äî kmg01_main","text":"adam_db object must contain table specified dataset columns specified  arm_var.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/kmg01.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"KMG01 Kaplan-Meier Plot 1. ‚Äî kmg01_main","text":"","code":"library(dplyr) library(dunlin)  col <- c(   \"A: Drug X\" = \"black\",   \"B: Placebo\" = \"blue\",   \"C: Combination\" = \"gray\" )  pre_data <- log_filter(syn_data, PARAMCD == \"OS\", \"adtte\") run(kmg01, pre_data, dataset = \"adtte\", col = col)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt01.html","id":null,"dir":"Reference","previous_headings":"","what":"LBT01 Lab Results and Change from Baseline by Visit Table. ‚Äî lbt01_main","title":"LBT01 Lab Results and Change from Baseline by Visit Table. ‚Äî lbt01_main","text":"LBT01 table provides overview Lab values change baseline respective arm course trial.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt01.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"LBT01 Lab Results and Change from Baseline by Visit Table. ‚Äî lbt01_main","text":"","code":"lbt01_main(   adam_db,   dataset = \"adlb\",   arm_var = \"ACTARM\",   lbl_overall = NULL,   row_split_var = NULL,   summaryvars = c(\"AVAL\", \"CHG\"),   visitvar = \"AVISIT\",   precision = list(default = 2L),   page_var = \"PARAMCD\",   .stats = c(\"n\", \"mean_sd\", \"median\", \"range\"),   skip = list(CHG = \"BASELINE\"),   ... )  lbt01_pre(adam_db, dataset = \"adlb\", ...)  lbt01"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt01.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"LBT01 Lab Results and Change from Baseline by Visit Table. ‚Äî lbt01_main","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt01.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"LBT01 Lab Results and Change from Baseline by Visit Table. ‚Äî lbt01_main","text":"adam_db (list data.frames) object containing ADaM datasets dataset (string) name table adam_db object. arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted row_split_var (character) additional row split variables. summaryvars (character) variables analyzed. label attribute corresponding column table adam_db used label. visitvar (string) typically one \"AVISIT\" user-defined visit incorporating \"ATPT\". precision (named list integer) names values found PARAMCD column values indicate number digits statistics. default set, parameter precision specified, value default used. page_var (string) variable name prior row split page. .stats (character) statistics names, see tern::analyze_vars(). skip Named (list) visit values need inhibited. ... additional arguments like .indent_mods, .labels.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt01.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"LBT01 Lab Results and Change from Baseline by Visit Table. ‚Äî lbt01_main","text":"main function returns rtables object. preprocessing function returns list data.frame.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt01.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"LBT01 Lab Results and Change from Baseline by Visit Table. ‚Äî lbt01_main","text":"Analysis Value column, displays number patients, mean, standard deviation, median range analysis value visit. Change Baseline column, displays number patient mean, standard deviation, median range changes relative baseline. Remove zero-count rows unless overridden prune_0 = FALSE. Split columns arm, typically ACTARM. include total column default. Sorted  based factor level; first PARAM labels alphabetic order chronological time point given AVISIT. Re-level customize order","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt01.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"LBT01 Lab Results and Change from Baseline by Visit Table. ‚Äî lbt01_main","text":"lbt01_main(): Main TLG function lbt01_pre(): Preprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt01.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"LBT01 Lab Results and Change from Baseline by Visit Table. ‚Äî lbt01_main","text":"adam_db object must contain table named dataset columns specified summaryvars.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt01.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"LBT01 Lab Results and Change from Baseline by Visit Table. ‚Äî lbt01_main","text":"","code":"run(lbt01, syn_data) #>                                                      A: Drug X                          B: Placebo                        C: Combination           #>                                                              Change from                        Change from                         Change from    #>                                          Value at Visit       Baseline       Value at Visit       Baseline      Value at Visit        Baseline     #>   Analysis Visit                             (N=15)            (N=15)            (N=15)            (N=15)           (N=15)             (N=15)      #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Alanine Aminotransferase Measurement                                                                                                             #>     BASELINE                                                                                                                                       #>       n                                        15                                  15                                 15                           #>       Mean (SD)                          18.655 (12.455)                     16.835 (11.080)                    22.385 (9.452)                     #>       Median                                 16.040                              17.453                             25.250                         #>       Min - Max                           2.43 - 44.06                        1.48 - 31.99                       0.57 - 37.23                      #>     WEEK 1 DAY 8                                                                                                                                   #>       n                                        15                15                15                15               15                 15        #>       Mean (SD)                          16.308 (10.850)   -2.348 (17.558)   22.055 (7.537)    5.220 (16.359)   19.574 (9.876)    -2.811 (10.902)  #>       Median                                 14.664            -5.369            22.476            7.252            19.425             -0.995      #>       Min - Max                           0.10 - 36.30     -30.18 - 22.66     9.72 - 33.81     -16.82 - 32.33    1.03 - 36.28      -19.61 - 18.45  #>     WEEK 2 DAY 15                                                                                                                                  #>       n                                        15                15                15                15               15                 15        #>       Mean (SD)                          16.646 (10.528)   -2.010 (15.773)   20.758 (9.578)    3.923 (14.084)   10.911 (7.721)    -11.474 (11.002) #>       Median                                 15.470            -6.427            18.499            6.248             9.850             -8.657      #>       Min - Max                           0.40 - 35.29     -29.99 - 32.86     1.56 - 42.84     -24.92 - 29.85    0.35 - 25.01      -27.38 - 2.52   #>     WEEK 3 DAY 22                                                                                                                                  #>       n                                        15                15                15                15               15                 15        #>       Mean (SD)                          17.488 (10.679)   -1.167 (15.759)   20.055 (8.086)    3.219 (16.285)   18.413 (9.513)     -3.973 (9.966)  #>       Median                                 14.224             1.355            21.852            5.345            19.529             -7.194      #>       Min - Max                           1.78 - 33.19     -40.09 - 18.58     3.46 - 34.44     -23.02 - 31.38    3.02 - 32.34      -18.70 - 17.30  #>     WEEK 4 DAY 29                                                                                                                                  #>       n                                        15                15                15                15               15                 15        #>       Mean (SD)                          16.793 (9.101)    -1.863 (15.499)   17.560 (9.857)    0.725 (13.170)   18.397 (11.618)   -3.989 (13.150)  #>       Median                                 12.816             3.098            17.687            -3.104           18.532             -1.684      #>       Min - Max                           3.58 - 34.00     -32.93 - 18.92     1.90 - 34.08     -16.29 - 22.18    0.72 - 34.47      -30.33 - 17.38  #>     WEEK 5 DAY 36                                                                                                                                  #>       n                                        15                15                15                15               15                 15        #>       Mean (SD)                          17.879 (7.239)    -0.776 (15.471)   17.417 (7.065)    0.581 (14.309)   15.173 (8.410)    -7.213 (10.518)  #>       Median                                 18.749             1.108            17.751            2.055            16.394             -8.121      #>       Min - Max                           3.99 - 29.40     -40.08 - 17.24     5.10 - 30.90     -21.68 - 23.41    0.28 - 26.73      -27.12 - 15.83  #>   C-Reactive Protein Measurement                                                                                                                   #>     BASELINE                                                                                                                                       #>       n                                        15                                  15                                 15                           #>       Mean (SD)                           9.032 (0.650)                       9.164 (0.900)                      8.652 (0.769)                     #>       Median                                  8.819                               9.472                              8.502                         #>       Min - Max                            7.81 - 9.93                        7.38 - 10.60                       7.73 - 10.86                      #>     WEEK 1 DAY 8                                                                                                                                   #>       n                                        15                15                15                15               15                 15        #>       Mean (SD)                           9.050 (1.222)     0.018 (1.242)     8.690 (0.990)    -0.474 (1.418)    9.507 (1.279)     0.854 (1.080)   #>       Median                                  8.960            -0.180             8.734            -0.074            9.830             1.107       #>       Min - Max                           6.87 - 11.33      -1.83 - 2.81      6.84 - 10.14      -3.14 - 1.55     7.27 - 11.09       -1.14 - 2.05   #>     WEEK 2 DAY 15                                                                                                                                  #>       n                                        15                15                15                15               15                 15        #>       Mean (SD)                           8.825 (0.990)    -0.207 (1.204)     9.371 (1.185)    0.207 (1.572)     8.890 (1.021)     0.238 (1.263)   #>       Median                                  8.860            -0.567             9.073            0.293             8.994             0.462       #>       Min - Max                           7.12 - 10.44      -2.12 - 2.05      8.06 - 12.73      -2.35 - 3.19     6.68 - 10.84       -2.50 - 2.89   #>     WEEK 3 DAY 22                                                                                                                                  #>       n                                        15                15                15                15               15                 15        #>       Mean (SD)                           9.134 (0.897)     0.102 (1.179)     9.288 (1.033)    0.124 (1.135)     9.176 (0.919)     0.523 (1.209)   #>       Median                                  9.318             0.090             9.413            -0.022            8.963             0.564       #>       Min - Max                           7.38 - 11.00      -1.57 - 1.86      7.42 - 10.66      -1.41 - 3.27     7.72 - 11.20       -2.25 - 3.26   #>     WEEK 4 DAY 29                                                                                                                                  #>       n                                        15                15                15                15               15                 15        #>       Mean (SD)                           8.728 (0.959)    -0.303 (1.226)     8.971 (0.704)    -0.194 (1.077)    8.662 (0.712)     0.010 (1.039)   #>       Median                                  8.704            -0.046             8.879            -0.375            8.718             0.143       #>       Min - Max                           6.70 - 10.81      -3.17 - 1.99      7.88 - 10.23      -1.59 - 1.54      7.21 - 9.60       -2.63 - 1.68   #>     WEEK 5 DAY 36                                                                                                                                  #>       n                                        15                15                15                15               15                 15        #>       Mean (SD)                           8.545 (0.846)    -0.487 (1.060)     9.165 (1.182)    0.000 (0.929)     8.654 (0.790)     0.002 (1.102)   #>       Median                                  8.601            -0.452             8.755            0.153             8.766             0.008       #>       Min - Max                           7.10 - 10.03      -2.39 - 1.66      7.86 - 12.50      -1.58 - 1.90      7.37 - 9.92       -3.14 - 1.67   #>   Immunoglobulin A Measurement                                                                                                                     #>     BASELINE                                                                                                                                       #>       n                                        15                                  15                                 15                           #>       Mean (SD)                           2.923 (0.059)                       2.866 (0.083)                      2.887 (0.120)                     #>       Median                                  2.911                               2.862                              2.896                         #>       Min - Max                            2.80 - 3.01                         2.76 - 3.01                        2.65 - 3.14                      #>     WEEK 1 DAY 8                                                                                                                                   #>       n                                        15                15                15                15               15                 15        #>       Mean (SD)                           2.885 (0.060)    -0.038 (0.082)     2.938 (0.137)    0.073 (0.152)     2.925 (0.091)     0.038 (0.128)   #>       Median                                  2.886            -0.010             2.972            0.109             2.931             0.021       #>       Min - Max                            2.76 - 2.96      -0.18 - 0.06       2.69 - 3.16      -0.27 - 0.27      2.78 - 3.10       -0.12 - 0.28   #>     WEEK 2 DAY 15                                                                                                                                  #>       n                                        15                15                15                15               15                 15        #>       Mean (SD)                           2.889 (0.141)    -0.034 (0.171)     2.928 (0.075)    0.063 (0.124)     2.913 (0.080)     0.026 (0.156)   #>       Median                                  2.871            -0.024             2.936            0.084             2.910             0.067       #>       Min - Max                            2.67 - 3.16      -0.34 - 0.27       2.79 - 3.03      -0.12 - 0.26      2.78 - 3.09       -0.28 - 0.26   #>     WEEK 3 DAY 22                                                                                                                                  #>       n                                        15                15                15                15               15                 15        #>       Mean (SD)                           2.875 (0.105)    -0.048 (0.120)     2.919 (0.114)    0.053 (0.151)     2.889 (0.082)     0.002 (0.128)   #>       Median                                  2.861            -0.046             2.938            0.045             2.899             0.020       #>       Min - Max                            2.67 - 3.07      -0.25 - 0.16       2.73 - 3.18      -0.19 - 0.33      2.75 - 3.02       -0.24 - 0.14   #>     WEEK 4 DAY 29                                                                                                                                  #>       n                                        15                15                15                15               15                 15        #>       Mean (SD)                           2.912 (0.134)    -0.010 (0.140)     2.886 (0.097)    0.020 (0.136)     2.869 (0.104)     -0.019 (0.141)  #>       Median                                  2.942             0.023             2.924            -0.012            2.840             -0.055      #>       Min - Max                            2.63 - 3.16      -0.39 - 0.19       2.58 - 2.96      -0.28 - 0.20      2.74 - 3.08       -0.31 - 0.22   #>     WEEK 5 DAY 36                                                                                                                                  #>       n                                        15                15                15                15               15                 15        #>       Mean (SD)                           2.933 (0.089)     0.010 (0.136)     2.899 (0.094)    0.034 (0.131)     2.902 (0.091)     0.015 (0.168)   #>       Median                                  2.938             0.031             2.936            0.059             2.921             0.026       #>       Min - Max                            2.78 - 3.08      -0.23 - 0.26       2.68 - 3.04      -0.25 - 0.19      2.78 - 3.13       -0.27 - 0.32"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt04.html","id":null,"dir":"Reference","previous_headings":"","what":"LBT04 Laboratory Abnormalities Not Present at Baseline Table. ‚Äî lbt04_main","title":"LBT04 Laboratory Abnormalities Not Present at Baseline Table. ‚Äî lbt04_main","text":"LBT04 table provides overview laboratory abnormalities present baseline.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt04.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"LBT04 Laboratory Abnormalities Not Present at Baseline Table. ‚Äî lbt04_main","text":"","code":"lbt04_main(   adam_db,   arm_var = \"ACTARM\",   lbl_overall = NULL,   analysis_abn_var = \"ANRIND\",   baseline_abn_var = \"BNRIND\",   row_split_var = \"PARCAT1\",   page_var = tail(row_split_var, 1L),   ... )  lbt04_pre(adam_db, ...)  lbt04_post(tlg, ...)  lbt04"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt04.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"LBT04 Laboratory Abnormalities Not Present at Baseline Table. ‚Äî lbt04_main","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt04.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"LBT04 Laboratory Abnormalities Not Present at Baseline Table. ‚Äî lbt04_main","text":"adam_db (list data.frames) object containing ADaM datasets arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted analysis_abn_var (string) column describing anomaly magnitude baseline_abn_var (string) column describing anomaly baseline. row_split_var (character) additional row split variables. page_var (string) variable name prior row split page. ... used. tlg (TableTree, Listing ggplot) object typically produced main function.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt04.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"LBT04 Laboratory Abnormalities Not Present at Baseline Table. ‚Äî lbt04_main","text":"main function returns rtables object. preprocessing function returns list data.frame. postprocessing function returns rtables object ElementaryTable (null report).","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt04.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"LBT04 Laboratory Abnormalities Not Present at Baseline Table. ‚Äî lbt04_main","text":"count LOW HIGH values. Lab test results missing analysis_abn_var values excluded. Split columns arm, typically ACTARM. include total column default.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt04.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"LBT04 Laboratory Abnormalities Not Present at Baseline Table. ‚Äî lbt04_main","text":"lbt04_main(): Main TLG function lbt04_pre(): Preprocessing lbt04_post(): Postprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt04.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"LBT04 Laboratory Abnormalities Not Present at Baseline Table. ‚Äî lbt04_main","text":"adam_db object must contain adlb table columns \"PARCAT1\", \"PARCAT2\", \"PARAM\", \"ANRIND\", column specified arm_var.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt04.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"LBT04 Laboratory Abnormalities Not Present at Baseline Table. ‚Äî lbt04_main","text":"","code":"run(lbt04, syn_data) #>   Laboratory Test                           A: Drug X    B: Placebo    C: Combination #>       Direction of Abnormality               (N=15)        (N=15)          (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   CHEMISTRY                                                                           #>     Alanine Aminotransferase Measurement                                              #>       Low                                      0/7           0/2        1/7 (14.3%)   #>       High                                     0/7           0/3            0/8       #>     C-Reactive Protein Measurement                                                    #>       Low                                      0/8       1/2 (50.0%)        0/6       #>       High                                 3/8 (37.5%)       0/2            0/7       #>     Immunoglobulin A Measurement                                                      #>       Low                                      0/5           0/8            0/7       #>       High                                 1/3 (33.3%)   1/8 (12.5%)        0/6       #>   COAGULATION                                                                         #>     Alanine Aminotransferase Measurement                                              #>       Low                                      0/3           0/6            0/4       #>       High                                     0/5           0/7            0/4       #>     C-Reactive Protein Measurement                                                    #>       Low                                      0/5           0/5        1/3 (33.3%)   #>       High                                     0/5       1/6 (16.7%)    1/4 (25.0%)   #>     Immunoglobulin A Measurement                                                      #>       Low                                      0/8           0/9            0/6       #>       High                                     0/8           0/9        1/6 (16.7%)   #>   HEMATOLOGY                                                                          #>     Alanine Aminotransferase Measurement                                              #>       Low                                      0/4           0/5            0/4       #>       High                                     0/6           0/5            0/4       #>     C-Reactive Protein Measurement                                                    #>       Low                                      0/5           0/4            0/3       #>       High                                     0/5           0/4            0/5       #>     Immunoglobulin A Measurement                                                      #>       Low                                      0/3           0/4            0/8       #>       High                                     0/3           0/4            0/7"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt04_lyt.html","id":null,"dir":"Reference","previous_headings":"","what":"lbt04 Layout ‚Äî lbt04_lyt","title":"lbt04 Layout ‚Äî lbt04_lyt","text":"lbt04 Layout","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt04_lyt.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"lbt04 Layout ‚Äî lbt04_lyt","text":"","code":"lbt04_lyt(   arm_var,   lbl_overall,   lbl_param,   lbl_abn_var,   var_parcat,   var_param,   row_split_var,   row_split_lbl,   analysis_abn_var,   variables,   page_var )"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt04_lyt.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"lbt04 Layout ‚Äî lbt04_lyt","text":"arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted lbl_param (string) label PARAM variable. lbl_abn_var (string) label analysis_abn_var variable. row_split_var (character) additional row split variables. variables (list) see tern::count_abnormal page_var (string) variable name prior row split page.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt05.html","id":null,"dir":"Reference","previous_headings":"","what":"LBT05 Table 1 (Default) Laboratory Abnormalities with Single and Replicated Marked. ‚Äî lbt05_main","title":"LBT05 Table 1 (Default) Laboratory Abnormalities with Single and Replicated Marked. ‚Äî lbt05_main","text":"LBT05 Table 1 (Default) Laboratory Abnormalities Single Replicated Marked.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt05.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"LBT05 Table 1 (Default) Laboratory Abnormalities with Single and Replicated Marked. ‚Äî lbt05_main","text":"","code":"lbt05_main(adam_db, arm_var = \"ACTARM\", lbl_overall = NULL, ...)  lbt05_pre(adam_db, ...)  lbt05_post(tlg, prune_0 = FALSE, ...)  lbt05"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt05.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"LBT05 Table 1 (Default) Laboratory Abnormalities with Single and Replicated Marked. ‚Äî lbt05_main","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt05.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"LBT05 Table 1 (Default) Laboratory Abnormalities with Single and Replicated Marked. ‚Äî lbt05_main","text":"adam_db (list data.frames) object containing ADaM datasets arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted ... used. tlg (TableTree, Listing ggplot) object typically produced main function. prune_0 (flag) remove 0 count rows","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt05.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"LBT05 Table 1 (Default) Laboratory Abnormalities with Single and Replicated Marked. ‚Äî lbt05_main","text":"main function returns rtables object. preprocessing function returns list data.frame. postprocessing function returns rtables object ElementaryTable (null report).","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt05.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"LBT05 Table 1 (Default) Laboratory Abnormalities with Single and Replicated Marked. ‚Äî lbt05_main","text":"remove rows zero counts default. Lab test results missing AVAL values excluded. Split columns arm, typically ACTARM.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt05.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"LBT05 Table 1 (Default) Laboratory Abnormalities with Single and Replicated Marked. ‚Äî lbt05_main","text":"lbt05_main(): Main TLG function lbt05_pre(): Preprocessing lbt05_post(): Postprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt05.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"LBT05 Table 1 (Default) Laboratory Abnormalities with Single and Replicated Marked. ‚Äî lbt05_main","text":"adam_db object must contain adlb table columns \"ONTRTFL\", \"PARCAT2\", \"PARAM\", \"ANRIND\", \"AVALCAT1\", column specified arm_var.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt05.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"LBT05 Table 1 (Default) Laboratory Abnormalities with Single and Replicated Marked. ‚Äî lbt05_main","text":"","code":"run(lbt05, syn_data) #>   Laboratory Test                            A: Drug X   B: Placebo   C: Combination #>       Direction of Abnormality                (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Alanine Aminotransferase Measurement (n)      15           14             14       #>     Low                                                                              #>       Single, not last                       1 (6.7%)        0          4 (28.6%)    #>       Last or replicated                     5 (33.3%)   4 (28.6%)      4 (28.6%)    #>       Any Abnormality                        6 (40.0%)   4 (28.6%)      8 (57.1%)    #>     High                                                                             #>       Single, not last                           0           0              0        #>       Last or replicated                         0           0              0        #>       Any Abnormality                            0           0              0        #>   C-Reactive Protein Measurement (n)            15           15             15       #>     Low                                                                              #>       Single, not last                       4 (26.7%)       0          3 (20.0%)    #>       Last or replicated                     3 (20.0%)   5 (33.3%)      6 (40.0%)    #>       Any Abnormality                        7 (46.7%)   5 (33.3%)      9 (60.0%)    #>     High                                                                             #>       Single, not last                       1 (6.7%)    3 (20.0%)          0        #>       Last or replicated                     4 (26.7%)   3 (20.0%)      6 (40.0%)    #>       Any Abnormality                        5 (33.3%)   6 (40.0%)      6 (40.0%)    #>   Immunoglobulin A Measurement (n)              13           14             14       #>     Low                                                                              #>       Single, not last                           0           0              0        #>       Last or replicated                         0           0              0        #>       Any Abnormality                            0           0              0        #>     High                                                                             #>       Single, not last                       6 (46.2%)    1 (7.1%)      2 (14.3%)    #>       Last or replicated                     3 (23.1%)   4 (28.6%)      3 (21.4%)    #>       Any Abnormality                        9 (69.2%)   5 (35.7%)      5 (35.7%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt05_lyt.html","id":null,"dir":"Reference","previous_headings":"","what":"lbt05 Layout ‚Äî lbt05_lyt","title":"lbt05 Layout ‚Äî lbt05_lyt","text":"lbt05 Layout","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt05_lyt.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"lbt05 Layout ‚Äî lbt05_lyt","text":"","code":"lbt05_lyt(arm_var, lbl_overall, lbl_param, lbl_anrind, map)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt05_lyt.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"lbt05 Layout ‚Äî lbt05_lyt","text":"arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted lbl_param (string) label PARAM variable. lbl_anrind (string) label ANRIND variable. map (data.frame) mapping PARAMs directions abnormality.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt06.html","id":null,"dir":"Reference","previous_headings":"","what":"LBT06 Table 1 (Default) Laboratory Abnormalities by Visit and Baseline Status Table 1. ‚Äî lbt06_main","title":"LBT06 Table 1 (Default) Laboratory Abnormalities by Visit and Baseline Status Table 1. ‚Äî lbt06_main","text":"LBT06 table produces standard laboratory abnormalities visit baseline status summary.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt06.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"LBT06 Table 1 (Default) Laboratory Abnormalities by Visit and Baseline Status Table 1. ‚Äî lbt06_main","text":"","code":"lbt06_main(   adam_db,   arm_var = \"ACTARM\",   lbl_overall = NULL,   page_var = \"PARAMCD\",   ... )  lbt06_pre(adam_db, ...)  lbt06_post(tlg, prune_0 = FALSE, ...)  lbt06"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt06.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"LBT06 Table 1 (Default) Laboratory Abnormalities by Visit and Baseline Status Table 1. ‚Äî lbt06_main","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt06.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"LBT06 Table 1 (Default) Laboratory Abnormalities by Visit and Baseline Status Table 1. ‚Äî lbt06_main","text":"adam_db (list data.frames) object containing ADaM datasets arm_var (string) arm variable used arm splitting. lbl_overall (string) label used overall column, set NULL overall column omitted page_var (string) variable name prior row split page. ... used. tlg (TableTree, Listing ggplot) object typically produced main function. prune_0 (flag) remove 0 count rows","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt06.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"LBT06 Table 1 (Default) Laboratory Abnormalities by Visit and Baseline Status Table 1. ‚Äî lbt06_main","text":"main function returns rtables object. preprocessing function returns list data.frame. postprocessing function returns rtables object ElementaryTable (null report).","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt06.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"LBT06 Table 1 (Default) Laboratory Abnormalities by Visit and Baseline Status Table 1. ‚Äî lbt06_main","text":"count \"LOW\" \"HIGH\" values ANRIND BNRIND. Lab test results missing ANRIND values excluded. Split columns arm, typically ACTARM. Keep zero count rows default.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt06.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"LBT06 Table 1 (Default) Laboratory Abnormalities by Visit and Baseline Status Table 1. ‚Äî lbt06_main","text":"lbt06_main(): Main TLG function lbt06_pre(): Preprocessing lbt06_post(): Postprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt06.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"LBT06 Table 1 (Default) Laboratory Abnormalities by Visit and Baseline Status Table 1. ‚Äî lbt06_main","text":"adam_db object must contain adlb table columns \"AVISIT\", \"ANRIND\", \"BNRIND\", \"ONTRTFL\", \"PARCAT2\", column specified arm_var.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt06.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"LBT06 Table 1 (Default) Laboratory Abnormalities by Visit and Baseline Status Table 1. ‚Äî lbt06_main","text":"","code":"run(lbt06, syn_data) #>   Visit                                                                             #>     Abnormality at Visit                  A: Drug X    B: Placebo    C: Combination #>               Baseline Status              (N=15)        (N=15)          (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Alanine Aminotransferase Measurement                                              #>     WEEK 1 DAY 8                                                                    #>       Low                                                                           #>                 Not low                      0/1           0/6            0/1       #>                 Low                          0/1           0/1            0/1       #>                 Total                        0/2           0/7            0/2       #>       High                                                                          #>                 Not high                     0/2           0/7            0/2       #>                 High                         0/0           0/0            0/0       #>                 Total                        0/2           0/7            0/2       #>     WEEK 2 DAY 15                                                                   #>       Low                                                                           #>                 Not low                      0/3           0/2            0/2       #>                 Low                          0/0           0/0            0/0       #>                 Total                        0/3           0/2            0/2       #>       High                                                                          #>                 Not high                     0/3           0/2            0/2       #>                 High                         0/0           0/0            0/0       #>                 Total                        0/3           0/2            0/2       #>     WEEK 3 DAY 22                                                                   #>       Low                                                                           #>                 Not low                      0/5           0/3        1/6 (16.7%)   #>                 Low                          0/0           0/0            0/0       #>                 Total                        0/5           0/3        1/6 (16.7%)   #>       High                                                                          #>                 Not high                     0/5           0/3            0/6       #>                 High                         0/0           0/0            0/0       #>                 Total                        0/5           0/3            0/6       #>     WEEK 4 DAY 29                                                                   #>       Low                                                                           #>                 Not low                      0/3           0/1            0/1       #>                 Low                          0/3           0/2            0/0       #>                 Total                        0/6           0/3            0/1       #>       High                                                                          #>                 Not high                     0/6           0/3            0/1       #>                 High                         0/0           0/0            0/0       #>                 Total                        0/6           0/3            0/1       #>     WEEK 5 DAY 36                                                                   #>       Low                                                                           #>                 Not low                      0/2           0/2            0/5       #>                 Low                          0/1           0/1            0/0       #>                 Total                        0/3           0/3            0/5       #>       High                                                                          #>                 Not high                     0/3           0/3            0/5       #>                 High                         0/0           0/0            0/0       #>                 Total                        0/3           0/3            0/5       #>   C-Reactive Protein Measurement                                                    #>     WEEK 1 DAY 8                                                                    #>       Low                                                                           #>                 Not low                      0/5           0/3            0/3       #>                 Low                          0/0           0/1            0/0       #>                 Total                        0/5           0/4            0/3       #>       High                                                                          #>                 Not high                     0/5           0/3        1/3 (33.3%)   #>                 High                         0/0           0/1            0/0       #>                 Total                        0/5           0/4        1/3 (33.3%)   #>     WEEK 2 DAY 15                                                                   #>       Low                                                                           #>                 Not low                      0/8           0/2            0/0       #>                 Low                          0/0           0/0            0/1       #>                 Total                        0/8           0/2            0/1       #>       High                                                                          #>                 Not high                 1/8 (12.5%)       0/1            0/1       #>                 High                         0/0           0/1            0/0       #>                 Total                    1/8 (12.5%)       0/2            0/1       #>     WEEK 3 DAY 22                                                                   #>       Low                                                                           #>                 Not low                      0/5           0/4            0/4       #>                 Low                          0/0       1/1 (100%)         0/2       #>                 Total                        0/5        1/5 (20%)         0/6       #>       High                                                                          #>                 Not high                  1/5 (20%)     1/5 (20%)         0/6       #>                 High                         0/0           0/0            0/0       #>                 Total                     1/5 (20%)     1/5 (20%)         0/6       #>     WEEK 4 DAY 29                                                                   #>       Low                                                                           #>                 Not low                      0/2        1/2 (50%)     1/3 (33.3%)   #>                 Low                          0/0           0/0            0/0       #>                 Total                        0/2        1/2 (50%)     1/3 (33.3%)   #>       High                                                                          #>                 Not high                     0/2           0/2            0/3       #>                 High                         0/0           0/0            0/0       #>                 Total                        0/2           0/2            0/3       #>     WEEK 5 DAY 36                                                                   #>       Low                                                                           #>                 Not low                      0/2           0/2            0/5       #>                 Low                          0/0       1/1 (100%)         0/1       #>                 Total                        0/2       1/3 (33.3%)        0/6       #>       High                                                                          #>                 Not high                  1/2 (50%)        0/3            0/6       #>                 High                         0/0           0/0            0/0       #>                 Total                     1/2 (50%)        0/3            0/6       #>   Immunoglobulin A Measurement                                                      #>     WEEK 1 DAY 8                                                                    #>       Low                                                                           #>                 Not low                      0/6           0/6            0/2       #>                 Low                          0/0           0/0            0/0       #>                 Total                        0/6           0/6            0/2       #>       High                                                                          #>                 Not high                     0/5       1/6 (16.7%)        0/2       #>                 High                         0/1           0/0            0/0       #>                 Total                        0/6       1/6 (16.7%)        0/2       #>     WEEK 2 DAY 15                                                                   #>       Low                                                                           #>                 Not low                      0/3           0/7            0/4       #>                 Low                          0/0           0/0            0/0       #>                 Total                        0/3           0/7            0/4       #>       High                                                                          #>                 Not high                     0/3           0/7         1/4 (25%)    #>                 High                         0/0           0/0            0/0       #>                 Total                        0/3           0/7         1/4 (25%)    #>     WEEK 3 DAY 22                                                                   #>       Low                                                                           #>                 Not low                      0/4           0/5            0/9       #>                 Low                          0/0           0/0            0/0       #>                 Total                        0/4           0/5            0/9       #>       High                                                                          #>                 Not high                     0/3           0/5            0/8       #>                 High                         0/1           0/0            0/1       #>                 Total                        0/4           0/5            0/9       #>     WEEK 4 DAY 29                                                                   #>       Low                                                                           #>                 Not low                      0/2           0/6            0/4       #>                 Low                          0/0           0/0            0/0       #>                 Total                        0/2           0/6            0/4       #>       High                                                                          #>                 Not high                 1/1 (100%)        0/6            0/3       #>                 High                         0/1           0/0            0/1       #>                 Total                     1/2 (50%)        0/6            0/4       #>     WEEK 5 DAY 36                                                                   #>       Low                                                                           #>                 Not low                      0/6           0/5            0/5       #>                 Low                          0/0           0/0            0/0       #>                 Total                        0/6           0/5            0/5       #>       High                                                                          #>                 Not high                     0/5           0/5            0/5       #>                 High                         0/1           0/0            0/0       #>                 Total                        0/6           0/5            0/5"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt06_lyt.html","id":null,"dir":"Reference","previous_headings":"","what":"lbt06 Layout ‚Äî lbt06_lyt","title":"lbt06 Layout ‚Äî lbt06_lyt","text":"lbt06 Layout","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt06_lyt.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"lbt06 Layout ‚Äî lbt06_lyt","text":"","code":"lbt06_lyt(   arm_var,   lbl_overall,   lbl_param,   lbl_visit,   lbl_anrind,   lbl_bnrind,   visitvar,   anrind_var,   bnrind_var,   page_var )"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt06_lyt.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"lbt06 Layout ‚Äî lbt06_lyt","text":"arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted lbl_param (string) text label PARAM variable. lbl_visit (string) text label AVISIT variable. lbl_anrind (string) text label ANRIND variable. lbl_bnrind (string) text label BNRIND variable. visitvar (string) typically \"AVISIT\" user-defined visit incorporating \"ATPT\". anrind_var (string) variable analysis reference range indicator. bnrind_var (string) variable baseline reference range indicator. page_var (string) variable name prior row split page.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt07.html","id":null,"dir":"Reference","previous_headings":"","what":"LBT07 Table 1 (Default) Laboratory Test Results and Change from Baseline by Visit. ‚Äî lbt07_main","title":"LBT07 Table 1 (Default) Laboratory Test Results and Change from Baseline by Visit. ‚Äî lbt07_main","text":"LBT07 table provides overview analysis values change baseline respective arm course trial.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt07.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"LBT07 Table 1 (Default) Laboratory Test Results and Change from Baseline by Visit. ‚Äî lbt07_main","text":"","code":"lbt07_main(   adam_db,   arm_var = \"ACTARM\",   lbl_overall = NULL,   param_var = \"PARAM\",   grad_dir_var = \"GRADE_DIR\",   grad_anl_var = \"GRADE_ANL\",   ... )  lbt07_pre(adam_db, ...)  lbt07_post(tlg, prune_0 = TRUE, ...)  lbt07"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt07.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"LBT07 Table 1 (Default) Laboratory Test Results and Change from Baseline by Visit. ‚Äî lbt07_main","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt07.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"LBT07 Table 1 (Default) Laboratory Test Results and Change from Baseline by Visit. ‚Äî lbt07_main","text":"adam_db (list data.frames) object containing ADaM datasets arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted param_var (string) name column storing parameters name. grad_dir_var (string) name column storing grade direction variable  required order obtain correct denominators building layout used define row splitting. grad_anl_var (string)  name column storing toxicity grade variable negative values ATOXGR replaced absolute values. ... used. tlg (TableTree, Listing ggplot) object typically produced main function. prune_0 (flag) remove 0 count rows","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt07.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"LBT07 Table 1 (Default) Laboratory Test Results and Change from Baseline by Visit. ‚Äî lbt07_main","text":"main function returns rtables object. preprocessing function returns list data.frame. postprocessing function returns rtables object ElementaryTable (null report).","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt07.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"LBT07 Table 1 (Default) Laboratory Test Results and Change from Baseline by Visit. ‚Äî lbt07_main","text":"Split columns arm, typically ACTARM.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt07.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"LBT07 Table 1 (Default) Laboratory Test Results and Change from Baseline by Visit. ‚Äî lbt07_main","text":"lbt07_main(): Main TLG function lbt07_pre(): Preprocessing lbt07_post(): Postprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt07.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"LBT07 Table 1 (Default) Laboratory Test Results and Change from Baseline by Visit. ‚Äî lbt07_main","text":"adam_db object must contain adlb table columns \"USUBJID\", \"ATOXGR\", \"ONTRTFL\" column specified arm_var.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt07.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"LBT07 Table 1 (Default) Laboratory Test Results and Change from Baseline by Visit. ‚Äî lbt07_main","text":"","code":"run(lbt07, syn_data) #>   Parameter                                                                           #>     Direction of Abnormality                 A: Drug X    B: Placebo   C: Combination #>               Highest NCI CTCAE Grade          (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Alanine Aminotransferase Measurement (n)       15           15             15       #>     LOW                                                                               #>               1                              3 (20.0%)        0              0        #>               2                              2 (13.3%)     1 (6.7%)       1 (6.7%)    #>               3                               1 (6.7%)     1 (6.7%)      6 (40.0%)    #>               4                              3 (20.0%)    2 (13.3%)      3 (20.0%)    #>               Any                            9 (60.0%)    4 (26.7%)      10 (66.7%)   #>   C-Reactive Protein Measurement (n)             15           15             15       #>     LOW                                                                               #>               1                              2 (13.3%)     1 (6.7%)      2 (13.3%)    #>               2                              5 (33.3%)    2 (13.3%)      5 (33.3%)    #>               3                              3 (20.0%)    4 (26.7%)      3 (20.0%)    #>               4                                  0         1 (6.7%)          0        #>               Any                            10 (66.7%)   8 (53.3%)      10 (66.7%)   #>     HIGH                                                                              #>               1                              3 (20.0%)     1 (6.7%)       1 (6.7%)    #>               2                              4 (26.7%)    4 (26.7%)      2 (13.3%)    #>               3                               1 (6.7%)    2 (13.3%)      4 (26.7%)    #>               4                                  0         1 (6.7%)          0        #>               Any                            8 (53.3%)    8 (53.3%)      7 (46.7%)    #>   Immunoglobulin A Measurement (n)               15           15             15       #>     HIGH                                                                              #>               1                              3 (20.0%)     1 (6.7%)       1 (6.7%)    #>               2                              5 (33.3%)    4 (26.7%)      2 (13.3%)    #>               3                              3 (20.0%)    3 (20.0%)      2 (13.3%)    #>               4                                  0            0           1 (6.7%)    #>               Any                            11 (73.3%)   8 (53.3%)      6 (40.0%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt07_lyt.html","id":null,"dir":"Reference","previous_headings":"","what":"lbt07 Layout ‚Äî lbt07_lyt","title":"lbt07 Layout ‚Äî lbt07_lyt","text":"lbt07 Layout","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt07_lyt.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"lbt07 Layout ‚Äî lbt07_lyt","text":"","code":"lbt07_lyt(   arm_var,   lbl_overall,   lbl_param_var,   lbl_grad_dir_var,   param_var,   grad_dir_var,   grad_anl_var,   map )"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt07_lyt.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"lbt07 Layout ‚Äî lbt07_lyt","text":"arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted lbl_param_var (string) label param_var variable. lbl_grad_dir_var (string) label grad_dir_var variable. param_var (string) name column storing parameters name. grad_dir_var (string) name column storing grade direction variable  required order obtain correct denominators building layout used define row splitting. grad_anl_var (string)  name column storing toxicity grade variable negative values ATOXGR replaced absolute values. map (data.frame) mapping PARAMs directions abnormality.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt14.html","id":null,"dir":"Reference","previous_headings":"","what":"LBT14 Laboratory Test Results Shift Table ‚Äì Highest NCI-CTCAE Grade Post-Baseline by Baseline Grade (Low or High Direction). ‚Äî lbt14_main","title":"LBT14 Laboratory Test Results Shift Table ‚Äì Highest NCI-CTCAE Grade Post-Baseline by Baseline Grade (Low or High Direction). ‚Äî lbt14_main","text":"LBT14 Laboratory Test Results Shift Table ‚Äì Highest NCI-CTCAE Grade Post-Baseline Baseline Grade (Low High Direction).","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt14.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"LBT14 Laboratory Test Results Shift Table ‚Äì Highest NCI-CTCAE Grade Post-Baseline by Baseline Grade (Low or High Direction). ‚Äî lbt14_main","text":"","code":"lbt14_main(   adam_db,   arm_var = \"ACTARM\",   lbl_overall = NULL,   gr_missing = \"incl\",   page_var = \"PARAMCD\",   ... )  lbt14_pre(adam_db, gr_missing = \"incl\", direction = \"low\", ...)  lbt14_post(tlg, prune_0 = TRUE, ...)  lbt14"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt14.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"LBT14 Laboratory Test Results Shift Table ‚Äì Highest NCI-CTCAE Grade Post-Baseline by Baseline Grade (Low or High Direction). ‚Äî lbt14_main","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt14.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"LBT14 Laboratory Test Results Shift Table ‚Äì Highest NCI-CTCAE Grade Post-Baseline by Baseline Grade (Low or High Direction). ‚Äî lbt14_main","text":"adam_db (list data.frames) object containing ADaM datasets arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted gr_missing (string) missing baseline grades handled. Defaults \"incl\" include \"Missing\" level. options \"excl\" exclude patients missing baseline grades \"gr_0\" convert missing baseline grades grade 0. page_var (string) variable name prior row split page. ... used. direction (string) one \"high\" \"low\" indicating shift direction detailed. tlg (TableTree, Listing ggplot) object typically produced main function. prune_0 (flag) remove 0 count rows","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt14.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"LBT14 Laboratory Test Results Shift Table ‚Äì Highest NCI-CTCAE Grade Post-Baseline by Baseline Grade (Low or High Direction). ‚Äî lbt14_main","text":"main function returns rtables object. preprocessing function returns list data.frame. postprocessing function returns rtables object ElementaryTable (null report).","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt14.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"LBT14 Laboratory Test Results Shift Table ‚Äì Highest NCI-CTCAE Grade Post-Baseline by Baseline Grade (Low or High Direction). ‚Äî lbt14_main","text":"table follows ADaMIG v1.1. worst grade recorded patient included table. missing baseline lab results, \"Missing\" level BTOXGR excluded. Grading takes value -4 4, negative value means abnormality direction low, positive value means abnormality direction high. Grades 0, 1, 2, 3, 4 counted \"Low\" direction = \"low\". Conversely, direction =  \"high\", Grades 0, -1, -2, -3, -4 counted `\"High\". Remove zero-count rows unless overridden prune_0 = FALSE. Split columns arm, typically ACTARM.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt14.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"LBT14 Laboratory Test Results Shift Table ‚Äì Highest NCI-CTCAE Grade Post-Baseline by Baseline Grade (Low or High Direction). ‚Äî lbt14_main","text":"lbt14_main(): Main TLG function lbt14_pre(): Preprocessing lbt14_post(): Postprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt14.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"LBT14 Laboratory Test Results Shift Table ‚Äì Highest NCI-CTCAE Grade Post-Baseline by Baseline Grade (Low or High Direction). ‚Äî lbt14_main","text":"adam_db object must contain adlb table columns \"USUBJID\", \"PARAM\", \"BTOXGR\", \"ATOXGR\", column specified arm_var.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt14.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"LBT14 Laboratory Test Results Shift Table ‚Äì Highest NCI-CTCAE Grade Post-Baseline by Baseline Grade (Low or High Direction). ‚Äî lbt14_main","text":"","code":"run(lbt14, syn_data) #>   Baseline Toxicity Grade                 A: Drug X   B: Placebo   C: Combination #>           Post-baseline NCI-CTCAE Grade    (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Alanine Aminotransferase Measurement                                            #>     Not Low                                  12           12             14       #>             Not Low                       5 (41.7%)   8 (66.7%)      5 (35.7%)    #>             1                             3 (25.0%)       0              0        #>             2                             2 (16.7%)    1 (8.3%)       1 (7.1%)    #>             3                                 0        1 (8.3%)      5 (35.7%)    #>             4                             2 (16.7%)   2 (16.7%)      3 (21.4%)    #>     1                                         1           2              0        #>             Not Low                       1 (100%)     2 (100%)          0        #>     2                                         1           1              0        #>             Not Low                           0        1 (100%)          0        #>             4                             1 (100%)        0              0        #>     3                                         1           0              1        #>             3                             1 (100%)        0           1 (100%)    #>   C-Reactive Protein Measurement                                                  #>     Not Low                                  14           13             12       #>             Not Low                       5 (35.7%)   7 (53.8%)      4 (33.3%)    #>             1                             2 (14.3%)       0          2 (16.7%)    #>             2                             5 (35.7%)   2 (15.4%)      4 (33.3%)    #>             3                             2 (14.3%)   3 (23.1%)      2 (16.7%)    #>             4                                 0        1 (7.7%)          0        #>     1                                         0           0              2        #>             Not Low                           0           0          1 (50.0%)    #>             2                                 0           0          1 (50.0%)    #>     2                                         0           1              0        #>             1                                 0        1 (100%)          0        #>     3                                         1           1              1        #>             3                             1 (100%)     1 (100%)       1 (100%)    #>   Immunoglobulin A Measurement                                                    #>     Not Low                                  15           15             15       #>             Not Low                       15 (100%)   15 (100%)      15 (100%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt14_lyt.html","id":null,"dir":"Reference","previous_headings":"","what":"lbt14 Layout ‚Äî lbt14_lyt","title":"lbt14 Layout ‚Äî lbt14_lyt","text":"lbt14 Layout","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt14_lyt.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"lbt14 Layout ‚Äî lbt14_lyt","text":"","code":"lbt14_lyt(arm_var, lbl_overall, lbl_param, lbl_btoxgr, page_var)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt14_lyt.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"lbt14 Layout ‚Äî lbt14_lyt","text":"arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted page_var (string) variable name prior row split page.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt15.html","id":null,"dir":"Reference","previous_headings":"","what":"LBT15 Laboratory Test Shifts to NCI-CTCAE Grade 3-4 Post-Baseline Table. ‚Äî lbt15_pre","title":"LBT15 Laboratory Test Shifts to NCI-CTCAE Grade 3-4 Post-Baseline Table. ‚Äî lbt15_pre","text":"LBT15 Laboratory Test Shifts NCI-CTCAE Grade 3-4 Post-Baseline Table.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt15.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"LBT15 Laboratory Test Shifts to NCI-CTCAE Grade 3-4 Post-Baseline Table. ‚Äî lbt15_pre","text":"","code":"lbt15_pre(adam_db, ...)  lbt15"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt15.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"LBT15 Laboratory Test Shifts to NCI-CTCAE Grade 3-4 Post-Baseline Table. ‚Äî lbt15_pre","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt15.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"LBT15 Laboratory Test Shifts to NCI-CTCAE Grade 3-4 Post-Baseline Table. ‚Äî lbt15_pre","text":"lbt04.R","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt15.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"LBT15 Laboratory Test Shifts to NCI-CTCAE Grade 3-4 Post-Baseline Table. ‚Äî lbt15_pre","text":"adam_db (list data.frames) object containing ADaM datasets ... used.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt15.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"LBT15 Laboratory Test Shifts to NCI-CTCAE Grade 3-4 Post-Baseline Table. ‚Äî lbt15_pre","text":"preprocessing function returns list data.frame.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt15.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"LBT15 Laboratory Test Shifts to NCI-CTCAE Grade 3-4 Post-Baseline Table. ‚Äî lbt15_pre","text":"lbt15_pre(): Preprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lbt15.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"LBT15 Laboratory Test Shifts to NCI-CTCAE Grade 3-4 Post-Baseline Table. ‚Äî lbt15_pre","text":"","code":"run(lbt15, syn_data) #>   Laboratory Test                          A: Drug X   B: Placebo    C: Combination #>       Analysis Toxicity Grade               (N=15)       (N=15)          (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   CHEMISTRY                                                                         #>     Alanine Aminotransferase Measurement                                            #>       Low                                     0/7          0/3        1/7 (14.3%)   #>       High                                    0/7          0/3            0/8       #>     C-Reactive Protein Measurement                                                  #>       Low                                     0/8          0/3            0/7       #>       High                                    0/8          0/2            0/7       #>     Immunoglobulin A Measurement                                                    #>       Low                                     0/5          0/8            0/7       #>       High                                    0/5          0/8            0/6       #>   COAGULATION                                                                       #>     Alanine Aminotransferase Measurement                                            #>       Low                                     0/4          0/7            0/4       #>       High                                    0/5          0/7            0/4       #>     C-Reactive Protein Measurement                                                  #>       Low                                     0/5          0/6            0/4       #>       High                                    0/5      1/6 (16.7%)    1/4 (25.0%)   #>     Immunoglobulin A Measurement                                                    #>       Low                                     0/8          0/9            0/6       #>       High                                    0/8          0/9        1/6 (16.7%)   #>   HEMATOLOGY                                                                        #>     Alanine Aminotransferase Measurement                                            #>       Low                                     0/5          0/5            0/4       #>       High                                    0/6          0/5            0/4       #>     C-Reactive Protein Measurement                                                  #>       Low                                     0/5          0/5            0/4       #>       High                                    0/5          0/4            0/5       #>     Immunoglobulin A Measurement                                                    #>       Low                                     0/3          0/4            0/8       #>       High                                    0/3          0/4            0/8"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/listing_format_chevron.html","id":null,"dir":"Reference","previous_headings":"","what":"Format for Chevron Listings ‚Äî listing_format_chevron","title":"Format for Chevron Listings ‚Äî listing_format_chevron","text":"Format Chevron Listings","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/listing_format_chevron.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Format for Chevron Listings ‚Äî listing_format_chevron","text":"","code":"listing_format_chevron()"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/listing_format_chevron.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Format for Chevron Listings ‚Äî listing_format_chevron","text":"list fmt_config.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lvls.html","id":null,"dir":"Reference","previous_headings":"","what":"Obtain levels from vector ‚Äî lvls","title":"Obtain levels from vector ‚Äî lvls","text":"Obtain levels vector","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lvls.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Obtain levels from vector ‚Äî lvls","text":"","code":"lvls(x)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lvls.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Obtain levels from vector ‚Äî lvls","text":"x (character) (factor) object obtain levels.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lvls.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Obtain levels from vector ‚Äî lvls","text":"character unique values.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/lvls.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Obtain levels from vector ‚Äî lvls","text":"factors, levels returned. characters, sorted unique values returned.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/main.html","id":null,"dir":"Reference","previous_headings":"","what":"Main ‚Äî main","title":"Main ‚Äî main","text":"retrieve set main function.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/main.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Main ‚Äî main","text":"","code":"main(x)  # S4 method for class 'chevron_tlg' main(x)  main(x) <- value  # S4 method for class 'chevron_tlg' main(x) <- value"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/main.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Main ‚Äî main","text":"x (chevron_tlg) input. value (function) returning tlg. Typically one _main function chevron.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/main.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Main ‚Äî main","text":"function stored main slot x argument.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/mht01.html","id":null,"dir":"Reference","previous_headings":"","what":"MHT01 Medical History Table. ‚Äî mht01_label","title":"MHT01 Medical History Table. ‚Äî mht01_label","text":"MHT01 table provides overview subjects medical history SOC Preferred Term.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/mht01.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"MHT01 Medical History Table. ‚Äî mht01_label","text":"","code":"mht01_label  mht01_main(   adam_db,   arm_var = \"ARM\",   row_split_var = \"MHBODSYS\",   lbl_overall = NULL,   summary_labels = list(all = mht01_label),   ... )  mht01_pre(adam_db, ...)  mht01_post(tlg, row_split_var = \"MHBODSYS\", prune_0 = TRUE, ...)  mht01"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/mht01.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"MHT01 Medical History Table. ‚Äî mht01_label","text":"object class character length 2. object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/mht01.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"MHT01 Medical History Table. ‚Äî mht01_label","text":"adam_db (list data.frames) object containing ADaM datasets arm_var (string) variable used column splitting row_split_var (character) additional row split variables. lbl_overall (string) label used overall column, set NULL overall column omitted summary_labels (list) summarize labels. See details. ... used. tlg (TableTree, Listing ggplot) object typically produced main function. prune_0 (flag) remove 0 count rows","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/mht01.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"MHT01 Medical History Table. ‚Äî mht01_label","text":"main function returns rtables object. preprocessing function returns list data.frame. postprocessing function returns rtables object ElementaryTable (null report).","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/mht01.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"MHT01 Medical History Table. ‚Äî mht01_label","text":"Numbers represent absolute numbers patients fraction N, absolute number event specified. Remove zero-count rows unless overridden prune_0 = FALSE. Split columns arm. include total column default. Order row_split_var alphabetically medical condition decreasing total number patients specific condition. summary_labels used control summary level. \"\" used, split summary statistic labels. One special case \"TOTAL\", overall population.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/mht01.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"MHT01 Medical History Table. ‚Äî mht01_label","text":"mht01_label: Default labels mht01_main(): Main TLG function mht01_pre(): Preprocessing mht01_post(): Postprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/mht01.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"MHT01 Medical History Table. ‚Äî mht01_label","text":"adam_db object must contain admh table columns \"MHBODSYS\" \"MHDECOD\".","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/mht01.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"MHT01 Medical History Table. ‚Äî mht01_label","text":"","code":"run(mht01, syn_data) #>   MedDRA System Organ Class                                A: Drug X    B: Placebo   C: Combination #>     MedDRA Preferred Term                                    (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Total number of patients with at least one condition     13 (86.7%)   14 (93.3%)     15 (100%)    #>   Total number of conditions                                   58           59             99       #>   cl A                                                                                              #>     Total number of patients with at least one condition   7 (46.7%)    6 (40.0%)      10 (66.7%)   #>     Total number of conditions                                 8            11             16       #>     trm A_2/2                                              5 (33.3%)    6 (40.0%)      6 (40.0%)    #>     trm A_1/2                                              3 (20.0%)     1 (6.7%)      6 (40.0%)    #>   cl B                                                                                              #>     Total number of patients with at least one condition   12 (80.0%)   11 (73.3%)     12 (80.0%)   #>     Total number of conditions                                 24           21             32       #>     trm B_3/3                                              8 (53.3%)    6 (40.0%)      7 (46.7%)    #>     trm B_1/3                                              5 (33.3%)    6 (40.0%)      8 (53.3%)    #>     trm B_2/3                                              5 (33.3%)    6 (40.0%)      5 (33.3%)    #>   cl C                                                                                              #>     Total number of patients with at least one condition   8 (53.3%)    6 (40.0%)      11 (73.3%)   #>     Total number of conditions                                 10           13             22       #>     trm C_2/2                                              6 (40.0%)    4 (26.7%)      8 (53.3%)    #>     trm C_1/2                                              4 (26.7%)    4 (26.7%)      5 (33.3%)    #>   cl D                                                                                              #>     Total number of patients with at least one condition   10 (66.7%)   7 (46.7%)      13 (86.7%)   #>     Total number of conditions                                 16           14             29       #>     trm D_1/3                                              4 (26.7%)    4 (26.7%)      7 (46.7%)    #>     trm D_2/3                                              6 (40.0%)    2 (13.3%)      7 (46.7%)    #>     trm D_3/3                                              2 (13.3%)    5 (33.3%)      7 (46.7%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/missing_rule.html","id":null,"dir":"Reference","previous_headings":"","what":"Missing rule ‚Äî missing_rule","title":"Missing rule ‚Äî missing_rule","text":"Missing rule","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/missing_rule.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Missing rule ‚Äî missing_rule","text":"","code":"missing_rule"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/missing_rule.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Missing rule ‚Äî missing_rule","text":"object class rule (inherits character) length 2.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/mla_dir.html","id":null,"dir":"Reference","previous_headings":"","what":"MLA Grade Direction Data ‚Äî mla_dir","title":"MLA Grade Direction Data ‚Äî mla_dir","text":"MLA Grade Direction Data","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/mla_dir.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"MLA Grade Direction Data ‚Äî mla_dir","text":"","code":"mla_dir"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/mla_dir.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"MLA Grade Direction Data ‚Äî mla_dir","text":"object class data.frame 76 rows 2 columns.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/mng01.html","id":null,"dir":"Reference","previous_headings":"","what":"MNG01 Mean Plot Graph. ‚Äî mng01_main","title":"MNG01 Mean Plot Graph. ‚Äî mng01_main","text":"Overview summary statistics across time arm selected data set.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/mng01.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"MNG01 Mean Plot Graph. ‚Äî mng01_main","text":"","code":"mng01_main(   adam_db,   dataset = \"adlb\",   x_var = \"AVISIT\",   y_var = \"AVAL\",   y_name = \"PARAM\",   y_unit = NULL,   arm_var = \"ACTARM\",   center_fun = \"mean\",   interval_fun = \"mean_ci\",   jitter = 0.3,   line_col = nestcolor::color_palette(),   line_type = NULL,   ggtheme = gg_theme_chevron(),   table = c(\"n\", center_fun, interval_fun),   ... )  mng01_pre(adam_db, dataset, x_var = \"AVISIT\", ...)  mng01"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/mng01.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"MNG01 Mean Plot Graph. ‚Äî mng01_main","text":"object class chevron_g length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/mng01.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"MNG01 Mean Plot Graph. ‚Äî mng01_main","text":"adam_db (list data.frames) object containing ADaM datasets dataset (string) name table adam_db object. x_var (string) name column dataset represent x-axis. y_var (string) name variable represented y-axis. y_name (string) variable name y. Used plot's subtitle. y_unit (string) name variable units y. Used plot's subtitle. NULL, y_name displayed subtitle. arm_var (string) variable used column splitting center_fun (string) function compute estimate value. interval_fun (string) function defining crossbar range. NULL, crossbar displayed. jitter (numeric) width spread data points x-axis; number 0 (jitter) 1 (high jitter), default 0.3 (slight jitter). line_col (character) describing colors use lines named character associating values arm_var color names. line_type (character) describing line type use lines named character associating values arm_var line types. ggtheme (theme) passed tern::g_lineplot(). table (character) names statistics displayed table. NULL, table displayed. ... passed tern::g_lineplot().","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/mng01.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"MNG01 Mean Plot Graph. ‚Äî mng01_main","text":"main function returns list ggplot objects. list ggplot objects. preprocessing function returns list data.frame.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/mng01.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"MNG01 Mean Plot Graph. ‚Äî mng01_main","text":"overall value. Preprocessing filters ANL01FL selected data set.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/mng01.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"MNG01 Mean Plot Graph. ‚Äî mng01_main","text":"mng01_main(): Main TLG Function mng01_pre(): Preprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/mng01.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"MNG01 Mean Plot Graph. ‚Äî mng01_main","text":"adam_db object must contain table specified dataset columns specified x_var, y_var, y_name, y_unit arm_var.","code":""},{"path":[]},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/mng01.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"MNG01 Mean Plot Graph. ‚Äî mng01_main","text":"","code":"col <- c(   \"A: Drug X\" = \"black\",   \"B: Placebo\" = \"blue\",   \"C: Combination\" = \"gray\" )  lt <- c(   \"A: Drug X\" = \"29\",   \"B: Placebo\" = \"99\",   \"C: Combination\" = \"solid\" )  run(   mng01,   syn_data,   dataset = \"adlb\",   x_var = c(\"AVISIT\", \"AVISITN\"),   line_col = col,   line_type = lt ) #> $`Alanine Aminotransferase Measurement`  #>  #> $`C-Reactive Protein Measurement`  #>  #> $`Immunoglobulin A Measurement`  #>"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/modify_character.html","id":null,"dir":"Reference","previous_headings":"","what":"Modify character ‚Äî modify_character","title":"Modify character ‚Äî modify_character","text":"Modify character","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/modify_character.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Modify character ‚Äî modify_character","text":"","code":"modify_character(x, y)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/nocoding.html","id":null,"dir":"Reference","previous_headings":"","what":"No Coding Available rule ‚Äî nocoding","title":"No Coding Available rule ‚Äî nocoding","text":"Coding Available rule","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/nocoding.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"No Coding Available rule ‚Äî nocoding","text":"","code":"nocoding"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/nocoding.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"No Coding Available rule ‚Äî nocoding","text":"object class rule (inherits character) length 2.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/obtain_value.html","id":null,"dir":"Reference","previous_headings":"","what":"Obtain value from a vector ‚Äî obtain_value","title":"Obtain value from a vector ‚Äî obtain_value","text":"Obtain value vector","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/obtain_value.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Obtain value from a vector ‚Äî obtain_value","text":"","code":"obtain_value(obj, index)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/occurrence_lyt.html","id":null,"dir":"Reference","previous_headings":"","what":"Occurrence Layout ‚Äî occurrence_lyt","title":"Occurrence Layout ‚Äî occurrence_lyt","text":"Occurrence Layout","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/occurrence_lyt.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Occurrence Layout ‚Äî occurrence_lyt","text":"","code":"occurrence_lyt(   arm_var,   lbl_overall,   row_split_var,   lbl_row_split,   medname_var,   lbl_medname_var,   summary_labels,   count_by )"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/occurrence_lyt.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Occurrence Layout ‚Äî occurrence_lyt","text":"arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted row_split_var (character) additional row split variables. medname_var (string) variable name medical treatment name. lbl_medname_var (string) label variable defining medication name. summary_labels (list) summarize labels. See details.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/outcome_rule.html","id":null,"dir":"Reference","previous_headings":"","what":"Outcome Rule ‚Äî outcome_rule","title":"Outcome Rule ‚Äî outcome_rule","text":"Outcome Rule","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/outcome_rule.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Outcome Rule ‚Äî outcome_rule","text":"","code":"outcome_rule"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/outcome_rule.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Outcome Rule ‚Äî outcome_rule","text":"object class rule (inherits character) length 6.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/pdt01.html","id":null,"dir":"Reference","previous_headings":"","what":"pdt01 Major Protocol Deviations Table. ‚Äî pdt01_main","title":"pdt01 Major Protocol Deviations Table. ‚Äî pdt01_main","text":"major protocol deviations table number subjects total number treatments medication class sorted alphabetically medication name sorted frequencies.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/pdt01.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"pdt01 Major Protocol Deviations Table. ‚Äî pdt01_main","text":"","code":"pdt01_main(   adam_db,   arm_var = \"ARM\",   lbl_overall = NULL,   dvcode_var = \"DVDECOD\",   dvterm_var = \"DVTERM\",   ... )  pdt01_pre(adam_db, ...)  pdt01_post(   tlg,   prune_0 = TRUE,   dvcode_var = \"DVDECOD\",   dvterm_var = \"DVTERM\",   ... )  pdt01"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/pdt01.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"pdt01 Major Protocol Deviations Table. ‚Äî pdt01_main","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/pdt01.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"pdt01 Major Protocol Deviations Table. ‚Äî pdt01_main","text":"adam_db (list data.frames) object containing ADaM datasets arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted dvcode_var (string) variable defining protocol deviation coded term. default DVDECOD. dvterm_var (string) variable defining protocol deviation term. default DVTERM. ... used. tlg (TableTree, Listing ggplot) object typically produced main function. prune_0 (flag) remove 0 count rows","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/pdt01.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"pdt01 Major Protocol Deviations Table. ‚Äî pdt01_main","text":"main function returns rtables object. preprocessing function returns list data.frame. postprocessing function returns rtables object ElementaryTable (null report).","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/pdt01.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"pdt01 Major Protocol Deviations Table. ‚Äî pdt01_main","text":"Data filtered major protocol deviations. (DVCAT == \"MAJOR\"). Numbers represent absolute numbers subjects fraction N, absolute numbers specified. Remove zero-count rows unless overridden prune_0 = FALSE. Split columns arm. include total column default. Sort medication class alphabetically within medication class decreasing total number patients specific medication.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/pdt01.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"pdt01 Major Protocol Deviations Table. ‚Äî pdt01_main","text":"pdt01_main(): Main TLG function pdt01_pre(): Preprocessing pdt01_post(): Postprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/pdt01.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"pdt01 Major Protocol Deviations Table. ‚Äî pdt01_main","text":"adam_db object must contain addv table columns specified dvcode_var dvterm_var well \"DVSEQ\".","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/pdt01.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"pdt01 Major Protocol Deviations Table. ‚Äî pdt01_main","text":"","code":"run(pdt01, syn_data) #>   Category                                                              A: Drug X   B: Placebo   C: Combination #>     Description                                                          (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Total number of patients with at least one major protocol deviation   2 (13.3%)   4 (26.7%)          0        #>   Total number of major protocol deviations                                 2           5              0        #>   EXCLUSION CRITERIA                                                                                            #>     Active or untreated or other excluded cns metastases                    0        1 (6.7%)          0        #>     Pregnancy criteria                                                      0        1 (6.7%)          0        #>   INCLUSION CRITERIA                                                                                            #>     Ineligible cancer type or current cancer stage                      1 (6.7%)        0              0        #>   MEDICATION                                                                                                    #>     Discontinued study drug for unspecified reason                          0        1 (6.7%)          0        #>     Received prohibited concomitant medication                              0        1 (6.7%)          0        #>   PROCEDURAL                                                                                                    #>     Eligibility-related test not done/out of window                         0        1 (6.7%)          0        #>     Failure to sign updated ICF within two visits                       1 (6.7%)        0              0"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/pdt01_lyt.html","id":null,"dir":"Reference","previous_headings":"","what":"pdt01 Layout ‚Äî pdt01_lyt","title":"pdt01 Layout ‚Äî pdt01_lyt","text":"pdt01 Layout","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/pdt01_lyt.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"pdt01 Layout ‚Äî pdt01_lyt","text":"","code":"pdt01_lyt(   arm_var,   lbl_overall,   dvcode_var,   lbl_dvcode_var,   dvterm_var,   lbl_dvterm_var )"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/pdt01_lyt.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"pdt01 Layout ‚Äî pdt01_lyt","text":"arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted dvcode_var (string) variable defining protocol deviation coded term. default DVDECOD. lbl_dvcode_var (string) label variable defining protocol deviation coded term. dvterm_var (string) variable defining protocol deviation term. default DVTERM. lbl_dvterm_var (string) label variable defining protocol deviation term.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/pdt02.html","id":null,"dir":"Reference","previous_headings":"","what":"pdt02 Major Protocol Deviations Related to Epidemic/Pandemic Table. ‚Äî pdt02_main","title":"pdt02 Major Protocol Deviations Related to Epidemic/Pandemic Table. ‚Äî pdt02_main","text":"major protocol deviations table number subjects total number Major Protocol Deviations Related Epidemic/Pandemic sorted alphabetically deviations name sorted frequencies.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/pdt02.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"pdt02 Major Protocol Deviations Related to Epidemic/Pandemic Table. ‚Äî pdt02_main","text":"","code":"pdt02_main(   adam_db,   arm_var = \"ARM\",   lbl_overall = NULL,   dvreas_var = \"DVREAS\",   dvterm_var = \"DVTERM\",   ... )  pdt02_pre(adam_db, ...)  pdt02_post(   tlg,   prune_0 = TRUE,   dvreas_var = \"DVREAS\",   dvterm_var = \"DVTERM\",   ... )  pdt02"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/pdt02.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"pdt02 Major Protocol Deviations Related to Epidemic/Pandemic Table. ‚Äî pdt02_main","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/pdt02.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"pdt02 Major Protocol Deviations Related to Epidemic/Pandemic Table. ‚Äî pdt02_main","text":"adam_db (list data.frames) object containing ADaM datasets arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted dvreas_var (string) variable defining reason deviation. default DVREAS. dvterm_var (string) variable defining protocol deviation term. default DVTERM. ... used. tlg (TableTree, Listing ggplot) object typically produced main function. prune_0 (flag) remove 0 count rows","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/pdt02.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"pdt02 Major Protocol Deviations Related to Epidemic/Pandemic Table. ‚Äî pdt02_main","text":"preprocessing function returns list data.frame. postprocessing function returns rtables object ElementaryTable (null report).","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/pdt02.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"pdt02 Major Protocol Deviations Related to Epidemic/Pandemic Table. ‚Äî pdt02_main","text":"Data filtered major protocol deviations related epidemic/pandemic. (AEPRELFL == \"Y\" & DVCAT == \"MAJOR\"). Numbers represent absolute numbers subjects fraction N, absolute numbers specified. Remove zero-count rows unless overridden prune_0 = FALSE. Split columns arm. include total column default. Sort deviation reason alphabetically within deviation reason decreasing total number patients specific deviation term.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/pdt02.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"pdt02 Major Protocol Deviations Related to Epidemic/Pandemic Table. ‚Äî pdt02_main","text":"pdt02_main(): Main TLG function pdt02_pre(): Preprocessing pdt02_post(): Postprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/pdt02.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"pdt02 Major Protocol Deviations Related to Epidemic/Pandemic Table. ‚Äî pdt02_main","text":"adam_db object must contain addv table columns specified dvreas_var dvterm_var.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/pdt02.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"pdt02 Major Protocol Deviations Related to Epidemic/Pandemic Table. ‚Äî pdt02_main","text":"","code":"run(pdt02, syn_data) #>   Primary Reason                                                                                     A: Drug X   B: Placebo   C: Combination #>     Description                                                                                       (N=15)       (N=15)         (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Total number of patients with at least one major protocol deviation related to epidemic/pandemic   1 (6.7%)        0              0        #>   Total number of major protocol deviations related to epidemic/pandemic                                 1           0              0        #>   Site action due to epidemic/pandemic                                                               1 (6.7%)        0              0        #>     Failure to sign updated ICF within two visits                                                    1 (6.7%)        0              0"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/pdt02_lyt.html","id":null,"dir":"Reference","previous_headings":"","what":"pdt02 Layout ‚Äî pdt02_lyt","title":"pdt02 Layout ‚Äî pdt02_lyt","text":"pdt02 Layout","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/pdt02_lyt.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"pdt02 Layout ‚Äî pdt02_lyt","text":"","code":"pdt02_lyt(   arm_var,   lbl_overall,   lbl_dvreas_var,   lbl_dvterm_var,   dvreas_var,   dvterm_var )"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/pdt02_lyt.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"pdt02 Layout ‚Äî pdt02_lyt","text":"arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted lbl_dvreas_var (string) label variable defining reason deviation. lbl_dvterm_var (string) label variable defining protocol deviation term. dvreas_var (string) variable defining reason deviation. default DVREAS. dvterm_var (string) variable defining protocol deviation term. default DVTERM.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/postprocess.html","id":null,"dir":"Reference","previous_headings":"","what":"Post process ‚Äî postprocess","title":"Post process ‚Äî postprocess","text":"retrieve set postprocess function.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/postprocess.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Post process ‚Äî postprocess","text":"","code":"postprocess(x)  # S4 method for class 'chevron_tlg' postprocess(x)  postprocess(x) <- value  # S4 method for class 'chevron_tlg' postprocess(x) <- value"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/postprocess.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Post process ‚Äî postprocess","text":"x (chevron_tlg) input. value (function) returning post-processed tlg.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/postprocess.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Post process ‚Äî postprocess","text":"function stored postprocess slot x argument.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/preprocess.html","id":null,"dir":"Reference","previous_headings":"","what":"Pre process ‚Äî preprocess","title":"Pre process ‚Äî preprocess","text":"retrieve set preprocess function.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/preprocess.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Pre process ‚Äî preprocess","text":"","code":"preprocess(x)  # S4 method for class 'chevron_tlg' preprocess(x)  preprocess(x) <- value  # S4 method for class 'chevron_tlg' preprocess(x) <- value"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/preprocess.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Pre process ‚Äî preprocess","text":"x (chevron_tlg) input. value (function) returning pre-processed list data.frames amenable tlg creation. Typically one _pre function chevron.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/preprocess.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Pre process ‚Äî preprocess","text":"function stored preprocess slot x argument.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/print_args.html","id":null,"dir":"Reference","previous_headings":"","what":"Print Arguments ‚Äî print_args","title":"Print Arguments ‚Äî print_args","text":"Print Arguments","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/print_args.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Print Arguments ‚Äî print_args","text":"","code":"print_args(run_call, additional_args, args, auto_pre = TRUE)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/print_list.html","id":null,"dir":"Reference","previous_headings":"","what":"Print list ‚Äî print_list","title":"Print list ‚Äî print_list","text":"Print list","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/print_list.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Print list ‚Äî print_list","text":"","code":"print_list(x, indent = 2L)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/proportion_lyt.html","id":null,"dir":"Reference","previous_headings":"","what":"Proportion layout ‚Äî proportion_lyt","title":"Proportion layout ‚Äî proportion_lyt","text":"Proportion layout","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/proportion_lyt.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Proportion layout ‚Äî proportion_lyt","text":"","code":"proportion_lyt(   lyt,   arm_var,   methods,   strata,   conf_level,   odds_ratio = TRUE,   rsp_var = \"IS_RSP\" )"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/proportion_lyt.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Proportion layout ‚Äî proportion_lyt","text":"lyt layout created rtables arm_var (string) variable used column splitting methods (list) named list, use named list control, example: methods = list(prop_conf_method = \"wald\", diff_conf_method = \"wald\", strat_diff_conf_method = \"ha\", diff_pval_method = \"fisher\", strat_diff_pval_method = \"schouten\") prop_conf_method controls methods calculating proportion confidence interval, diff_conf_method controls methods calculating unstratified difference confidence interval, strat_diff_conf_method controls methods calculating stratified difference confidence interval, diff_pval_method controls methods calculating unstratified p-value odds ratio, strat_diff_pval_method controls methods calculating stratified p-value odds ratio, see details tern strata (string) stratification factors, e.g. strata = c(\"STRATA1\", \"STRATA2\"), default NULL conf_level (numeric) level confidence interval, default 0.95. odds_ratio (flag) odds ratio calculated, default TRUE","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/reexports.html","id":null,"dir":"Reference","previous_headings":"","what":"Objects exported from other packages ‚Äî reexports","title":"Objects exported from other packages ‚Äî reexports","text":"objects imported packages. Follow links see documentation. dunlin get_arg, reformat formatters with_label","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/report_null.html","id":null,"dir":"Reference","previous_headings":"","what":"Creates NULL Report ‚Äî report_null","title":"Creates NULL Report ‚Äî report_null","text":"Creates NULL Report","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/report_null.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Creates NULL Report ‚Äî report_null","text":"","code":"report_null(tlg, ...)  # S4 method for class 'NULL' report_null(tlg, ind = 2L, ...)  # S4 method for class 'VTableTree' report_null(tlg, ind = 2L, ...)  # S4 method for class 'listing_df' report_null(tlg, ind = 2L, ...)  # S4 method for class 'list' report_null(tlg, ind = 2L, ...)  # S4 method for class 'ANY' report_null(tlg, ...)  standard_null_report()"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/report_null.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Creates NULL Report ‚Äî report_null","text":"tlg convert null report. ... used. ind (integer) indentation outputs class VTableTree.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/report_null.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Creates NULL Report ‚Äî report_null","text":"tlg object NULL report tlg NULL, TableTree 0 rows, listing_df 0 rows list 0 elements.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/report_null.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Creates NULL Report ‚Äî report_null","text":"","code":"report_null(NULL) #>                                                                                            #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>      Null Report: No observations met the reporting criteria for inclusion in this output."},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt01.html","id":null,"dir":"Reference","previous_headings":"","what":"RMPT01Duration of Exposure for Risk Management Plan Table. ‚Äî rmpt01_main","title":"RMPT01Duration of Exposure for Risk Management Plan Table. ‚Äî rmpt01_main","text":"RMPT01 table provides overview duration exposure.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt01.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"RMPT01Duration of Exposure for Risk Management Plan Table. ‚Äî rmpt01_main","text":"","code":"rmpt01_main(   adam_db,   summaryvars = \"AVALCAT1\",   show_tot = TRUE,   row_split_var = NULL,   col_split_var = NULL,   overall_col_lbl = NULL,   ... )  rmpt01_pre(adam_db, summaryvars = \"AVALCAT1\", ...)  rmpt01_post(tlg, prune_0 = FALSE, ...)  rmpt01"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt01.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"RMPT01Duration of Exposure for Risk Management Plan Table. ‚Äî rmpt01_main","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt01.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"RMPT01Duration of Exposure for Risk Management Plan Table. ‚Äî rmpt01_main","text":"adam_db (list data.frames) object containing ADaM datasets summaryvars (string) variables analyzed. label attribute corresponding columns adex table adam_db used label. show_tot (flag) whether display cumulative total. row_split_var (string) name column containing variable split exposure . col_split_var (string) additional column splitting variable. overall_col_lbl (string) name overall column. NULL, overall level added. ... used. tlg (TableTree, Listing ggplot) object typically produced main function. prune_0 (flag) remove 0 count rows","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt01.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"RMPT01Duration of Exposure for Risk Management Plan Table. ‚Äî rmpt01_main","text":"main function returns rtables object. preprocessing function returns list data.frame. postprocessing function returns rtables object ElementaryTable (null report).","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt01.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"RMPT01Duration of Exposure for Risk Management Plan Table. ‚Äî rmpt01_main","text":"Person time sum exposure across patients. Summary statistics default based number patients corresponding N row (number non-missing values). remove zero-count rows unless overridden prune_0 = TRUE.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt01.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"RMPT01Duration of Exposure for Risk Management Plan Table. ‚Äî rmpt01_main","text":"rmpt01_main(): Main TLG function rmpt01_pre(): Preprocessing rmpt01_post(): Postprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt01.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"RMPT01Duration of Exposure for Risk Management Plan Table. ‚Äî rmpt01_main","text":"adam_db object must contain adex table \"AVAL\" columns specified summaryvars.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt01.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"RMPT01Duration of Exposure for Risk Management Plan Table. ‚Äî rmpt01_main","text":"","code":"run(rmpt01, syn_data, col_split_var = \"SEX\") #>                                                   F                           M             #>                                        Patients     Person time    Patients     Person time #>   Duration of exposure                  (N=30)        (N=30)        (N=15)        (N=15)    #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   < 1 month                            3 (10.0%)        45         1 (6.7%)         22      #>   1 to <3 months                       8 (26.7%)        554        5 (33.3%)        283     #>   3 to <6 months                       8 (26.7%)       1042        5 (33.3%)        686     #>   >=6 months                          11 (36.7%)       2447        4 (26.7%)        834     #>   Total patients number/person time   30 (100.0%)      4088       15 (100.0%)      1825"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt01_lyt.html","id":null,"dir":"Reference","previous_headings":"","what":"rmpt01 Layout ‚Äî rmpt01_lyt","title":"rmpt01 Layout ‚Äî rmpt01_lyt","text":"rmpt01 Layout","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt01_lyt.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"rmpt01 Layout ‚Äî rmpt01_lyt","text":"","code":"rmpt01_lyt(   summaryvars,   lbl_summaryvars,   show_tot,   row_split_var,   col_split_var,   overall_col_lbl )"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt01_lyt.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"rmpt01 Layout ‚Äî rmpt01_lyt","text":"summaryvars (string) variables analyzed. label attribute corresponding columns adex table adam_db used label. lbl_summaryvars (character) label associated analyzed variables. show_tot (flag) whether display cumulative total. row_split_var (character) additional row split variables. col_split_var (string) additional column splitting variable. overall_col_lbl (string) name overall column. NULL, overall level added.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt03.html","id":null,"dir":"Reference","previous_headings":"","what":"rmpt03Duration of Exposure for Risk Management Plan Table. ‚Äî rmpt03_main","title":"rmpt03Duration of Exposure for Risk Management Plan Table. ‚Äî rmpt03_main","text":"rmpt03 table provides overview duration exposure.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt03.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"rmpt03Duration of Exposure for Risk Management Plan Table. ‚Äî rmpt03_main","text":"","code":"rmpt03_main(   adam_db,   summaryvars = \"AGEGR1\",   show_tot = TRUE,   row_split_var = NULL,   col_split_var = \"SEX\",   overall_col_lbl = \"All Genders\",   ... )  rmpt03_pre(adam_db, summaryvars = \"AGEGR1\", ...)  rmpt03"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt03.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"rmpt03Duration of Exposure for Risk Management Plan Table. ‚Äî rmpt03_main","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt03.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"rmpt03Duration of Exposure for Risk Management Plan Table. ‚Äî rmpt03_main","text":"adam_db (list data.frames) object containing ADaM datasets summaryvars (string) variables analyzed. label attribute corresponding columns adex table adam_db used label. show_tot (flag) whether display cumulative total. row_split_var (string) name column containing variable split exposure . col_split_var (string) additional column splitting variable. overall_col_lbl (string) name overall column. NULL, overall level added. ... used.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt03.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"rmpt03Duration of Exposure for Risk Management Plan Table. ‚Äî rmpt03_main","text":"main function returns rtables object. preprocessing function returns list data.frame.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt03.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"rmpt03Duration of Exposure for Risk Management Plan Table. ‚Äî rmpt03_main","text":"Person time sum exposure across patients. Summary statistics default based number patients corresponding N row (number non-missing values). remove zero-count rows unless overridden prune_0 = TRUE.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt03.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"rmpt03Duration of Exposure for Risk Management Plan Table. ‚Äî rmpt03_main","text":"rmpt03_main(): Main TLG function rmpt03_pre(): Preprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt03.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"rmpt03Duration of Exposure for Risk Management Plan Table. ‚Äî rmpt03_main","text":"","code":"pre_data <- dunlin::propagate(syn_data, \"adsl\", \"AGEGR1\", \"USUBJID\") #>  #> Updating: adae with: AGEGR1 #> Updating: adsaftte with: AGEGR1 #> Updating: adcm with: AGEGR1 #> Updating: addv with: AGEGR1 #> Updating: adeg with: AGEGR1 #> Updating: adex with: AGEGR1 #> Updating: adlb with: AGEGR1 #> Updating: admh with: AGEGR1 #> Skipping: adrs #> Updating: adsub with: AGEGR1 #> Skipping: adtte #> Updating: advs with: AGEGR1 run(rmpt03, pre_data) #>                                                   F                           M                      All Genders        #>                                        Patients     Person time    Patients     Person time    Patients     Person time #>   Age Group                             (N=30)        (N=30)        (N=15)        (N=15)        (N=45)        (N=45)    #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   <65                                 30 (100.0%)      4088       15 (100.0%)      1825       45 (100.0%)      5913     #>   Total patients number/person time   30 (100.0%)      4088       15 (100.0%)      1825       45 (100.0%)      5913"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt04.html","id":null,"dir":"Reference","previous_headings":"","what":"RMPT04Extent of Exposure by Ethnic Origin for Risk Management Plan Table. ‚Äî rmpt04_main","title":"RMPT04Extent of Exposure by Ethnic Origin for Risk Management Plan Table. ‚Äî rmpt04_main","text":"RMPT04 table provides overview duration exposure extent.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt04.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"RMPT04Extent of Exposure by Ethnic Origin for Risk Management Plan Table. ‚Äî rmpt04_main","text":"","code":"rmpt04_main(   adam_db,   summaryvars = \"ETHNIC\",   show_tot = TRUE,   row_split_var = NULL,   col_split_var = NULL,   overall_col_lbl = NULL,   ... )  rmpt04_pre(adam_db, summaryvars = \"ETHNIC\", ...)  rmpt04"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt04.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"RMPT04Extent of Exposure by Ethnic Origin for Risk Management Plan Table. ‚Äî rmpt04_main","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt04.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"RMPT04Extent of Exposure by Ethnic Origin for Risk Management Plan Table. ‚Äî rmpt04_main","text":"adam_db (list data.frames) object containing ADaM datasets summaryvars (string) variables analyzed. label attribute corresponding columns adex table adam_db used label. show_tot (flag) whether display cumulative total. row_split_var (character) additional row split variables. col_split_var (string) additional column splitting variable. overall_col_lbl (string) name overall column. NULL, overall level added. ... used.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt04.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"RMPT04Extent of Exposure by Ethnic Origin for Risk Management Plan Table. ‚Äî rmpt04_main","text":"main function returns rtables object. preprocessing function returns list data.frame.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt04.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"RMPT04Extent of Exposure by Ethnic Origin for Risk Management Plan Table. ‚Äî rmpt04_main","text":"Person time sum exposure across patients. Summary statistics default based number patients corresponding N row (number non-missing values). remove zero-count rows unless overridden prune_0 = TRUE.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt04.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"RMPT04Extent of Exposure by Ethnic Origin for Risk Management Plan Table. ‚Äî rmpt04_main","text":"rmpt04_main(): Main TLG function rmpt04_pre(): Preprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt04.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"RMPT04Extent of Exposure by Ethnic Origin for Risk Management Plan Table. ‚Äî rmpt04_main","text":"","code":"run(rmpt04, syn_data) #>                                        Patients     Person time #>   ETHNIC                                (N=45)        (N=45)    #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   HISPANIC OR LATINO                   2 (4.4%)         309     #>   NOT HISPANIC OR LATINO              41 (91.1%)       5555     #>   NOT REPORTED                         2 (4.4%)         49      #>   Total patients number/person time   45 (100.0%)      5913"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt05.html","id":null,"dir":"Reference","previous_headings":"","what":"RMPT05 Extent of Exposure by Race for Risk Management Plan Table. ‚Äî rmpt05_main","title":"RMPT05 Extent of Exposure by Race for Risk Management Plan Table. ‚Äî rmpt05_main","text":"RMPT05 table provides overview duration exposure extent.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt05.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"RMPT05 Extent of Exposure by Race for Risk Management Plan Table. ‚Äî rmpt05_main","text":"","code":"rmpt05_main(   adam_db,   summaryvars = \"RACE\",   show_tot = TRUE,   row_split_var = NULL,   col_split_var = NULL,   overall_col_lbl = NULL,   ... )  rmpt05_pre(adam_db, summaryvars = \"RACE\", ...)  rmpt05"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt05.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"RMPT05 Extent of Exposure by Race for Risk Management Plan Table. ‚Äî rmpt05_main","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt05.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"RMPT05 Extent of Exposure by Race for Risk Management Plan Table. ‚Äî rmpt05_main","text":"adam_db (list data.frames) object containing ADaM datasets summaryvars (string) variables analyzed. label attribute corresponding columns adex table adam_db used label. show_tot (flag) whether display cumulative total. row_split_var (character) additional row split variables. col_split_var (string) additional column splitting variable. overall_col_lbl (string) name overall column. NULL, overall level added. ... used.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt05.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"RMPT05 Extent of Exposure by Race for Risk Management Plan Table. ‚Äî rmpt05_main","text":"main function returns rtables object. preprocessing function returns list data.frame.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt05.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"RMPT05 Extent of Exposure by Race for Risk Management Plan Table. ‚Äî rmpt05_main","text":"Person time sum exposure across patients. Summary statistics default based number patients corresponding N row (number non-missing values). remove zero-count rows unless overridden prune_0 = TRUE.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt05.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"RMPT05 Extent of Exposure by Race for Risk Management Plan Table. ‚Äî rmpt05_main","text":"rmpt05_main(): Main TLG function rmpt05_pre(): Preprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt05.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"RMPT05 Extent of Exposure by Race for Risk Management Plan Table. ‚Äî rmpt05_main","text":"","code":"run(rmpt05, syn_data) #>                                        Patients     Person time #>   RACE                                  (N=45)        (N=45)    #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   ASIAN                               26 (57.8%)       3309     #>   BLACK OR AFRICAN AMERICAN            9 (20.0%)       1139     #>   WHITE                                7 (15.6%)       1231     #>   AMERICAN INDIAN OR ALASKA NATIVE     3 (6.7%)         234     #>   Total patients number/person time   45 (100.0%)      5913"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt06.html","id":null,"dir":"Reference","previous_headings":"","what":"RMPT06 Table 1 (Default) Seriousness, Outcomes, Severity, Frequency with 95% CI for Risk Management Plan. ‚Äî rmpt06_main","title":"RMPT06 Table 1 (Default) Seriousness, Outcomes, Severity, Frequency with 95% CI for Risk Management Plan. ‚Äî rmpt06_main","text":"RMPT06 Table 1 (Default) Seriousness, Outcomes, Severity, Frequency 95% CI Risk Management Plan.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt06.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"RMPT06 Table 1 (Default) Seriousness, Outcomes, Severity, Frequency with 95% CI for Risk Management Plan. ‚Äî rmpt06_main","text":"","code":"rmpt06_main(   adam_db,   arm_var = \"ACTARM\",   lbl_overall = NULL,   method = \"clopper-pearson\",   conf_level = 0.95,   show_diff = FALSE,   ref_group = NULL,   method_diff = \"wald\",   conf_level_diff = 0.95,   grade_groups = NULL,   ... )  rmpt06_pre(adam_db, ...)  rmpt06_post(tlg, prune_0 = FALSE, ...)  rmpt06"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt06.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"RMPT06 Table 1 (Default) Seriousness, Outcomes, Severity, Frequency with 95% CI for Risk Management Plan. ‚Äî rmpt06_main","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt06.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"RMPT06 Table 1 (Default) Seriousness, Outcomes, Severity, Frequency with 95% CI for Risk Management Plan. ‚Äî rmpt06_main","text":"adam_db (list data.frames) object containing ADaM datasets arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted method (string) method used construct confidence interval. See tern::estimate_proportion. conf_level (proportion) confidence level interval. See tern::estimate_proportion. show_diff (flag) whether show difference patient least one adverse event  groups. ref_group (string) reference group difference. method_diff (string) method used construct confidence interval difference groups. conf_level_diff (proportion) confidence level interval difference groups. grade_groups (list) grade groups displayed. ... used. tlg (TableTree, Listing ggplot) object typically produced main function. prune_0 (flag) remove 0 count rows","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt06.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"RMPT06 Table 1 (Default) Seriousness, Outcomes, Severity, Frequency with 95% CI for Risk Management Plan. ‚Äî rmpt06_main","text":"main function returns rtables object. preprocessing function returns list data.frame. postprocessing function returns rtables object ElementaryTable (null report).","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt06.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"RMPT06 Table 1 (Default) Seriousness, Outcomes, Severity, Frequency with 95% CI for Risk Management Plan. ‚Äî rmpt06_main","text":"rmpt06_main(): Main TLG function rmpt06_pre(): Preprocessing rmpt06_post(): Postprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt06.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"RMPT06 Table 1 (Default) Seriousness, Outcomes, Severity, Frequency with 95% CI for Risk Management Plan. ‚Äî rmpt06_main","text":"","code":"run(rmpt06, syn_data) #>                                                                   A: Drug X      B: Placebo    C: Combination #>                                                                     (N=15)         (N=15)          (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Number of patients with at least one adverse event              13 (86.7%)     14 (93.3%)     15 (100.0%)   #>   95% CI for % of patients with at least one AE                  (59.5, 98.3)   (68.1, 99.8)   (78.2, 100.0)  #>   Total number of AEs                                                 58             59              99       #>   Total number of patients with at least one AE by worst grade                                                #>     Grade 1                                                           0           1 (6.7%)        1 (6.7%)    #>     Grade 2                                                        1 (6.7%)       1 (6.7%)        1 (6.7%)    #>     Grade 3                                                        1 (6.7%)      2 (13.3%)        1 (6.7%)    #>     Grade 4                                                       3 (20.0%)      2 (13.3%)       2 (13.3%)    #>     Grade 5 (fatal outcome)                                       8 (53.3%)      8 (53.3%)       10 (66.7%)   #>   Number of patients with at least one serious AE                 12 (80.0%)     12 (80.0%)      11 (73.3%)   #>   Number of patients with at least one AE by outcome                                                          #>     Fatal outcome                                                 8 (61.5%)      8 (57.1%)       10 (66.7%)   #>     Unresolved                                                    4 (30.8%)      6 (42.9%)       9 (60.0%)    #>     Recovered/Resolved                                            9 (69.2%)      8 (57.1%)       11 (73.3%)   #>     Resolved with sequelae                                        5 (38.5%)      4 (28.6%)       7 (46.7%)    #>     Recovering/Resolving                                          9 (69.2%)      6 (42.9%)       13 (86.7%)   #>     Unknown outcome                                               2 (15.4%)      4 (28.6%)       7 (46.7%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt06_lyt.html","id":null,"dir":"Reference","previous_headings":"","what":"rmpt06 Layout ‚Äî rmpt06_lyt","title":"rmpt06 Layout ‚Äî rmpt06_lyt","text":"rmpt06 Layout","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt06_lyt.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"rmpt06 Layout ‚Äî rmpt06_lyt","text":"","code":"rmpt06_lyt(   arm_var,   lbl_overall,   method,   conf_level,   show_diff,   ref_group,   method_diff,   conf_level_diff,   grade_groups )"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rmpt06_lyt.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"rmpt06 Layout ‚Äî rmpt06_lyt","text":"arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rspt01.html","id":null,"dir":"Reference","previous_headings":"","what":"RSPT01 Binary Outcomes Summary. ‚Äî rspt01_main","title":"RSPT01 Binary Outcomes Summary. ‚Äî rspt01_main","text":"RSPT01 template may used summarize binary outcome response variable single time point. Typical application oncology","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rspt01.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"RSPT01 Binary Outcomes Summary. ‚Äî rspt01_main","text":"","code":"rspt01_main(   adam_db,   dataset = \"adrs\",   arm_var = \"ARM\",   ref_group = NULL,   odds_ratio = TRUE,   perform_analysis = \"unstrat\",   strata = NULL,   conf_level = 0.95,   methods = list(),   ... )  rspt01_pre(adam_db, ...)  rspt01_post(tlg, prune_0 = TRUE, ...)  rspt01"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rspt01.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"RSPT01 Binary Outcomes Summary. ‚Äî rspt01_main","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rspt01.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"RSPT01 Binary Outcomes Summary. ‚Äî rspt01_main","text":"adam_db (list data.frames) object containing ADaM datasets dataset (string) name table adam_db object. arm_var (string) variable used column splitting ref_group (string) name reference group, value identical values arm_var, specified, default use first level value arm_var. odds_ratio (flag) odds ratio calculated, default TRUE perform_analysis (string) option display statistical comparisons using stratified analyses, unstratified analyses, , e.g. c(\"unstrat\", \"strat\"). unstratified displayed default strata (string) stratification factors, e.g. strata = c(\"STRATA1\", \"STRATA2\"), default NULL conf_level (numeric) level confidence interval, default 0.95. methods (list) named list, use named list control, example: methods = list(prop_conf_method = \"wald\", diff_conf_method = \"wald\", strat_diff_conf_method = \"ha\", diff_pval_method = \"fisher\", strat_diff_pval_method = \"schouten\") prop_conf_method controls methods calculating proportion confidence interval, diff_conf_method controls methods calculating unstratified difference confidence interval, strat_diff_conf_method controls methods calculating stratified difference confidence interval, diff_pval_method controls methods calculating unstratified p-value odds ratio, strat_diff_pval_method controls methods calculating stratified p-value odds ratio, see details tern ... used. tlg (TableTree, Listing ggplot) object typically produced main function. prune_0 (flag) remove 0 count rows","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rspt01.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"RSPT01 Binary Outcomes Summary. ‚Äî rspt01_main","text":"main function returns rtables object. preprocessing function returns list data.frame. postprocessing function returns rtables object ElementaryTable (null report).","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rspt01.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"RSPT01 Binary Outcomes Summary. ‚Äî rspt01_main","text":"overall value.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rspt01.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"RSPT01 Binary Outcomes Summary. ‚Äî rspt01_main","text":"rspt01_main(): Main TLG function rspt01_pre(): Preprocessing rspt01_post(): Postprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rspt01.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"RSPT01 Binary Outcomes Summary. ‚Äî rspt01_main","text":"","code":"library(dplyr) library(dunlin)  proc_data <- log_filter(syn_data, PARAMCD == \"BESRSPI\", \"adrs\")  run(rspt01, proc_data) #> Warning: Chi-squared approximation may be incorrect #>                                          A: Drug X          B: Placebo         C: Combination   #>                                            (N=15)             (N=15)               (N=15)       #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Responders                             10 (66.7%)         9 (60.0%)            11 (73.3%)     #>   95% CI (Wald, with correction)        (39.5, 93.9)       (31.9, 88.1)         (47.6, 99.0)    #>   Unstratified Analysis                                                                         #>     Difference in Response rate (%)                            -6.7                 6.7         #>       95% CI (Wald, with correction)                      (-47.7, 34.4)        (-32.7, 46.0)    #>     p-value (Chi-Squared Test)                                0.7048               0.6903       #>   Odds Ratio (95% CI)                                   0.75 (0.17 - 3.33)   1.37 (0.29 - 6.60) #>   Complete Response (CR)                 4 (26.7%)          4 (26.7%)            7 (46.7%)      #>     95% CI (Wald, with correction)     (0.95, 52.38)      (0.95, 52.38)        (18.09, 75.25)   #>   Partial Response (PR)                  6 (40.0%)          5 (33.3%)            4 (26.7%)      #>     95% CI (Wald, with correction)     (11.87, 68.13)     (6.14, 60.52)        (0.95, 52.38)    #>   Stable Disease (SD)                    5 (33.3%)          6 (40.0%)            4 (26.7%)      #>     95% CI (Wald, with correction)     (6.14, 60.52)      (11.87, 68.13)       (0.95, 52.38)     run(rspt01, proc_data,   odds_ratio = FALSE, perform_analysis = c(\"unstrat\", \"strat\"),   strata = c(\"STRATA1\", \"STRATA2\"), methods = list(diff_pval_method = \"fisher\") ) #> Warning: Less than 5 observations in some strata. #> Warning: Less than 5 observations in some strata. #> Warning: <5 data points in some strata. CMH test may be incorrect. #> Warning: <5 data points in some strata. CMH test may be incorrect. #>                                                A: Drug X        B: Placebo     C: Combination #>                                                  (N=15)           (N=15)           (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Responders                                   10 (66.7%)       9 (60.0%)        11 (73.3%)   #>   95% CI (Wald, with correction)              (39.5, 93.9)     (31.9, 88.1)     (47.6, 99.0)  #>   Unstratified Analysis                                                                       #>     Difference in Response rate (%)                                -6.7             6.7       #>       95% CI (Wald, with correction)                          (-47.7, 34.4)    (-32.7, 46.0)  #>     p-value (Fisher's Exact Test)                                 1.0000           1.0000     #>   Stratified Analysis                                                                         #>     Difference in Response rate (%)                               -11.0             22.5      #>       95% CI (CMH, without correction)                        (-42.7, 20.7)     (-3.5, 48.5)  #>     p-value (Cochran-Mantel-Haenszel Test)                        0.5731           0.3088     #>   Complete Response (CR)                       4 (26.7%)        4 (26.7%)        7 (46.7%)    #>     95% CI (Wald, with correction)           (0.95, 52.38)    (0.95, 52.38)    (18.09, 75.25) #>   Partial Response (PR)                        6 (40.0%)        5 (33.3%)        4 (26.7%)    #>     95% CI (Wald, with correction)           (11.87, 68.13)   (6.14, 60.52)    (0.95, 52.38)  #>   Stable Disease (SD)                          5 (33.3%)        6 (40.0%)        4 (26.7%)    #>     95% CI (Wald, with correction)           (6.14, 60.52)    (11.87, 68.13)   (0.95, 52.38)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rspt01_lyt.html","id":null,"dir":"Reference","previous_headings":"","what":"rspt01 Layout ‚Äî rspt01_lyt","title":"rspt01 Layout ‚Äî rspt01_lyt","text":"rspt01 Layout","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rspt01_lyt.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"rspt01 Layout ‚Äî rspt01_lyt","text":"","code":"rspt01_lyt(   arm_var,   rsp_var,   ref_group,   odds_ratio,   perform_analysis,   strata,   conf_level,   methods )"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/rspt01_lyt.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"rspt01 Layout ‚Äî rspt01_lyt","text":"arm_var (string) variable used column splitting","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/run.html","id":null,"dir":"Reference","previous_headings":"","what":"Run the TLG-generating pipeline ‚Äî run","title":"Run the TLG-generating pipeline ‚Äî run","text":"Run TLG-generating pipeline","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/run.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Run the TLG-generating pipeline ‚Äî run","text":"","code":"run(   object,   adam_db,   auto_pre = TRUE,   verbose = FALSE,   unwrap = FALSE,   ...,   user_args = list(...) )  # S4 method for class 'chevron_tlg' run(   object,   adam_db,   auto_pre = TRUE,   verbose = get_arg(\"chevron.run.verbose\", \"R_CHEVRON_RUN_VERBOSE\", FALSE),   unwrap = get_arg(\"chevron.run.unwrap\", \"R_CHEVRON_RUN_UNWRAP\", verbose),   ...,   user_args = list(...) )"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/run.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Run the TLG-generating pipeline ‚Äî run","text":"object (chevron_tlg) input. adam_db (list data.frames) object containing ADaM datasets auto_pre (flag) whether perform default pre processing step. verbose (flag) whether print argument information. unwrap (flag)  whether print preprocessing postprocessing main function together associated layout function. ... extra arguments pass pre-processing, main post-processing functions. user_args (list) arguments ....","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/run.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Run the TLG-generating pipeline ‚Äî run","text":"rtables (chevron_t), rlistings (chevron_l), grob (chevron_g) ElementaryTable (null report) depending class chevron_tlg object passed object argument.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/run.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Run the TLG-generating pipeline ‚Äî run","text":"functions stored preprocess, main postprocess slots chevron_tlg objects called respectively, preprocessing, main postprocessing functions. executing run method chevron_tlg object, auto_pre TRUE, adam_bd list first passed preprocessing function. resulting list passed main function produces table, graph listings list objects. output passed postprocessing function performed final modifications returning output. Additional arguments specified ... user_args passed three functions.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/run.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Run the TLG-generating pipeline ‚Äî run","text":"","code":"run(mng01, syn_data, auto_pre = TRUE, dataset = \"adlb\") #> $`Alanine Aminotransferase Measurement`  #>  #> $`C-Reactive Protein Measurement`  #>  #> $`Immunoglobulin A Measurement`  #>"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/s_summary_na.html","id":null,"dir":"Reference","previous_headings":"","what":"Summary factor allowing NA ‚Äî s_summary_na","title":"Summary factor allowing NA ‚Äî s_summary_na","text":"Summary factor allowing NA","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/s_summary_na.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Summary factor allowing NA ‚Äî s_summary_na","text":"","code":"s_summary_na(   x,   labelstr,   denom = c(\"n\", \"N_row\", \"N_col\"),   .N_row,   .N_col,   ... )"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/s_summary_na.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Summary factor allowing NA ‚Äî s_summary_na","text":"x (factor) input. denom (string) denominator choice. .N_row (integer) number rows row-split dataset. .N_col (integer) number rows column-split dataset. ... used","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/script.html","id":null,"dir":"Reference","previous_headings":"","what":"Create Script for TLG Generation ‚Äî script","title":"Create Script for TLG Generation ‚Äî script","text":"Create Script TLG Generation","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/script.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Create Script for TLG Generation ‚Äî script","text":"","code":"script_funs(x, adam_db, args, name = deparse(substitute(x)))  # S4 method for class 'chevron_tlg' script_funs(x, adam_db, args, name = deparse(substitute(x)))  # S4 method for class 'chevron_simple' script_funs(x, adam_db, args, name = deparse(substitute(x)))"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/script.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Create Script for TLG Generation ‚Äî script","text":"x (chevron_tlg) input. adam_db (string) name dataset. args (string) name argument list. name (string) name template.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/script.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Create Script for TLG Generation ‚Äî script","text":"character can integrated executable script.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/script.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Create Script for TLG Generation ‚Äî script","text":"","code":"script_funs(aet04, adam_db = \"syn_data\", args = \"args\") #>  [1] \"# Edit Preprocessing Function.\"                                                          #>  [2] \"preprocess(aet04) <- \"                                                                   #>  [3] \"function (adam_db, ...) \"                                                                #>  [4] \"{\"                                                                                       #>  [5] \"    atoxgr_lvls <- c(\\\"1\\\", \\\"2\\\", \\\"3\\\", \\\"4\\\", \\\"5\\\")\"                                 #>  [6] \"    adam_db$adae <- adam_db$adae %>% filter(.data$ANL01FL == \"                           #>  [7] \"        \\\"Y\\\") %>% mutate(AEBODSYS = reformat(.data$AEBODSYS, nocoding), \"               #>  [8] \"        AEDECOD = reformat(.data$AEDECOD, nocoding), ATOXGR = factor(.data$ATOXGR, \"     #>  [9] \"            levels = atoxgr_lvls))\"                                                      #> [10] \"    adam_db\"                                                                             #> [11] \"}\"                                                                                       #> [12] \"\"                                                                                        #> [13] \"# Create TLG\"                                                                            #> [14] \"tlg_output <- run(object = aet04, adam_db = syn_data, verbose = TRUE, user_args = args)\""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/set_section_div.html","id":null,"dir":"Reference","previous_headings":"","what":"Set Section Dividers ‚Äî set_section_div","title":"Set Section Dividers ‚Äî set_section_div","text":"Set Section Dividers","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/set_section_div.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Set Section Dividers ‚Äî set_section_div","text":"","code":"set_section_div(x)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/set_section_div.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Set Section Dividers ‚Äî set_section_div","text":"x (integerish) value section divider added.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/set_section_div.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Set Section Dividers ‚Äî set_section_div","text":"invisible NULL. Set chevron.section_div option.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/set_section_div.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Set Section Dividers ‚Äî set_section_div","text":"Section dividers empty lines sections tables. E.g. 1 used first row split empty line added. Currently works aet02, cmt01a mht01 template.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/smart_prune.html","id":null,"dir":"Reference","previous_headings":"","what":"Prune table up to an ElementaryTable ‚Äî smart_prune","title":"Prune table up to an ElementaryTable ‚Äî smart_prune","text":"Avoid returning NULL table empty.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/smart_prune.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Prune table up to an ElementaryTable ‚Äî smart_prune","text":"","code":"smart_prune(tlg)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/smart_prune.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Prune table up to an ElementaryTable ‚Äî smart_prune","text":"tlg (TableTree) object.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/smart_prune.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Prune table up to an ElementaryTable ‚Äî smart_prune","text":"pruned TableTree.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/split_rows_by_recursive.html","id":null,"dir":"Reference","previous_headings":"","what":"Count or summarize by groups ‚Äî split_rows_by_recursive","title":"Count or summarize by groups ‚Äî split_rows_by_recursive","text":"Count summarize groups","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/split_rows_by_recursive.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Count or summarize by groups ‚Äî split_rows_by_recursive","text":"","code":"split_rows_by_recursive(lyt, row_split_var, ...)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/split_rows_by_recursive.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Count or summarize by groups ‚Äî split_rows_by_recursive","text":"lyt (PreDataTableLayouts) rtable layout. row_split_var (character) variable split rows . ... arguments split_rows_by","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/std_listing.html","id":null,"dir":"Reference","previous_headings":"","what":"Standard Main Listing Function ‚Äî std_listing","title":"Standard Main Listing Function ‚Äî std_listing","text":"Standard Main Listing Function","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/std_listing.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Standard Main Listing Function ‚Äî std_listing","text":"","code":"std_listing(   adam_db,   dataset,   key_cols,   disp_cols,   split_into_pages_by_var,   unique_rows = FALSE,   ... )"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/std_listing.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Standard Main Listing Function ‚Äî std_listing","text":"adam_db (list data.frames) object containing ADaM datasets dataset (string) name table adam_db object. key_cols (character) names columns treated key columns rendering listing. Key columns allow group repeat occurrences. disp_cols (character) names non-key columns displayed listing rendered. split_into_pages_by_var (character NULL) name variable split listing . unique_rows (flag) whether keep unique rows listing. ... additional arguments passed rlistings::as_listing.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/std_listing.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Standard Main Listing Function ‚Äî std_listing","text":"main function returns rlistings list object.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/std_postprocessing.html","id":null,"dir":"Reference","previous_headings":"","what":"Standard Post Processing ‚Äî std_postprocessing","title":"Standard Post Processing ‚Äî std_postprocessing","text":"Standard Post Processing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/std_postprocessing.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Standard Post Processing ‚Äî std_postprocessing","text":"","code":"std_postprocessing(tlg, ...)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/std_postprocessing.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Standard Post Processing ‚Äî std_postprocessing","text":"tlg post process. ... additional arguments passed report_null.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/std_postprocessing.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Standard Post Processing ‚Äî std_postprocessing","text":"processed tlg null report.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/std_postprocessing.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Standard Post Processing ‚Äî std_postprocessing","text":"","code":"library(rtables) #> Loading required package: formatters #>  #> Attaching package: ‚Äòformatters‚Äô #> The following object is masked from ‚Äòpackage:base‚Äô: #>  #>     %||% #> Loading required package: magrittr #>  #> Attaching package: ‚Äòmagrittr‚Äô #> The following objects are masked from ‚Äòpackage:testthat‚Äô: #>  #>     equals, is_less_than, not #>  #> Attaching package: ‚Äòrtables‚Äô #> The following object is masked from ‚Äòpackage:utils‚Äô: #>  #>     str std_postprocessing(build_table(basic_table() |> analyze(\"Species\"), iris), ind = 10L) #>                        all obs #>           ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>           setosa         50    #>           versicolor     50    #>           virginica      50"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/summarize_vars_allow_na.html","id":null,"dir":"Reference","previous_headings":"","what":"Summarize variables allow NA ‚Äî summarize_vars_allow_na","title":"Summarize variables allow NA ‚Äî summarize_vars_allow_na","text":"Summarize variables allow NA","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/summarize_vars_allow_na.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Summarize variables allow NA ‚Äî summarize_vars_allow_na","text":"","code":"summarize_vars_allow_na(   lyt,   vars,   var_labels = vars,   nested = TRUE,   ...,   show_labels = \"default\",   table_names = vars,   section_div = NA_character_,   .stats = c(\"n\", \"count_fraction\"),   .formats = list(count_fraction = format_count_fraction_fixed_dp),   .labels = NULL,   .indent_mods = NULL,   inclNAs = TRUE )"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/syn_data.html","id":null,"dir":"Reference","previous_headings":"","what":"Example adam Synthetic Data ‚Äî syn_data","title":"Example adam Synthetic Data ‚Äî syn_data","text":"Example adam Synthetic Data","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/syn_data.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Example adam Synthetic Data ‚Äî syn_data","text":"","code":"syn_data"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/syn_data.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Example adam Synthetic Data ‚Äî syn_data","text":"named list 13 data.frames: - adsl - adae - adsaftte - adcm - addv - adeg - adex - adlb - admh - adrs - adsub - adtte - advs","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/syn_data.html","id":"source","dir":"Reference","previous_headings":"","what":"Source","title":"Example adam Synthetic Data ‚Äî syn_data","text":"based package random.cdisc.data","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ttet01.html","id":null,"dir":"Reference","previous_headings":"","what":"TTET01 Binary Outcomes Summary. ‚Äî ttet01_main","title":"TTET01 Binary Outcomes Summary. ‚Äî ttet01_main","text":"TTET01 template may used summarize binary outcome response variable single time point. Typical application oncology","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ttet01.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"TTET01 Binary Outcomes Summary. ‚Äî ttet01_main","text":"","code":"ttet01_main(   adam_db,   dataset = \"adtte\",   arm_var = \"ARM\",   ref_group = NULL,   summarize_event = TRUE,   perform_analysis = \"unstrat\",   strata = NULL,   ... )  ttet01_pre(adam_db, dataset = \"adtte\", ...)  ttet01_post(tlg, prune_0 = TRUE, ...)  ttet01"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ttet01.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"TTET01 Binary Outcomes Summary. ‚Äî ttet01_main","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ttet01.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"TTET01 Binary Outcomes Summary. ‚Äî ttet01_main","text":"adam_db (list data.frames) object containing ADaM datasets dataset (string) name table adam_db object. arm_var (string) variable used column splitting ref_group (string) name reference group, value identical values arm_var, specified, default use first level value arm_var. summarize_event (flag) event description displayed, default TRUE perform_analysis (string) option display statistical comparisons using stratified analyses, unstratified analyses, , e.g. c(\"unstrat\", \"strat\"). unstratified displayed default strata (string) stratification factors, e.g. strata = c(\"STRATA1\", \"STRATA2\"), default NULL ... arguments passed control_surv_time(), control_coxph(), control_survtp(), surv_timepoint(). details, see documentation tern. Commonly used arguments include pval_method, conf_level, conf_type, quantiles, ties, time_point, method, etc. tlg (TableTree, Listing ggplot) object typically produced main function. prune_0 (flag) remove 0 count rows","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ttet01.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"TTET01 Binary Outcomes Summary. ‚Äî ttet01_main","text":"main function returns rtables object. preprocessing function returns list data.frame. postprocessing function returns rtables object ElementaryTable (null report).","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ttet01.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"TTET01 Binary Outcomes Summary. ‚Äî ttet01_main","text":"overall value.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ttet01.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"TTET01 Binary Outcomes Summary. ‚Äî ttet01_main","text":"ttet01_main(): Main TLG function ttet01_pre(): Preprocessing ttet01_post(): Postprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ttet01.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"TTET01 Binary Outcomes Summary. ‚Äî ttet01_main","text":"","code":"library(dplyr) library(dunlin)  proc_data <- log_filter(syn_data, PARAMCD == \"PFS\", \"adtte\") run(ttet01, proc_data) #>                                       A: Drug X        B: Placebo      C: Combination  #>                                         (N=15)           (N=15)            (N=15)      #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Patients with event (%)             7 (46.7%)         12 (80%)          8 (53.3%)    #>     Earliest contributing event                                                        #>       Death                               5                11                 7        #>       Disease Progression                 2                 1                 1        #>   Patients without event (%)          8 (53.3%)          3 (20%)          7 (46.7%)    #>   Time to Event (MONTHS)                                                               #>     Median                               8.6               6.2               8.4       #>       95% CI                          (7.3, NE)        (4.8, 7.6)         (7.0, NE)    #>     25% and 75%-ile                    3.8, NE          4.7, 8.4           5.8, NE     #>     Range                           1.2 to 9.5 {1}     0.9 to 9.1      0.9 to 9.5 {1}  #>   Unstratified Analysis                                                                #>     p-value (log-rank)                                   0.0973            0.9111      #>     Hazard Ratio                                          2.18              1.06       #>     95% CI                                            (0.85, 5.60)      (0.38, 2.94)   #>   6 MONTHS                                                                             #>     Patients remaining at risk            11                8                11        #>     Event Free Rate (%)                 73.33             53.33             73.33      #>     95% CI                          (50.95, 95.71)   (28.09, 78.58)    (50.95, 95.71)  #>     Difference in Event Free Rate                        -20.00             0.00       #>       95% CI                                         (-53.74, 13.74)   (-31.65, 31.65) #>       p-value (Z-test)                                   0.2453            1.0000      #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>  #>   {1} - Censored observation: range maximum #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   run(ttet01, proc_data,   summarize_event = FALSE, perform_analysis = c(\"unstrat\", \"strat\"),   strata = c(\"STRATA1\", \"STRATA2\"),   conf_type = \"log-log\",   time_point = c(6, 12),   method = \"both\" ) #>                                       A: Drug X        B: Placebo      C: Combination  #>                                         (N=15)           (N=15)            (N=15)      #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Patients with event (%)             7 (46.7%)         12 (80%)          8 (53.3%)    #>   Patients without event (%)          8 (53.3%)          3 (20%)          7 (46.7%)    #>   Time to Event (MONTHS)                                                               #>     Median                               8.6               6.2               8.4       #>       95% CI                          (2.6, NE)        (2.2, 7.6)         (3.8, NE)    #>     25% and 75%-ile                    3.8, NE          4.7, 8.4           5.8, NE     #>     Range                           1.2 to 9.5 {1}     0.9 to 9.1      0.9 to 9.5 {1}  #>   Unstratified Analysis                                                                #>     p-value (log-rank)                                   0.0973            0.9111      #>     Hazard Ratio                                          2.18              1.06       #>     95% CI                                            (0.85, 5.60)      (0.38, 2.94)   #>   Stratified Analysis                                                                  #>     p-value (log-rank)                                   0.1505            0.8372      #>     Hazard Ratio                                          2.11              0.86       #>     95% CI                                            (0.75, 5.96)      (0.21, 3.49)   #>   6 MONTHS                                                                             #>     Patients remaining at risk            11                8                11        #>     Event Free Rate (%)                 73.33             53.33             73.33      #>     95% CI                          (43.62, 89.05)   (26.32, 74.38)    (43.62, 89.05)  #>     Difference in Event Free Rate                        -20.00             0.00       #>       95% CI                                         (-53.74, 13.74)   (-31.65, 31.65) #>       p-value (Z-test)                                   0.2453            1.0000      #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>  #>   {1} - Censored observation: range maximum #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ttet01_lyt.html","id":null,"dir":"Reference","previous_headings":"","what":"ttet01 Layout ‚Äî ttet01_lyt","title":"ttet01 Layout ‚Äî ttet01_lyt","text":"ttet01 Layout","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ttet01_lyt.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"ttet01 Layout ‚Äî ttet01_lyt","text":"","code":"ttet01_lyt(   arm_var,   ref_group,   summarize_event,   perform_analysis,   strata,   timeunit,   event_lvls,   control_survt,   control_cox_ph,   control_survtp,   ... )"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/ttet01_lyt.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"ttet01 Layout ‚Äî ttet01_lyt","text":"arm_var (string) variable used column splitting timeunit (string) time unit get AVALU, default \"Months\" ... used.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/unwrap_layout.html","id":null,"dir":"Reference","previous_headings":"","what":"Extracting Layout Function. ‚Äî unwrap_layout","title":"Extracting Layout Function. ‚Äî unwrap_layout","text":"Extracting Layout Function.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/unwrap_layout.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Extracting Layout Function. ‚Äî unwrap_layout","text":"","code":"unwrap_layout(x, pattern = \"_lyt$\")"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/unwrap_layout.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Extracting Layout Function. ‚Äî unwrap_layout","text":"x (function) containing call layout function. pattern (string) identifying layout functions","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/unwrap_layout.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Extracting Layout Function. ‚Äî unwrap_layout","text":"invisible NULL print content layout functions found body x.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/unwrap_layout.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"Extracting Layout Function. ‚Äî unwrap_layout","text":"","code":"unwrap_layout(aet01_main) #> Layout function: #>   aet01_lyt: #> function (arm_var, lbl_overall, anl_vars, anl_lbls, lbl_vars)  #> { #>     lyt_base <- basic_table(show_colcounts = TRUE) %>% split_cols_by_with_overall(arm_var,  #>         lbl_overall) #>     lyt_ae1 <- lyt_base %>% analyze_num_patients(vars = \"USUBJID\",  #>         .stats = c(\"unique\", \"nonunique\"), .labels = c(unique = render_safe(\"Total number of {patient_label} with at least one AE\"),  #>             nonunique = \"Total number of AEs\"), .formats = list(unique = format_count_fraction_fixed_dp,  #>             nonunique = \"xx\"), show_labels = \"hidden\") #>     lyt_adsl <- lyt_base %>% count_patients_with_event(\"USUBJID\",  #>         filters = c(DTHFL = \"Y\"), denom = \"N_col\", .labels = c(count_fraction = \"Total number of deaths\"),  #>         table_names = \"TotDeath\") %>% count_patients_with_event(\"USUBJID\",  #>         filters = c(DCSREAS = \"ADVERSE EVENT\"), denom = \"N_col\",  #>         .labels = c(count_fraction = render_safe(\"Total number of {patient_label} withdrawn from study due to an AE\")),  #>         table_names = \"TotWithdrawal\") #>     lyt_ae2 <- lyt_base %>% count_patients_recursive(anl_vars = anl_vars,  #>         anl_lbls = anl_lbls, lbl_vars = lbl_vars) #>     return(list(ae1 = lyt_ae1, ae2 = lyt_ae2, adsl = lyt_adsl)) #> }"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/var_labels_for.html","id":null,"dir":"Reference","previous_headings":"","what":"Retrieve labels for certain variables ‚Äî var_labels_for","title":"Retrieve labels for certain variables ‚Äî var_labels_for","text":"Retrieve labels certain variables","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/var_labels_for.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Retrieve labels for certain variables ‚Äî var_labels_for","text":"","code":"var_labels_for(df, vars)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/var_labels_for.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"Retrieve labels for certain variables ‚Äî var_labels_for","text":"df (data.frame) containing columns label attribute. vars (character) variable names df.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/var_labels_for.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"Retrieve labels for certain variables ‚Äî var_labels_for","text":"character replaced placeholders label attribute.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/var_labels_for.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"Retrieve labels for certain variables ‚Äî var_labels_for","text":"labels returned column label attribute, otherwise column name returned. values brackets  replaced dunlin::render_safe.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/vst01.html","id":null,"dir":"Reference","previous_headings":"","what":"VST01 Vital Sign Results and change from Baseline By Visit Table. ‚Äî vst01_main","title":"VST01 Vital Sign Results and change from Baseline By Visit Table. ‚Äî vst01_main","text":"VST01 table provides overview Vital Sign values change baseline respective arm course trial.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/vst01.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"VST01 Vital Sign Results and change from Baseline By Visit Table. ‚Äî vst01_main","text":"","code":"vst01_main(   adam_db,   dataset = \"advs\",   arm_var = \"ACTARM\",   lbl_overall = NULL,   row_split_var = NULL,   summaryvars = c(\"AVAL\", \"CHG\"),   visitvar = \"AVISIT\",   precision = list(default = 2L),   page_var = \"PARAMCD\",   .stats = c(\"n\", \"mean_sd\", \"median\", \"range\"),   skip = list(CHG = \"BASELINE\"),   ... )  vst01_pre(adam_db, dataset = \"advs\", ...)  vst01"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/vst01.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"VST01 Vital Sign Results and change from Baseline By Visit Table. ‚Äî vst01_main","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/vst01.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"VST01 Vital Sign Results and change from Baseline By Visit Table. ‚Äî vst01_main","text":"adam_db (list data.frames) object containing ADaM datasets dataset (string) name table adam_db object. arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted row_split_var (character) additional row split variables. summaryvars (character) variables analyzed. label attribute corresponding column table adam_db used label. visitvar (string) typically one \"AVISIT\" user-defined visit incorporating \"ATPT\". precision (named list integer) names values found PARAMCD column values indicate number digits statistics. default set, parameter precision specified, value default used. page_var (string) variable name prior row split page. .stats (character) statistics names, see tern::analyze_vars(). skip Named (list) visit values need inhibited. ... additional arguments like .indent_mods, .labels.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/vst01.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"VST01 Vital Sign Results and change from Baseline By Visit Table. ‚Äî vst01_main","text":"main function returns rtables object. preprocessing function returns list data.frame.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/vst01.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"VST01 Vital Sign Results and change from Baseline By Visit Table. ‚Äî vst01_main","text":"Analysis Value column, displays number patients, mean, standard deviation, median range analysis value visit. Change Baseline column, displays number patient mean, standard deviation, median range changes relative baseline. Remove zero-count rows unless overridden prune_0 = FALSE. Split columns arm, typically ACTARM. include total column default. Sorted  based factor level; first PARAM labels alphabetic order chronological time point given AVISIT. Re-level customize order","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/vst01.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"VST01 Vital Sign Results and change from Baseline By Visit Table. ‚Äî vst01_main","text":"vst01_main(): Main TLG function vst01_pre(): Preprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/vst01.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"VST01 Vital Sign Results and change from Baseline By Visit Table. ‚Äî vst01_main","text":"adam_db object must contain table named dataset columns specified summaryvars.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/vst01.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"VST01 Vital Sign Results and change from Baseline By Visit Table. ‚Äî vst01_main","text":"","code":"library(dunlin)  proc_data <- log_filter(   syn_data,   PARAMCD %in% c(\"DIABP\", \"SYSBP\"), \"advs\" ) run(vst01, proc_data) #>                                          A: Drug X                            B: Placebo                          C: Combination            #>                                                   Change from                          Change from                           Change from    #>                               Value at Visit       Baseline        Value at Visit        Baseline        Value at Visit        Baseline     #>   Analysis Visit                  (N=15)            (N=15)             (N=15)             (N=15)             (N=15)             (N=15)      #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Diastolic Blood Pressure                                                                                                                  #>     SCREENING                                                                                                                               #>       n                             15                 0                 15                 0                  15                 0         #>       Mean (SD)              94.385 (17.067)        NE (NE)       106.381 (20.586)       NE (NE)        106.468 (12.628)       NE (NE)      #>       Median                      94.933              NE              111.133               NE              108.359               NE        #>       Min - Max               55.71 - 122.00        NE - NE        60.21 - 131.91        NE - NE         83.29 - 127.17        NE - NE      #>     BASELINE                                                                                                                                #>       n                             15                                   15                                    15                           #>       Mean (SD)              96.133 (22.458)                      108.111 (15.074)                      103.149 (19.752)                    #>       Median                      93.328                              108.951                               102.849                         #>       Min - Max               60.58 - 136.59                       83.44 - 131.62                        66.05 - 136.55                     #>     WEEK 1 DAY 8                                                                                                                            #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              98.977 (21.359)    2.844 (28.106)    104.110 (16.172)   -4.001 (21.867)    100.826 (19.027)   -2.323 (25.018)  #>       Median                      92.447            -4.066            107.703             3.227             103.058             -2.476      #>       Min - Max               67.55 - 130.37    -32.82 - 47.68     70.91 - 132.89     -52.94 - 28.63     70.04 - 128.68     -55.15 - 41.81  #>     WEEK 2 DAY 15                                                                                                                           #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              99.758 (14.477)    3.626 (21.189)    97.473 (17.296)    -10.638 (20.831)   94.272 (16.961)    -8.877 (27.229)  #>       Median                     101.498             1.731             99.501             -9.727             96.789            -10.155      #>       Min - Max               71.98 - 122.81    -39.50 - 47.57     53.80 - 125.81     -55.15 - 25.26     63.45 - 117.47     -73.10 - 46.54  #>     WEEK 3 DAY 22                                                                                                                           #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              99.101 (26.109)    2.968 (34.327)    91.984 (16.925)    -16.127 (21.881)   94.586 (13.560)    -8.563 (21.713)  #>       Median                     101.146            -0.271             91.244            -14.384             98.398            -16.075      #>       Min - Max               47.68 - 162.22    -47.87 - 76.64     67.80 - 119.72     -53.06 - 22.52     73.50 - 115.43     -37.90 - 32.66  #>     WEEK 4 DAY 29                                                                                                                           #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              103.400 (22.273)   7.267 (30.740)    96.467 (19.451)    -11.644 (25.922)   108.338 (18.417)    5.189 (21.881)  #>       Median                      98.168             2.510             97.385            -16.793            107.555             7.966       #>       Min - Max               63.09 - 148.25    -38.43 - 61.90     63.35 - 131.57     -57.11 - 48.13     68.78 - 132.52     -33.96 - 41.50  #>     WEEK 5 DAY 36                                                                                                                           #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              93.222 (18.536)    -2.911 (28.873)   97.890 (20.701)    -10.221 (27.593)   95.317 (16.401)    -7.832 (19.827)  #>       Median                      90.799            -3.385             99.049            -11.319             93.876             -4.665      #>       Min - Max               63.55 - 139.11    -48.63 - 47.35     69.47 - 137.64     -54.38 - 37.85     71.91 - 138.54     -44.47 - 29.11  #>   Systolic Blood Pressure                                                                                                                   #>     SCREENING                                                                                                                               #>       n                             15                 0                 15                 0                  15                 0         #>       Mean (SD)              154.073 (33.511)       NE (NE)       157.840 (34.393)       NE (NE)        152.407 (22.311)       NE (NE)      #>       Median                     156.169              NE              161.670               NE              149.556               NE        #>       Min - Max               78.31 - 210.70        NE - NE        79.76 - 210.40        NE - NE        108.21 - 184.88        NE - NE      #>     BASELINE                                                                                                                                #>       n                             15                                   15                                    15                           #>       Mean (SD)              145.925 (28.231)                     152.007 (28.664)                      154.173 (26.317)                    #>       Median                     142.705                              157.698                               155.282                         #>       Min - Max               85.21 - 195.68                       98.90 - 194.62                        86.65 - 192.68                     #>     WEEK 1 DAY 8                                                                                                                            #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              156.509 (21.097)   10.584 (34.598)   147.480 (33.473)   -4.527 (48.895)    143.319 (30.759)   -10.854 (34.553) #>       Median                     160.711             5.802            155.030             2.758             145.548             -5.636      #>       Min - Max              126.84 - 185.53    -53.28 - 91.52     85.22 - 189.88     -77.34 - 90.98     90.37 - 191.58     -65.71 - 49.04  #>     WEEK 2 DAY 15                                                                                                                           #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              144.202 (33.676)   -1.723 (27.067)   136.892 (30.178)   -15.115 (37.794)   148.622 (27.088)   -5.551 (44.670)  #>       Median                     144.253             5.325            142.679            -14.083            147.102            -11.512      #>       Min - Max               62.56 - 203.66    -53.89 - 44.16     70.34 - 174.27     -83.07 - 62.39    108.82 - 200.23    -69.54 - 113.59  #>     WEEK 3 DAY 22                                                                                                                           #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              154.887 (35.374)   8.962 (38.455)    149.761 (28.944)   -2.247 (44.835)    150.460 (21.352)   -3.712 (37.984)  #>       Median                     158.938            17.191            155.044             -1.796            156.505             -7.606      #>       Min - Max              112.32 - 218.83    -47.28 - 96.18     84.42 - 192.92    -110.20 - 94.02     94.70 - 180.41     -74.91 - 72.74  #>     WEEK 4 DAY 29                                                                                                                           #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              150.159 (32.249)   4.234 (32.965)    156.043 (22.863)    4.036 (42.494)    145.714 (22.980)   -8.458 (33.175)  #>       Median                     145.506             3.754            149.094            -10.000            150.797            -14.432      #>       Min - Max               69.37 - 210.43    -89.16 - 54.32    113.57 - 195.10     -71.44 - 77.75    106.91 - 188.09     -41.95 - 65.16  #>     WEEK 5 DAY 36                                                                                                                           #>       n                             15                15                 15                 15                 15                 15        #>       Mean (SD)              155.964 (30.945)   10.039 (42.252)   156.387 (35.274)    4.380 (51.782)    143.592 (33.170)   -10.581 (44.799) #>       Median                     158.142             1.448            164.552             7.060             148.501             -2.385      #>       Min - Max              110.61 - 212.47    -53.91 - 90.45     63.28 - 198.79    -131.34 - 86.84     92.18 - 191.05     -78.77 - 64.35"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/vst02_1.html","id":null,"dir":"Reference","previous_headings":"","what":"VST02 Vital Sign Abnormalities Table. ‚Äî vst02_1_main","title":"VST02 Vital Sign Abnormalities Table. ‚Äî vst02_1_main","text":"Vital Sign Parameters outside Normal Limits Regardless Abnormality Baseline.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/vst02_1.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"VST02 Vital Sign Abnormalities Table. ‚Äî vst02_1_main","text":"","code":"vst02_1_main(   adam_db,   arm_var = \"ACTARM\",   lbl_overall = NULL,   exclude_base_abn = FALSE,   ... )  vst02_pre(adam_db, ...)  vst02_post(tlg, prune_0 = FALSE, ...)  vst02_1"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/vst02_1.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"VST02 Vital Sign Abnormalities Table. ‚Äî vst02_1_main","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/vst02_1.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"VST02 Vital Sign Abnormalities Table. ‚Äî vst02_1_main","text":"adam_db (list data.frames) object containing ADaM datasets arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted exclude_base_abn (flag) whether baseline abnormality excluded. ... used. tlg (TableTree, Listing ggplot) object typically produced main function. prune_0 (flag) remove 0 count rows","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/vst02_1.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"VST02 Vital Sign Abnormalities Table. ‚Äî vst02_1_main","text":"main function returns rtables object. preprocessing function returns list data.frame. postprocessing function returns rtables object ElementaryTable (null report).","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/vst02_1.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"VST02 Vital Sign Abnormalities Table. ‚Äî vst02_1_main","text":"count LOW HIGH values. Results \"LOW LOW\" treated \"LOW\", \"HIGH HIGH\" \"HIGH\". include total column default. remove zero-count rows unless overridden prune_0 = TRUE.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/vst02_1.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"VST02 Vital Sign Abnormalities Table. ‚Äî vst02_1_main","text":"vst02_1_main(): Main TLG function vst02_pre(): Preprocessing vst02_post(): Postprocessing","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/vst02_1.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"VST02 Vital Sign Abnormalities Table. ‚Äî vst02_1_main","text":"adam_db object must contain advs table \"PARAM\", \"ANRIND\" \"BNRIND\" columns.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/vst02_1.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"VST02 Vital Sign Abnormalities Table. ‚Äî vst02_1_main","text":"","code":"run(vst02_1, syn_data) #>   Assessment                   A: Drug X      B: Placebo     C: Combination #>    Abnormality                  (N=15)          (N=15)           (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Diastolic Blood Pressure                                                  #>     Low                      8/15 (53.3%)     9/15 (60%)      8/15 (53.3%)  #>     High                     10/15 (66.7%)   5/15 (33.3%)     8/15 (53.3%)  #>   Pulse Rate                                                                #>     Low                       9/15 (60%)      3/15 (20%)      5/15 (33.3%)  #>     High                     2/15 (13.3%)     6/15 (40%)      5/15 (33.3%)  #>   Respiratory Rate                                                          #>     Low                      13/15 (86.7%)   10/15 (66.7%)   13/15 (86.7%)  #>     High                     7/15 (46.7%)    10/15 (66.7%)   11/15 (73.3%)  #>   Systolic Blood Pressure                                                   #>     Low                      7/15 (46.7%)     9/15 (60%)     11/15 (73.3%)  #>     High                     10/15 (66.7%)    9/15 (60%)       9/15 (60%)   #>   Temperature                                                               #>     Low                       12/15 (80%)    13/15 (86.7%)   11/15 (73.3%)  #>     High                     14/15 (93.3%)    12/15 (80%)    14/15 (93.3%)  #>   Weight                                                                    #>     Low                       3/15 (20%)      3/15 (20%)      4/15 (26.7%)  #>     High                     4/15 (26.7%)    4/15 (26.7%)     5/15 (33.3%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/vst02_2.html","id":null,"dir":"Reference","previous_headings":"","what":"VST02 Vital Sign Abnormalities Table. ‚Äî vst02_2_main","title":"VST02 Vital Sign Abnormalities Table. ‚Äî vst02_2_main","text":"Vital Sign Parameters outside Normal Limits Among Patients without Abnormality Baseline.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/vst02_2.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"VST02 Vital Sign Abnormalities Table. ‚Äî vst02_2_main","text":"","code":"vst02_2_main(   adam_db,   arm_var = \"ACTARM\",   lbl_overall = NULL,   exclude_base_abn = TRUE,   ... )  vst02_2"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/vst02_2.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"VST02 Vital Sign Abnormalities Table. ‚Äî vst02_2_main","text":"object class chevron_t length 1.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/vst02_2.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"VST02 Vital Sign Abnormalities Table. ‚Äî vst02_2_main","text":"adam_db (list data.frames) object containing ADaM datasets arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted exclude_base_abn (flag) whether baseline abnormality excluded. ... used.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/vst02_2.html","id":"value","dir":"Reference","previous_headings":"","what":"Value","title":"VST02 Vital Sign Abnormalities Table. ‚Äî vst02_2_main","text":"main function returns rtables object. preprocessing function returns list data.frame. postprocessing function returns rtables object ElementaryTable (null report).","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/vst02_2.html","id":"details","dir":"Reference","previous_headings":"","what":"Details","title":"VST02 Vital Sign Abnormalities Table. ‚Äî vst02_2_main","text":"count LOW HIGH values. Results \"LOW LOW\" treated \"LOW\", \"HIGH HIGH\" \"HIGH\". include total column default. remove zero-count rows unless overridden prune_0 = TRUE.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/vst02_2.html","id":"functions","dir":"Reference","previous_headings":"","what":"Functions","title":"VST02 Vital Sign Abnormalities Table. ‚Äî vst02_2_main","text":"vst02_2_main(): Main TLG function","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/vst02_2.html","id":"note","dir":"Reference","previous_headings":"","what":"Note","title":"VST02 Vital Sign Abnormalities Table. ‚Äî vst02_2_main","text":"adam_db object must contain advs table \"PARAM\", \"ANRIND\" \"BNRIND\" columns.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/vst02_2.html","id":"ref-examples","dir":"Reference","previous_headings":"","what":"Examples","title":"VST02 Vital Sign Abnormalities Table. ‚Äî vst02_2_main","text":"","code":"run(vst02_2, syn_data) #>   Assessment                  A: Drug X      B: Placebo    C: Combination #>    Abnormality                  (N=15)         (N=15)          (N=15)     #>   ‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî‚Äî #>   Diastolic Blood Pressure                                                #>     Low                      6/11 (54.5%)    9/15 (60%)      6/12 (50%)   #>     High                     8/12 (66.7%)   4/11 (36.4%)    7/13 (53.8%)  #>   Pulse Rate                                                              #>     Low                       9/15 (60%)     3/15 (20%)     5/13 (38.5%)  #>     High                     2/14 (14.3%)   4/12 (33.3%)    5/15 (33.3%)  #>   Respiratory Rate                                                        #>     Low                      7/9 (77.8%)    7/11 (63.6%)   11/12 (91.7%)  #>     High                     6/14 (42.9%)   7/11 (63.6%)    9/13 (69.2%)  #>   Systolic Blood Pressure                                                 #>     Low                      5/13 (38.5%)   8/12 (66.7%)   10/14 (71.4%)  #>     High                     8/13 (61.5%)   8/13 (61.5%)    8/13 (61.5%)  #>   Temperature                                                             #>     Low                       8/10 (80%)    7/9 (77.8%)      8/10 (80%)   #>     High                      8/8 (100%)    7/8 (87.5%)    12/13 (92.3%)  #>   Weight                                                                  #>     Low                       3/15 (20%)     3/15 (20%)     3/14 (21.4%)  #>     High                     4/14 (28.6%)   4/15 (26.7%)    5/14 (35.7%)"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/vst02_lyt.html","id":null,"dir":"Reference","previous_headings":"","what":"vst02_1 Layout ‚Äî vst02_lyt","title":"vst02_1 Layout ‚Äî vst02_lyt","text":"vst02_1 Layout","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/vst02_lyt.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"vst02_1 Layout ‚Äî vst02_lyt","text":"","code":"vst02_lyt(   arm_var,   lbl_overall,   exclude_base_abn,   lbl_vs_assessment,   lbl_vs_abnormality )"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/vst02_lyt.html","id":"arguments","dir":"Reference","previous_headings":"","what":"Arguments","title":"vst02_1 Layout ‚Äî vst02_lyt","text":"arm_var (string) variable used column splitting lbl_overall (string) label used overall column, set NULL overall column omitted exclude_base_abn (flag) whether exclude subjects baseline abnormality numerator denominator. lbl_vs_assessment (string) label assessment variable. lbl_vs_abnormality (string) label abnormality variable.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/yes_no_rule.html","id":null,"dir":"Reference","previous_headings":"","what":"Yes/No rule in title case ‚Äî yes_no_rule","title":"Yes/No rule in title case ‚Äî yes_no_rule","text":"Yes/rule title case","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/yes_no_rule.html","id":"ref-usage","dir":"Reference","previous_headings":"","what":"Usage","title":"Yes/No rule in title case ‚Äî yes_no_rule","text":"","code":"yes_no_rule"},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/reference/yes_no_rule.html","id":"format","dir":"Reference","previous_headings":"","what":"Format","title":"Yes/No rule in title case ‚Äî yes_no_rule","text":"object class rule (inherits character) length 8.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/news/index.html","id":"chevron-028","dir":"Changelog","previous_headings":"","what":"chevron 0.2.8","title":"chevron 0.2.8","text":"New unwrap argument prints preprocessing, main, postprocessing layout function upon execution run method. chevron.run.verbose option R_CHEVRON_RUN_VERBOSE environment variable control verbose argument run method, chevron.run.unwrap option R_CHEVRON_RUN_UNWRAP environment variable control unwrap argument.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/news/index.html","id":"chevron-027","dir":"Changelog","previous_headings":"","what":"chevron 0.2.7","title":"chevron 0.2.7","text":"CRAN release: 2024-10-09 Add AEL02, AEL03 CML02A_gl templates. Modify post processing MHT01 allow multiple row_split_var. Improve report_null method facilitate creation null reports. Export std_postprocessing function simplify post processing logic. AET01 can now additionally display number death withdrawal using show_wd argument. MNG01 line type can now controlled line_type argument. script_funs doesn‚Äôt rely anymore source code pre processing functions.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/news/index.html","id":"chevron-026","dir":"Changelog","previous_headings":"","what":"chevron 0.2.6","title":"chevron 0.2.6","text":"CRAN release: 2024-04-25 Added assertion class summaryvars argument dmt01(). Additional arguments can passed ael01_nollt run method, instance split resulting listing. strat argument kmg01_main now deprecated - use strata instead. grob_list gg_list now deprecated - use list() instead.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/news/index.html","id":"chevron-025","dir":"Changelog","previous_headings":"","what":"chevron 0.2.5","title":"chevron 0.2.5","text":"CRAN release: 2024-02-01 MNG01 plot can now displayed without error bars can display continuous temporal scale x axis. Add chevron_simple class contains main function. Remove details argument script_funs, add name argument. run method, argument passed ... combined one passed user_arg. ... arguments priority. AET05 preprocessing now filters \"(AE|CQ|SMQ)TTE\" rather \"AETTE\". Rename dataset ADAETTE syn_data object ADSAFTTE. Trim dataset remove unused variables. Use uppercase variable names AET05 AET05_ALL. string replacing NA values tables now controlled tern_default_na_str option set package load. Specified minimal version package dependencies.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/news/index.html","id":"chevron-024","dir":"Changelog","previous_headings":"","what":"chevron 0.2.4","title":"chevron 0.2.4","text":"TTET01 now uses ‚ÄúNE‚Äù represent NA values.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/news/index.html","id":"chevron-023","dir":"Changelog","previous_headings":"","what":"chevron 0.2.3","title":"chevron 0.2.3","text":"Fix argument printing run method. Remove six unused tables syn_data object. Fix EGT03 allow multiple parameters. Update TTET01 provide meaningful error message stratification variables exist analysis dataset. PDT01 preprocessing now filters addv retain major protocol deviation. AEL01_NOLLT now argument unique keep unique rows listing. AET01_AESI, EGT02 LBT14 now remove check preprocessing function. COXT01 drop levels arm_var preprocessing function now. MNG01 uses ggtheme argument set graphic parameters instead now defunct show_h_grid, show_v_grid legend_pos arguments. table arguments now controls behavior table. arguments show_n show_table now defunct. Add RMPT06 template. stats precision arguments now control statistical analysis numbers digits presented DMT01. FSTG01 FSTG02 template removes max_colwidth argument. Default font size plot set 7. Introduce set_section_div function add empty line separator specified row splits. AET02 template default order ‚ÄúTotal number events‚Äù ‚ÄúTotal number patients least one adverse event‚Äù switched.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/news/index.html","id":"chevron-022","dir":"Changelog","previous_headings":"","what":"chevron 0.2.2","title":"chevron 0.2.2","text":"Allow EGT03 include multiple parameters. Allow KMG01 include stratified variables. Allow LBT06 LBT14 split pages. Allow AET02, CMT01A change summary statistics summary_labels argument. Add FSTG02 template. Update argument \"is_event\" KMG01 \"IS_EVENT\". Update argument \"is_rsp\" FSTG01 \"IS_RSP\". FSTG01 FSTG02 stratification variable labels truncated fit page. Update script chevron_tlg objects. details argument deprecated. Fix issue run method executed .call verbose argument.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/news/index.html","id":"chevron-021","dir":"Changelog","previous_headings":"","what":"chevron 0.2.1","title":"chevron 0.2.1","text":"Placeholder strings now replaced layout creation using dunlin::render_safe function. New chevron_catalog vignette details usage version chevron templates. run method renders errors faster thanks new internal do_call function. Add verbose argument run method print argument used. Add row_split_var page_var argument template. dataset slot chevron_tlg class removed. Add CFBT01 template. VST01, EGT01 LBT01 now following CFBT01. default parameters displayed page . Add RMPT03, RMPT04 RMPT05 follow RMPT01. Add COXT01 template. COXT02 now based COXT01. Add AET05 AET05_ALL templates. Add LBT15 based LBT04. LBT04 new arguments make flexible. Update EGT03 use ACTARMCD default arm variable, remove preprocessing filtering ‚ÄúHR‚Äù. Update EXT01 allow displayed PARCAT2. Update LBT06 template use PARAM row split. Convert AVISIT factor order levels according AVISITN preprocessing. Update MNG01 numeric jitter argument controls width data spread along x-axis.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/news/index.html","id":"chevron-020","dir":"Changelog","previous_headings":"","what":"chevron 0.2.0","title":"chevron 0.2.0","text":"Remove usage dm class object. chevron functions now expect list data.frame adam_db argument. Remove variants template names. Remove deprecated getter functions get_main, get_preprocess get_postprocess. Simplify pre function add data checks main function. Remove redundant assertion functions. Add templates: AET10, KMG01, RSPT01, RMPT01, COXT02, FSTG01, LBT06.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/news/index.html","id":"chevron-014","dir":"Changelog","previous_headings":"","what":"chevron 0.1.4","title":"chevron 0.1.4","text":"Use list replace character template arguments.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/news/index.html","id":"chevron-013","dir":"Changelog","previous_headings":"","what":"chevron 0.1.3","title":"chevron 0.1.3","text":"Add templates: AET01_AESI, EGT03, EGT05_QTCAT, LBT04, LBT05, LBT07, LBT14, PDT01, PDT02. Deprecation previous getter function like get_main main main<-. Add chevron_t, chevron_l chevron_g subclass chevron_tlg. Add script_funs script_args obtain string representation full code. Update current templates.","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/news/index.html","id":"chevron-012","dir":"Changelog","previous_headings":"","what":"chevron 0.1.2","title":"chevron 0.1.2","text":"Update snapshot tests","code":""},{"path":"https://insightsengineering.github.io/chevron/v0.2.8/news/index.html","id":"chevron-011","dir":"Changelog","previous_headings":"","what":"chevron 0.1.1","title":"chevron 0.1.1","text":"First release implementation : AET01, AET02, AET03, AET04, CMT01A, CMT02_PT, DMT01, DST01, DTHT01, EGT01, EGT02, EXT01, LBT01, MHT01, MNG01, VST01, VST02.","code":""}]
